0001835378-23-000116.txt : 20230808 0001835378-23-000116.hdr.sgml : 20230808 20230808163931 ACCESSION NUMBER: 0001835378-23-000116 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 71 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230808 DATE AS OF CHANGE: 20230808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innovid Corp. CENTRAL INDEX KEY: 0001835378 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40048 FILM NUMBER: 231152076 BUSINESS ADDRESS: STREET 1: 30 IRVING PLACE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 2129667555 MAIL ADDRESS: STREET 1: 30 IRVING PLACE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 FORMER COMPANY: FORMER CONFORMED NAME: ION Acquisition Corp 2 Ltd. DATE OF NAME CHANGE: 20201207 10-Q 1 ctv-20230630.htm 10-Q ctv-20230630
00018353782023Q2False12/31P3Y00018353782023-01-012023-06-300001835378us-gaap:CommonStockMember2023-01-012023-06-300001835378us-gaap:WarrantMember2023-01-012023-06-3000018353782023-08-04xbrli:shares00018353782023-06-30iso4217:USD00018353782022-12-31iso4217:USDxbrli:shares00018353782023-04-012023-06-3000018353782022-04-012022-06-3000018353782022-01-012022-06-300001835378us-gaap:CommonStockMember2021-12-310001835378us-gaap:AdditionalPaidInCapitalMember2021-12-310001835378us-gaap:RetainedEarningsMember2021-12-3100018353782021-12-310001835378us-gaap:CommonStockMember2022-01-012022-03-310001835378us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100018353782022-01-012022-03-310001835378us-gaap:RetainedEarningsMember2022-01-012022-03-310001835378us-gaap:CommonStockMember2022-03-310001835378us-gaap:AdditionalPaidInCapitalMember2022-03-310001835378us-gaap:RetainedEarningsMember2022-03-3100018353782022-03-310001835378us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001835378us-gaap:CommonStockMember2022-04-012022-06-300001835378us-gaap:RetainedEarningsMember2022-04-012022-06-300001835378us-gaap:CommonStockMember2022-06-300001835378us-gaap:AdditionalPaidInCapitalMember2022-06-300001835378us-gaap:RetainedEarningsMember2022-06-3000018353782022-06-300001835378us-gaap:CommonStockMember2022-12-310001835378us-gaap:AdditionalPaidInCapitalMember2022-12-310001835378us-gaap:RetainedEarningsMember2022-12-310001835378us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100018353782023-01-012023-03-310001835378us-gaap:CommonStockMember2023-01-012023-03-310001835378us-gaap:RetainedEarningsMember2023-01-012023-03-310001835378us-gaap:CommonStockMember2023-03-310001835378us-gaap:AdditionalPaidInCapitalMember2023-03-310001835378us-gaap:RetainedEarningsMember2023-03-3100018353782023-03-310001835378us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001835378us-gaap:CommonStockMember2023-04-012023-06-300001835378us-gaap:RetainedEarningsMember2023-04-012023-06-300001835378us-gaap:CommonStockMember2023-06-300001835378us-gaap:AdditionalPaidInCapitalMember2023-06-300001835378us-gaap:RetainedEarningsMember2023-06-300001835378ctv:TVSquaredMember2022-02-282022-02-280001835378ctv:TVSquaredMember2022-02-280001835378us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-06-300001835378us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-04-012023-06-300001835378us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-01-012023-06-300001835378us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-04-012022-06-300001835378us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-01-012022-06-30ctv:reportingUnit0001835378us-gaap:CustomerRelationshipsMember2023-01-012023-06-300001835378us-gaap:TechnologyBasedIntangibleAssetsMember2023-01-012023-06-300001835378us-gaap:TradeNamesMember2023-01-012023-06-300001835378us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001835378us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001835378us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-06-300001835378us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001835378us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001835378us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-06-300001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-12-310001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-06-300001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-06-300001835378ctv:WarrantsLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300001835378ctv:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Member2023-06-300001835378us-gaap:FairValueInputsLevel1Memberctv:PrivateWarrantsMember2023-06-300001835378ctv:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001835378ctv:CustomerAMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-04-012023-06-30xbrli:pure0001835378ctv:CustomerAMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-06-300001835378us-gaap:RealEstateMember2023-06-300001835378us-gaap:RealEstateMember2022-12-310001835378ctv:CarsMember2023-06-300001835378ctv:CarsMember2022-12-310001835378ctv:PublicWarrantsMember2023-06-300001835378ctv:PrivateWarrantsMember2023-06-300001835378us-gaap:WarrantMember2023-06-300001835378us-gaap:WarrantMember2022-12-3100018353782022-08-04ctv:subsidiary0001835378us-gaap:RevolvingCreditFacilityMember2022-08-030001835378us-gaap:RevolvingCreditFacilityMember2022-08-040001835378srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2022-08-040001835378srt:ScenarioForecastMemberus-gaap:RevolvingCreditFacilityMember2023-08-042023-08-040001835378us-gaap:RevolvingCreditFacilityMember2022-08-042022-08-040001835378srt:ScenarioForecastMemberctv:A2023ModificationAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-08-042023-08-040001835378us-gaap:LineOfCreditMemberctv:AmendedCreditAgreementMaturingDecember2020Member2022-12-310001835378us-gaap:LineOfCreditMemberctv:AmendedCreditAgreementMaturingDecember2020Member2023-06-300001835378us-gaap:RevolvingCreditFacilityMember2023-06-300001835378us-gaap:RevolvingCreditFacilityMember2022-12-3100018353782023-01-012023-01-310001835378us-gaap:LineOfCreditMember2023-03-012023-03-3100018353782023-05-012023-05-310001835378us-gaap:LineOfCreditMember2023-06-012023-06-300001835378srt:MinimumMemberctv:AmendedCreditAgreementMaturingOctober2018Memberus-gaap:LineOfCreditMemberus-gaap:PrimeRateMember2021-01-012021-12-310001835378ctv:AmendedCreditAgreementMaturingOctober2018Memberus-gaap:LineOfCreditMemberus-gaap:PrimeRateMembersrt:MaximumMember2021-01-012021-12-310001835378us-gaap:PrimeRateMemberctv:NewRevolvingCreditFacilityMember2022-01-012022-12-310001835378us-gaap:PrimeRateMembersrt:MaximumMemberctv:NewRevolvingCreditFacilityMember2022-01-012022-12-310001835378srt:SubsidiariesMember2023-06-300001835378ctv:IsraeliSubsidiaryMember2023-06-300001835378us-gaap:CostOfSalesMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2023-04-012023-06-300001835378us-gaap:CostOfSalesMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-04-012022-06-300001835378us-gaap:CostOfSalesMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2023-01-012023-06-300001835378us-gaap:CostOfSalesMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-06-300001835378us-gaap:ResearchAndDevelopmentExpenseMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2023-04-012023-06-300001835378us-gaap:ResearchAndDevelopmentExpenseMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-04-012022-06-300001835378us-gaap:ResearchAndDevelopmentExpenseMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2023-01-012023-06-300001835378us-gaap:ResearchAndDevelopmentExpenseMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-06-300001835378us-gaap:SellingAndMarketingExpenseMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2023-04-012023-06-300001835378us-gaap:SellingAndMarketingExpenseMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-04-012022-06-300001835378us-gaap:SellingAndMarketingExpenseMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2023-01-012023-06-300001835378us-gaap:SellingAndMarketingExpenseMemberctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-06-300001835378ctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:GeneralAndAdministrativeExpenseMember2023-04-012023-06-300001835378ctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:GeneralAndAdministrativeExpenseMember2022-04-012022-06-300001835378ctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-06-300001835378ctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-06-300001835378ctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2023-04-012023-06-300001835378ctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-04-012022-06-300001835378ctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2023-01-012023-06-300001835378ctv:LegacyPlanAnd2021PlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-06-300001835378srt:MinimumMember2023-01-012023-06-300001835378us-gaap:EmployeeStockOptionMember2023-01-012023-06-300001835378us-gaap:ShareBasedPaymentArrangementEmployeeMember2022-12-310001835378us-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-12-310001835378us-gaap:ShareBasedPaymentArrangementEmployeeMember2023-01-012023-06-300001835378us-gaap:ShareBasedPaymentArrangementEmployeeMember2023-06-300001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMember2022-12-310001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMember2022-01-012022-12-310001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMember2023-01-012023-06-300001835378us-gaap:ShareBasedPaymentArrangementNonemployeeMember2023-06-300001835378srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-300001835378us-gaap:RestrictedStockUnitsRSUMembersrt:MaximumMember2023-01-012023-06-300001835378us-gaap:RestrictedStockUnitsRSUMember2023-06-300001835378us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-300001835378us-gaap:WarrantMember2023-04-012023-06-300001835378us-gaap:WarrantMember2022-04-012022-06-300001835378us-gaap:WarrantMember2023-01-012023-06-300001835378us-gaap:WarrantMember2022-01-012022-06-300001835378ctv:PaycheckProtectionProgramMember2023-04-012023-06-300001835378ctv:PaycheckProtectionProgramMember2022-04-012022-06-300001835378ctv:PaycheckProtectionProgramMember2023-01-012023-06-300001835378ctv:PaycheckProtectionProgramMember2022-01-012022-06-30ctv:segment0001835378country:US2023-04-012023-06-300001835378country:US2022-04-012022-06-300001835378country:US2023-01-012023-06-300001835378country:US2022-01-012022-06-300001835378country:CA2023-04-012023-06-300001835378country:CA2022-04-012022-06-300001835378country:CA2023-01-012023-06-300001835378country:CA2022-01-012022-06-300001835378srt:AsiaPacificMember2023-04-012023-06-300001835378srt:AsiaPacificMember2022-04-012022-06-300001835378srt:AsiaPacificMember2023-01-012023-06-300001835378srt:AsiaPacificMember2022-01-012022-06-300001835378us-gaap:EMEAMember2023-04-012023-06-300001835378us-gaap:EMEAMember2022-04-012022-06-300001835378us-gaap:EMEAMember2023-01-012023-06-300001835378us-gaap:EMEAMember2022-01-012022-06-300001835378srt:LatinAmericaMember2023-04-012023-06-300001835378srt:LatinAmericaMember2022-04-012022-06-300001835378srt:LatinAmericaMember2023-01-012023-06-300001835378srt:LatinAmericaMember2022-01-012022-06-300001835378country:IL2023-06-300001835378country:IL2022-12-310001835378country:US2023-06-300001835378country:US2022-12-310001835378ctv:RestOfTheWorldMember2023-06-300001835378ctv:RestOfTheWorldMember2022-12-310001835378ctv:OptionsAndRSUsMember2023-04-012023-06-300001835378ctv:OptionsAndRSUsMember2022-04-012022-06-300001835378ctv:OptionsAndRSUsMember2023-01-012023-06-300001835378ctv:OptionsAndRSUsMember2022-01-012022-06-300001835378us-gaap:RestrictedStockUnitsRSUMember2023-04-012023-06-300001835378us-gaap:RestrictedStockUnitsRSUMember2022-04-012022-06-300001835378us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-300001835378us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001835378us-gaap:EmployeeStockOptionMember2023-04-012023-06-300001835378us-gaap:EmployeeStockOptionMember2022-04-012022-06-300001835378us-gaap:EmployeeStockOptionMember2023-01-012023-06-300001835378us-gaap:EmployeeStockOptionMember2022-01-012022-06-300001835378us-gaap:WarrantMember2023-04-012023-06-300001835378us-gaap:WarrantMember2022-04-012022-06-300001835378us-gaap:WarrantMember2023-01-012023-06-300001835378us-gaap:WarrantMember2022-01-012022-06-300001835378us-gaap:SubsequentEventMember2023-08-02
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 10-Q
____________________________
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2023
OR
¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 001-40048
____________________________
Innovid Corp.
(Exact name of registrant as specified in its charter)
____________________________
Delaware87-3769599
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
30 Irving Place, 12th Floor
New York, New York
10003
(Address of Principal Executive Offices)
(Zip Code)
+1 (212) 966-7555
Registrant's telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.0001 per shareCTVNew York Stock Exchange
Warrants to purchase one share of Common stock, each at an exercise price of $11.50 per shareCTVWSNew York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large, accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large, accelerated filer¨Accelerated filerx
Non-accelerated filer¨Smaller reporting companyx
Emerging growth companyx
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No x
The registrant had outstanding 139,303,254 shares of common stock as of August 4, 2023.



TABLE OF CONTENTS
2

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements. These forward-looking statements include, without limitation, statements relating to expectations for future financial performance, business strategies or expectations for our business. These statements are based on the beliefs and assumptions of the management of Innovid. Although Innovid believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, it cannot assure you that it will achieve or realize these plans, intentions or expectations. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this Form 10-Q, words such as “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “seek,” “should,” “strive,” “target,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
Should one or more of a number of known and unknown risks and uncertainties materialize, or should any of our assumptions prove incorrect, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include, but are not limited to:
• our public securities’ potential liquidity and trading;
• our ability to raise financing in the future;
• our success in retaining or recruiting, or changes required in, our officers, key employees or directors;
• changes in applicable laws or regulations;
• our ability to maintain and expand relationships with advertisers;
• decreases and/or changes in CTV audience viewership behavior;
• Innovid’s ability to make the right investment decisions and to innovate and develop new solutions;
• the accuracy of Innovid’s estimates of market opportunity, forecasts of market growth and projections of future financial performance;
• the extent of investment required in Innovid’s sales and marketing efforts;
• Innovid’s ability to effectively manage its growth;
• sustained overall demand for advertising;
• the impact of the COVID-19 pandemic;
• the continued acceptance of digital advertising by consumers and the impact of opt-in, opt-out or ad-blocking technologies;
• Innovid’s ability to scale its platform and infrastructure to support anticipated growth and transaction volume;
• the impact of increasing competition in the digital advertising space, including with competitors who have significantly more resources;
• other risks and uncertainties indicated in this report, including those set forth under the section titled “Risk Factors” and those incorporated by reference to our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “2022 Annual Report on Form 10-K”), which was filed with the Securities and Exchange Commission (“SEC”) on March 3, 2023.
These forward-looking statements are based on information available as of the date of this Quarterly Report on Form 10-Q and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
3

As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. You should not place undue reliance on these forward-looking statements.
WHERE TO FIND MORE INFORMATION
Our website address is www.innovid.com. We may use our website as a means of disclosing material non-public information. Such disclosures will be included on our website in the “Investors” section or at investors.innovid.com. We may also use certain social media channels, such as LinkedIn, Facebook or Twitter, as a means of disclosing information about us and our business to our colleagues, customers, investors and the public. While not all of the information that the Company posts to the Innovid website or to social media accounts is of a material nature, some information could be deemed to be material. Accordingly, investors should monitor our website and certain of our social media channels, in addition to following our press releases, SEC filings and public conference calls and webcasts. However, information contained on, or that can be accessed through, these communications channels do not constitute a part of this Quarterly Report and are not incorporated by reference herein. Our SEC filings are available to you on the SEC’s website at http://www.sec.gov. This site contains reports and other information regarding issuers that file electronically with the SEC. The information on that website is not part of this Quarterly Report and is not incorporated by reference herein.


Part I
Item 1. Financial Statements
INNOVID, CORP. AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except stock and per stock data)



June 30, 2023

December 31, 2022
(Unaudited)
ASSETS


Cash and cash equivalents
$43,384 $37,541 
Short-term bank deposits 10,000 
Trade receivables, net (allowance for credit losses of $330 and $65 at June 30, 2023, and December 31, 2022, respectively)
43,238 43,653 
Prepaid expenses and other current assets
4,123 2,640 
Total current assets
90,745 93,834 
Long-term deposit
260 277 
Long-term restricted deposits
396 430 
Property and equipment, net
18,959 14,322 
Goodwill
102,473 116,976 
Intangible assets, net27,659 29,918 
Operating lease right of use asset2,008 2,910 
Other non-current assets834 938 
Total non-current assets
152,589 165,771 
TOTAL ASSETS
$243,334 $259,605 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade payables4,421 3,361 
Employees and payroll accruals10,969 10,165 
Lease liabilities - current portion1,611 2,186 
Accrued expenses and other current liabilities5,194 5,474 
Total current liabilities
22,195 21,186 
Long-term debt20,000 20,000 
Lease liabilities - non-current portion1,081 1,636 
Other non-current liabilities9,461 6,554 
Warrants liability1,022 4,301 
Total non-current liabilities
31,564 32,491 
TOTAL LIABILITIES
53,759 53,677 
COMMITMENTS AND CONTINGENT LIABILITIES (Note 7)
Common stock: $0.0001 par value - Authorized: 500,000,000 at June 30, 2023, and December 31, 2022; Issued and outstanding: 138,737,104 and 133,882,414 at June 30, 2023, and December 31, 2022, respectively
13 13 
Additional paid-in capital367,970 356,801 
Accumulated deficit(178,408)(150,886)
Total stockholders’ equity189,575 205,928 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$243,334 $259,605 
The accompanying notes are an integral part of the condensed consolidated financial statements.
5


INNOVID, CORP. AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except stock and per stock data)




Three months ended June 30,Six months ended June 30,

2023202220232022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Revenues$34,546 $33,088 $65,031 $58,950 
Cost of revenues (1)8,591 7,351 16,856 13,277 
Research and development (1)6,876 9,710 13,993 16,964 
Sales and marketing (1)11,460 14,320 23,097 24,671 
General and administrative (1)8,924 9,955 18,574 21,410 
Depreciation and amortization2,064 926 4,094 1,599 
Goodwill impairment14,503  14,503  
Operating loss(17,872)(9,174)(26,086)(18,971)
Finance income, net(248)(13,306)(2,723)(15,617)
Loss before taxes
(17,624)4,132 (23,363)(3,354)
Taxes on income 1,335 (168)4,159 (205)
Net (loss) income(18,959)4,300 (27,522)(3,149)
Net (loss) income attributable to common stockholders$(18,959)$4,300 $(27,522)$(3,149)
Net (loss) income per stock attributable to common stockholders
Basic $(0.14)$0.03 $(0.20)$(0.02)
Diluted $(0.14)$0.03 $(0.20)$(0.02)
Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders
Basic137,643,910 132,152,652 134,296,569 128,220,893 
Diluted137,643,910 139,988,123 134,296,569 128,220,893 
The accompanying notes are an integral part of the condensed consolidated financial statements.
(1) Exclusive of depreciation, amortization and goodwill impairment presented separately.

6


INNOVID, CORP. AND ITS SUBSIDIARIES CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(In thousands, except stock data)








Common stock
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Number
Amount
Balance as of December 31, 2021
119,017,380 $12 $293,719 $(132,476)$161,255 
Common stock and equity awards issued for acquisition of TVS11,549,465 1 47,151 — 47,152 
Stock-based compensation— — 1,496 — 1,496 
Stock options exercised1,521,927 — 462 — 462 
Net loss— — — (7,449)(7,449)
Balance as of March 31, 2022 (unaudited)132,088,772 $13 $342,828 $(139,925)$202,916 
Stock-based compensation—  4,628 — 4,628 
Stock options exercised322,943 — 174 — 174 
Net income—  — 4,300 4,300 
Balance as of June 30, 2022 (unaudited)132,411,715 $13 $347,630 $(135,625)$212,018 
Common stock
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Number
Amount
Balance as of December 31, 2022
133,882,414 $13 $356,801 $(150,886)$205,928 
Stock-based compensation— — 4,897 — 4,897 
Stock options exercised and RSUs vested2,734,320 — 250 — 250 
Net loss— — — (8,563)(8,563)
Balance as of March 31, 2023 (unaudited)136,616,734 $13 $361,948 $(159,449)$202,512 
Stock-based compensation— — 5,658 — 5,658 
Stock options exercised and RSUs vested2,120,370 — 364 — 364 
Net loss— — — (18,959)(18,959)
Balance as of June 30, 2023 (unaudited)138,737,104 $13 $367,970 $(178,408)$189,575 
The accompanying notes are an integral part of the condensed consolidated financial statements.

7


INNOVID, CORP. AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, except stock and per stock data)
Six Months Ended June 30, 2023
2023

2022
Cash flows from operating activities:(Unaudited)(Unaudited)
Net loss$(27,522)$(3,149)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization4,094 1,599 
Goodwill impairment14,503  
Stock-based compensation9,865 5,634 
Change in fair value of warrants(3,279)(15,946)
Changes in operating assets and liabilities
Decrease / (increase) in trade receivables, net415 (4,624)
Increase in prepaid expenses and other current assets(1,390)(747)
Decrease in operating lease right of use assets902 872 
Increase / (decrease) in trade payables1,060 (321)
Increase in employees and payroll accruals804 1,044 
Decrease in operating lease liabilities(1,130)(1,208)
Increase in accrued expenses and other current liabilities2,626 945 
Net cash provided by / (used in) operating activities
948 (15,901)
Cash flows from investing activities:
Acquisition of business, net of cash acquired (99,568)
Internal use software capitalization(5,591)(3,516)
Purchase of property and equipment(189)(221)
Withdrawal of short-term bank deposits10,000  
Increase in deposits27 32 
Net cash provided by / (used in) investing activities
4,247 (103,273)
Cash flows from financing activities:
Proceeds from loans10,000 9,000 
Repayment of loans(10,000) 
Payment of SPAC merger transaction costs (3,185)
Proceeds from exercise of options614 636 
Net cash provided by financing activities
614 6,451 
Increase (decrease) in cash, cash equivalents, and restricted cash5,809 (112,723)
Cash, cash equivalents, and restricted cash at the beginning of the period37,971 157,158 
Cash, cash equivalents, and restricted cash at the end of the period $43,780 $44,435 
Supplemental disclosure of cash flows activities:
(1) Cash paid during the period for:
Income taxes paid, net of tax refunds$879 $363 
Interest$782 $137 
(2) Non-cash transactions:
Business combination consideration paid in stock$ $47,152 
Reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets
Cash and cash equivalents43,384 44,024 
Long-term restricted deposits396 411 
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows$43,780 $44,435 
The accompanying notes are an integral part of the condensed consolidated financial statements.
8


INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)

1. DESCRIPTION OF BUSINESS
Innovid Corp. together with its consolidated subsidiaries, the “Company” or “Innovid”, is a leading independent software platform that provides an ad serving and creative personalization platform for the creation, delivery, and measurement of TV ads across connected TV (“CTV”), mobile TV and desktop TV environments to advertisers, publishers and media agencies.
Innovid Corp. was originally incorporated as ION Acquisition Corp. 2 Ltd. (“ION”), a special purpose acquisition company, on November 23, 2020 and Innovid Corp. was the surviving entity following the completion of its merger with ION on November 30, 2021 (the “ION Transaction”).
On February 28, 2022, the Company completed the acquisition of TV Squared Limited (“TVS”, together with ION’s Transaction, the “Transactions”) by way of stock purchase agreement (“Stock Purchase Agreement”). The Company acquired all of the equity of TVSquared for an aggregate amount of $100,000 in cash, 11,549,465 shares of the Company common stock at fair value of $3.80 per share and the issuance of 949,893 fully vested stock options of the Company at a weighted average fair value of $3.49, subject to certain adjustments as defined in the Stock Purchase Agreement.
Innovid Corp.’s common stock and warrants are trading on the NYSE under the symbols “CTV” and “CTV.WS,” respectively, since December 1, 2021.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The unaudited interim condensed consolidated financial statements have been prepared in accordance with US GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative US GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Updates (“ASU”) of the Financial Accounting Standards Board (“FASB”) and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by US GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation. The Company’s interim period results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year.
The condensed consolidated balance sheet as of December 31, 2022, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by US GAAP for complete financial statements.
These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and footnotes included in the Company’s 2022 Annual Report on Form 10-K.
The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2022, have been applied consistently in these unaudited interim condensed consolidated financial statements, unless otherwise stated.
Use of Estimates
The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments, and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
9


INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Accounting Policies
Software development costs
Software development costs, which are included in property and equipment, net, consists of capitalized costs related to the purchase and development of internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing or obtaining the software.
Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the estimated useful life of the software, which is three years. The amortization is presented within depreciation and amortization in the condensed consolidated statements of operations. During the three and six months ended June 30, 2023 (unaudited), the Company capitalized $2,825 and $6,281, respectively, and during the three and six months ended June 30, 2022 (unaudited), the Company capitalized $2,335 and $4,006, respectively, related to internal-use software cost.
Impairment of long-lived assets
Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss. During the three and six months ended June 30, 2023 (unaudited), the Company tested its long-lived assets for recoverability and concluded that no impairment should be recognized.
Goodwill and acquired intangible assets
Goodwill and acquired intangible assets have been recorded in the Company's financial statements resulting from     various business combinations. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is subject to an annual impairment test.
Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. The Company currently has one reporting unit.
ASC 350, Intangibles—Goodwill and other (“ASC 350”) requires goodwill to be tested for impairment at least annually and, in certain circumstances, between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. The Company elects to perform an annual impairment test of goodwill as of October 1 of each year, or more frequently if impairment indicators are present. During the three months ended June 30, 2023, the Company recorded Goodwill impairment in the amount of $14,503. Refer to Note 3 for further details.
Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date.
Customer relationships, acquired technology and trade name are being amortized over the estimated useful life of approximately 11 years, 6 years, and 4 years, respectively, using the straight-line amortization method.
The amortization of customer relationships, acquired technology and trade names, is presented within depreciation and amortization in the condensed consolidated statements of operations.

10


INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Fair value of financial instruments
The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.
Level 3 - Unobservable inputs which are supported by little or no market activity.
The Company’s financial instruments consist of cash and cash equivalents, restricted deposits, trade receivables, net, trade payables, employees, payroll accruals, accrued expenses and other current liabilities and current portion of long-term debts. Their historical carrying amounts represent the approximate fair value due to the short-term maturities of these instruments.
The Company’s investments in money market funds are classified as cash equivalents and measured at fair value. The Company measures its warrant liability at fair value.
The goodwill impairment recorded in the second quarter of 2023 was estimated using the Company's stock price, a Level 1 input, adjusted for an estimated control premium.
The following tables present information about the Company’s financial instruments that are measured at fair value on a recurring basis:

June 30, 2023
(Unaudited)

Level 1
Level 2
Level 3
Assets:
Money market funds$36,323 $ $ 
Liabilities:
Warrants liability$1,022 $ $ 

December 31, 2022

Level 1
Level 2
Level 3
Assets:
Money market funds$18,948 $ $ 
Certificates of deposit 20,000  
Liabilities:
Warrants liability$1,265 $ $3,036 
The change in the fair value of the Level 3 warrant liability is summarized below:

June 30,December 31,June 30,

20232022

2022
(Unaudited)(Unaudited)
Beginning of the period
$3,036 $15,462 $15,462 
Change in fair value(2,330)(12,426)(13,132)
Transfer to level 1(706)  
End of the period$ $3,036 $2,330 
11


INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
As of June 30, 2023, the Company’s warrant liability includes the Warrants (refer to Note 5), that were originally issued in connection with ION’s initial public offering, the “ION IPO,” which were transferred to the Company as part of the ION’s Transaction. The Company’s Warrants are recorded on the balance sheet at fair value with changes in fair value recognized through earnings. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement the valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.
The Company has determined that the fair value of the Public Warrants and Transferred Private Warrants (refer to Note 5) Warrants, at the balance sheet date is determined by the closing price of the Company’s warrants, and are within Level 1 of the fair value hierarchy. The closing price of the Public Warrants and Transferred Private Warrants was $0.10 as of June 30, 2023 the price for Public Warrants was $0.40 as of December 31, 2022.
The Transferred Private Warrants are no longer classified as Level 3 as of June 30, 2023. Refer to Note 5, Warrants for further discussion.
Gains and losses from the remeasurement of the Public and Private Warrants’ liability is recognized in finance income, net in the condensed consolidated statements of operations.
Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instruments. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect these estimates.
Concentrations of credit risks
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net.
Most of the Company’s cash and cash equivalents are invested in deposits with major banks in the US and Israel. The Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed federally insured limits. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.
The Company’s trade receivables, net is mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.
The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
One of the Company’s customers accounted for more than 10% of the Company’s total revenues during the three and six months ended June 30, 2023.

Three months ended June 30,Six months ended June 30,

2023

20222023

2022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Customer A
16 %*)16 %*)
*) less than 10%
Revenue recognition
Most of the Company’s revenues are derived from providing Ad serving solutions to advertisers, media agencies and publishers. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display and other channels.
The Company also provides measurement services to advertisers and agencies, streaming platforms and publishers. The measurement service provides analytics and the ability to track performance of advertising campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.
12


INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
The Company also provides creative services for the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.
The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied.
For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis.
Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.
Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period.
Revenues related to creative projects are recognized at a point in time when the Company delivers an ad unit. Creative services projects are usually delivered within a week.
The Company’s accounts receivable consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less.
The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be canceled without cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts.
The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract.
Ad serving services were 77.3% and 78.4% of the Company’s revenues for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), respectively and were 77.2% and 83.4% of the Company’s revenues for the six months ended June 30, 2023 (unaudited) and 2022 (unaudited). Measurement services were 22.7% and 21.6% for the three months ended June 30, 2023 (unaudited) and June 30, 2022 (unaudited), respectively and were 22.8% and 16.6% of the Company’s revenues for the six months ended June 30, 2023 (unaudited) and 2022 (unaudited).
Costs to obtain a contract
Contract costs include commission programs to compensate sales employees for generating sales orders with new customers or for new services with existing customers. Generally, the commissions are commensurate. The Company elected to apply the practical expedient and recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less. If commissions are not commensurate, the Company capitalizes these commissions. Capitalized commission costs were immaterial for the three and six months ended June 30, 2023 (unaudited) and June 30, 2022 (unaudited).

13


INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Trade receivable, net
The Company records trade receivable for amounts invoiced and yet unbilled invoices. The Company makes estimates of expected credit losses for the allowance for doubtful accounts based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The estimated credit loss allowance is recorded as general and administrative expenses on the Company's condensed consolidated statements of operations.
Income taxes and tax contingencies
Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts.
The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.
ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income.
On December 20, 2017, Congress passed the “US Tax Act.” The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations and the preparation and analysis of information not previously relevant or regularly produced. The US Tax Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.
Recently Adopted Accounting Pronouncements
In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. ASU 2016-13 requires enhanced qualitative and quantitative disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The adoption has impacted how the Company assesses its estimates for credit losses but did not have a material impact on these unaudited interim condensed consolidated financial statements.
14


INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)

3. GOODWILL
The changes in the carrying amount of goodwill:
Goodwill
Total value
Balance as of January 1, 2023$116,976 
Goodwill impairment(14,503)
Balance as of June 30, 2023$102,473 
The Company periodically analyzes whether any indicators of goodwill impairment have occurred. In the second quarter of 2023, the Company experienced a decline in its stock price resulting in its market capitalization being less than the carrying value of its one reporting unit. Thus, the Company performed quantitative assessments of the Company’s reporting unit. The fair value was determined based on the market approach. The market approach utilizes the Company's market capitalization plus an appropriate control premium. Market capitalization is determined by multiplying the number of common stock outstanding by the market price of its common stock. The control premium is determined by utilizing publicly available data from studies for similar transactions of public companies.
As a result of this assessment, the Company recorded a goodwill impairment of $14,503 as of June 30, 2023.

4. LEASES
Innovid's lease portfolio primarily consists of real estate properties. Short-term leases with a term of 12 months or less are not recorded on the balance sheet. Innovid does not separate lease components from non-lease components.
The Company is a lessee in all its lease agreements. The Company records lease liabilities based on the present value of lease payments over the lease term. Innovid generally uses an incremental borrowing rate to discount its lease liabilities, as the rate implicit in the lease is typically not readily determinable. Certain lease agreements include renewal options that are under the Company's control. Innovid includes optional renewal periods in the lease term only when it is reasonably certain that Innovid will exercise its option.
Variable lease payments are primarily related to payments to lessors for taxes, maintenance, insurance and other operating costs. The Company's lease agreements do not contain any significant residual value guarantees or restrictive covenants.
The Company has the following operating ROU assets and lease liabilities:

June 30, 2023December 31, 2022
(Unaudited)
ROU assetsLease liabilitiesROU assetsLease liabilities
Real Estate$2,008 $2,692 $2,886 $3,801 
Cars  24 21 
Total operating leases$2,008 $2,692 $2,910 $3,822 





15

INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
The following table summarizes the lease costs recognized in the interim condensed consolidated statement of operations:

Three months ended June 30,Six months ended June 30,
2023202220232022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Operating lease cost$458 $472 $921 $947 
Short term lease cost320 126 583 208 
Variable lease cost25 6 46 10 
Total lease cost$803 $604 $1,550 $1,165 

As of June 30, 2023 (unaudited), the weighted-average remaining lease term and weighted-average discount rate for operating leases are 1.8 years and 2.5%, respectively.
The following table presents supplementary cash flow information regarding the Company's operating leases:
Six months ended June 30, 2023Six months ended June 30, 2022
(Unaudited)(Unaudited)
Cash paid for amounts included in the measurement of lease liabilities$1,035 $1,133 
The following table summarizes the future payments of Innovid for its operating lease liabilities:
Six months ended June 30, 2023
(Unaudited)
2023 Remaining$1,124 
2024972 
2025636 
Total undiscounted lease payments$2,732 
Less: Interest(40)
Total lease liabilities$2,692 

5. WARRANTS
As of June 30, 2023, the Company had 3,162,500 Public Warrants and 7,060,000 Private Warrants outstanding. As of June 30, 2023, the majority of the Private Warrants (the “Transferred Private Warrants”) had been transferred from their initial holder to other transferees. The Transferred Private Warrants terms are now identical to the Public Warrants resulting in use of the same price for valuation purposes.
The Company’s Warrants’ fair value as of June 30, 2023 (unaudited), and December 31, 2022, was $1,022 and $4,301, respectively. Gains and losses related to the Company’s Warrants are recognized in “Finance income, net.” See Note 9 for further details.





16

INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
6. LONG-TERM DEBT
On August 4, 2022, two wholly owned subsidiaries of the Company, Innovid LLC and TV Squared Inc, entered an amended and restated loan and security agreement with Silicon Valley Bank (the “2022 A&R Agreement”), to increase the revolving line of credit from $15,000 to $50,000 (the “New Revolving Credit Facility”). The 2022 A&R Agreement and the New Revolving Credit Facility were amended by a First Loan Modification Agreement dated August 2, 2023 (the “2023 Modification Agreement”). The interest for the New Revolving Credit Facility is payable monthly in arrears. The New Revolving Credit Facility bears interest at an annual rate which is the greater of (a) WSJ Prime Rate plus 0.25% or (b) 4.25%, on the aggregate outstanding balance. Additional fees include fees in an amount of 0.20% per annum of the average unused portion of the New Revolving Credit Facility to be paid quarterly in arrears. The Company will also pay non-refundable commitment fees of $40 and $75 at inception and first anniversary date, respectively, together with a modification fee of $20 payable on the date of the 2023 Modification Agreement. The maturity date of the 2022 A&R Agreement, as amended by the 2023 Modification Agreement, is June 30, 2025. The New Revolving Credit Facility is subject to certain customary conditions precedent to the credit extension as stated in the 2022 A&R Agreement.
The New Revolving Credit Facility requires the Company to comply with all covenants, primarily maintaining an adjusted quick ratio of at least 1.30 to 1.00. As defined in the 2022 A&R Agreement, “adjusted quick ratio” is the ratio of (a) quick assets to (b) current liabilities minus the current portion of deferred revenue. “Quick assets” are determined as the Company’s unrestricted cash plus accounts receivable, net, and is determined according to US GAAP. The Company is also required to maintain the minimum quarterly adjusted EBITDA as defined in the 2022 A&R Agreement, as amended by the 2023 Modification Agreement, if the Company does not maintain the quarterly adjusted quick ratio of at least 1.50 to 1.00.
As of June 30, 2023 (unaudited), and December 31, 2022, the Company utilized $20,000 of the $50,000 credit line. In January 2023, the Company repaid $5,000 under the credit line and $5,000 was subsequently drawn in March 2023. In May 2023, the Company repaid $5,000 under the credit line and $5,000 was subsequently drawn in June 2023.
As of June 30, 2023 (unaudited), the Company is in compliance with all the covenants.
Prior to the 2022 A&R Agreement, the credit installments bore US dollar denominated interest at an annual rate equal to 0.75%-1% plus the prime rate on the outstanding principal of each credit installment and prior to the 2023 Modification Agreement the New Revolving Credit Facility bore interest at an annual rate which was the greater of (a) WSJ Prime Rate plus 0.75% or (b) 4.25%.

7. COMMITMENTS AND CONTINGENT LIABILITIES
Pledges and bank guarantees
1.In conjunction with the 2022 A&R Agreement (see Note 6, Long-term Debt), Innovid LLC pledged 65,000 common stocks of its Israeli Subsidiary, NIS 0.01 par value each.
2.The Israeli Subsidiary pledged bank deposits in an aggregate amount of $601 in connection with an office rent agreement and credit cards.
3.Innovid Inc. obtained bank guarantees in an aggregate amount of $231 in connection with its office lease agreements.







17

INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Legal contingencies
On March 4, 2022, a lawsuit was filed in the United States District Court for the Western District of Texas by the Nielsen, Company (US) LLC against TVS alleging infringement of US Patent No.10,063,378. On June 1, 2022, TVS moved to transfer the case to the Southern District of New York. On February 24, 2023, the case was transferred to the Southern District of New York. On March 23, 2023, the parties jointly filed their proposed case management plan and scheduling order, which the Court entered and thereafter opened discovery. That order sets the close of fact discovery for October 23, 2023, and the close of expert discovery for January 23, 2024, but does not set a date for trial. On the same day, TV Squared filed a motion for judgment on the pleadings under Federal Rule 12(c) arguing invalidity of all asserted patent claims. Briefing concluded on April 24, 2023, and the motion remains pending. The plaintiff has not specified the amount sought in the litigation. Given the uncertainty of litigation and the preliminary stage of the lawsuit, the Company is unable at this time to give an estimate of the amount or range of potential loss, if any, which might result to the Company if the outcome in such litigation was unfavorable. As of June 30, 2023, the Company did not record a loss contingency.

8. STOCK-BASED COMPENSATION
Stock-based compensation expense is related to awards issued pursuant to the Legacy Innovid Stock Option Plan (“Legacy Plan”) and 2021 Innovid Corp. Incentive Plan (“2021 Plan”) and is summarized as follows:

Three months ended June 30,Six months ended June 30,

2023202220232022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Cost of goods sold
$435 $383 $876 $488 
Research and development
1,229 920 2,403 1,399 
Sales and marketing
1,690 1,529 3,269 2,109 
General and administrative
1,980 1,306 3,410 1,734 
Total
$5,334 $4,138 $9,958 $5,730 
18

INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
In connection with the awards granted to service providers and non-employee consultants, the Company’s expense is immaterial in the periods presented.
During the three and six months ended June 30, 2023 (unaudited), the Company capitalized stock-based compensation expense of $325 and $690 of internal-use software costs, respectively.
During the three and six months ended June 30, 2022, the Company capitalized stock-based compensation expense of $490, respectively, in internal-use software cost.
Stock Options
Stock options may be granted to officers, directors, employees and non-employee consultants of the Company. Each option granted under the Plan expires no later than 10 years from the date of grant. The options vest usually over four years from commencement of employment or service start date. Any options forfeited or not exercised before expiration become available for future grants.
A summary of the employees’ stock option activity for the six months ended June 30, 2023 (unaudited), is as follows:

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of period
10,658,085 $1.15 6.85$5,923 
Granted832,232 1.55 
Forfeited(207,449)1.89 
Expired(163,640)1.65 
Exercised(1,376,572)0.45 
Outstanding at end of period
9,742,656 $1.26 7.08$14,232 
Exercisable options at end of period
6,563,845 $0.99 6.37$11,356 
A summary of the consultants’ stock option activity for the six months ended June 30, 2023 (unaudited), is as follows:

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of period
69,542 $0.47 4.21$86 
Forfeited  
Exercised  
Outstanding at end of period
69,542 $0.47 3.72$156 
Exercisable options at end of period
66,196 $0.46 3.53$149 
As of June 30, 2023 (unaudited), the Company had approximately $3,945 of total unrecognized compensation cost related to non-vested stock options. That cost is expected to be recognized over a weighted-average period of 1.92 years.
19

INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
Restricted Stock Units
Restricted Stock Units (“RSUs”) may be granted to officers, directors, employees and non-employee consultants of the Company, and generally vest over a three- or four-year period.
A summary of the employees’ RSU activity under the 2021 Plan for the six months ended June 30, 2023 (unaudited), is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of period
7,989,825 $5.60 
Granted12,096,238 1.28 
Vested(3,424,868)5.27 
Forfeited(1,113,878)4.88 
Outstanding at end of period
15,547,317 $2.36 
A summary of the consultants’ RSU activity under the 2021 Plan for the six months ended June 30, 2023 (unaudited), is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of period
130,268 $6.60 
Granted107,343 1.18 
Vested(53,250)6.60 
Forfeited(8,226)6.60 
Outstanding at end of period
176,135 $3.30 
The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Innovid’s common stock on the date of grant.
As of June 30, 2023 (unaudited), $33,727 of unrecognized compensation cost related to RSUs is expected to be recognized as expense over the weighted average period of 2.3 years.

9. FINANCE INCOME, NET
The Company recognizes the gains and losses from the remeasurement of the warrants liability related to the Public Warrants and Private Placement Warrants, as defined in Note 5, Warrants, in “Finance income, net” in the condensed consolidated statements of operations. The unrealized gain from changes in the fair value of the Company Warrants for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $565 and $13,159, respectively. The unrealized gain from changes in the fair value of the Company Warrants for the six months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $3,279 and $15,946, respectively.
The Company also recognized interest expenses in “Finance income, net” in the condensed consolidated statements of operations. Interest expenses for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $420 and $76, respectively. Interest expenses for the six months ended June 30, 2023 and 2022, were $782 and $137, respectively.

20

INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
10. INCOME TAX
The Company recorded a provision for incomes taxes of $1,335 and a net tax benefit of $168 for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), respectively, and a net expense of $4,159 and a net tax benefit of $205 for the six months ended June 30, 2023 and 2022, respectively.
The Company’s effective tax rates were (7.6)% and (4.1)% for the three months ended June 30, 2023 and 2022, respectively, and (17.8)% and 6.1% for the six months ended June 30, 2023 and 2022, respectively.
For the three months ended June 30, 2023 (unaudited), the net effect of discrete items increased the effective tax rate by 0.2%. Excluding these items, the Company’s effective tax rate would have been (7.4)%. For the six months ended June 30, 2023, the net effect of discrete items increased the effective tax rate by 1.1%. Excluding these items, the Company’s effective tax rate would have been (18.9)%.
For the three months ended June 30, 2022 (unaudited), the net effect of discrete items increased the effective tax rate by 3.3%. Excluding these items, the Company’s effective tax rate would have been (7.4)%. For the six months ended June 30, 2022, the net effect of discrete items decreased the effective tax rate by 4.6%. Excluding these items, the Company’s effective tax rate would have been 10.7%.
The increase in year-to-date tax expense primarily results from a shift in the Company’s foreign earnings, resulting in higher profitability and current tax expense, with no offsetting deferred tax benefit as a result of an overall valuation allowance.
In addition, certain temporary differences associated with the capitalization of research and development under IRC Section 174 and deductibility of stock compensation that would normally not impact the effective tax rate or overall tax expense, could cause the US to generate current state tax expense with no corresponding deferred tax benefit. Unless the US tax rules around research and development (Section 174) are modified, there will continue to be an adverse impact on our effective rates for income taxes paid.
Lastly, the current tax expense is increased as compared to prior years, in both the foreign jurisdictions and the US, because of decreased net operating losses available due to prior year utilization.

11. SEGMENT REPORTING
The Company operates as one operating segment, which primarily focuses on the software platform for advertising, measurement, and creative. Our CEO is the chief operating decision-maker, and manages and allocates resources to the operations of the Company on an entity-wide basis.
Revenue by geographical location are as follows:

Three months ended June 30,Six months ended June 30,

2023

202220232022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
US$31,567 $29,569 $59,214 $52,952 
Canada465 302 853 490 
APAC734 1,025 1,549 1,956 
EMEA1,595 1,914 3,038 3,043 
LATAM185 278 377 509 
Total revenues
$34,546 $33,088 $65,031 $58,950 
21

INNOVID, CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except stock and per stock data)
The Company’s property and equipment, net and ROU assets by geographical location is as follows:
June 30,
December 31,
2023

2022
(Unaudited)
Israel$2,388 $2,707 
US18,212 14,065 
Rest of the World 367 460 
Total
$20,967 $17,232 

12. BASIC AND DILUTED NET (LOSS) INCOME PER SHARE
Basic and diluted net (loss) income per share attributable to common stockholders was calculated as follows:
Three months ended June 30,Six months ended June 30,
2023

20222023

2022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Numerator:
Net (loss) income$(18,959)$4,300 $(27,522)$(3,149)
Net (loss) income attributable to common stockholders basic and diluted
$(18,959)$4,300 $(27,522)$(3,149)
Denominator:
Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders`
Basic weighted average number of shares outstanding137,643,910 132,152,652 134,296,569 128,220,893 
Effect of dilutive securities options and RSU (share equivalent) 7,835,471   
Diluted weighted average number of shares outstanding137,643,910 139,988,123 134,296,569 128,220,893 
Net profit (loss) per stock attributable to common stockholders
Basic$(0.14)$0.03 $(0.20)$(0.02)
Diluted$(0.14)$0.03 $(0.20)$(0.02)
The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
Three months ended June 30,Six months ended June 30,
2023

20222023

2022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Unvested RSU outstanding 15,723,452 7,991,829 15,723,452 8,002,502 
Options outstanding9,812,198 3,533,772 9,812,198 12,363,179 
Warrants outstanding10,222,500 10,222,500 10,222,500 10,222,500 

13. SUBSEQUENT EVENTS
On August 2, 2023, two wholly owned subsidiaries of the Company, Innovid LLC and TV Squared Inc, entered the 2023 Modification Agreement with Silicon Valley Bank, a division of First-Citizen Bank & Trust Company. Refer to Note 6 for further details.
22


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our interim unaudited condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report and our audited financial statements and notes contained in our Annual Report on Form 10-K for the year ended December 31, 2022 (our “2022 Annual Report on Form 10-K”). In addition to our historical condensed consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed in our 2022 Annual Report on Form 10-K as such factors may be updated from time to time in our other filings with the SEC, including elsewhere in this Quarterly Report, including under the heading “Cautionary Statements Regarding Forward-Looking Statements.”

Company Overview
Innovid is an enterprise cloud software platform that provides critical technology infrastructure for the creation, delivery, and measurement of advertising across connected TV (CTV), mobile TV, and desktop TV environments. As of June 30, 2023, according to Kantar Media, over 50% of the top 200 TV advertisers by US advertising spend are utilizing our platform in their advertising delivery infrastructure. Our technology, purposely built for CTV, combined with our position as a media-agnostic provider, has allowed us to win top TV advertisers and grow market share; while the growth of CTV combined with our usage-based revenue model continues to contribute to our overall growth.
We serve advertisers across multiple verticals, including Anheuser-Busch InBev, Verizon, CVS, Kellogg's, Mercedes-Benz, Target, and Sanofi, and target the largest global TV advertisers globally, including in the US, Germany, UK, Mexico, Argentina, Colombia, Israel, Singapore, Japan, and Australia. During the second quarter of 2023, approximately 9% of Innovid's revenue was generated by our customers outside of the US. As part of our measurement solutions go-to-market strategy, we partner with the largest streaming platform providers in the world, including Disney, Hulu, ESPN, and NBCU. In addition, we work closely with agency holding companies such as WPP, Publicis Groupe, Omnicom Group Inc, Interpublic Group of Cos., and Dentsu Inc. Our clients span all major industry verticals, including consumer packaged goods, pharmaceutical and healthcare, retail, financial services, automotive, and technology.
Innovid's revenue growth closely correlates with the growth of CTV advertising. CTV accounted for 51% and 50% of all video impressions served by Innovid during the three months ending June 30, 2023, and June 30, 2022, respectively. During the three months ending June 30, 2023, this represented a year-over-year increase of 11% in CTV video impressions served by Innovid. Video impressions served by Innovid during the second quarters of 2023 and 2022 attributed to mobile were 36% and 38%, respectively, and for desktop TV were 13% and 12%, respectively. In the second quarter of 2023, video impressions increase 1% for mobile TV and 17% for desktop TV compared to the same period in the prior year.

Transactions
Innovid Corp. was originally incorporated as ION Acquisition Corp. 2 Ltd. (“ION”), a special purpose acquisition company, on November 23, 2020 and Innovid Corp. was the surviving entity following the completion of its merger with ION on November 30, 2021 (the “ION Transaction”).
On February 28, 2022, the Company completed the acquisition of TV Squared Limited (“TVS”, together with ION’s Transaction, the “Transactions”) by way of stock purchase agreement (“Stock Purchase Agreement”). The Company acquired all the equity of TVS for an aggregate amount of 100.0 million in cash, 11,549,465 shares of the Company common stock at fair value of $3.80 per share, and other conditions as defined in the Stock Purchase Agreement.

23


Use of Estimates
The preparation of the condensed consolidated financial statements in conformity with US GAAP requires us to make estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Key Factors Affecting Our Performance
There are several factors that have impacted, and we believe, may continue to impact our results of operations and growth.
These factors include:
Continued market demand. Our performance depends on continued global demand across the advertising ecosystem for independent third-party ad serving, personalization, and measurement of digital ads. Advertisers, programmatic platforms, social media channels and digital publishers are collectively placing increased emphasis on the quality and effectiveness of digital ad spend across all channels, formats and devices.
Our growth is primarily driven by CTV, the fastest growing segment of digital ad spend, and our results depend on our ability to monetize continued market growth of CTV ad spend.
Growth of volume of CTV ad impressions of existing customers. Our results also depend on our ability to retain our existing customers and on our customers’ continued investment in CTV advertising. Customer retention will continue to impact our results as TV investment continues to shift from linear to CTV and the volume of CTV impressions grows.
Upsell of additional services. An additional contributor to our efforts in expanding revenue generated by our customers is our investment in cross-selling our solutions. We cross-sell our personalized creative solutions to primary ad serving customers, who, for example, begin using our services with standard digital video ads and then introduce personalized formats over time. We also cross-sell our advanced measurement solutions, which provide real-time metrics to inform optimization of TV campaigns while in market. The success of these efforts will impact our results of operations.
New client accounts: We intend to continue targeting new brand, media agency and digital publisher customers who are currently utilizing solutions provided by our competitors or point solutions. Our results of operations will be impacted by our ability to attract new customers.
Seasonality: We experience revenue fluctuations that coincide with seasonal changes in the digital ad spending of our customers, in particular television ad spending patterns. Advertisers typically allocate the largest portion of their media budgets to the fourth quarter of the calendar year to coincide with increased holiday purchasing. As a result, the fourth quarter of the year typically reflects our highest level of revenues while the first quarter typically reflects our lowest level of revenues. However, this traditional revenue seasonality may also be impacted by certain external factors or major events that also impact traditional television advertising patterns such as supply chain disruptions and silicon/chip shortages. We expect our revenues to continue to fluctuate based on seasonal factors that affect the advertising industry as a whole and for these seasonal fluctuations in ad spend to impact quarter-over-quarter results. We believe that the year-over-year comparison of results more appropriately reflects the overall performance of our business.

Global Markets
The majority of our clients are global advertisers and operate at a significant scale. Innovid serves customers globally through a delivery footprint including the US, APAC, EMEA, and LATAM. During the second quarter of 2023, approximately 9% of Innovid’s revenue was generated outside the US.
We continue to service international markets to meet the needs of our global customer base and to accelerate new customer acquisition in key geographies outside of the US. We believe our continuing ability to service international markets will impact our results of operations.

24


Components of Results of Operations
Revenues
We generate the majority of our revenues from providing Ad serving solutions to advertisers, media agencies and publishers. We focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers primarily across CTV, mobile TV, and desktop TV.
InnovidXP, our cross-platform TV Ad measurement solution, launched last year, measures the efficiency of CTV advertising and in-flight optimizations for TV marketers. We will continue to invest in advanced measurement capability and provide solutions to advertisers , streaming platforms and agencies as their needs evolve in the highly fragmented CTV ecosystem.
We provide creative services for the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.
We generate the majority of our revenues from the sale and delivery of our products within the US. For information with respect to sales by geographic markets, refer to Note 11, Segment Reporting to the Condensed Consolidated Financial Statements included under Item 1, Financial Statements and Supplementary Data. Our CEO is the chief operating decision-maker, and manages and allocates resources to the operations of the Company on an entity-wide basis.
We anticipate that revenues from our US sales will continue to constitute a majority of our revenues in future periods.
Cost of revenues
Cost of revenues consists primarily of costs to run our ad serving, creative and measurement solutions. These costs include hosting and ad serving fees, data costs, personnel costs including stock-based compensation, professional services costs and facility related costs. We allocate overhead, including rent and other facility related costs and communication costs, based on headcount.
Research and development
Research and development expenses consist primarily of personnel costs, including stock-based compensation, professional services costs, hosting and facility related costs. We allocate overhead including rent and other facility related costs and communication costs based on headcount. These expenses may vary from period to period as a percentage of revenue, depending primarily upon when we choose to make more significant investments.
Research and development costs are charged to the condensed consolidated statements of operations as incurred. ASC 350-40, Internal-Use Software (“ASC 350-40”), requires the capitalization of certain costs incurred during the application development stage. Any costs incurred for upgrades and functionality enhancements of the software are also capitalized.
Sales and marketing
Sales and marketing expenses consist primarily of personnel costs, including commissions, stock-based compensation, professional services costs and facility related costs, as well as costs related to advertising, promotional materials, public relations, and other sales and marketing programs. We allocate overhead, including rent and other facility related costs and communication costs based on headcount.
General and administrative
General and administrative expenses consist primarily of personnel costs, including stock-based compensation, for executive management, finance, accounting, human capital, legal and other administrative functions as well as professional services costs and facility related costs. We allocate overhead, including rent and other facility related costs, and communication costs based on headcount.

25


Results of Operations
Three and six months ended June 30, 2023, compared to the three and six months ended June 30, 2022
Three months ended June 30,Six months ended June 30,
2023202220232022
(in thousands)% of Revenue(in thousands)% of Revenue(in thousands)% of Revenue(in thousands)% of Revenue
Revenues$34,546 100 %$33,088 100 %$65,031 100 %$58,950 100 %
Cost of revenues8,591 25 %7,351 22 %16,856 26 %13,277 23 %
Research and development6,876 20 %9,710 29 %13,993 22 %16,964 29 %
Sales and marketing11,460 33 %14,320 43 %23,097 36 %24,671 42 %
General and administrative8,924 26 %9,955 30 %18,574 29 %21,410 36 %
Depreciation and amortization2,064 %926 %4,094 %1,599 %
Goodwill impairment14,503 42 %— — %14,503 22 %— — %
Operating loss(17,872)(52)%(9,174)(28)%(26,086)(40)%(18,971)(32)%
Finance income, net(248)(1)%(13,306)(40)%(2,723)(4)%(15,617)(26)%
(Loss) income before taxes
(17,624)(51)%4,132 12 %(23,363)(36)%(3,354)(6)%
Taxes on income1,335 %(168)(1)%4,159 %(205)— %
Net (loss) income$(18,959)(55)%$4,300 13 %$(27,522)(42)%$(3,149)(5)%
Revenues
The growth and scaling of CTV was the key driver of Innovid’s revenue growth in the second quarter of 2023. As TV ad spend continues to shift from linear to CTV, we continue to benefit from the natural volume growth of CTV impressions we delivered for our existing and new customers.
Total revenue increased by $1.5 million, or 4%, from $33.1 million in the three months ended June 30, 2022 to $34.5 million in the three months ended June 30, 2023. The increase is attributed to the ad serving volume growth and the growth of the measurement offering. Cross-selling of the measurement solution to our core clients contributed to the overall increase in the measurement revenue.
Total revenue increased by $6.0 million, or 10%, from $59.0 million in the six months ended June 30, 2022 to $65.0 million in the six months ended June 30, 2023. Four months of TVS activity was included in our operations in the same period in 2022 due to the timing of the acquisition.
There was no meaningful impact of changes in average cost per impression on total revenue.
Cost of revenues (exclusive of depreciation, amortization and goodwill impairment shown below)
Three months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Cost of revenues$8,591 25 %$7,351 22 %$1,240 17 %
26


Cost of revenue increased by $1.2 million, or 17%, from $7.4 million in the three months ended June 30, 2022, to $8.6 million in the three months ended June 30, 2023, primarily driven by a $1.8 million increase related to hosting and data costs associated with our integrated measurement solution. This was partially offset by a decrease in personnel related costs resulted from our operating efficiency measures including headcount reduction.

Six months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Cost of revenues$16,856 

26 %$13,277 23 %$3,579 27 %
Cost of revenue increased by $3.6 million, or 27%, from $13.3 million in the six months ended June 30, 2022, to $16.9 million in the six months ended June 30, 2023, primarily driven by a $3.6 million increase in hosting and data costs associated with our measurement solution included in our operations following the TVS acquisition. This was partially offset by a decrease in personnel related costs resulted from our operating efficiency measures including headcount reduction.
Research and development (exclusive of depreciation, amortization and goodwill impairment shown below)
Three months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Research and development$6,876 20 %$9,710 29 %$(2,834)(29)%
Research and development expenses decreased by $(2.8) million, or (29)%, from $9.7 million in the three months ended June 30, 2022, to $6.9 million in the three months ended June 30, 2023, primarily driven by a decrease of $1.9 million in personnel costs, a decrease of $0.5 million in technology infrastructure and hosting fees, and a decrease of $0.4 million in consulting fees resulted from our operating efficiency measures including headcount reduction.
Six months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Research and development$13,993 

22 %$16,964 29 %$(2,971)(18)%

Research and development expenses decreased by $(3.0) million, or (18)%, from $17.0 million in the six months ended June 30, 2022, to $14.0 million in the six months ended June 30, 2023, primarily driven by a decrease of $1.9 million in personnel costs, a decrease of $0.6 million in technology infrastructure and hosting fees, and a decrease of $0.5 millions in consulting fees resulted from our operating efficiency measures including headcount reduction.
Sales and marketing (exclusive of depreciation, amortization and goodwill impairment shown below)
Three months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Sales and marketing$11,460 33 %$14,320 43 %$(2,860)(20)%
Sales and marketing expenses decreased by $(2.9) million, or (20)%, from $14.3 million in the three months ended June 30, 2022, to $11.5 million in the three months ended June 30, 2023, primarily driven by a decrease in personnel costs of $1.9 million due to lower headcount. In addition, there was a $0.6 million decrease in marketing expenses and other cost efficiency.
27


Six months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Sales and marketing$23,097 

36 %$24,671 42 %$(1,574)(6)%
Sales and marketing expenses decreased by $(1.6) million, or (6)%, from $24.7 million in the six months ended June 30, 2022, to $23.1 million in the six months ended June 30, 2023, primarily driven by a decrease in personnel costs of $0.5 million due to lower headcount. In addition, there was a decrease in marketing costs of $0.8 million and other cost efficiency.
General and administrative (exclusive of depreciation, amortization and goodwill impairment shown below)
Three months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
General and administrative$8,924 26 %$9,955 30 %$(1,031)(10)%
General and administrative expenses decreased by $(1.0) million, or (10)%, from $10.0 million in the three months ended June 30, 2022, to $8.9 million in the three months ended June 30, 2023, primarily driven by a decrease in professional fees of $1.3 million and legal fees of $0.5 million related to the TVS acquisition in the 2022 period. This was partially offset by an increase in executive bonuses of $0.7 million.
Six months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
General and administrative$18,574 

29 %$21,410 36 %$(2,836)(13)%
General and administrative expenses decreased by $(2.8) million, or (13)%, from $21.4 million in the six months ended June 30, 2022, to $18.6 million in the six months ended June 30, 2023, primarily driven by a decrease in professional fees of $3.4 million and a decrease of $1.8 million in legal fees both related to the TVS acquisition. In addition, there was a decrease of $1.1 million in Directors and Officers insurance expense during the period. This was partially offset by an increase in stock compensation of $1.8 million and an increase in executive bonuses and other personnel costs of $1.7 million.
Depreciation and amortization
Three months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Depreciation and amortization $2,064 %$926 %$1,138 123 %
Depreciation and amortization expenses increased by $1.1 million, or 123%, from $0.9 million in the three months ended June 30, 2022, to $2.1 million in the three months ended June 30, 2023. The increase was mostly driven by $0.7 million amortization expense of internal-use software projects during the period.
Six months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Depreciation and amortization$4,094 %$1,599 %$2,495 156 %
Depreciation and amortization expenses increased by $2.5 million, or 156%, from $1.6 million in the six months ended June 30, 2022, to $4.1 million in the six months ended June 30, 2023. The increase was driven by additional amortization expense of $1.0 million for TVS intangible assets during the period as well as $1.5 million amortization expense of internal-use software projects.
28


Goodwill impairment
Three months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Goodwill impairment$14,503 42 %$— — %$14,503 100 %
Goodwill impairment increased by $14.5 million, or 100%, from $0.0 million in the three months ended June 30, 2022, to $14.5 million in the three months ended June 30, 2023. The continued decline in the Company’s stock price during the second quarter of 2023 was viewed as a triggering event, which required an assessment for possible goodwill impairment as of June 30, 2023. We performed this assessment during the six months ended June 30, 2023 and determined that the fair value of the reporting unit exceed its carrying value during the three months ended June 30, 2023. The fair value was determined based on the market approach. As a result of this assessment, the Company recorded a goodwill impairment in the amount of $14.5 million.
Six months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Goodwill impairment$14,503 22 %$— — %$14,503 100 %
Goodwill impairment increased by $14.5 million, or 100%, from $0.0 million in the six months ended June 30, 2022, to $14.5 million in the six months ended June 30, 2023 for the reasons described above.
Finance income, net
Three months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Finance income, net$(248)(1)%$(13,306)(40)%$13,058 (98)%
Finance income decreased by $13.1 million, or (98)%, from $(13.3) million in the three months ended June 30, 2022, to $(0.2) million in the three months ended June 30, 2023. This was predominantly driven by a decrease of the fair value of our warrants. The fair value of the warrants is influenced by market volatility impacting Company’s share price which is an underlying input for the valuation.
Six months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Finance income, net$(2,723)

(4)%$(15,617)(26)%$12,894 (83)%
Finance income decreased by $12.9 million, or (83)%, from $(15.6) million in the six months ended June 30, 2022, to $(2.7) million in the six months ended June 30, 2023. This was predominantly driven by a decrease of the fair value of our warrants. The fair value of the warrants is influenced by market volatility impacting Company’s share price which is an underlying input for the valuation.
Taxes on income
Three months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Taxes on income$1,335 %$(168)(1)%$1,503 (895)%
29


The Company’s effective tax rates were (7.6)% and (4.1)% for the three months ended June 30, 2023 and 2022, respectively.
Six months ended June 30,
20232022
(in thousands)% of Revenue(in thousands)% of Revenue$ Variance% Variance
Taxes on income$4,159 

%$(205)— %$4,364 (2129)%
Tax expense increased by $4.4 million from $(0.2) million in the six months ended June 30, 2022 to $4.2 million in the six months ended June 30, 2023. The Company’s effective tax rates were (17.8)% and 6.1% for the six months ended June 30, 2023 and 2022, respectively.
The increase in year-to-date tax expense primarily resulted from a shift in the Company’s foreign earnings, resulting in higher profitability and current tax expense, with no offsetting deferred tax benefit as a result of an overall valuation allowance.
In addition, certain temporary differences associated with the capitalization of research and development under IRC Section 174 and deductibility of stock compensation that would normally not impact the effective tax rate or overall tax expense, cause the US to generate current state tax expense with no corresponding deferred tax benefit. Unless the US tax rules around research and development (Section 174) are modified, there will continue to be an adverse impact on our effective rates for income taxes paid.
Lastly, the current tax expense is increased as compared to prior years, in both the foreign jurisdictions and the US, because of decreased net operating losses available due to prior year utilization.

Liquidity and Capital Resources
We have financed our operations, business acquisition and capital expenditures primarily through utilization of cash generated from operations and cash proceeds from the ION’s transaction, as well as borrowings under our credit facilities.
As of June 30, 2023, we had cash, cash equivalents and restricted cash of $43.8 million and net working capital, consisting of current assets less current liabilities, of $68.6 million. As of June 30, 2023, we had an accumulated deficit of $178.4 million, $76.0 million thereof results from the cumulative accretion of preferred stock to redemption value prior to the conversion of all preferred stock into our common stock upon the closing of the ION’s transaction.
We believe our existing cash and cash equivalents and anticipated net cash provided by operating activities, together with available borrowings under our credit facility, will be sufficient to meet our cash needs and working capital requirements for at least the next 12 months. However, if our operating performance during the next 12 months is below our expectations, our liquidity and ability to operate our business could be adversely affected. We are closely monitoring the effect that current economic conditions may have on our working capital requirements. To date, the global events have not had a material negative impact on our cash flow or liquidity. Our future capital requirements and the adequacy of available funds will depend on many factors.
30


Sources of Liquidity
Revolving Line of Credit
On August 4, 2022, two of our wholly owned subsidiaries, Innovid LLC and TV Squared Inc, entered into an amended and restated loan and security agreement with Silicon Valley Bank (the “2022 A&R Agreement”), to increase the revolving line of credit from $15.0 million to $50.0 million (the “New Revolving Credit Facility”). The 2022 A&R Agreement and the New Revolving Credit Facility were amended by a First Loan Modification Agreement dated August 2, 2023 (the “2023 Modification Agreement”). The interest for the New Revolving Credit Facility is payable monthly in arrears. The New Revolving Credit Facility bears interest at an annual rate which is the greater of (a) WSJ Prime Rate plus 0.25% or (b) 4.25%, on the aggregate outstanding balance. Additional fees include fees in an amount of 0.20% per annum of the average unused portion of the New Revolving Credit Facility to be paid quarterly in arrears. The maturity date of the 2022 A&R Agreement, as amended by the 2023 Modification Agreement, is June 30, 2025. The New Revolving Credit Facility is subject to certain customary conditions precedent to the credit extension as stated in the 2022 A&R Agreement.
The New Revolving Credit Facility requires the Company to comply with all covenants, primarily maintaining an adjusted quick ratio of at least 1.30 to 1.00. As defined in the 2022 A&R Agreement “adjusted quick ratio” is the ratio of (a) quick assets to (b) current liabilities minus the current portion of deferred revenue. “Quick assets” are determined as the Company’s unrestricted cash plus accounts receivable, net, and is determined according to US GAAP. The Company is also required to maintain the minimum quarterly adjusted EBITDA as defined in the 2022 A&R Agreement, as amended by the 2023 Modification Agreement, if the Company does not maintain the quarterly adjusted quick ratio of at least 1.50 to 1.00.
As of June 30, 2023, we were in compliance with all covenants.
As of June 30, 2023 and December 31, 2022, the Company utilized $20.0 million of the $50.0 million credit line. In January 2023, the Company repaid $5.0 million under the credit line and $5.0 million was subsequently drawn in March 2023. In May 2023, the Company repaid $5.0 million under the credit line and $5.0 million was subsequently drawn in June 2023.
Interest expenses for the six months ended June 30, 2023, and 2022 were $0.8 million and $0.1 million, respectively. They were recorded in the “Finance income, net” in the condensed consolidated statements of operations.

Cash Flows
Six months ended June 30, 2023, compared to the six months ended June 30, 2022
The following table summarizes our cash flows for the periods presented:
Six months ended June 30,
20232022
Net cash provided by / (used in) operating activities$948 $(15,901)
Net cash provided by / (used in) investing activities4,247 (103,273)
Net cash provided by financing activities614 6,451 
Increase (decrease) in cash, cash equivalents and restricted cash
$5,809 $(112,723)
Operating Activities
Our cash flows from operating activities are primarily influenced by growth in our operations, increases or decreases in collections from our customers and payments to our vendors, as well as increases in personnel related expenses as we scale up our business. The timing of cash receipts from customers and payments to vendors and providers can significantly impact our cash flows from operating activities. In addition, we expect seasonality to impact quarterly cash flows from operating activities.
Cash provided by/(used in) operating activities is calculated by adjusting our net loss for changes in working capital, as well as by excluding non-cash items such as depreciation and amortization, goodwill impairment, stock-based compensation and change in fair value of warrants.
31


For the six month period ended June 30, 2023, net cash provided by operating activities was $0.9 million, attributable to net loss of $(27.5), adjusted for non-cash charges of $25.2 and $3.3 cash provided by changes in working capital. Our non-cash charges primarily consisted of goodwill impairment and stock based compensation.
For the six month period ended June 30, 2022, net cash used in operating activities was $(15.9) million, attributable to net loss of $(3.1), adjusted for non-cash charges of $(8.7) and $(4.0) use of cash from changes in working capital. Our non-cash charges primarily consisted of change in fair value warrants.
The changes in our working capital compared to the prior period in the amount of $7.3 million were a result of a decrease in trade receivables due to a shorter collection period. This decrease was partially off-set by an increase in prepaid expenses due to the timing of payments for some of our subscriptions. The changes in working capital were also related to an increase in accrued expense, other current liabilities and trade payables due to accrual and the timing of payments for personnel costs, prepaid software subscription fees and changes due to the acquisition of TVS.
Investing Activities
For the six month period ended June 30, 2023, $4.2 million of net cash was provided by investing activities compared to net cash used in investing activities of $103.3 million for the six month period ended June 30, 2022, was primarily driven by net cash consideration paid of $99.6 million to acquire TVS in 2022. Further, the decrease of $10.0 million in short-term deposit, which was terminated in March, 2023, increased cash provided by investing activity. This impact was offset by an increase of $2.1 million of investment in internal software development work.     
Financing Activities
For the six month period ended June 30, 2023, $0.6 million of net cash was provided by financing activities compared to $6.5 million for the six month period ended June 30, 2022. This decrease in cash provided was primarily due to a drawdown of our credit facility of $9.0 million in the prior period, offset by a decrease in the amount of transaction costs of $3.2 million.

Contractual Obligations and Known Future Cash Requirements
Lease Commitments
We rent our facilities under operating lease agreements that expire on various dates, the latest of which is in 2025 excluding any options for renewal. The minimum rental payments under operating leases for rental of premises as of June 30, 2023 for the next five years totaled $2.7 million, which is comprised of $1.6 million and $1.1 million in the next 12 months and more than 12 months, respectively.
Pledges and Bank Guarantees
In connection with the 2022 A&R Agreement, we pledged 65,000 shares of common stock of our Israeli subsidiary, NIS 0.01 par value each.
We have a total of $0.6 million of pledged bank deposits as of June 30, 2023, related to office leases and credit cards. We obtained bank guarantees in an aggregate amount of $0.2 million in connection with our office lease agreements.
On March 4, 2022, a lawsuit was filed in the United States District Court for the Western District of Texas by the Nielsen, Company (US) LLC against TVS alleging infringement of US Patent No.10,063,378. On June 1, 2022, TVS moved to transfer the case to the Southern District of New York. On February 24, 2023, the case was transferred to the Southern District of New York. On March 23, 2023, the parties jointly filed their proposed case management plan and scheduling order, which the Court entered and thereafter opened discovery. That order sets the close of fact discovery for October 23, 2023, and the close of expert discovery for January 23, 2024, but does not set a date for trial. On the same day, TV Squared filed a motion for judgment on the pleadings under Federal Rule 12(c) arguing invalidity of all asserted patent claims. Briefing concluded on April 24, 2023, and the motion remains pending. The plaintiff has not specified the amount sought in the litigation. Given the uncertainty of litigation and the preliminary stage of the lawsuit, the Company is unable at this time to give an estimate of the amount or range of potential loss, if any, which might result to the Company if the outcome in such litigation was unfavorable. As of June 30, 2023, the Company did not record a loss contingency.

32



Key Metrics and Non-GAAP Financial Measures
Adjusted EBITDA
In addition to our results determined in accordance with US GAAP, we believe that certain non-GAAP financial measures, including Adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) and Adjusted EBITDA Margin are useful in evaluating our business. The following table presents a reconciliation of Adjusted EBITDA, a non-GAAP financial measure, to the most directly comparable financial measure prepared in accordance with GAAP.
Three months ended June 30,
Six months ended June 30,
(in thousands)2023202220232022
Net (loss) income$(18,959)$4,300 $(27,522)$(3,149)
Net (loss) income margin(55)%13 %(42)%(5)%
Depreciation and amortization 2,064 926 4,094 1,599 
Goodwill impairment14,503 — 14,503 — 
Stock-based compensation5,334 4,138 9,958 5,730 
Finance income, net (a) (248)(13,306)(2,723)(15,617)
Transaction related expenses (b)— 164 — 392 
Acquisition related expenses (c)— 768 — 4,971 
Retention bonus expenses (d)148 1,000 445 1,000 
Legal claims 342 435 656 435 
Severance cost (e)— — 845 — 
Other23 83 272 175 
Taxes on income1,335 (168)4,159 (205)
Adjusted EBITDA
$4,542 $(1,660)$4,687 $(4,669)
Adjusted EBITDA margin
13.1 %(5.0)%7.2 %(7.9)%
(a) Finance income, net consists mostly of remeasurement related to revaluation of our warrants, remeasurement of our foreign subsidiary’s monetary
assets, liabilities and operating results, and our interest expense.
(b) Transaction related expenses consist of cost related to the SPAC merger transaction.
(c) Acquisition related expenses consists of professional fees associated with the acquisition of TVS.
(d) Retention bonus expenses consists of retention bonuses for TVS employees.
(e) Severance cost is related to the personnel reductions that occurred during the first quarter of 2023.

We use Adjusted EBITDA and Adjusted EBITDA Margin as measures of operational efficiency to understand and evaluate our core business operations. We believe that these non-GAAP financial measures are also useful to investors for period to period comparisons of our core business. Additionally, these figures provide an understanding and evaluation of our trends when comparing our operating results, on a consistent basis, by excluding items that we do not believe are indicative of our core operating performance.
These non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for an analysis of our results as reported under GAAP. Some of the limitations of these measures are:
they do not reflect changes in, or cash requirements for, our working capital needs;
Adjusted EBITDA does not reflect our capital expenditures or future requirements for capital expenditures or contractual commitments;
they do not reflect costs of acquiring and integrating businesses, which will continue to be a part of our growth strategy;
they do not reflect one-time, non-recurring, bonus costs and third party costs associated with the SPAC merger transaction and regulatory filings;
they do not reflect goodwill impairment;
they do not reflect severance costs;
33


they do not reflect income tax expense or the cash requirements to pay income taxes;
they do not reflect our interest expense or the cash requirements necessary to service interest or principal payments on our debt; and
although depreciation and amortization are non-cash charges related mainly to intangible assets, certain assets being depreciated and amortized will have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements.
Other companies in our industry may calculate these non-GAAP financial measures differently than we do, limiting their usefulness as a comparative measure. You should compensate for these limitations by relying primarily on our US GAAP results and using the non-GAAP financial measures only supplementally. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by total revenue.
Operational Metrics
In addition, Innovid’s management considers the number of core clients, annual core clients retention and annual core clients net revenue retention in evaluating the performance of the business. These metrics are reported annually. Prior to our acquisition of TVS in 2022, our definition of a core client included only advertisers that generated at least $100,000 revenue in a twelfth-months period. Following our acquisition of TVS, we have included publishers as core clients.

Off-Balance Sheet Arrangements
As of June 30, 2023, we did not have any relationships with unconsolidated organizations or financial partnerships, such as structured finance or special purpose entities that would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations are based on our unaudited interim condensed consolidated financial statements, which have been prepared in accordance with US GAAP. The preparation of these financial statements requires us to make estimates, assumptions and judgments that affect the amounts reported in our condensed consolidated financial statements and the accompanying notes to condensed consolidated financial statements. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates.
While our significant accounting policies are described in more detail in Note 2, Summary of Significant Accounting Policies of our unaudited interim condensed consolidated financial statements included in Item 1. “Financial Statements and Supplementary Data”, we believe the following accounting policies to be the most critical to the judgments and estimates used in the preparation of our interim condensed consolidated financial statements.
Revenue Recognition
Most of the Company’s revenues are derived from providing Ad serving solutions to advertisers, media agencies and publishers. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display and other channels.
The Company also provides measurement services to advertisers and agencies, streaming platforms and publishers. The measurement service provides analytics and the ability to track performance of advertising campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.
The Company also provides creative services for the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.
34


The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied.
For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis.
Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.
Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period.
Revenues related to creative projects are recognized at a point in time when the Company delivers an ad unit. Creative services projects are usually delivered within a week.
The Company’s accounts receivable, consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less.
The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be canceled without cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts.
The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract.
Fair value of financial instruments
The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.
Level 3 - Unobservable inputs which are supported by little or no market activity.
The Company’s financial instruments consist of cash and cash equivalents, restricted deposits, trade receivables, net, trade payables, employees, payroll accruals, accrued expenses and other current liabilities and current portion of long-term debts. Their historical carrying amounts represent the approximate fair value due to the short-term maturities of these instruments.
The Company’s investments in money market funds are classified as cash equivalents and measured at fair value. The Company measures its warrant liability at fair value.
35


The goodwill impairment recorded in the second quarter of 2023 was estimated using the Company's stock price, a Level 1 input, adjusted for an estimated control premium.
As of June 30, 2023, the Company’s warrant liability includes the Warrants, that were originally issued in connection with ION’s initial public offering, the “ION IPO,” which were transferred to the Company as part of the ION’s Transaction. The Company’s Warrants are recorded on the balance sheet at fair value with changes in fair value recognized through earnings. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement the valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.
The Company has determined that the fair value of the Public Warrants and Transferred Private Warrants, at the balance sheet date is determined by the closing price of the Company’s warrants, and are within Level 1 of the fair value hierarchy.
The Transferred Private Warrants are no longer classified as Level 3 as of June 30, 2023.
Gains and losses from the remeasurement of the Public and Private Warrants’ liability is recognized in finance income, net in the condensed consolidated statements of operations.
Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instruments. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect these estimates.
Impairment of long-lived assets
Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss. During the three month period and six months ended June 30, 2023 (unaudited), the Company tested its long-lived assets for recoverability and concluded that no impairment should be recognized.
Goodwill and intangible assets
Goodwill and acquired intangible assets have been recorded in the Company's financial statements resulting from     various business combinations. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is subject to an annual impairment test.
Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill would be reassigned using a relative fair value allocation approach. The Company currently has one reporting unit.
ASC 350, Intangibles—Goodwill and other (“ASC 350”) requires goodwill to be tested for impairment at least annually and, in certain circumstances, between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. The Company elects to perform an annual impairment test of goodwill as of October 1 of each year, or more frequently if impairment indicators are present. During the three months ended June 30, 2023, the Company recorded Goodwill impairment in the amount of $14,503.
Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date.
Customer relationships, acquired technology and trade name are being amortized over the estimated useful life of approximately 11 years, 6 years, and 4 years, respectively, using straight-line amortization method.
The amortization of customer relationships, acquired technology and trade name is presented within depreciation and amortization in the condensed consolidated statements of operations.
36


Capitalized software development costs
Software development costs, which are included in property and equipment, net, consists of capitalized costs related to the purchase and development of internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing or obtaining the software.
Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the estimated useful life of the software, which is three years. The amortization is presented within depreciation and amortization in the condensed consolidated statements of operations.
Income taxes and tax contingencies
Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts.
The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.
ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income.
On December 20, 2017, Congress passed the “US Tax Act.” The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations and the preparation and analysis of information not previously relevant or regularly produced. The US Tax Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.

Recent Accounting Pronouncements
For information on recent accounting standards, see “Part I - Item 1. Financial Statements and Supplementary Data - Note 2. Summary of Significant Accounting Policies”.


37


Item 3. Quantitative and Qualitative Disclosures About Market Risk
As a smaller reporting company, as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, we are not required to provide this information.

Item 4. Controls and Procedures
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.
Management’s Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our CEO and CFO, we evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended as of June 30, 2023. Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.
Changes in Internal Control Over Financial Reporting
There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
38


Part II
Item 1. Legal Proceedings
We are not presently party to any legal proceedings or aware of any claims which we believe would have, individually or in the aggregate, a material adverse effect on our consolidated business prospects, financial condition, liquidity, results of operation, cash flows, or capital levels. We may from time to time be party to litigation and subject to claims incident to the ordinary course of business.
On March 4, 2022, a lawsuit was filed in the United States District Court for the Western District of Texas by The Nielsen, Company (US) LLC against TVS alleging infringement of US Patent No.10,063,378. On June 1, 2022, TVS moved to transfer the case to the Southern District of New York. On February 24, 2023, the case was transferred to the Southern District of New York. On March 23, 2023, the parties jointly filed their proposed case management plan and scheduling order, which the Court entered and thereafter opened discovery. That order sets the close of fact discovery for October 23, 2023, and the close of expert discovery for January 23, 2024, but does not set a date for trial. On the same day, TV Squared filed a motion for judgment on the pleadings under Federal Rule 12(c) arguing invalidity of all asserted patent claims. Briefing concluded on April 24, 2023, and the motion remains pending. The plaintiff has not specified the amount sought in the litigation. Given the uncertainty of litigation and the preliminary stage of the lawsuit, the Company is unable at this time to give an estimate of the amount or range of potential loss, if any, which might result to the Company if the outcome in such litigation was unfavorable. As of June 30, 2023, the Company did not record a loss contingency.

Item 1A. Risk Factors
Except as described in Item 1A of Part II of our Form 10-Q filed for the quarterly period ended March 31 2023, there have been no material changes to our risk factors as previously disclosed in Item 1A of Part I of our 2022 Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Unregistered Sales of Equity Securities
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not Applicable.
Item 5. Other Information
N/A.
Item 6. Exhibits
39


Incorporated by Reference
Exhibit NumberDescriptionFormFile No.ExhibitFiling dateFiled furnished herewith
2.18-K001-400482.106/29/21
3.110-K001-400483.103/18/22
3.28-K001-400483.212/06/21
4.18-K001-400484.112/06/21
4.28-K001-400484.212/06/21
4.38-K001-400484.102/18/21
31.1*
31.2*
32.1**
32.2**
10.1*
10.210-Q001-4004810.108/10/22
10.3*
* Filed herewith.
**Furnished herewith.
40


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
INNOVID CORP.

Date: August 8, 2023
By:
/s/ Zvika Netter
Zvika Netter
Chief Executive Officer
Date: August 8, 2023
By:
/s/ Tanya Andreev-Kaspin
Tanya Andreev-Kaspin
Chief Financial Officer

41
EX-10.1 2 exhibit101amendedandrestat.htm EX-10.1 Document

Innovid Corp.

Amended and Restated Non-Employee Director Compensation Program

(EFFECTIVE JUNE 6, 2023)

Non-employee members of the board of directors (the “Board”) of Innovid, Corp. (the “Company”) shall receive cash and equity compensation as set forth in this Amended and Restated Non-Employee Director Compensation Program (this “Program”). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any subsidiary of the Company (each, a “Non-Employee Director”) who is entitled to receive such cash or equity compensation unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non- Employee Directors. This Program shall become effective as of the date set forth above (the “Effective Date”).

Cash Compensation

The schedule of annual retainers (the “Annual Retainers”) for the Non-Employee Directors is as follows:

Position
Amount
Annual Retainer
$30,000
Lead Independent Director
$25,000
Chair of Audit Committee
$20,000
Chair of Compensation Committee
$20,000
Chair of Nominating and Governance
Committee
$20,000
Member of Audit Committee (non-Chair)
$10,000
Member of Compensation Committee (non-
Chair)
$10,000
Member of Nominating and Governance
Committee (non-Chair)
$10,000

For the avoidance of doubt, the Annual Retainers in the table above are additive and a Non- Employee Director shall be eligible to earn an Annual Retainer for each position in which he or she serves. The Annual Retainers shall be earned on a quarterly basis based on a calendar quarter and shall be paid in cash by the Company in arrears not later than the fifteenth (15th) day following the end of each calendar quarter. In the event a Non-Employee Director does not serve as a Non- Employee Director, or in the applicable position, for an entire calendar quarter, the retainer paid





to such Non-Employee Director shall be prorated for the portion of such calendar quarter actually served as a Non-Employee Director, or in such position, as applicable.

Equity Compensation

Each Non-Employee Director shall be granted the following awards of Restricted Stock Units (each, an “RSU Award”) or Other Stock or Cash Based Awards (each, a “Stock Based Award”) under and subject to the terms and provisions of the Equity Plan under and within the meaning of the Company’s 2021 Incentive Award Plan or any other applicable Company equity incentive plan then-maintained by the Company (the “Equity Plan”). Each RSU Award or Stock Based Award shall be granted subject to an award agreement in substantially the form previously approved by the Board, and in the following amounts:

Initial RSU Award
A number of Restricted Stock Units (rounded to the nearest whole number) equal to $350,000 divided by the Reference Price.
Subsequent RSU Award
A Stock Based Award with a Grant Date Value equal to $175,000, which, unless otherwise determined by the Board will be granted in the form of a number of Restricted Stock Units equal to
$175,000 divided by the Reference Price.

For purposes of this Program, the “Reference Price” shall mean the closing sales price of one share of the Company’s common stock on the date of grant or on the last preceding trading day if the date of grant is not a trading day. “Grant Date Value” shall mean the value as determined in accordance with the Company’s consolidated financial statements.

A.Initial RSU Awards. Each Non-Employee Director who is initially elected or appointed to the Board after the Effective Date shall receive the Initial RSU Award on the date of such initial election or appointment. No Non-Employee Director shall be granted more than one Initial RSU Award.

B.Subsequent RSU Awards. A Non-Employee Director who is serving as a Non-Employee Director as of the date of the annual meeting of the Company’s stockholders (“Annual Meeting”) each calendar year beginning with calendar year 2023, shall be automatically granted a Subsequent RSU Award on the date of such Annual Meeting; provided, however, that any Subsequent RSU Award granted to a Non-Employee Director who was elected or appointed for the first time to the Board after the most recent Annual Meeting shall be pro-rated to reflect the initial partial year of service based on the number of days served from the date of the Non- Employee Director’s election or appointment to the Board through the date of the first Annual Meeting thereafter. For the avoidance of doubt, a Non-Employee Director elected for the first time to the Board at an Annual Meeting shall only receive an Initial RSU Award in connection with such election, and shall not receive any Subsequent RSU Award on the date of such meeting as well.





C.Termination of Employment of Employee Directors. Members of the Board who are employees of the Company or any subsidiary of the Company who subsequently terminate their employment with the Company and subsidiary of the Company and remain on the Board will not receive an Initial RSU Award, but to the extent that they are otherwise entitled as a Non- Employee Director, will receive, after termination of employment with the Company and any subsidiary of the Company, a Subsequent RSU Award.

D.Terms of RSU Awards Granted to Non-Employee Directors.

1.Vesting.

a.Initial RSU Awards. Each Initial RSU Award shall vest and become exercisable in substantially equal installments on each of the first three (3) anniversaries of the date of grant, such that the Initial RSU Award shall be fully vested on the third (3rd) anniversary of the date of grant, subject to the Non-Employee Director continuing in service as a Non-Employee Director through each such vesting date.

b.Subsequent RSU Awards. Each Subsequent RSU Award shall vest in a single installment on the earlier of the date of the next Annual Meeting or the first anniversary of the date of grant, subject to the Non-Employee Director continuing in service as a Non-Employee Director through such vesting date.

c.Forfeiture of RSU Awards; Change in Control Vesting. Unless the Board otherwise determines, any portion of an Initial RSU Award or Subsequent RSU Award which is unvested at the time of a Non-Employee Director’s termination of service on the Board as a Non-Employee Director shall be immediately forfeited upon such termination of service and shall not thereafter become vested. All of a Non-Employee Director’s Initial RSU Awards and Subsequent RSU Awards shall vest in full immediately prior to the occurrence of a Change in Control (as defined in the Equity Plan), to the extent outstanding at such time.

* * * * *

EX-10.3 3 exhibit103-svbmodification.htm EX-10.3 Document

FIRST LOAN MODIFICATION AGREEMENT
    This First Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of August 2, 2023, by and among (a) SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY (SUCCESSOR BY PURCHASE TO THE FEDERAL DEPOSIT INSURANCE CORPORATION AS RECEIVER FOR SILICON VALLEY BRIDGE BANK, N.A. (AS SUCCESSOR TO SILICON VALLEY BANK)) (“Bank”) and (b) (i) INNOVID LLC, a Delaware limited liability company with its principal place of business located at 30 Irving Place 12th Floor New York, NY 10003 (“Innovid LLC”), and (ii) TV SQUARED INC, a Delaware corporation with its principal place of business located at 30 Irving Place 12th Floor New York, NY 10003 (“TV Squared”). Innovid LLC and TV Squared, are hereinafter jointly, severally, individually and collectively, “Borrower”).
1.DESCRIPTION OF EXISTING INDEBTEDNESS AND OBLIGATIONS. Among other indebtedness and obligations which may be owing by Borrower to Bank, Borrower is indebted to Bank pursuant to a loan arrangement dated as of August 4, 2022, evidenced by, among other documents, a certain Amended and Restated Loan and Security Agreement dated as of August 4, 2022, between Borrower and Bank (as may be amended, modified, restated, replaced or supplemented from time to time, the “Loan Agreement”). Capitalized terms used but not otherwise defined herein shall have the same meaning as in the Loan Agreement.
2.DESCRIPTION OF COLLATERAL. Repayment of the Obligations is secured by, among other property, (a) the Collateral, as defined in the Loan Agreement, (b) the Intellectual Property Collateral as defined in a certain Intellectual Property Security Agreement dated as of August 4, 2022 between Innovid LLC and Bank (the “Innovid LLC IP Security Agreement”), (c) the Intellectual Property Collateral as defined in a certain Intellectual Property Security Agreement dated as of August 4, 2022 between TV Squared and Bank (the “TV Squared IP Security Agreement”), and (d) the Secured Sums as defined in that certain Deed of Pledge dated as of October 25, 2012 executed and delivered by Innovid LLC to Bank (together with any other collateral security granted to Bank, the “Security Documents”). Hereinafter, the Security Documents, together with all other documents evidencing or securing the Obligations shall be referred to as the “Existing Loan Documents”.
3.DESCRIPTION OF CHANGE IN TERMS.
A.Modifications to Loan Agreement.
1Borrower hereby acknowledges and agrees that Borrower will deliver to Bank, on or before the date that is 30 days from the date of this Loan Modification Agreement, in form and substance satisfactory to Bank: (a) an Acord 28 certificate reflecting Borrower’s property policy; (b) an Acord 25 certificate reflecting Borrower’s general liability policy; (c) an endorsement to Borrower’s general liability insurance policy naming Bank as an additional insured; (d) an endorsement to Borrower’s property insurance policy naming Bank as the sole lender’s loss payee; and (e) an endorsement to Borrower’s general liability and property insurance policies stating that the insurer will provide Bank with 30 days’ prior to such policies being cancelled or altered in any material respect. Borrower acknowledges and agrees that the failure of Borrower to satisfy the requirements set forth in the immediately preceding sentence shall result in an immediate Event of Default under the Loan Agreement for which there shall be no grace or cure period.
2The Loan Agreement shall be amended by deleting the following, appearing as Section 5.9(a) thereof:
“    (a)    Maintain Borrower’s and any of its Subsidiaries’ primary operating accounts, depository accounts, the Cash Collateral Account and primary securities/investment accounts, and all of their non-shekel cash with Bank or Bank’s Affiliates. provided however: (X) Borrower may maintain Dollar deposit accounts with financial institutions in Israel (other than Bank or Bank’s Affiliates) provided that the aggregate amount of funds held in all such accounts together shall not exceed Five Hundred Thousand Dollars ($500,000.00) in the aggregate at any time; (Y) subject the provisions of Section 7.13: (i) Innovid Media Ltd may maintain its existing NIS deposit account no. 640-557740 with Poalim in Israel, and (ii) Innovid AU Pty Ltd, may maintain an operating account with a financial institutions in Australia (other than Bank or Bank’s Affiliates) provided that the aggregate amount of funds held in such
1





account. shall not exceed Two Hundred Fifty Thousand Dollars ($250,000.00) in the aggregate at any time (iii) Innovid Argentina SRL may maintain (A) its existing Argentine peso deposit account no. 208-006911/9 with Santander Rio Bank and (B) its existing Argentine peso deposit account no. 7968-4 066-5 with Banco Galicia, and (iv) Innovid EU Limited may maintain its account with Barclays ending 382, provided that the aggregate amount of funds held in such account shall not exceed Five Hundred Thousand Dollars ($500,000.00) in the aggregate at any time, and (v) TV Squared Limited may maintain its accounts with Royal Bank of Scotland and (vi) TV Squared GMBH may maintain its account with Commerzbank AG. Any Guarantor shall maintain all depository, operating and securities/investment accounts with Bank and Bank’s Affiliates. The Bank acknowledges that Innovid LLC, funds payroll and accounts payable for its subsidiaries including in Israel, Argentina, Europe and Australia. As such, the balance in any of these accounts (as specified above) may be, for up to five (5) Business Days per month, greater than the amounts stated in this 5.9(a) paragraph, subject however to any limitations set forth herein, including without limitations sub-section (j) to the “Permitted Investments” definition.”
            and inserting in lieu thereof the following:
“    (a)    Maintain (i) the Cash Collateral Account and (ii) Borrower’s and any of its Subsidiaries’ primary operating accounts, depository accounts, and excess cash with Bank or Bank’s Affiliates, which accounts for (A) Borrower and its Subsidiaries shall represent greater than 50.0% of the Dollar value of all of Borrower’s and its Subsidiaries’ accounts at all financial institutions, and (B) Borrower shall represent greater than 50.0% of the Dollar value of all of Borrower’s accounts at all financial institutions. Any Guarantor shall maintain all depository accounts, operating accounts, and excess cash with Bank and Bank’s Affiliates. Subject to the foregoing limitation, Borrower’s Foreign Subsidiaries may maintain their primary operating and deposit accounts with financial institutions, other than Bank or Bank’s Affiliates (for clarity, amounts maintained in any such accounts shall be included in the calculations set forth in the immediately preceding sentence).”
3The Loan Agreement shall be amended by deleting the following, appearing as Section 5.10 thereof:
“    5.10    Financial Covenants.
(a)    Adjusted Quick Ratio. Maintain at all times, to be tested as of the last day of each month, a ratio of Quick Assets to Current Liabilities minus the current portion of Deferred Revenue (“AQR”) of at least 1.30 to 1.00. Notwithstanding anything to the contrary, the Bank acknowledges and confirms that the AQR will be based on Parent’s consolidated financials.
(b)    Adjusted EBITDA. Maintain at all times when Borrower (based on Parent’s consolidated financials statements filed with the SEC) does not maintain AQR of at least 1:50 to 1:00, measured as of the end of each fiscal quarter during the following periods, Adjusted EBITDA (as defined in Parent’s SEC filings) of at least the following:

2





PeriodMinimum Adjusted EBITDA
Calendar quarter ending on March 31, 2022
($3,500,000)
Calendar quarter ending on June 30, 2022
$750,000
Calendar quarter ending on September 30, 2022$1,500,000
Calendar quarter ending on December 31, 2022$3,000,000
Calendar quarter ending on March 31, 2023($3,500,000)
Calendar quarter ending on June 30, 2023$1,500,000
Calendar quarter ending on September 30, 2023$3,000,000
Calendar quarter ending on December 31, 2023$5,000,000
With respect to any period ending after December 31, 2023, the EBITDA levels applicable to such period shall be determined by Bank, in its sole discretion, until December 31, 2023 based upon, among other factors, budgets, sales projections, operating plans and other financial information of Borrower that Bank deems relevant, including, without limitation, Borrower’s financial projections. With respect thereto: Borrower’s failure to deliver to Bank, on or before December 1, 2023 Borrower’s budgets, sales projections, operating plans and other financial information of Borrower that Bank deems relevant and reasonably requested by Bank prior to such date, including, without limitation, Borrower’s quarterly and annual financial projections, together with any related business forecasts used in the preparation of such projections, with respect to Borrower’s 2024 fiscal year, shall result in an immediate Event of Default for which there shall be no grace or cure period.”
            and inserting in lieu thereof the following:
“    5.10    Financial Covenants.
(a)    Adjusted Quick Ratio. Maintain at all times, calculated on a consolidated basis with respect to Parent and its Subsidiaries (which shall in all cases include Borrower), to be tested as of the last day of each month, a ratio of Quick Assets to Current Liabilities minus the current portion of Deferred Revenue (“AQR”) of at least 1.30 to 1.00.
(b)    Adjusted EBITDA. Maintain at all times, to be tested as of the last day of each calendar quarter, Adjusted EBITDA, calculated on a consolidated basis with respect to Parent and its Subsidiaries (which shall in all cases include Borrower), in an amount equal to at least the amount set forth in the table below corresponding to such calendar quarter:
3






PeriodMinimum Adjusted EBITDA
Calendar quarter ending on March 31, 2022
($3,500,000)
Calendar quarter ending on June 30, 2022
$750,000
Calendar quarter ending on September 30, 2022$1,500,000
Calendar quarter ending on December 31, 2022$3,000,000
Calendar quarter ending on March 31, 2023($3,500,000)
Calendar quarter ending on June 30, 2023($1,000,000)
Calendar quarter ending on September 30, 2023$750,000
Calendar quarter ending on December 31, 2023$750,000
Calendar quarter ending on March 31, 2024($3,000,000)
Calendar quarter ending on June 30, 2024$3,250,000
Calendar quarter ending on September 30, 2024$750,000
Calendar quarter ending on December 31, 2024$6,500,000
With respect to the period ending after December 31, 2024 through and including March 31, 2025, the EBITDA levels applicable to such period shall be determined by Bank, in its sole discretion, until March 31, 2025 based upon, among other factors, budgets, sales projections, operating plans and other financial information of Borrower that Bank deems relevant, including, without limitation, Borrower’s financial projections. With respect thereto, Borrower’s failure to deliver to Bank, on or before December 31, 2024 Borrower’s budgets, sales projections, operating plans and other financial information of Borrower that Bank deems relevant and reasonably requested by Bank prior to such date, including, without limitation, Borrower’s quarterly and annual financial projections, together with any related business forecasts used in the preparation of such projections, with respect to the period ending after December 31, 2024 through and including March 31, 2025, shall result in an immediate Event of Default for which there shall be no grace or cure period.
4





Notwithstanding the foregoing, Bank will not test the financial covenant set forth in this Section 5.10(b) for any calendar quarter with respect to which Borrower has provided evidence, satisfactory to Bank in its sole discretion, that Borrower had AQR, calculated on a consolidated basis with respect to Parent and its Subsidiaries (which shall in all cases include Borrower), greater than or equal to 1.50 to 1.00 at all times for such calendar quarter; provided, however if Borrower’s AQR, calculated on a consolidated basis with respect to Parent and its Subsidiaries (which shall in all cases include Borrower) is at any time, less than 1.50 to 1.00 in any calendar quarter, Borrower shall have also maintained at all times, in the immediately preceding calendar quarter, as of the last day of such calendar quarter, the required minimum Adjusted EBITDA level set forth above for such calendar quarter.”
4The Loan Agreement shall be amended by inserting the following new definitions, appearing alphabetically in Section 12.2 thereof:
“    “Domestic Subsidiary” means a Subsidiary organized under the laws of the United States or any state or territory thereof or the District of Columbia.”
“    “Foreign Subsidiary” means any Subsidiary which is not a Domestic Subsidiary.”
“    “Interest Expense” means for any fiscal period, interest expense (whether cash or non-cash) determined in accordance with GAAP for the relevant period ending on such date, including, in any event, interest expense with respect to any Credit Extension and other Indebtedness of Parent and its Subsidiaries (which shall in all cases include Borrower), including, without limitation or duplication, all commissions, discounts, or related amortization and other fees and charges with respect to letters of credit and bankers’ acceptance financing and the net costs associated with interest rate swap, cap, and similar arrangements, and the interest portion of any deferred payment obligation (including leases of all types).”
“    “Net Income” means, as calculated on a consolidated basis for Parent and its Subsidiaries (which shall in all cases include Borrower), for any period as at any date of determination, the net profit (or loss), after provision for taxes, of Parent and its Subsidiaries (which shall in all cases include Borrower) for such period taken as a single accounting period.”
“    “Parent” is defined in the definition of “Change in Control”.”
“    “Total Liabilities” is on any day, calculated on a consolidated basis with respect to Parent and its Subsidiaries (which shall in all cases include Borrower), obligations that should, under GAAP, be classified as liabilities on Parent’s and its Subsidiaries’ (which shall in call cases include Borrower) consolidated balance sheet, including all Indebtedness.”
5The Loan Agreement shall be amended by deleting the following definitions, appearing in Section 12.2 thereof:

“    “Adjusted EBITDA” means, as determined in accordance with GAAP, (a) net income, plus (b) to the extent deducted in the calculation of net income, interest, taxes, depreciation and amortization, plus (c) to the extent deducted in the calculation of net income, non-cash stock-based compensation, as set forth on Borrower’s most recent consolidated balance sheet and income statement delivered to Bank pursuant to Section 5.3.”

“    “Advances” or “Advances” means a revolving credit loan (or revolving credit loans) under the Revolving Line (including, for the avoidance of doubt, Non-Formula Advances).”

5





“    “Current Liabilities” are all obligations and liabilities of Borrower to Bank (including without limitation, all obligations and liabilities in connection with the Revolving Line), plus, without duplication, the aggregate amount of Borrower’s Total Liabilities that mature within one (1) year.”

“    “IP Agreement” is that certain Intellectual Property Security Agreement between Borrower and Bank dated as of the Effective Date, as may be amended, modified or restated from time to time.”

“    “Quick Assets” is, on any date, Parent’s, consolidated, unrestricted and unencumbered cash maintained with Bank and Borrower’s net billed accounts receivable.”

            and inserting in lieu thereof the following:
“    “Adjusted EBITDA” means, as determined in accordance with GAAP, calculated on a consolidated basis with respect to Parent and its Subsidiaries (which shall in all cases include Borrower), (a) Net Income, plus (b) to the extent deducted in the calculation of Net Income, (i) Interest Expense, (ii) depreciation amortization and impairment expense, (iii) income tax expense, (iv) non-cash stock-based compensation, (v) non-recurring expenses solely with respect to (A) Borrower’s calendar quarters ending June 30, 2023, September 30, 2023 and December 31, 2023, in an aggregate amount not to exceed $1,000,000.00 in any such calendar quarter and $2,500,000.00 in the aggregate for all addbacks for the calendar quarters ending June 30, 2023, September 30, 2023 and December 31, 2023 measured together, and (B) the fiscal year ending December 31, 2024, in an aggregate amount not to exceed $750,000.00 in any calendar quarter and $2,000,000.00 in the aggregate for all such addbacks in such fiscal year measured together, (vi) one (1) time expenses approved by Bank in writing in its sole discretion, and (vii) non-cash finance expenses, minus (c) fees and expenses related to capitalized software, plus (d) to the extent included in the calculation of Net Income, non-cash finance income.”
“    “Advances” or “Advances” means a revolving credit loan (or revolving credit loans) under the Revolving Line.”

“    “Current Liabilities” are, calculated on a consolidated basis with respect to Parent and its Subsidiaries (which shall in all cases include Borrower), all obligations and liabilities of Parent and its Subsidiaries (which shall in all cases include Borrower) to Bank (including without limitation, all obligations and liabilities in connection with the Revolving Line), plus, without duplication, the aggregate amount of Parent’s and its Subsidiaries (which shall in all cases include Borrower) Total Liabilities that mature within one (1) year.”
“    “IP Agreement” is, collectively, (a) that certain Intellectual Property Security Agreement between Innovid LLC and Bank dated as of the Effective Date, and (b) that certain Intellectual Property Security Agreement between TV Squared and Bank dated as of the Effective Date, in each case, as may be amended, modified or restated from time to time.”
“    “Quick Assets” is, on any date, (a) (i) calculated on a consolidated basis with respect to Parent and its Subsidiaries (which shall in all cases include Borrower), unrestricted and unencumbered cash maintained with Bank and (ii) Borrower’s cash maintained at financial institutions other than Bank, so long as such account is subject to a Control Agreement satisfactory to Bank in its sole discretion, plus (b) calculated on a consolidated basis with respect to Parent and its Subsidiaries (which shall in all cases include Borrower), net billed accounts receivable.”

B.Schedule I (LSA Provisions) to the Loan Agreement is deleted in its entirety and replaced with Schedule I (LSA Provisions) attached as Annex A hereto.
6





C.The Compliance Statement appearing as Exhibit A to the Loan Agreement is hereby deleted and replaced with the Compliance Statement attached as Schedule 1 hereto.
4.FEES AND EXPENSES. Borrower shall pay to Bank a modification fee equal to Twenty Thousand Dollars ($20,000.00), which fee shall be fully earned, due and payable on the date hereof. Borrower shall also reimburse Bank for all legal fees and expenses incurred in connection with this amendment to the Existing Loan Documents.
5.PERFECTION CERTIFICATES.
A.Innovid LLC hereby ratifies, confirms and reaffirms, all and singular, the terms and disclosures contained in that certain Perfection Certificate of Innovid LLC dated as of August 2, 2023 (the “Innovid LLC Perfection Certificate”), and acknowledges, confirms and agrees that the disclosures and information Innovid LLC provided to Bank in such Perfection Certificate have not changed, as of the date hereof.
B.TV Squared hereby ratifies, confirms and reaffirms, all and singular, the terms and disclosures contained in that certain Perfection Certificate of TV Squared dated as of August, 2023 (the “TV Squared Perfection Certificate”), and acknowledges, confirms and agrees that the disclosures and information TV Squared provided to Bank in such Perfection Certificate have not changed, as of the date hereof.
Borrower hereby acknowledges and agrees that all references in the Loan Agreement to the “Perfection Certificate” shall mean and include the Innovid LLC Perfection Certificate and the TV Squared Perfection Certificate referred to herein.
6.RATIFICATION OF IP SECURITY AGREEMENTS.
A.Innovid LLC hereby ratifies, confirms and reaffirms, all and singular, the terms and conditions of the Innovid LLC IP Security Agreement, and acknowledges, confirms and agrees that the Innovid LLC IP Security Agreement contains an accurate and complete listing of all Intellectual Property Collateral as defined in the Innovid LLC IP Security Agreement, and shall remain in full force and effect.
B.TV Squared hereby ratifies, confirms and reaffirms, all and singular, the terms and conditions of the TV Squared IP Security Agreement, and acknowledges, confirms and agrees that the TV Squared IP Security Agreement contains an accurate and complete listing of all Intellectual Property Collateral as defined in the TV Squared IP Security Agreement, and shall remain in full force and effect.     
7.CONSISTENT CHANGES. The Existing Loan Documents are hereby amended wherever necessary to reflect the changes described above.
8.RATIFICATION OF LOAN DOCUMENTS. Borrower hereby ratifies, confirms, and reaffirms all terms and conditions of all security or other collateral granted to Bank, and confirms that the indebtedness secured thereby includes, without limitation, the Obligations.
9.RELEASE BY BORROWER.

A.FOR GOOD AND VALUABLE CONSIDERATION, Borrower hereby forever relieves, releases, and discharges Bank and its present or former employees, officers, directors, agents, representatives, attorneys, and each of them, from any and all claims, debts, liabilities, demands, obligations, promises, acts, agreements, costs and expenses, actions and causes of action, of every type, kind, nature, description or character whatsoever, whether known or unknown, suspected or unsuspected, absolute or contingent, arising out of or in any manner whatsoever connected with or related to facts, circumstances, issues, controversies or claims existing or arising from the beginning of time through and including the date of execution of this Loan Modification Agreement (collectively “Released Claims”). Without limiting the foregoing, the Released Claims shall include any and all liabilities or claims arising out of or in any manner whatsoever connected with or related to the Loan Documents, the Recitals hereto, any instruments, agreements or
7





documents executed in connection with any of the foregoing or the origination, negotiation, administration, servicing and/or enforcement of any of the foregoing.
B.In furtherance of this release, Borrower expressly acknowledges and waives any and all rights under Section 1542 of the California Civil Code, which provides as follows:
A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party.” (Emphasis added.)

C.By entering into this release, Borrower recognizes that no facts or representations are ever absolutely certain and it may hereafter discover facts in addition to or different from those which it presently knows or believes to be true, but that it is the intention of Borrower hereby to fully, finally and forever settle and release all matters, disputes and differences, known or unknown, suspected or unsuspected; accordingly, if Borrower should subsequently discover that any fact that it relied upon in entering into this release was untrue, or that any understanding of the facts was incorrect, Borrower shall not be entitled to set aside this release by reason thereof, regardless of any claim of mistake of fact or law or any other circumstances whatsoever. Borrower acknowledges that it is not relying upon and has not relied upon any representation or statement made by Bank with respect to the facts underlying this release or with regard to any of such party’s rights or asserted rights.
D.This release may be pleaded as a full and complete defense and/or as a cross-complaint or counterclaim against any action, suit, or other proceeding that may be instituted, prosecuted or attempted in breach of this release. Borrower acknowledges that the release contained herein constitutes a material inducement to Bank to enter into this Loan Modification Agreement, and that Bank would not have done so but for Bank’s expectation that such release is valid and enforceable in all events.
E.Borrower hereby represents and warrants to Bank, and Bank is relying thereon, as follows:
1Except as expressly stated in this Loan Modification Agreement, neither Bank nor any agent, employee or representative of Bank has made any statement or representation to Borrower regarding any fact relied upon by Borrower in entering into this Loan Modification Agreement.

2Borrower has made such investigation of the facts pertaining to this Loan Modification Agreement and all of the matters appertaining thereto, as it deems necessary.

3The terms of this Loan Modification Agreement are contractual and not a mere recital.

4This Loan Modification Agreement has been carefully read by Borrower, the contents hereof are known and understood by Borrower, and this Loan Modification Agreement is signed freely, and without duress, by Borrower.

5Borrower represents and warrants that it is the sole and lawful owner of all right, title and interest in and to every claim and every other matter which it releases herein, and that it has not heretofore assigned or transferred, or purported to assign or transfer, to any person, firm or entity any claims or other matters herein released. Borrower shall indemnify Bank, defend and hold it harmless from and against all claims based upon or arising in connection with prior assignments or purported assignments or transfers of any claims or matters released herein.
10.CONTINUING VALIDITY. Borrower understands and agrees that in modifying the existing Obligations, Bank is relying upon Borrower’s representations, warranties, and agreements, as set forth in the Existing Loan Documents. Except as expressly modified pursuant to this Loan Modification Agreement, the terms of the Existing Loan Documents remain unchanged and in full force and effect. Bank’s agreement to modifications to the existing Obligations pursuant to this Loan Modification Agreement in no way shall obligate Bank to make any future modifications to the Obligations. Nothing in this Loan Modification Agreement shall constitute a satisfaction of the Obligations. It is the intention of Bank and Borrower to retain as liable parties all makers of Existing Loan
8





Documents, unless the party is expressly released by Bank in writing. No maker will be released by virtue of this Loan Modification Agreement.
11.COUNTERSIGNATURE. This Loan Modification Agreement shall become effective only when it shall have been executed by Borrower and Bank.
12.ELECTRONIC EXECUTION OF DOCUMENTS. The words “ execution,” “ signed,” “ signature” and words of like import in this Loan Modification Agreement shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity and enforceability as a manually executed signature or the use of a paper-based recordkeeping systems, as the case may be, to the extent and as provided for in any applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act.
13.GOVERNING LAW. This First Loan Modification Agreement and the rights and obligations of the parties hereto shall be governed by and construed in accordance with the laws of the State of New York.

[The remainder of this page is intentionally left blank]



9





IN WITNESS WHEREOF, the parties hereto have caused this Loan Modification Agreement to be executed as of the date first written above.


BANK:


FIRST-CITIZENS BANK & TRUST COMPANY (SUCCESSOR BY PURCHASE TO THE FEDERAL DEPOSIT INSURANCE CORPORATION AS RECEIVER FOR SILICON VALLEY BRIDGE BANK, N.A. (AS SUCCESSOR TO SILICON VALLEY BANK))


By_/s/ Jaime Mariano_________________________
Name: Jaime E. Mariano
Title: Managing Director, Corporate Banking Credit
Solutions


BORROWER:


INNOVID LLC


By_/s/ Zvika Netter__________________________
Name: Zvika Netter
Title: President and Chief Executive Officer

TV SQUARED INC


By_/s/ Zvika Netter___________________________
Name: Zvika Netter
Title: Director






Annex A

SCHEDULE I
LSA PROVISIONS

LSA Section
LSA Provision
1.1(a) – Revolving Line –
Availability
Amounts borrowed under the Revolving Line may be prepaid or repaid and, prior to the Revolving Line Maturity Date, reborrowed, subject to the applicable terms and conditions precedent herein.
1.4(a)(i) – Interest Payments –
Advances
Interest on the principal amount of each Advance is payable in arrears (A) monthly on each Payment Date, (B) on the date of any prepayment and
(C) on the Revolving Line Maturity Date.
1.4(b)(i) – Interest Rate – Advances
The outstanding principal amount of any Advance shall accrue interest at a floating rate per annum equal to the greater of (1) four and one-quarter of one percent (4.25%) and (2) the Prime Rate plus the Prime Rate Margin, which interest shall be payable in accordance with Section 1.4(a).
1.4(e) – Interest Computation
Interest shall be computed on the basis of the actual number of days elapsed and a 360-day year for any Credit Extension outstanding.
1.5(a) – Revolving Line Commitment Fee and Anniversary Fee
(a) A fully earned, non-refundable commitment fee of Forty Thousand Dollars ($40,000) on the Effective Date, and (b) an anniversary fee equal to Seventy Five Thousand Dollars ($75,000), which is due and payable on the earlier to occur of (i) each anniversary of the Effective Date, (ii) the termination of this Agreement, or (iii) the occurrence of an Event of Default, and shall be fully earned and non-refundable as of such date.
8.8 – Borrower Liability
Each Borrower hereunder shall be jointly and severally obligated to repay all Credit Extensions made hereunder and any other Obligations related thereto, regardless of which Borrower actually receives said Credit Extension, as if each Borrower hereunder directly received all Credit Extensions.
12.2 – “Borrower”
Borrower” means, individually and collectively, jointly and severally, (i) Innovid LLC, a Delaware limited liability company with its principal place of business at 30 Irving Place 12th Floor New York, NY 10003 (“Innovid LLC”) and (ii) TV Squared Inc, a Delaware corporation with its principal place of business at 30 Irving Pl, Fl 12, New York, NY 10003 (“TV Squared”).
12.2 – “Effective Date”
Effective Date” is August 4, 2022.
12.2 – “Payment Date”
Payment Date” is with respect to Advances, the last calendar day of each month.
12.2 – “Prime Rate”
Prime Rate” is the rate of interest per annum from time to time published in the money rates section of The Wall Street Journal or any successor publication thereto as the “prime rate” then in effect; provided that if such rate of interest, as set forth from time to time in the money rates section of The Wall Street Journal, becomes unavailable for any reason as determined by Bank, the “Prime Rate” shall mean the rate of interest per annum announced by Bank as its prime rate in effect at its principal office in the State of California (such Bank announced Prime Rate not being intended to be the lowest rate of interest charged by Bank in connection with extensions of credit to debtors); provided that, in the event such rate of interest is less than zero percent (0.0%) per annum, such rate shall be deemed to be zero percent (0.0%) per annum for purposes of this Agreement.
12.2 – “Prime Rate Margin”
Prime Rate Margin” is one-quarter of one percent (0.25%).
12.2 – “Revolving Line”
Revolving Line” is an aggregate principal amount equal to Fifty Million Dollars ($50,000,000).
12.2 – “Revolving Line Maturity Date”
Revolving Line Maturity Date” is June 30, 2025.








SCHEDULE 1

EXHIBIT A
COMPLIANCE STATEMENT

TO:        SILICON VALLEY BANK,                    Date:                 
        a division of First-Citizens Bank & Trust Company        
FROM:     INNOVID LLC and TV SQUARED INC
        

Under the terms and conditions of the Loan and Security Agreement between Borrower and Bank (as amended, modified, supplemented and/or restated from time to time, the “Agreement”), Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below. Attached are the required documents evidencing such compliance, setting forth calculations prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes. Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.
Please indicate compliance status by circling Yes/No under “Complies” column.
Reporting CovenantsRequiredComplies
Monthly financial statementsMonthly within 30 daysYes No
Quarterly financial statements (income statement, cash flow, and balance sheet)Quarterly, when reported to the SEC
Annual financial statements (CPA Audited)FYE within 180 daysYes No
10-Q, 10-K and 8-K
Within 5 days after filing with
SEC
Yes No
Annual operating budgets, Capitalization table and projectionsas soon as available, at least annually, and within 10 days following board approval, and as revisedYes No
Copies of materials provided to the Boardat the same time it is delivered to the Board membersYes No
The following Intellectual Property was registered after the Effective Date (if no registrations, state “None”)
____________________________________________________________________________

    
Financial Covenants
RequiredActualComplies
Maintain as indicated:
Adjusted Quick Ratio (at all times; tested monthly)1.30:1.00___:1.00Yes No
Minimum Adjusted EBITDA (at all times; tested quarterly)________*$________Yes No N/A**

*As set forth in Section 5.10(b) of the Agreement.
**Testing subject to Section 5.10(b) of the Agreement.

The following financial covenant analysis and information set forth in Schedule 1 attached hereto are true and accurate as of the date of this Compliance Statement.

The following are the exceptions with respect to the statements above: (If no exceptions exist, state “No exceptions to note.”)
Schedule 1 to Compliance Statement

Financial Covenants of Borrower




In the event of a conflict between this Schedule and the Loan Agreement, the terms of the Loan Agreement shall govern.
Dated:    ____________________
I.    Adjusted Quick Ratio (tested monthly on a consolidated basis for Parent and its Subsidiaries (which shall in all cases include Borrower)) (Section 5.10 (a))
Required: > 1.30:1.00

Actual:    

A.Aggregate value of the unrestricted and unencumbered cash of Parent and its Subsidiaries (which shall in all cases include Borrower) maintained with Bank$
B.Aggregate value of Borrower’s cash maintained at financial institutions other than Bank, so long as such account is subject to a Control Agreement satisfactory to Bank in its sole discretion$
C.Aggregate value of the net billed accounts receivable of Parent and its Subsidiaries (which shall in all cases include Borrower)$
D.Quick Assets (the sum of lines A, B, and C)$
E.Aggregate value of obligations and liabilities of Parent and its Subsidiaries (which shall in all cases include Borrower) to Bank$
F.Aggregate value of liabilities of Parent and its Subsidiaries (which shall in all cases include Borrower) that matures within one (1) year$
G.Current Liabilities (the sum of line E and F)$
H.Adjusted Quick Ratio (line E divided by line G)


Is line H equal to or greater than the ratio set forth above?

          No, not in compliance              Yes, in compliance

II.    Adjusted EBITDA (tested monthly on a consolidated basis for Parent and its Subsidiaries (which shall in all cases include Borrower)) (Section 5.10 (b))
Required: See chart below




PeriodMinimum Adjusted EBITDA
Calendar quarter ending on March 31, 2022
($3,500,000)
Calendar quarter ending on June 30, 2022
$750,000
Calendar quarter ending on September 30, 2022$1,500,000
Calendar quarter ending on December 31, 2022$3,000,000
Calendar quarter ending on March 31, 2023($3,500,000)
Calendar quarter ending on June 30, 2023($1,000,000)
Calendar quarter ending on September 30, 2023$750,000
Calendar quarter ending on December 31, 2023$750,000
Calendar quarter ending on March 31, 2024($3,000,000)
Calendar quarter ending on June 30, 2024$3,250,000
Calendar quarter ending on September 30, 2024$750,000
Calendar quarter ending on December 31, 2024$6,500,000

Actual:




A.Net Income$__________
B.To the extent included in the determination of Net Income
1.    Interest Expense$__________
2.    Income tax expense$__________
3.    Depreciation expense$__________
4.    Amortization and impairment expense$__________
5. Non-cash stock-based compensation$__________
6. non-recurring expenses solely with respect to (a) Borrower’s calendar quarters ending June 30, 2023, September 30, 2023 and December 31, 2023, in an aggregate amount not to exceed $1,000,000.00 in any such calendar quarter and $2,500,000.00 in the aggregate for all addbacks for the calendar quarters ending June 30, 2023, September 30, 2023 and December 31, 2023 measured together, and (b) the fiscal year ending December 31, 2024, in an aggregate amount not to exceed $750,000.00 in any calendar quarter and $2,000,000.00 in the aggregate for all such addbacks in such fiscal year measured together
$__________
7. One (1) time expenses approved by Bank in writing in its sole discretion
$__________
8. Non-cash finance expenses
$__________
9.    The sum of lines 1 through 8$__________
C.Capitalized Software Costs$__________
D.Non-cash finance income$__________
E.Adjusted EBITDA (the sum of lines A and B, minus line C, minus Line D)$__________


Is line E equal to or greater than _______*?

*As set forth in the chart above.

      No, not in compliance              Yes, in compliance __________ N/A**


** Testing subject to Section 5.10(b) of the Agreement.


EX-31.1 4 exhibit311q22023.htm EX-31.1 Document
Exhibit 31.1


CERTIFICATION
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Zvika Netter, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and



Exhibit 31.1
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 8, 2023
/s/ Zvika Netter
Zvika Netter
Chief Executive Officer



EX-31.2 5 exhibit312q22023.htm EX-31.2 Document
Exhibit 31.2


CERTIFICATION
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Tanya Andreev-Kaspin, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and



Exhibit 31.2
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 8, 2023
/s/ Tanya Andreev-Kaspin
Tanya Andreev-Kaspin
Chief Financial Officer


EX-32.1 6 exhibit321q22023.htm EX-32.1 Document
Exhibit 32.1


CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(i) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: August 8, 2023             /s/ Zvika Netter
Zvika Netter
Chief Executive Officer

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.


EX-32.2 7 exhibit322q22023.htm EX-32.2 Document
Exhibit 32.2


CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(i) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: August 8, 2023                 /s/ Tanya Andreev-Kaspin
Tanya Andreev-Kaspin
Chief Financial Officer

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.



EX-101.SCH 8 ctv-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000007 - Disclosure - DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - GOODWILL link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - LONG-TERM DEBT link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - FINANCE INCOME, NET link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - INCOME TAX link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 9954701 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 9954702 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954703 - Disclosure - GOODWILL (Tables) link:presentationLink link:calculationLink link:definitionLink 9954704 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954705 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954706 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 9954707 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 9954708 - Disclosure - DESCRIPTION OF BUSINESS (Details) link:presentationLink link:calculationLink link:definitionLink 9954709 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954710 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954711 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 9954712 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk (Details) link:presentationLink link:calculationLink link:definitionLink 9954713 - Disclosure - GOODWILL - Schedule of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954714 - Disclosure - GOODWILL - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954715 - Disclosure - LEASES - Schedule of Operating ROU Assets and Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954716 - Disclosure - LEASES - Lease Costs Recognized in the Condensed Consolidated Statement of Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 9954717 - Disclosure - LEASES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954718 - Disclosure - LEASES - Supplementary Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954719 - Disclosure - LEASES - Schedule of Operating Lease Liabilities Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9954719 - Disclosure - LEASES - Schedule of Operating Lease Liabilities Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 9954720 - Disclosure - WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 9954721 - Disclosure - LONG-TERM DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 9954722 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 9954723 - Disclosure - STOCK-BASED COMPENSATION - Stock Option Activity Under Plan (Details) link:presentationLink link:calculationLink link:definitionLink 9954724 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954725 - Disclosure - STOCK-BASED COMPENSATION - Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954726 - Disclosure - STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954727 - Disclosure - FINANCE INCOME, NET (Details) link:presentationLink link:calculationLink link:definitionLink 9954728 - Disclosure - INCOME TAX (Details) link:presentationLink link:calculationLink link:definitionLink 9954729 - Disclosure - SEGMENT REPORTING - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954730 - Disclosure - SEGMENT REPORTING - Revenue and Property and Equipment, by Geographical Areas (Details) link:presentationLink link:calculationLink link:definitionLink 9954731 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Basic and Diluted Net (Loss) Income Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954732 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954733 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 ctv-20230630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 ctv-20230630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 ctv-20230630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Provision for income taxes Deferred Income Taxes and Tax Credits Consolidated Entities [Axis] Consolidated Entities [Axis] Variable Rate [Domain] Variable Rate [Domain] Consultants Share-Based Payment Arrangement, Nonemployee [Member] Accrued expenses and other current liabilities Accrued Liabilities, Current LATAM Latin America [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Research and development Research and Development Expense Changes in operating assets and liabilities Increase (Decrease) in Operating Capital [Abstract] Expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Award Type [Domain] Award Type [Domain] Outstanding at the beginning of the period (in shares) Outstanding at the ending of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number LONG-TERM DEBT FINANCE INCOME, NET Debt Disclosure [Text Block] Options And RSU's Options And RSU's [Member] Options And RSU's Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Payments to acquire Payments to Acquire Businesses, Gross Revolving Credit Facility Revolving Credit Facility [Member] Long-term restricted deposits Long Term Restricted Deposit Long Term Restricted Deposit Segment Reporting [Abstract] Trade payables Accounts Payable, Current Outstanding exercisable, weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term COMMITMENTS AND CONTINGENT LIABILITIES (Note 7) Commitments and Contingencies Exercisable options at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Transfer to level 1 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Conversion of Warrants Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Conversion of Warrants Schedule of Revenue and Property and Equipment, by Geographical Areas Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Business combination consideration paid in stock Noncash or Part Noncash Acquisition, Equity Instrument Consideration, Equity Issued Noncash or Part Noncash Acquisition, Equity Instrument Consideration, Equity Issued Geographical [Axis] Geographical [Axis] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] INCOME TAX Income Tax Disclosure [Text Block] Private Warrants Private Warrants [Member] Private Warrants Concentration Risk [Line Items] Concentration Risk [Line Items] Customer [Axis] Customer [Axis] Business Acquisition [Line Items] Business Acquisition [Line Items] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Impairments of long-lived assets Impairment, Long-Lived Asset, Held-for-Use Diluted (in dollars per share) Net profit (loss) per stock attributable to common stockholders – diluted (in dollars per share) Earnings Per Share, Diluted Derivative liability fair value Derivative Liability, Subject to Master Netting Arrangement, before Offset Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Trade receivables, net (allowance for credit losses of $330 and $65 at June 30, 2023, and December 31, 2022, respectively) Accounts Receivable, after Allowance for Credit Loss, Current Goodwill [Roll Forward] Goodwill [Roll Forward] Share price (in dollars per share) Business Acquisition, Share Price Level 3 Fair Value, Inputs, Level 3 [Member] Line of Credit Line of Credit [Member] Outstanding at the beginning of the period (in shares) Outstanding at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Stock options exercised Stock Issued During Period, Value, Stock Options Exercised Trading Symbol Trading Symbol Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Net (loss) income Net (loss) income Net loss Net Income (Loss) Total current liabilities Liabilities, Current LEASES Lessee, Operating Leases [Text Block] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Entity Ex Transition Period Entity Ex Transition Period Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Stock options exercised (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Acquired finite-lived intangible assets, weighted average useful life Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Number of share units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Level 1 Fair Value, Inputs, Level 1 [Member] Goodwill Goodwill, beginning balance Goodwill, ending balance Goodwill Equity Components [Axis] Equity Components [Axis] Exercise price per share (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Long-term deposit Long Term Other Deposit Long Term Other Deposit Entity Small Business Entity Small Business Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders Weighted Average Number of Shares Outstanding, Basic [Abstract] Local Phone Number Local Phone Number Decrease / (increase) in trade receivables, net Increase (Decrease) in Accounts Receivable Forecast Forecast [Member] Subsidiaries Subsidiaries [Member] Legacy Plan and 2021 Plan Legacy Plan and 2021 Plan [Member] Legacy Plan and 2021 Plan Measurement Frequency [Axis] Measurement Frequency [Axis] Warrants to purchase one share of Common stock, each at an exercise price of $11.50 per share Warrant Warrants outstanding Warrant [Member] Lease liabilities - non-current portion Operating Lease, Liability, Noncurrent Restricted Stock Units (RSUs) Unvested RSU outstanding Restricted Stock Units (RSUs) [Member] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Total undiscounted lease payments Lessee, Operating Lease, Liability, Undiscounted Lease Payments Lessee, Operating Lease, Liability, Undiscounted Lease Payments Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Income Statement Location [Axis] Income Statement Location [Axis] Line of Credit Facility [Table] Line of Credit Facility [Table] Net (loss) income per stock attributable to common stockholders Denominator: Earnings Per Share, Basic and Diluted EPS [Abstract] Earnings Per Share, Basic and Diluted EPS Schedule of Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Rest of the World Rest of the World [Member] Rest of the World [Member] Number of wholly owned subsidiaries Number Of Wholly Owned Subsidiaries Number Of Wholly Owned Subsidiaries Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Product and Service [Domain] Product and Service [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Debt related interest expense Interest Expense, Debt Grantee Status [Axis] Grantee Status [Axis] Short-term Debt [Line Items] Short-Term Debt [Line Items] Summary of Lease Cost Lease, Cost [Table Text Block] Research and development Research and Development Expense [Member] Amended Credit Agreement Maturing October 2018 Amended Credit Agreement Maturing October 2018 [Member] Amended Credit Agreement Maturing October 2018 Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Derivative Instruments and Hedging Activities Disclosure [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Quarterly adjusted quick ratio Quarterly Adjusted Quick Ratio Quarterly Adjusted Quick Ratio Non-cash transactions Noncash Investing and Financing Items [Abstract] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] General and administrative General and Administrative Expense [Member] Outstanding option, weighted average remaining contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Summary of Significant Accounting Policies [Line Items] Summary of Significant Accounting Policies [Line Items] Summary of Significant Accounting Policies [Line Items] Less: Interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Use of Estimates Use of Estimates, Policy [Policy Text Block] Commitments and Contingencies [Line Items] Commitments and Contingencies [Line Items] Commitments and Contingencies Entity File Number Entity File Number Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Share Based Payment Arrangement, Restricted Stock Unit, Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Lease liabilities - current portion Operating Lease, Liability, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Entity Shell Company Entity Shell Company Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Recently Adopted Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Increase in deposits Proceeds From (Payments For) Deposits, Investing Activities Proceeds From (Payments For) Deposits, Investing Activities Cash, cash equivalents, and restricted cash at the beginning of the period Cash, cash equivalents, and restricted cash at the end of the period Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Customer A Customer A [Member] Customer A 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Variable lease cost Variable Lease, Cost Operating lease cost Operating Lease, Cost Impairment of long-lived assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Common stock, shares issued (in shares) Common Stock, Shares, Issued Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Operating Leases Assets And Liabilities [Line Items] Operating Leases Assets And Liabilities [Line Items] Operating Leases Assets And Liabilities Security Exchange Name Security Exchange Name Options outstanding Employee Stock Option [Member] WARRANTS Derivative Instruments and Hedging Activities Disclosure [Text Block] Finance income, net Finance Income (Expenses), Net Finance Income (Expenses), Net Period for cost yet to be recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Cost not yet recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Withdrawal of short-term bank deposits Withdrawal of Short-term Bank Deposits Withdrawal of Short-term Bank Deposits Document Type Document Type Warrants Liability Warrants Liability [Member] Warrants Liability Annual interest rate (in percent) Line of Credit Facility, Interest Rate During Period Short term lease cost Short-Term Lease, Cost Common stock and equity awards issued for acquisition of TVS Stock Issued During Period, Value, Acquisitions EMEA EMEA [Member] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Warrants liability Warrant Liability, Noncurrent Warrant Liability, Noncurrent Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Subsequent Event [Table] Subsequent Event [Table] STOCK-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Weighted average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Prime rate (in percent) Debt Instrument, Prime Rate Percentage Debt Instrument, Prime Rate Percentage Business Acquisition [Axis] Business Acquisition [Axis] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Trade receivables, allowance for doubtful receivables Accounts Receivable, Allowance for Credit Loss, Current Subsequent Event Subsequent Event [Member] Customer Concentration Risk Customer Concentration Risk [Member] Ad serving services Revenue Recognition, Advertisement Serving Services, Percentage Revenue Recognition, Advertisement Serving Services, Percentage Variable Rate [Axis] Variable Rate [Axis] Income Statement [Abstract] Income Statement [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period TV Squared TV Squared [Member] TV Squared Title of 12(b) Security Title of 12(b) Security Capitalization cost Capitalized Computer Software, Additions Money market funds Cash and Cash Equivalents, Fair Value Disclosure Decrease in operating lease right of use assets Increase (Decrease) In Operating Lease Right Of Use Assets Increase (Decrease) In Operating Lease Right Of Use Assets Warrants liability Derivative Liability Numerator: Net Income (Loss) Attributable to Parent [Abstract] Outstanding at the beginning of the period (in dollars per share) Outstanding at the ending of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Line of credit quick ratio Line Of Credit Quick Ratio Line Of Credit Quick Ratio Income Tax Disclosure [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Total lease cost Lease, Cost Capitalized stock-based compensation expense Share-Based Payment Arrangement, Amount Capitalized Statistical Measurement [Axis] Statistical Measurement [Axis] Entity Interactive Data Current Entity Interactive Data Current Adjustments to reconcile net loss to net cash used in operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Effect of discrete items, increase (decrease) in effective tax rate Effective Income Tax Rate Discrete Items Percent Effective Income Tax Rate Discrete Items Percent Schedule Of Operating Leases Assets And Liabilities [Table] Schedule Of Operating Leases Assets And Liabilities [Table] Schedule Of Operating Leases Assets And Liabilities Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding New Revolving Credit Facility New Revolving Credit Facility [Member] New Revolving Credit Facility Goodwill and acquired intangible assets Goodwill and Intangible Assets, Policy [Policy Text Block] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accumulated deficit Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Revenue recognition Revenue from Contract with Customer [Policy Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Leases [Abstract] 2023 Modification Agreement 2023 Modification Agreement [Member] 2023 Modification Agreement Entity Address, State or Province Entity Address, State or Province Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Certificates of deposit Certificates of Deposit, at Carrying Value Other Income and Expenses [Abstract] Concentrations of credit risks Concentration Risk, Credit Risk, Policy [Policy Text Block] Total non-current assets Assets, Noncurrent Common stock, par value (in dollars per share) Ordinary shares, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Net cash provided by / (used in) investing activities Net Cash Provided by (Used in) Investing Activities Class of Stock [Domain] Class of Stock [Domain] Customer [Domain] Customer [Domain] Net (loss) income attributable to common stockholders, basic Net Income (Loss) Available to Common Stockholders, Basic Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Amount of options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt Instrument [Axis] Debt Instrument [Axis] Effective tax expense (benefit) Effective Income Tax Rate Reconciliation, Percent Lease liabilities Operating Lease, Liability Credit Facility [Axis] Credit Facility [Axis] TOTAL LIABILITIES Liabilities DESCRIPTION OF BUSINESS Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Increase in prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Measurement Frequency [Domain] Measurement Frequency [Domain] Plan Name [Axis] Plan Name [Axis] Debt Disclosure [Abstract] Canada CANADA Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Earnings Per Share [Abstract] Subsequent Event [Line Items] Subsequent Event [Line Items] Software development costs Research, Development, and Computer Software, Policy [Policy Text Block] Sales and marketing Selling and Marketing Expense Common stock: $0.0001 par value - Authorized: 500,000,000 at June 30, 2023, and December 31, 2022; Issued and outstanding: 138,737,104 and 133,882,414 at June 30, 2023, and December 31, 2022, respectively Common Stock, Value, Issued General and administrative General and Administrative Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Trade name Trade Names [Member] Issued, fully vested stock option (in shares) Business Acquisition, Equity Interest Issued or Issuable, Fully Vested Stock Option Business Acquisition, Equity Interest Issued or Issuable, Fully Vested Stock Option Israeli Subsidiary Israeli Subsidiary [Member] Israeli Subsidiary [Member] Total current assets Assets, Current Bank deposits pledged Bank Deposits, Pledged Bank Deposits, Pledged Schedules of Concentration of Risk, by Risk Factor Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Long-term restricted deposits Restricted Cash Supplemental disclosure of cash flows activities: Supplemental Cash Flow Information [Abstract] Entity Filer Category Entity Filer Category Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Concentration risk, percentage Concentration Risk, Percentage Beginning of the period End of the period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value APAC Asia Pacific [Member] Warrants outstanding (in shares) Class of Warrant or Right, Outstanding Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Schedule of Goodwill Schedule of Goodwill [Table Text Block] Net cash provided by / (used in) operating activities Net Cash Provided by (Used in) Operating Activities Outstanding exercisable intrinsic value at the end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Israel ISRAEL Class of Stock [Axis] Class of Stock [Axis] Change in fair value of warrants Fair Value Adjustment of Warrants Depreciation and amortization Depreciation, Depletion and Amortization Internal use software capitalization Payments to Develop Software Increase in employees and payroll accruals Increase (Decrease) in Employee Related Liabilities Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Cars Cars [Member] Cars Long-lived tangible assets Long-Lived Assets Goodwill impairment Goodwill impairment Goodwill impairment Goodwill, Impairment Loss Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Short-term bank deposits Short Term Bank Deposit, Current Short Term Bank Deposit, Current Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Non-refundable commitment fees Line of Credit Facility, Commitment Fee Amount Subsequent Events [Abstract] Subsequent Events [Abstract] Loss before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Level 2 Fair Value, Inputs, Level 2 [Member] Entity Emerging Growth Company Entity Emerging Growth Company Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Employees Share-Based Payment Arrangement, Employee [Member] Document Fiscal Period Focus Document Fiscal Period Focus 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Increase in accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Antidilutive Securities [Axis] Antidilutive Securities [Axis] Outstanding at the beginning of the period (in dollars per share) Outstanding at the end of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Common stock, par value $0.0001 per share Common stock Common Stock [Member] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] BASIC AND DILUTED NET (LOSS) INCOME PER SHARE Earnings Per Share [Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Stock options exercised and RSUs vested (in shares) Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Shares Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Shares Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Software development costs Software and Software Development Costs [Member] Minimum Minimum [Member] Property and equipment, net Property, Plant and Equipment, Net Schedule of Share Based Payment Arrangement, Option, Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Operating ROU Assets and Lease Liabilities Assets And Liabilities Lessee [Table Text Block] Assets And Liabilities Lessee Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Proceeds from loans Proceeds from Issuance of Long-Term Debt Decrease in operating lease liabilities Increase (Decrease) in Operating Lease Liability Income taxes paid, net of tax refunds Income Taxes Paid, Net Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities COMMITMENTS AND CONTINGENT LIABILITIES Commitments and Contingencies Disclosure [Text Block] Accumulated deficit Retained Earnings [Member] Schedule of Stock-based Compensation Expenses Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity Other non-current assets Other Assets, Noncurrent Basic (in dollars per share) Net profit (loss) per stock attributable to common stockholders – basic (in dollars per share) Earnings Per Share, Basic Operating lease right of use asset ROU assets Operating Lease, Right-of-Use Asset Accounting Policies [Abstract] Accounting Policies [Abstract] 2023 Remaining Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Public Warrants Public Warrants [Member] Public Warrants [Member] Net (loss) income attributable to common stockholders, diluted Net Income (Loss) Available to Common Stockholders, Diluted Entity Address, City or Town Entity Address, City or Town Total non-current liabilities Liabilities, Noncurrent Document Transition Report Document Transition Report Bank guarantees Bank Guarantees In connection With Office Lease Agreement Bank Guarantees In connection With Office Lease Agreement Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Fair value of financial instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Technology Technology-Based Intangible Assets [Member] Increase / (decrease) in trade payables Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Repayment of line of credit Repayments of Lines of Credit Document Information [Table] Document Information [Table] Gain from changes in the fair value Equity Securities, FV-NI, Unrealized Gain Weighted average fair value (in dollars per share) Business Acquisition, Fully Vested Stock Option, Weighted Average Fair Value Business Acquisition, Fully Vested Stock Option, Weighted Average Fair Value Liability Class [Axis] Liability Class [Axis] Summary of Significant Accounting Policies [Table] Summary of Significant Accounting Policies [Table] Summary of Significant Accounting Policies [Table] Amended Credit Agreement Maturing December 2020 Amended Credit Agreement Maturing December 2020 [Member] Amended Credit Agreement Maturing December 2020 Additional paid-in capital Additional Paid in Capital Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Document Information [Line Items] Document Information [Line Items] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Proceeds from exercise of options Proceeds from Stock Options Exercised Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Income taxes and tax contingencies Income Tax, Policy [Policy Text Block] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Shares issued as consideration (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Outstanding intrinsic value at the beginning of the period Outstanding intrinsic value at the end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Entity Registrant Name Entity Registrant Name Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders – Effect of dilutive securities - options And RSU (share equivalent) (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Payment term Revenue From Contract With Customer, Payment Term Revenue From Contract With Customer, Payment Term Common stocks and equity awards issued for acquisition of TVS (in shares) Stock Issued During Period, Shares, Acquisitions Cost of goods sold Cost of Sales [Member] Effective tax rate increase (decrease) Effective Income Tax Rate Reconciliation, Tax Credit, Percent Document Period End Date Document Period End Date Proceeds from line of credit Proceeds from Lines of Credit Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Exercisable exercise price at the end of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Repayment of loans Repayments of Long-Term Debt Entity Central Index Key Entity Central Index Key Liabilities: Liabilities, Fair Value Disclosure [Abstract] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Stock-based compensation expenses Share-Based Payment Arrangement, Expense Taxes on income Taxes on income Income Tax Expense (Benefit) Employees and payroll accruals Employee-related Liabilities, Current Number of operating segments Number of Operating Segments Revenue Benchmark Revenue Benchmark [Member] Operating lease, weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Revenues Revenue from Contract with Customer, Excluding Assessed Tax Entity [Domain] Entity [Domain] Amendment Flag Amendment Flag Legal Entity [Axis] Legal Entity [Axis] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Acquisition of business, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Operating lease, weighted average discount rate, percent Operating Lease, Weighted Average Discount Rate, Percent Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Assets: Assets, Fair Value Disclosure [Abstract] Credit Facility [Domain] Credit Facility [Domain] Measurement serving services Revenue Recognition, Measurement Serving, Percentage Revenue Recognition, Measurement Serving, Percentage Debt instrument, variable rate Debt Instrument, Basis Spread on Variable Rate Useful lives (in years) Property, Plant and Equipment, Useful Life GOODWILL Goodwill Disclosure [Text Block] Long-term debt Long-Term Debt, Excluding Current Maturities Sales and marketing Selling and Marketing Expense [Member] Modification fee amount Line Of Credit Facility, Modification Fee Amount Line Of Credit Facility, Modification Fee Amount Diluted (in shares) Weighted-average number of stocks used in computing net (loss) income per stock attributable to common stockholders - Diluted weighted average number of shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Grantee Status [Domain] Grantee Status [Domain] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Additional paid-in capital Additional Paid-in Capital [Member] Commitments and Contingencies [Table] Commitments and Contingencies [Table] Commitments and Contingencies Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price TOTAL ASSETS Assets Cover [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition US UNITED STATES Fair Value, Recurring Fair Value, Recurring [Member] Other non-current liabilities Other Liabilities, Noncurrent Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Total lease liabilities Lessee, Operating Lease, Liability, to be Paid Prime Rate Prime Rate [Member] SEGMENT REPORTING Segment Reporting Disclosure [Text Block] Paycheck Protection Program Paycheck Protection Program [Member] Paycheck Protection Program Increase (decrease) in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Equity Component [Domain] Equity Component [Domain] Stock options exercised and RSUs vested Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Value Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Value Scenario [Axis] Scenario [Axis] Basic (in shares) Weighted-average number of stocks used in computing net (loss) income per stock attributable to common stockholders - Basic weighted average number of shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Operating loss Operating Income (Loss) Schedule of Short-term Debt [Table] Schedule of Short-Term Debt [Table] Real Estate Real Estate [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Number of reporting units Number of Reporting Units Payment of SPAC merger transaction costs Payments of Merger Related Costs, Financing Activities Consolidated Entities [Domain] Consolidated Entities [Domain] Cost of revenues Cost of Revenue Shares of subsidiary pledged (in shares) Number Of Securities Pledged Number Of Securities Pledged Average annual fee unused portion (in percent) Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Statement [Line Items] Statement [Line Items] Concentration Risk [Table] Concentration Risk [Table] Scenario [Domain] Scenario [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Line of credit Long-Term Line of Credit Customer relationships Customer Relationships [Member] EX-101.PRE 12 ctv-20230630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 13 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover - shares
6 Months Ended
Jun. 30, 2023
Aug. 04, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2023  
Document Transition Report false  
Entity File Number 001-40048  
Entity Registrant Name Innovid Corp.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 87-3769599  
Entity Address, Address Line One 30 Irving Place,  
Entity Address, Address Line Two 12th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10003  
City Area Code 212  
Local Phone Number 966-7555  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   139,303,254
Entity Central Index Key 0001835378  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Common stock, par value $0.0001 per share    
Document Information [Line Items]    
Title of 12(b) Security Common stock, par value $0.0001 per share  
Trading Symbol CTV  
Security Exchange Name NYSE  
Warrants to purchase one share of Common stock, each at an exercise price of $11.50 per share    
Document Information [Line Items]    
Title of 12(b) Security Warrants to purchase one share of Common stock, each at an exercise price of $11.50 per share  
Trading Symbol CTVWS  
Security Exchange Name NYSE  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
ASSETS    
Cash and cash equivalents $ 43,384 $ 37,541
Short-term bank deposits 0 10,000
Trade receivables, net (allowance for credit losses of $330 and $65 at June 30, 2023, and December 31, 2022, respectively) 43,238 43,653
Prepaid expenses and other current assets 4,123 2,640
Total current assets 90,745 93,834
Long-term deposit 260 277
Long-term restricted deposits 396 430
Property and equipment, net 18,959 14,322
Goodwill 102,473 116,976
Intangible assets, net 27,659 29,918
Operating lease right of use asset 2,008 2,910
Other non-current assets 834 938
Total non-current assets 152,589 165,771
TOTAL ASSETS 243,334 259,605
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Trade payables 4,421 3,361
Employees and payroll accruals 10,969 10,165
Lease liabilities - current portion 1,611 2,186
Accrued expenses and other current liabilities 5,194 5,474
Total current liabilities 22,195 21,186
Long-term debt 20,000 20,000
Lease liabilities - non-current portion 1,081 1,636
Other non-current liabilities 9,461 6,554
Warrants liability 1,022 4,301
Total non-current liabilities 31,564 32,491
TOTAL LIABILITIES 53,759 53,677
COMMITMENTS AND CONTINGENT LIABILITIES (Note 7)
Common stock: $0.0001 par value - Authorized: 500,000,000 at June 30, 2023, and December 31, 2022; Issued and outstanding: 138,737,104 and 133,882,414 at June 30, 2023, and December 31, 2022, respectively 13 13
Additional paid-in capital 367,970 356,801
Accumulated deficit (178,408) (150,886)
Total stockholders’ equity 189,575 205,928
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 243,334 $ 259,605
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Trade receivables, allowance for doubtful receivables $ 330 $ 65
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 138,737,104 133,882,414
Common stock, shares outstanding (in shares) 138,737,104 133,882,414
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenues $ 34,546 $ 33,088 $ 65,031 $ 58,950
Cost of revenues [1] 8,591 7,351 16,856 13,277
Research and development [1] 6,876 9,710 13,993 16,964
Sales and marketing [1] 11,460 14,320 23,097 24,671
General and administrative [1] 8,924 9,955 18,574 21,410
Depreciation and amortization 2,064 926 4,094 1,599
Goodwill impairment 14,503 0 14,503 0
Operating loss (17,872) (9,174) (26,086) (18,971)
Finance income, net (248) (13,306) (2,723) (15,617)
Loss before taxes (17,624) 4,132 (23,363) (3,354)
Taxes on income 1,335 (168) 4,159 (205)
Net (loss) income (18,959) 4,300 (27,522) (3,149)
Net (loss) income attributable to common stockholders, basic (18,959) 4,300 (27,522) (3,149)
Net (loss) income attributable to common stockholders, diluted $ (18,959) $ 4,300 $ (27,522) $ (3,149)
Net (loss) income per stock attributable to common stockholders        
Basic (in dollars per share) $ (0.14) $ 0.03 $ (0.20) $ (0.02)
Diluted (in dollars per share) $ (0.14) $ 0.03 $ (0.20) $ (0.02)
Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders        
Basic (in shares) 137,643,910 132,152,652 134,296,569 128,220,893
Diluted (in shares) 137,643,910 139,988,123 134,296,569 128,220,893
[1] Exclusive of depreciation, amortization and goodwill impairment presented separately.
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021   119,017,380    
Beginning balance at Dec. 31, 2021 $ 161,255 $ 12 $ 293,719 $ (132,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stocks and equity awards issued for acquisition of TVS (in shares)   11,549,465    
Common stock and equity awards issued for acquisition of TVS 47,152 $ 1 47,151  
Stock-based compensation 1,496   1,496  
Stock options exercised (in shares)   1,521,927    
Stock options exercised 462   462  
Net (loss) income (7,449)     (7,449)
Ending balance (in shares) at Mar. 31, 2022   132,088,772    
Ending balance at Mar. 31, 2022 202,916 $ 13 342,828 (139,925)
Beginning balance (in shares) at Dec. 31, 2021   119,017,380    
Beginning balance at Dec. 31, 2021 161,255 $ 12 293,719 (132,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income (3,149)      
Ending balance (in shares) at Jun. 30, 2022   132,411,715    
Ending balance at Jun. 30, 2022 212,018 $ 13 347,630 (135,625)
Beginning balance (in shares) at Mar. 31, 2022   132,088,772    
Beginning balance at Mar. 31, 2022 202,916 $ 13 342,828 (139,925)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 4,628   4,628  
Stock options exercised (in shares)   322,943    
Stock options exercised 174   174  
Net (loss) income 4,300     4,300
Ending balance (in shares) at Jun. 30, 2022   132,411,715    
Ending balance at Jun. 30, 2022 $ 212,018 $ 13 347,630 (135,625)
Beginning balance (in shares) at Dec. 31, 2022 133,882,414 133,882,414    
Beginning balance at Dec. 31, 2022 $ 205,928 $ 13 356,801 (150,886)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 4,897   4,897  
Stock options exercised and RSUs vested (in shares)   2,734,320    
Stock options exercised and RSUs vested 250   250  
Net (loss) income (8,563)     (8,563)
Ending balance (in shares) at Mar. 31, 2023   136,616,734    
Ending balance at Mar. 31, 2023 $ 202,512 $ 13 361,948 (159,449)
Beginning balance (in shares) at Dec. 31, 2022 133,882,414 133,882,414    
Beginning balance at Dec. 31, 2022 $ 205,928 $ 13 356,801 (150,886)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income $ (27,522)      
Ending balance (in shares) at Jun. 30, 2023 138,737,104 138,737,104    
Ending balance at Jun. 30, 2023 $ 189,575 $ 13 367,970 (178,408)
Beginning balance (in shares) at Mar. 31, 2023   136,616,734    
Beginning balance at Mar. 31, 2023 202,512 $ 13 361,948 (159,449)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 5,658   5,658  
Stock options exercised and RSUs vested (in shares)   2,120,370    
Stock options exercised and RSUs vested 364   364  
Net (loss) income $ (18,959)     (18,959)
Ending balance (in shares) at Jun. 30, 2023 138,737,104 138,737,104    
Ending balance at Jun. 30, 2023 $ 189,575 $ 13 $ 367,970 $ (178,408)
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net loss $ (27,522) $ (3,149)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4,094 1,599
Goodwill impairment 14,503 0
Stock-based compensation 9,865 5,634
Change in fair value of warrants (3,279) (15,946)
Changes in operating assets and liabilities    
Decrease / (increase) in trade receivables, net 415 (4,624)
Increase in prepaid expenses and other current assets (1,390) (747)
Decrease in operating lease right of use assets 902 872
Increase / (decrease) in trade payables 1,060 (321)
Increase in employees and payroll accruals 804 1,044
Decrease in operating lease liabilities (1,130) (1,208)
Increase in accrued expenses and other current liabilities 2,626 945
Net cash provided by / (used in) operating activities 948 (15,901)
Cash flows from investing activities:    
Acquisition of business, net of cash acquired 0 (99,568)
Internal use software capitalization (5,591) (3,516)
Purchase of property and equipment (189) (221)
Withdrawal of short-term bank deposits 10,000 0
Increase in deposits 27 32
Net cash provided by / (used in) investing activities 4,247 (103,273)
Cash flows from financing activities:    
Proceeds from loans 10,000 9,000
Repayment of loans (10,000) 0
Payment of SPAC merger transaction costs 0 (3,185)
Proceeds from exercise of options 614 636
Net cash provided by financing activities 614 6,451
Increase (decrease) in cash, cash equivalents, and restricted cash 5,809 (112,723)
Cash, cash equivalents, and restricted cash at the beginning of the period 37,971 157,158
Cash, cash equivalents, and restricted cash at the end of the period 43,780 44,435
Supplemental disclosure of cash flows activities:    
Income taxes paid, net of tax refunds 879 363
Interest 782 137
Non-cash transactions    
Business combination consideration paid in stock 0 47,152
Reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets    
Cash and cash equivalents 43,384 44,024
Long-term restricted deposits 396 411
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows $ 43,780 $ 44,435
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.2
DESCRIPTION OF BUSINESS
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
DESCRIPTION OF BUSINESS DESCRIPTION OF BUSINESS
Innovid Corp. together with its consolidated subsidiaries, the “Company” or “Innovid”, is a leading independent software platform that provides an ad serving and creative personalization platform for the creation, delivery, and measurement of TV ads across connected TV (“CTV”), mobile TV and desktop TV environments to advertisers, publishers and media agencies.
Innovid Corp. was originally incorporated as ION Acquisition Corp. 2 Ltd. (“ION”), a special purpose acquisition company, on November 23, 2020 and Innovid Corp. was the surviving entity following the completion of its merger with ION on November 30, 2021 (the “ION Transaction”).
On February 28, 2022, the Company completed the acquisition of TV Squared Limited (“TVS”, together with ION’s Transaction, the “Transactions”) by way of stock purchase agreement (“Stock Purchase Agreement”). The Company acquired all of the equity of TVSquared for an aggregate amount of $100,000 in cash, 11,549,465 shares of the Company common stock at fair value of $3.80 per share and the issuance of 949,893 fully vested stock options of the Company at a weighted average fair value of $3.49, subject to certain adjustments as defined in the Stock Purchase Agreement.
Innovid Corp.’s common stock and warrants are trading on the NYSE under the symbols “CTV” and “CTV.WS,” respectively, since December 1, 2021.
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The unaudited interim condensed consolidated financial statements have been prepared in accordance with US GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative US GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Updates (“ASU”) of the Financial Accounting Standards Board (“FASB”) and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by US GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation. The Company’s interim period results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year.
The condensed consolidated balance sheet as of December 31, 2022, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by US GAAP for complete financial statements.
These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and footnotes included in the Company’s 2022 Annual Report on Form 10-K.
The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2022, have been applied consistently in these unaudited interim condensed consolidated financial statements, unless otherwise stated.
Use of Estimates
The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments, and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Accounting Policies
Software development costs
Software development costs, which are included in property and equipment, net, consists of capitalized costs related to the purchase and development of internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing or obtaining the software.
Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the estimated useful life of the software, which is three years. The amortization is presented within depreciation and amortization in the condensed consolidated statements of operations. During the three and six months ended June 30, 2023 (unaudited), the Company capitalized $2,825 and $6,281, respectively, and during the three and six months ended June 30, 2022 (unaudited), the Company capitalized $2,335 and $4,006, respectively, related to internal-use software cost.
Impairment of long-lived assets
Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss. During the three and six months ended June 30, 2023 (unaudited), the Company tested its long-lived assets for recoverability and concluded that no impairment should be recognized.
Goodwill and acquired intangible assets
Goodwill and acquired intangible assets have been recorded in the Company's financial statements resulting from     various business combinations. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is subject to an annual impairment test.
Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. The Company currently has one reporting unit.
ASC 350, Intangibles—Goodwill and other (“ASC 350”) requires goodwill to be tested for impairment at least annually and, in certain circumstances, between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. The Company elects to perform an annual impairment test of goodwill as of October 1 of each year, or more frequently if impairment indicators are present. During the three months ended June 30, 2023, the Company recorded Goodwill impairment in the amount of $14,503. Refer to Note 3 for further details.
Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date.
Customer relationships, acquired technology and trade name are being amortized over the estimated useful life of approximately 11 years, 6 years, and 4 years, respectively, using the straight-line amortization method.
The amortization of customer relationships, acquired technology and trade names, is presented within depreciation and amortization in the condensed consolidated statements of operations.
Fair value of financial instruments
The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.
Level 3 - Unobservable inputs which are supported by little or no market activity.
The Company’s financial instruments consist of cash and cash equivalents, restricted deposits, trade receivables, net, trade payables, employees, payroll accruals, accrued expenses and other current liabilities and current portion of long-term debts. Their historical carrying amounts represent the approximate fair value due to the short-term maturities of these instruments.
The Company’s investments in money market funds are classified as cash equivalents and measured at fair value. The Company measures its warrant liability at fair value.
The goodwill impairment recorded in the second quarter of 2023 was estimated using the Company's stock price, a Level 1 input, adjusted for an estimated control premium.
The following tables present information about the Company’s financial instruments that are measured at fair value on a recurring basis:

June 30, 2023
(Unaudited)

Level 1
Level 2
Level 3
Assets:
Money market funds$36,323 $— $— 
Liabilities:
Warrants liability$1,022 $— $— 

December 31, 2022

Level 1
Level 2
Level 3
Assets:
Money market funds$18,948 $— $— 
Certificates of deposit— 20,000 — 
Liabilities:
Warrants liability$1,265 $— $3,036 
The change in the fair value of the Level 3 warrant liability is summarized below:

June 30,December 31,June 30,

20232022

2022
(Unaudited)(Unaudited)
Beginning of the period
$3,036 $15,462 $15,462 
Change in fair value(2,330)(12,426)(13,132)
Transfer to level 1(706)— — 
End of the period$— $3,036 $2,330 
As of June 30, 2023, the Company’s warrant liability includes the Warrants (refer to Note 5), that were originally issued in connection with ION’s initial public offering, the “ION IPO,” which were transferred to the Company as part of the ION’s Transaction. The Company’s Warrants are recorded on the balance sheet at fair value with changes in fair value recognized through earnings. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement the valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations.
The Company has determined that the fair value of the Public Warrants and Transferred Private Warrants (refer to Note 5) Warrants, at the balance sheet date is determined by the closing price of the Company’s warrants, and are within Level 1 of the fair value hierarchy. The closing price of the Public Warrants and Transferred Private Warrants was $0.10 as of June 30, 2023 the price for Public Warrants was $0.40 as of December 31, 2022.
The Transferred Private Warrants are no longer classified as Level 3 as of June 30, 2023. Refer to Note 5, Warrants for further discussion.
Gains and losses from the remeasurement of the Public and Private Warrants’ liability is recognized in finance income, net in the condensed consolidated statements of operations.
Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instruments. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect these estimates.
Concentrations of credit risks
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net.
Most of the Company’s cash and cash equivalents are invested in deposits with major banks in the US and Israel. The Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed federally insured limits. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.
The Company’s trade receivables, net is mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.
The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
One of the Company’s customers accounted for more than 10% of the Company’s total revenues during the three and six months ended June 30, 2023.

Three months ended June 30,Six months ended June 30,

2023

20222023

2022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Customer A
16 %*)16 %*)
*) less than 10%
Revenue recognition
Most of the Company’s revenues are derived from providing Ad serving solutions to advertisers, media agencies and publishers. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display and other channels.
The Company also provides measurement services to advertisers and agencies, streaming platforms and publishers. The measurement service provides analytics and the ability to track performance of advertising campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.
The Company also provides creative services for the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.
The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied.
For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis.
Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.
Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period.
Revenues related to creative projects are recognized at a point in time when the Company delivers an ad unit. Creative services projects are usually delivered within a week.
The Company’s accounts receivable consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less.
The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be canceled without cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts.
The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract.
Ad serving services were 77.3% and 78.4% of the Company’s revenues for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), respectively and were 77.2% and 83.4% of the Company’s revenues for the six months ended June 30, 2023 (unaudited) and 2022 (unaudited). Measurement services were 22.7% and 21.6% for the three months ended June 30, 2023 (unaudited) and June 30, 2022 (unaudited), respectively and were 22.8% and 16.6% of the Company’s revenues for the six months ended June 30, 2023 (unaudited) and 2022 (unaudited).
Costs to obtain a contract
Contract costs include commission programs to compensate sales employees for generating sales orders with new customers or for new services with existing customers. Generally, the commissions are commensurate. The Company elected to apply the practical expedient and recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less. If commissions are not commensurate, the Company capitalizes these commissions. Capitalized commission costs were immaterial for the three and six months ended June 30, 2023 (unaudited) and June 30, 2022 (unaudited).
Trade receivable, net
The Company records trade receivable for amounts invoiced and yet unbilled invoices. The Company makes estimates of expected credit losses for the allowance for doubtful accounts based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The estimated credit loss allowance is recorded as general and administrative expenses on the Company's condensed consolidated statements of operations.
Income taxes and tax contingencies
Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts.
The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.
ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income.
On December 20, 2017, Congress passed the “US Tax Act.” The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations and the preparation and analysis of information not previously relevant or regularly produced. The US Tax Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.
Recently Adopted Accounting Pronouncements
In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. ASU 2016-13 requires enhanced qualitative and quantitative disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The adoption has impacted how the Company assesses its estimates for credit losses but did not have a material impact on these unaudited interim condensed consolidated financial statements.
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.23.2
GOODWILL
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL GOODWILL
The changes in the carrying amount of goodwill:
Goodwill
Total value
Balance as of January 1, 2023$116,976 
Goodwill impairment(14,503)
Balance as of June 30, 2023$102,473 
The Company periodically analyzes whether any indicators of goodwill impairment have occurred. In the second quarter of 2023, the Company experienced a decline in its stock price resulting in its market capitalization being less than the carrying value of its one reporting unit. Thus, the Company performed quantitative assessments of the Company’s reporting unit. The fair value was determined based on the market approach. The market approach utilizes the Company's market capitalization plus an appropriate control premium. Market capitalization is determined by multiplying the number of common stock outstanding by the market price of its common stock. The control premium is determined by utilizing publicly available data from studies for similar transactions of public companies.
As a result of this assessment, the Company recorded a goodwill impairment of $14,503 as of June 30, 2023.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.23.2
LEASES
6 Months Ended
Jun. 30, 2023
Leases [Abstract]  
LEASES LEASES
Innovid's lease portfolio primarily consists of real estate properties. Short-term leases with a term of 12 months or less are not recorded on the balance sheet. Innovid does not separate lease components from non-lease components.
The Company is a lessee in all its lease agreements. The Company records lease liabilities based on the present value of lease payments over the lease term. Innovid generally uses an incremental borrowing rate to discount its lease liabilities, as the rate implicit in the lease is typically not readily determinable. Certain lease agreements include renewal options that are under the Company's control. Innovid includes optional renewal periods in the lease term only when it is reasonably certain that Innovid will exercise its option.
Variable lease payments are primarily related to payments to lessors for taxes, maintenance, insurance and other operating costs. The Company's lease agreements do not contain any significant residual value guarantees or restrictive covenants.
The Company has the following operating ROU assets and lease liabilities:

June 30, 2023December 31, 2022
(Unaudited)
ROU assetsLease liabilitiesROU assetsLease liabilities
Real Estate$2,008 $2,692 $2,886 $3,801 
Cars— — 24 21 
Total operating leases$2,008 $2,692 $2,910 $3,822 
The following table summarizes the lease costs recognized in the interim condensed consolidated statement of operations:

Three months ended June 30,Six months ended June 30,
2023202220232022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Operating lease cost$458 $472 $921 $947 
Short term lease cost320 126 583 208 
Variable lease cost25 46 10 
Total lease cost$803 $604 $1,550 $1,165 

As of June 30, 2023 (unaudited), the weighted-average remaining lease term and weighted-average discount rate for operating leases are 1.8 years and 2.5%, respectively.
The following table presents supplementary cash flow information regarding the Company's operating leases:
Six months ended June 30, 2023Six months ended June 30, 2022
(Unaudited)(Unaudited)
Cash paid for amounts included in the measurement of lease liabilities$1,035 $1,133 
The following table summarizes the future payments of Innovid for its operating lease liabilities:
Six months ended June 30, 2023
(Unaudited)
2023 Remaining$1,124 
2024972 
2025636 
Total undiscounted lease payments$2,732 
Less: Interest(40)
Total lease liabilities$2,692 
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.23.2
WARRANTS
6 Months Ended
Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
WARRANTS WARRANTSAs of June 30, 2023, the Company had 3,162,500 Public Warrants and 7,060,000 Private Warrants outstanding. As of June 30, 2023, the majority of the Private Warrants (the “Transferred Private Warrants”) had been transferred from their initial holder to other transferees. The Transferred Private Warrants terms are now identical to the Public Warrants resulting in use of the same price for valuation purposes.The Company’s Warrants’ fair value as of June 30, 2023 (unaudited), and December 31, 2022, was $1,022 and $4,301, respectively. Gains and losses related to the Company’s Warrants are recognized in “Finance income, net.” See Note 9 for further details.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.23.2
LONG-TERM DEBT
6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
LONG-TERM DEBT LONG-TERM DEBT
On August 4, 2022, two wholly owned subsidiaries of the Company, Innovid LLC and TV Squared Inc, entered an amended and restated loan and security agreement with Silicon Valley Bank (the “2022 A&R Agreement”), to increase the revolving line of credit from $15,000 to $50,000 (the “New Revolving Credit Facility”). The 2022 A&R Agreement and the New Revolving Credit Facility were amended by a First Loan Modification Agreement dated August 2, 2023 (the “2023 Modification Agreement”). The interest for the New Revolving Credit Facility is payable monthly in arrears. The New Revolving Credit Facility bears interest at an annual rate which is the greater of (a) WSJ Prime Rate plus 0.25% or (b) 4.25%, on the aggregate outstanding balance. Additional fees include fees in an amount of 0.20% per annum of the average unused portion of the New Revolving Credit Facility to be paid quarterly in arrears. The Company will also pay non-refundable commitment fees of $40 and $75 at inception and first anniversary date, respectively, together with a modification fee of $20 payable on the date of the 2023 Modification Agreement. The maturity date of the 2022 A&R Agreement, as amended by the 2023 Modification Agreement, is June 30, 2025. The New Revolving Credit Facility is subject to certain customary conditions precedent to the credit extension as stated in the 2022 A&R Agreement.
The New Revolving Credit Facility requires the Company to comply with all covenants, primarily maintaining an adjusted quick ratio of at least 1.30 to 1.00. As defined in the 2022 A&R Agreement, “adjusted quick ratio” is the ratio of (a) quick assets to (b) current liabilities minus the current portion of deferred revenue. “Quick assets” are determined as the Company’s unrestricted cash plus accounts receivable, net, and is determined according to US GAAP. The Company is also required to maintain the minimum quarterly adjusted EBITDA as defined in the 2022 A&R Agreement, as amended by the 2023 Modification Agreement, if the Company does not maintain the quarterly adjusted quick ratio of at least 1.50 to 1.00.
As of June 30, 2023 (unaudited), and December 31, 2022, the Company utilized $20,000 of the $50,000 credit line. In January 2023, the Company repaid $5,000 under the credit line and $5,000 was subsequently drawn in March 2023. In May 2023, the Company repaid $5,000 under the credit line and $5,000 was subsequently drawn in June 2023.
As of June 30, 2023 (unaudited), the Company is in compliance with all the covenants.
Prior to the 2022 A&R Agreement, the credit installments bore US dollar denominated interest at an annual rate equal to 0.75%-1% plus the prime rate on the outstanding principal of each credit installment and prior to the 2023 Modification Agreement the New Revolving Credit Facility bore interest at an annual rate which was the greater of (a) WSJ Prime Rate plus 0.75% or (b) 4.25%.
FINANCE INCOME, NET
The Company recognizes the gains and losses from the remeasurement of the warrants liability related to the Public Warrants and Private Placement Warrants, as defined in Note 5, Warrants, in “Finance income, net” in the condensed consolidated statements of operations. The unrealized gain from changes in the fair value of the Company Warrants for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $565 and $13,159, respectively. The unrealized gain from changes in the fair value of the Company Warrants for the six months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $3,279 and $15,946, respectively.
The Company also recognized interest expenses in “Finance income, net” in the condensed consolidated statements of operations. Interest expenses for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $420 and $76, respectively. Interest expenses for the six months ended June 30, 2023 and 2022, were $782 and $137, respectively.
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENT LIABILITIES
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENT LIABILITIES COMMITMENTS AND CONTINGENT LIABILITIES
Pledges and bank guarantees
1.In conjunction with the 2022 A&R Agreement (see Note 6, Long-term Debt), Innovid LLC pledged 65,000 common stocks of its Israeli Subsidiary, NIS 0.01 par value each.
2.The Israeli Subsidiary pledged bank deposits in an aggregate amount of $601 in connection with an office rent agreement and credit cards.
3.Innovid Inc. obtained bank guarantees in an aggregate amount of $231 in connection with its office lease agreements.
Legal contingenciesOn March 4, 2022, a lawsuit was filed in the United States District Court for the Western District of Texas by the Nielsen, Company (US) LLC against TVS alleging infringement of US Patent No.10,063,378. On June 1, 2022, TVS moved to transfer the case to the Southern District of New York. On February 24, 2023, the case was transferred to the Southern District of New York. On March 23, 2023, the parties jointly filed their proposed case management plan and scheduling order, which the Court entered and thereafter opened discovery. That order sets the close of fact discovery for October 23, 2023, and the close of expert discovery for January 23, 2024, but does not set a date for trial. On the same day, TV Squared filed a motion for judgment on the pleadings under Federal Rule 12(c) arguing invalidity of all asserted patent claims. Briefing concluded on April 24, 2023, and the motion remains pending. The plaintiff has not specified the amount sought in the litigation. Given the uncertainty of litigation and the preliminary stage of the lawsuit, the Company is unable at this time to give an estimate of the amount or range of potential loss, if any, which might result to the Company if the outcome in such litigation was unfavorable. As of June 30, 2023, the Company did not record a loss contingency.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
Stock-based compensation expense is related to awards issued pursuant to the Legacy Innovid Stock Option Plan (“Legacy Plan”) and 2021 Innovid Corp. Incentive Plan (“2021 Plan”) and is summarized as follows:

Three months ended June 30,Six months ended June 30,

2023202220232022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Cost of goods sold
$435 $383 $876 $488 
Research and development
1,229 920 2,403 1,399 
Sales and marketing
1,690 1,529 3,269 2,109 
General and administrative
1,980 1,306 3,410 1,734 
Total
$5,334 $4,138 $9,958 $5,730 
In connection with the awards granted to service providers and non-employee consultants, the Company’s expense is immaterial in the periods presented.
During the three and six months ended June 30, 2023 (unaudited), the Company capitalized stock-based compensation expense of $325 and $690 of internal-use software costs, respectively.
During the three and six months ended June 30, 2022, the Company capitalized stock-based compensation expense of $490, respectively, in internal-use software cost.
Stock Options
Stock options may be granted to officers, directors, employees and non-employee consultants of the Company. Each option granted under the Plan expires no later than 10 years from the date of grant. The options vest usually over four years from commencement of employment or service start date. Any options forfeited or not exercised before expiration become available for future grants.
A summary of the employees’ stock option activity for the six months ended June 30, 2023 (unaudited), is as follows:

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of period
10,658,085 $1.15 6.85$5,923 
Granted832,232 1.55 
Forfeited(207,449)1.89 
Expired(163,640)1.65 
Exercised(1,376,572)0.45 
Outstanding at end of period
9,742,656 $1.26 7.08$14,232 
Exercisable options at end of period
6,563,845 $0.99 6.37$11,356 
A summary of the consultants’ stock option activity for the six months ended June 30, 2023 (unaudited), is as follows:

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of period
69,542 $0.47 4.21$86 
Forfeited— — 
Exercised— — 
Outstanding at end of period
69,542 $0.47 3.72$156 
Exercisable options at end of period
66,196 $0.46 3.53$149 
As of June 30, 2023 (unaudited), the Company had approximately $3,945 of total unrecognized compensation cost related to non-vested stock options. That cost is expected to be recognized over a weighted-average period of 1.92 years.
Restricted Stock Units
Restricted Stock Units (“RSUs”) may be granted to officers, directors, employees and non-employee consultants of the Company, and generally vest over a three- or four-year period.
A summary of the employees’ RSU activity under the 2021 Plan for the six months ended June 30, 2023 (unaudited), is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of period
7,989,825 $5.60 
Granted12,096,238 1.28 
Vested(3,424,868)5.27 
Forfeited(1,113,878)4.88 
Outstanding at end of period
15,547,317 $2.36 
A summary of the consultants’ RSU activity under the 2021 Plan for the six months ended June 30, 2023 (unaudited), is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of period
130,268 $6.60 
Granted107,343 1.18 
Vested(53,250)6.60 
Forfeited(8,226)6.60 
Outstanding at end of period
176,135 $3.30 
The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Innovid’s common stock on the date of grant.
As of June 30, 2023 (unaudited), $33,727 of unrecognized compensation cost related to RSUs is expected to be recognized as expense over the weighted average period of 2.3 years.
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.23.2
FINANCE INCOME, NET
6 Months Ended
Jun. 30, 2023
Other Income and Expenses [Abstract]  
FINANCE INCOME, NET LONG-TERM DEBT
On August 4, 2022, two wholly owned subsidiaries of the Company, Innovid LLC and TV Squared Inc, entered an amended and restated loan and security agreement with Silicon Valley Bank (the “2022 A&R Agreement”), to increase the revolving line of credit from $15,000 to $50,000 (the “New Revolving Credit Facility”). The 2022 A&R Agreement and the New Revolving Credit Facility were amended by a First Loan Modification Agreement dated August 2, 2023 (the “2023 Modification Agreement”). The interest for the New Revolving Credit Facility is payable monthly in arrears. The New Revolving Credit Facility bears interest at an annual rate which is the greater of (a) WSJ Prime Rate plus 0.25% or (b) 4.25%, on the aggregate outstanding balance. Additional fees include fees in an amount of 0.20% per annum of the average unused portion of the New Revolving Credit Facility to be paid quarterly in arrears. The Company will also pay non-refundable commitment fees of $40 and $75 at inception and first anniversary date, respectively, together with a modification fee of $20 payable on the date of the 2023 Modification Agreement. The maturity date of the 2022 A&R Agreement, as amended by the 2023 Modification Agreement, is June 30, 2025. The New Revolving Credit Facility is subject to certain customary conditions precedent to the credit extension as stated in the 2022 A&R Agreement.
The New Revolving Credit Facility requires the Company to comply with all covenants, primarily maintaining an adjusted quick ratio of at least 1.30 to 1.00. As defined in the 2022 A&R Agreement, “adjusted quick ratio” is the ratio of (a) quick assets to (b) current liabilities minus the current portion of deferred revenue. “Quick assets” are determined as the Company’s unrestricted cash plus accounts receivable, net, and is determined according to US GAAP. The Company is also required to maintain the minimum quarterly adjusted EBITDA as defined in the 2022 A&R Agreement, as amended by the 2023 Modification Agreement, if the Company does not maintain the quarterly adjusted quick ratio of at least 1.50 to 1.00.
As of June 30, 2023 (unaudited), and December 31, 2022, the Company utilized $20,000 of the $50,000 credit line. In January 2023, the Company repaid $5,000 under the credit line and $5,000 was subsequently drawn in March 2023. In May 2023, the Company repaid $5,000 under the credit line and $5,000 was subsequently drawn in June 2023.
As of June 30, 2023 (unaudited), the Company is in compliance with all the covenants.
Prior to the 2022 A&R Agreement, the credit installments bore US dollar denominated interest at an annual rate equal to 0.75%-1% plus the prime rate on the outstanding principal of each credit installment and prior to the 2023 Modification Agreement the New Revolving Credit Facility bore interest at an annual rate which was the greater of (a) WSJ Prime Rate plus 0.75% or (b) 4.25%.
FINANCE INCOME, NET
The Company recognizes the gains and losses from the remeasurement of the warrants liability related to the Public Warrants and Private Placement Warrants, as defined in Note 5, Warrants, in “Finance income, net” in the condensed consolidated statements of operations. The unrealized gain from changes in the fair value of the Company Warrants for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $565 and $13,159, respectively. The unrealized gain from changes in the fair value of the Company Warrants for the six months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $3,279 and $15,946, respectively.
The Company also recognized interest expenses in “Finance income, net” in the condensed consolidated statements of operations. Interest expenses for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $420 and $76, respectively. Interest expenses for the six months ended June 30, 2023 and 2022, were $782 and $137, respectively.
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.23.2
INCOME TAX
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
INCOME TAX INCOME TAX
The Company recorded a provision for incomes taxes of $1,335 and a net tax benefit of $168 for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), respectively, and a net expense of $4,159 and a net tax benefit of $205 for the six months ended June 30, 2023 and 2022, respectively.
The Company’s effective tax rates were (7.6)% and (4.1)% for the three months ended June 30, 2023 and 2022, respectively, and (17.8)% and 6.1% for the six months ended June 30, 2023 and 2022, respectively.
For the three months ended June 30, 2023 (unaudited), the net effect of discrete items increased the effective tax rate by 0.2%. Excluding these items, the Company’s effective tax rate would have been (7.4)%. For the six months ended June 30, 2023, the net effect of discrete items increased the effective tax rate by 1.1%. Excluding these items, the Company’s effective tax rate would have been (18.9)%.
For the three months ended June 30, 2022 (unaudited), the net effect of discrete items increased the effective tax rate by 3.3%. Excluding these items, the Company’s effective tax rate would have been (7.4)%. For the six months ended June 30, 2022, the net effect of discrete items decreased the effective tax rate by 4.6%. Excluding these items, the Company’s effective tax rate would have been 10.7%.
The increase in year-to-date tax expense primarily results from a shift in the Company’s foreign earnings, resulting in higher profitability and current tax expense, with no offsetting deferred tax benefit as a result of an overall valuation allowance.
In addition, certain temporary differences associated with the capitalization of research and development under IRC Section 174 and deductibility of stock compensation that would normally not impact the effective tax rate or overall tax expense, could cause the US to generate current state tax expense with no corresponding deferred tax benefit. Unless the US tax rules around research and development (Section 174) are modified, there will continue to be an adverse impact on our effective rates for income taxes paid.
Lastly, the current tax expense is increased as compared to prior years, in both the foreign jurisdictions and the US, because of decreased net operating losses available due to prior year utilization.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT REPORTING
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
SEGMENT REPORTING SEGMENT REPORTING
The Company operates as one operating segment, which primarily focuses on the software platform for advertising, measurement, and creative. Our CEO is the chief operating decision-maker, and manages and allocates resources to the operations of the Company on an entity-wide basis.
Revenue by geographical location are as follows:

Three months ended June 30,Six months ended June 30,

2023

202220232022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
US$31,567 $29,569 $59,214 $52,952 
Canada465 302 853 490 
APAC734 1,025 1,549 1,956 
EMEA1,595 1,914 3,038 3,043 
LATAM185 278 377 509 
Total revenues
$34,546 $33,088 $65,031 $58,950 
The Company’s property and equipment, net and ROU assets by geographical location is as follows:
June 30,
December 31,
2023

2022
(Unaudited)
Israel$2,388 $2,707 
US18,212 14,065 
Rest of the World 367 460 
Total
$20,967 $17,232 
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.23.2
BASIC AND DILUTED NET (LOSS) INCOME PER SHARE
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
BASIC AND DILUTED NET (LOSS) INCOME PER SHARE BASIC AND DILUTED NET (LOSS) INCOME PER SHARE
Basic and diluted net (loss) income per share attributable to common stockholders was calculated as follows:
Three months ended June 30,Six months ended June 30,
2023

20222023

2022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Numerator:
Net (loss) income$(18,959)$4,300 $(27,522)$(3,149)
Net (loss) income attributable to common stockholders basic and diluted
$(18,959)$4,300 $(27,522)$(3,149)
Denominator:
Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders`
Basic weighted average number of shares outstanding137,643,910 132,152,652 134,296,569 128,220,893 
Effect of dilutive securities options and RSU (share equivalent)— 7,835,471 — — 
Diluted weighted average number of shares outstanding137,643,910 139,988,123 134,296,569 128,220,893 
Net profit (loss) per stock attributable to common stockholders
Basic$(0.14)$0.03 $(0.20)$(0.02)
Diluted$(0.14)$0.03 $(0.20)$(0.02)
The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
Three months ended June 30,Six months ended June 30,
2023

20222023

2022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Unvested RSU outstanding 15,723,452 7,991,829 15,723,452 8,002,502 
Options outstanding9,812,198 3,533,772 9,812,198 12,363,179 
Warrants outstanding10,222,500 10,222,500 10,222,500 10,222,500 
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTSOn August 2, 2023, two wholly owned subsidiaries of the Company, Innovid LLC and TV Squared Inc, entered the 2023 Modification Agreement with Silicon Valley Bank, a division of First-Citizen Bank & Trust Company. Refer to Note 6 for further details.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The unaudited interim condensed consolidated financial statements have been prepared in accordance with US GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative US GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Updates (“ASU”) of the Financial Accounting Standards Board (“FASB”) and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by US GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation. The Company’s interim period results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year.
The condensed consolidated balance sheet as of December 31, 2022, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by US GAAP for complete financial statements.
These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and footnotes included in the Company’s 2022 Annual Report on Form 10-K.
The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2022, have been applied consistently in these unaudited interim condensed consolidated financial statements, unless otherwise stated.
Use of Estimates Use of EstimatesThe preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments, and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Software development costs
Software development costs
Software development costs, which are included in property and equipment, net, consists of capitalized costs related to the purchase and development of internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing or obtaining the software.
Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the estimated useful life of the software, which is three years. The amortization is presented within depreciation and amortization in the condensed consolidated statements of operations.
Impairment of long-lived assets Impairment of long-lived assetsLong-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss.
Goodwill and acquired intangible assets
Goodwill and acquired intangible assets
Goodwill and acquired intangible assets have been recorded in the Company's financial statements resulting from     various business combinations. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is subject to an annual impairment test.
Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. The Company currently has one reporting unit.
ASC 350, Intangibles—Goodwill and other (“ASC 350”) requires goodwill to be tested for impairment at least annually and, in certain circumstances, between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. The Company elects to perform an annual impairment test of goodwill as of October 1 of each year, or more frequently if impairment indicators are present. During the three months ended June 30, 2023, the Company recorded Goodwill impairment in the amount of $14,503. Refer to Note 3 for further details.
Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date.
Customer relationships, acquired technology and trade name are being amortized over the estimated useful life of approximately 11 years, 6 years, and 4 years, respectively, using the straight-line amortization method.
The amortization of customer relationships, acquired technology and trade names, is presented within depreciation and amortization in the condensed consolidated statements of operations.
Fair value of financial instruments
Fair value of financial instruments
The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.
Level 3 - Unobservable inputs which are supported by little or no market activity.
The Company’s financial instruments consist of cash and cash equivalents, restricted deposits, trade receivables, net, trade payables, employees, payroll accruals, accrued expenses and other current liabilities and current portion of long-term debts. Their historical carrying amounts represent the approximate fair value due to the short-term maturities of these instruments.
The Company’s investments in money market funds are classified as cash equivalents and measured at fair value. The Company measures its warrant liability at fair value.
The goodwill impairment recorded in the second quarter of 2023 was estimated using the Company's stock price, a Level 1 input, adjusted for an estimated control premium.
Concentrations of credit risks
Concentrations of credit risks
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net.
Most of the Company’s cash and cash equivalents are invested in deposits with major banks in the US and Israel. The Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed federally insured limits. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.
The Company’s trade receivables, net is mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.
The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
Revenue recognition
Revenue recognition
Most of the Company’s revenues are derived from providing Ad serving solutions to advertisers, media agencies and publishers. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display and other channels.
The Company also provides measurement services to advertisers and agencies, streaming platforms and publishers. The measurement service provides analytics and the ability to track performance of advertising campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.
The Company also provides creative services for the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.
The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied.
For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis.
Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.
Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period.
Revenues related to creative projects are recognized at a point in time when the Company delivers an ad unit. Creative services projects are usually delivered within a week.
The Company’s accounts receivable consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less.
The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be canceled without cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts.
The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract.
Costs to obtain a contract
Contract costs include commission programs to compensate sales employees for generating sales orders with new customers or for new services with existing customers. Generally, the commissions are commensurate. The Company elected to apply the practical expedient and recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less. If commissions are not commensurate, the Company capitalizes these commissions. Capitalized commission costs were immaterial for the three and six months ended June 30, 2023 (unaudited) and June 30, 2022 (unaudited).
Trade receivable, net
The Company records trade receivable for amounts invoiced and yet unbilled invoices. The Company makes estimates of expected credit losses for the allowance for doubtful accounts based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The estimated credit loss allowance is recorded as general and administrative expenses on the Company's condensed consolidated statements of operations.
Income taxes and tax contingencies
Income taxes and tax contingencies
Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts.
The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.
ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income.
On December 20, 2017, Congress passed the “US Tax Act.” The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations and the preparation and analysis of information not previously relevant or regularly produced. The US Tax Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.
Recently Adopted Accounting Pronouncements Recently Adopted Accounting PronouncementsIn June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. ASU 2016-13 requires enhanced qualitative and quantitative disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The adoption has impacted how the Company assesses its estimates for credit losses but did not have a material impact on these unaudited interim condensed consolidated financial statements.
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables present information about the Company’s financial instruments that are measured at fair value on a recurring basis:

June 30, 2023
(Unaudited)

Level 1
Level 2
Level 3
Assets:
Money market funds$36,323 $— $— 
Liabilities:
Warrants liability$1,022 $— $— 

December 31, 2022

Level 1
Level 2
Level 3
Assets:
Money market funds$18,948 $— $— 
Certificates of deposit— 20,000 — 
Liabilities:
Warrants liability$1,265 $— $3,036 
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The change in the fair value of the Level 3 warrant liability is summarized below:

June 30,December 31,June 30,

20232022

2022
(Unaudited)(Unaudited)
Beginning of the period
$3,036 $15,462 $15,462 
Change in fair value(2,330)(12,426)(13,132)
Transfer to level 1(706)— — 
End of the period$— $3,036 $2,330 
Schedules of Concentration of Risk, by Risk Factor
One of the Company’s customers accounted for more than 10% of the Company’s total revenues during the three and six months ended June 30, 2023.

Three months ended June 30,Six months ended June 30,

2023

20222023

2022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Customer A
16 %*)16 %*)
*) less than 10%
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.23.2
GOODWILL (Tables)
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The changes in the carrying amount of goodwill:
Goodwill
Total value
Balance as of January 1, 2023$116,976 
Goodwill impairment(14,503)
Balance as of June 30, 2023$102,473 
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.23.2
LEASES (Tables)
6 Months Ended
Jun. 30, 2023
Leases [Abstract]  
Schedule of Operating ROU Assets and Lease Liabilities
The Company has the following operating ROU assets and lease liabilities:

June 30, 2023December 31, 2022
(Unaudited)
ROU assetsLease liabilitiesROU assetsLease liabilities
Real Estate$2,008 $2,692 $2,886 $3,801 
Cars— — 24 21 
Total operating leases$2,008 $2,692 $2,910 $3,822 
Summary of Lease Cost
The following table summarizes the lease costs recognized in the interim condensed consolidated statement of operations:

Three months ended June 30,Six months ended June 30,
2023202220232022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Operating lease cost$458 $472 $921 $947 
Short term lease cost320 126 583 208 
Variable lease cost25 46 10 
Total lease cost$803 $604 $1,550 $1,165 
The following table presents supplementary cash flow information regarding the Company's operating leases:
Six months ended June 30, 2023Six months ended June 30, 2022
(Unaudited)(Unaudited)
Cash paid for amounts included in the measurement of lease liabilities$1,035 $1,133 
Schedule of Operating Lease, Liability, Maturity
The following table summarizes the future payments of Innovid for its operating lease liabilities:
Six months ended June 30, 2023
(Unaudited)
2023 Remaining$1,124 
2024972 
2025636 
Total undiscounted lease payments$2,732 
Less: Interest(40)
Total lease liabilities$2,692 
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expenses
Stock-based compensation expense is related to awards issued pursuant to the Legacy Innovid Stock Option Plan (“Legacy Plan”) and 2021 Innovid Corp. Incentive Plan (“2021 Plan”) and is summarized as follows:

Three months ended June 30,Six months ended June 30,

2023202220232022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Cost of goods sold
$435 $383 $876 $488 
Research and development
1,229 920 2,403 1,399 
Sales and marketing
1,690 1,529 3,269 2,109 
General and administrative
1,980 1,306 3,410 1,734 
Total
$5,334 $4,138 $9,958 $5,730 
Schedule of Share Based Payment Arrangement, Option, Activity
A summary of the employees’ stock option activity for the six months ended June 30, 2023 (unaudited), is as follows:

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of period
10,658,085 $1.15 6.85$5,923 
Granted832,232 1.55 
Forfeited(207,449)1.89 
Expired(163,640)1.65 
Exercised(1,376,572)0.45 
Outstanding at end of period
9,742,656 $1.26 7.08$14,232 
Exercisable options at end of period
6,563,845 $0.99 6.37$11,356 
A summary of the consultants’ stock option activity for the six months ended June 30, 2023 (unaudited), is as follows:

Amount
of
options
Weighted
average
exercise
price
Weighted
average
remaining contractual term
(in years)
Aggregate intrinsic value (in thousands)
Outstanding at beginning of period
69,542 $0.47 4.21$86 
Forfeited— — 
Exercised— — 
Outstanding at end of period
69,542 $0.47 3.72$156 
Exercisable options at end of period
66,196 $0.46 3.53$149 
Schedule of Share Based Payment Arrangement, Restricted Stock Unit, Activity
A summary of the employees’ RSU activity under the 2021 Plan for the six months ended June 30, 2023 (unaudited), is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of period
7,989,825 $5.60 
Granted12,096,238 1.28 
Vested(3,424,868)5.27 
Forfeited(1,113,878)4.88 
Outstanding at end of period
15,547,317 $2.36 
A summary of the consultants’ RSU activity under the 2021 Plan for the six months ended June 30, 2023 (unaudited), is as follows:

Number of share units
Weighted
average
grant date
fair value
Outstanding at beginning of period
130,268 $6.60 
Granted107,343 1.18 
Vested(53,250)6.60 
Forfeited(8,226)6.60 
Outstanding at end of period
176,135 $3.30 
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT REPORTING (Tables)
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Schedule of Revenue and Property and Equipment, by Geographical Areas
Revenue by geographical location are as follows:

Three months ended June 30,Six months ended June 30,

2023

202220232022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
US$31,567 $29,569 $59,214 $52,952 
Canada465 302 853 490 
APAC734 1,025 1,549 1,956 
EMEA1,595 1,914 3,038 3,043 
LATAM185 278 377 509 
Total revenues
$34,546 $33,088 $65,031 $58,950 
The Company’s property and equipment, net and ROU assets by geographical location is as follows:
June 30,
December 31,
2023

2022
(Unaudited)
Israel$2,388 $2,707 
US18,212 14,065 
Rest of the World 367 460 
Total
$20,967 $17,232 
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.23.2
BASIC AND DILUTED NET (LOSS) INCOME PER SHARE (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
Basic and diluted net (loss) income per share attributable to common stockholders was calculated as follows:
Three months ended June 30,Six months ended June 30,
2023

20222023

2022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Numerator:
Net (loss) income$(18,959)$4,300 $(27,522)$(3,149)
Net (loss) income attributable to common stockholders basic and diluted
$(18,959)$4,300 $(27,522)$(3,149)
Denominator:
Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders`
Basic weighted average number of shares outstanding137,643,910 132,152,652 134,296,569 128,220,893 
Effect of dilutive securities options and RSU (share equivalent)— 7,835,471 — — 
Diluted weighted average number of shares outstanding137,643,910 139,988,123 134,296,569 128,220,893 
Net profit (loss) per stock attributable to common stockholders
Basic$(0.14)$0.03 $(0.20)$(0.02)
Diluted$(0.14)$0.03 $(0.20)$(0.02)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
Three months ended June 30,Six months ended June 30,
2023

20222023

2022
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Unvested RSU outstanding 15,723,452 7,991,829 15,723,452 8,002,502 
Options outstanding9,812,198 3,533,772 9,812,198 12,363,179 
Warrants outstanding10,222,500 10,222,500 10,222,500 10,222,500 
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.23.2
DESCRIPTION OF BUSINESS (Details) - TV Squared
$ / shares in Units, $ in Thousands
Feb. 28, 2022
USD ($)
$ / shares
shares
Business Acquisition [Line Items]  
Payments to acquire | $ $ 100,000
Shares issued as consideration (in shares) | shares 11,549,465
Share price (in dollars per share) | $ / shares $ 3.80
Issued, fully vested stock option (in shares) | shares 949,893
Weighted average fair value (in dollars per share) | $ / shares $ 3.49
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
reportingUnit
$ / shares
Jun. 30, 2022
USD ($)
Dec. 31, 2022
$ / shares
Summary of Significant Accounting Policies [Line Items]          
Impairments of long-lived assets $ 0   $ 0    
Number of reporting units | reportingUnit     1    
Goodwill impairment $ 14,503,000 $ 0 $ 14,503,000 $ 0  
Payment term     60 days    
Ad serving services 77.30% 78.40% 77.20% 83.40%  
Measurement serving services 22.70% 21.60% 22.80% 16.60%  
Level 1 | Public Warrants          
Summary of Significant Accounting Policies [Line Items]          
Exercise price per share (in dollars per share) | $ / shares $ 0.10   $ 0.10   $ 0.40
Level 1 | Private Warrants          
Summary of Significant Accounting Policies [Line Items]          
Exercise price per share (in dollars per share) | $ / shares $ 0.10   $ 0.10    
Customer relationships          
Summary of Significant Accounting Policies [Line Items]          
Acquired finite-lived intangible assets, weighted average useful life     11 years    
Technology          
Summary of Significant Accounting Policies [Line Items]          
Acquired finite-lived intangible assets, weighted average useful life     6 years    
Trade name          
Summary of Significant Accounting Policies [Line Items]          
Acquired finite-lived intangible assets, weighted average useful life     4 years    
Software development costs          
Summary of Significant Accounting Policies [Line Items]          
Useful lives (in years) 3 years   3 years    
Capitalization cost $ 2,825,000 $ 2,335,000 $ 6,281,000 $ 4,006,000  
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Level 1    
Assets:    
Money market funds $ 36,323 $ 18,948
Certificates of deposit   0
Liabilities:    
Warrants liability 1,022 1,265
Level 2    
Assets:    
Money market funds 0 0
Certificates of deposit   20,000
Liabilities:    
Warrants liability 0 0
Level 3    
Assets:    
Money market funds 0 0
Certificates of deposit   0
Liabilities:    
Warrants liability $ 0 $ 3,036
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - Fair Value, Recurring - Warrants Liability - Level 3 - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Beginning of the period $ 3,036 $ 15,462 $ 15,462
Change in fair value (2,330) (13,132) (12,426)
Transfer to level 1 (706) 0 0
End of the period $ 0 $ 2,330 $ 3,036
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Revenue Benchmark | Customer Concentration Risk | Customer A    
Concentration Risk [Line Items]    
Concentration risk, percentage 16.00% 16.00%
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.23.2
GOODWILL - Schedule of Goodwill (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Goodwill [Roll Forward]        
Goodwill, beginning balance     $ 116,976  
Goodwill impairment $ (14,503) $ 0 (14,503) $ 0
Goodwill, ending balance $ 102,473   $ 102,473  
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.23.2
GOODWILL - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]        
Goodwill impairment $ 14,503 $ 0 $ 14,503 $ 0
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.23.2
LEASES - Schedule of Operating ROU Assets and Lease Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Operating Leases Assets And Liabilities [Line Items]    
ROU assets $ 2,008 $ 2,910
Lease liabilities 2,692 3,822
Real Estate    
Operating Leases Assets And Liabilities [Line Items]    
ROU assets 2,008 2,886
Lease liabilities 2,692 3,801
Cars    
Operating Leases Assets And Liabilities [Line Items]    
ROU assets 0 24
Lease liabilities $ 0 $ 21
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.23.2
LEASES - Lease Costs Recognized in the Condensed Consolidated Statement of Earnings (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Leases [Abstract]        
Operating lease cost $ 458 $ 472 $ 921 $ 947
Short term lease cost 320 126 583 208
Variable lease cost 25 6 46 10
Total lease cost $ 803 $ 604 $ 1,550 $ 1,165
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.23.2
LEASES - Narrative (Details)
Jun. 30, 2023
Leases [Abstract]  
Operating lease, weighted average remaining lease term 1 year 9 months 18 days
Operating lease, weighted average discount rate, percent 2.50%
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.23.2
LEASES - Supplementary Cash Flow Information (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Leases [Abstract]    
Cash paid for amounts included in the measurement of lease liabilities $ 1,035 $ 1,133
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.23.2
LEASES - Schedule of Operating Lease Liabilities Maturity (Details)
$ in Thousands
Jun. 30, 2023
USD ($)
Leases [Abstract]  
2023 Remaining $ 1,124
2024 972
2025 636
Total undiscounted lease payments 2,732
Less: Interest (40)
Total lease liabilities $ 2,692
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.23.2
WARRANTS (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Public Warrants    
Class of Warrant or Right [Line Items]    
Warrants outstanding (in shares) 3,162,500  
Private Warrants    
Class of Warrant or Right [Line Items]    
Warrants outstanding (in shares) 7,060,000  
Warrant    
Class of Warrant or Right [Line Items]    
Derivative liability fair value $ 1,022 $ 4,301
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.23.2
LONG-TERM DEBT (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Aug. 04, 2023
USD ($)
Aug. 04, 2022
USD ($)
subsidiary
Jun. 30, 2023
USD ($)
May 31, 2023
USD ($)
Mar. 31, 2023
USD ($)
Jan. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
Aug. 03, 2022
USD ($)
Line of Credit Facility [Line Items]                  
Number of wholly owned subsidiaries | subsidiary   2              
Repayment of line of credit       $ 5   $ 5,000      
Revolving Credit Facility                  
Line of Credit Facility [Line Items]                  
Line of credit   $ 50,000 $ 50,000       $ 50,000   $ 15,000
Average annual fee unused portion (in percent)   0.20%              
Non-refundable commitment fees   $ 40              
Line of credit quick ratio   1.30              
Quarterly adjusted quick ratio   1.50              
Revolving Credit Facility | Forecast                  
Line of Credit Facility [Line Items]                  
Annual interest rate (in percent) 4.25%                
Non-refundable commitment fees $ 75                
Revolving Credit Facility | Forecast | 2023 Modification Agreement                  
Line of Credit Facility [Line Items]                  
Modification fee amount $ 20                
Revolving Credit Facility | Maximum                  
Line of Credit Facility [Line Items]                  
Prime rate (in percent)   0.25%              
Line of Credit                  
Line of Credit Facility [Line Items]                  
Proceeds from line of credit     5   $ 5,000        
Line of Credit | Amended Credit Agreement Maturing December 2020                  
Line of Credit Facility [Line Items]                  
Line of credit     $ 20,000       $ 20,000    
Line of Credit | Minimum | Amended Credit Agreement Maturing October 2018 | Prime Rate                  
Line of Credit Facility [Line Items]                  
Debt instrument, variable rate               0.75%  
Line of Credit | Maximum | Amended Credit Agreement Maturing October 2018 | Prime Rate                  
Line of Credit Facility [Line Items]                  
Debt instrument, variable rate               1.00%  
New Revolving Credit Facility | Prime Rate                  
Line of Credit Facility [Line Items]                  
Debt instrument, variable rate             0.75%    
New Revolving Credit Facility | Maximum | Prime Rate                  
Line of Credit Facility [Line Items]                  
Debt instrument, variable rate             4.25%    
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENT LIABILITIES (Details) - USD ($)
$ / shares in Units, $ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Commitments and Contingencies [Line Items]    
Ordinary shares, par value (in dollars per share) $ 0.0001 $ 0.0001
Bank guarantees $ 231  
Israeli Subsidiary    
Commitments and Contingencies [Line Items]    
Bank deposits pledged $ 601  
Subsidiaries    
Commitments and Contingencies [Line Items]    
Shares of subsidiary pledged (in shares) 65,000  
Ordinary shares, par value (in dollars per share) $ 0.01  
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION - Stock Option Activity Under Plan (Details) - Legacy Plan and 2021 Plan - Employees - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expenses $ 5,334 $ 4,138 $ 9,958 $ 5,730
Cost of goods sold        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expenses 435 383 876 488
Research and development        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expenses 1,229 920 2,403 1,399
Sales and marketing        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expenses 1,690 1,529 3,269 2,109
General and administrative        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Stock-based compensation expenses $ 1,980 $ 1,306 $ 3,410 $ 1,734
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Capitalized stock-based compensation expense $ 325 $ 490 $ 690 $ 490
Cost not yet recognized 3,945   $ 3,945  
Period for cost yet to be recognized     1 year 11 months 1 day  
Options outstanding        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period     4 years  
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Cost not yet recognized $ 33,727   $ 33,727  
Period for cost yet to be recognized     2 years 3 months 18 days  
Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expiration period     10 years  
Minimum | Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period     3 years  
Maximum | Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period     4 years  
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Employees    
Amount of options    
Outstanding at the beginning of the period (in shares) 10,658,085  
Granted (in shares) 832,232  
Forfeited (in shares) (207,449)  
Expired (in shares) (163,640)  
Exercised (in shares) (1,376,572)  
Outstanding at the end of the period (in shares) 9,742,656 10,658,085
Exercisable options at the end of the period (in shares) 6,563,845  
Weighted average exercise price    
Outstanding at the beginning of the period (in dollars per share) $ 1.15  
Granted (in dollars per share) 1.55  
Forfeited (in dollars per share) 1.89  
Expired (in dollars per share) 1.65  
Exercised (in dollars per share) 0.45  
Outstanding at the end of the period (in dollars per share) 1.26 $ 1.15
Exercisable exercise price at the end of the period (in dollars per share) $ 0.99  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Outstanding option, weighted average remaining contractual term (in years) 7 years 29 days 6 years 10 months 6 days
Outstanding exercisable, weighted average remaining contractual term (in years) 6 years 4 months 13 days  
Outstanding intrinsic value at the beginning of the period $ 5,923  
Outstanding intrinsic value at the end of the period 14,232 $ 5,923
Outstanding exercisable intrinsic value at the end of the period $ 11,356  
Consultants    
Amount of options    
Outstanding at the beginning of the period (in shares) 69,542  
Forfeited (in shares) 0  
Exercised (in shares) 0  
Outstanding at the end of the period (in shares) 69,542 69,542
Exercisable options at the end of the period (in shares) 66,196  
Weighted average exercise price    
Outstanding at the beginning of the period (in dollars per share) $ 0.47  
Forfeited (in dollars per share) 0  
Exercised (in dollars per share) 0  
Outstanding at the end of the period (in dollars per share) 0.47 $ 0.47
Exercisable exercise price at the end of the period (in dollars per share) $ 0.46  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Outstanding option, weighted average remaining contractual term (in years) 3 years 8 months 19 days 4 years 2 months 15 days
Outstanding exercisable, weighted average remaining contractual term (in years) 3 years 6 months 10 days  
Outstanding intrinsic value at the beginning of the period $ 86  
Outstanding intrinsic value at the end of the period 156 $ 86
Outstanding exercisable intrinsic value at the end of the period $ 149  
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details)
6 Months Ended
Jun. 30, 2023
$ / shares
shares
Employees  
Number of share units  
Outstanding at the beginning of the period (in shares) | shares 7,989,825
Granted (in shares) | shares 12,096,238
Vested (in shares) | shares (3,424,868)
Forfeited (in shares) | shares (1,113,878)
Outstanding at the ending of the period (in shares) | shares 15,547,317
Weighted average grant date fair value  
Outstanding at the beginning of the period (in dollars per share) | $ / shares $ 5.60
Granted (in dollars per share) | $ / shares 1.28
Vested (in dollars per share) | $ / shares 5.27
Forfeited (in dollars per share) | $ / shares 4.88
Outstanding at the ending of the period (in dollars per share) | $ / shares $ 2.36
Consultants  
Number of share units  
Outstanding at the beginning of the period (in shares) | shares 130,268
Granted (in shares) | shares 107,343
Vested (in shares) | shares (53,250)
Forfeited (in shares) | shares (8,226)
Outstanding at the ending of the period (in shares) | shares 176,135
Weighted average grant date fair value  
Outstanding at the beginning of the period (in dollars per share) | $ / shares $ 6.60
Granted (in dollars per share) | $ / shares 1.18
Vested (in dollars per share) | $ / shares 6.60
Forfeited (in dollars per share) | $ / shares 6.60
Outstanding at the ending of the period (in dollars per share) | $ / shares $ 3.30
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.23.2
FINANCE INCOME, NET (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Paycheck Protection Program        
Short-term Debt [Line Items]        
Debt related interest expense $ 420 $ 76 $ 782 $ 137
Warrant        
Short-term Debt [Line Items]        
Gain from changes in the fair value $ 565 $ 13,159 $ 3,279 $ 15,946
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.23.2
INCOME TAX (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Tax Disclosure [Abstract]        
Taxes on income $ 1,335 $ (168) $ 4,159 $ (205)
Provision for income taxes   $ 168    
Effective tax expense (benefit) (7.60%) (4.10%) (17.80%) 6.10%
Effect of discrete items, increase (decrease) in effective tax rate 0.20% 3.30% 1.10% (4.60%)
Effective tax rate increase (decrease) (7.40%) 7.40% (18.90%) 10.70%
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT REPORTING - Narrative (Details)
6 Months Ended
Jun. 30, 2023
segment
Segment Reporting [Abstract]  
Number of operating segments 1
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT REPORTING - Revenue and Property and Equipment, by Geographical Areas (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues $ 34,546 $ 33,088 $ 65,031 $ 58,950  
Long-lived tangible assets 20,967   20,967   $ 17,232
US          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues 31,567 29,569 59,214 52,952  
Long-lived tangible assets 18,212   18,212   14,065
Canada          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues 465 302 853 490  
APAC          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues 734 1,025 1,549 1,956  
EMEA          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues 1,595 1,914 3,038 3,043  
LATAM          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Revenues 185 $ 278 377 $ 509  
Israel          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Long-lived tangible assets 2,388   2,388   2,707
Rest of the World          
Revenues from External Customers and Long-Lived Assets [Line Items]          
Long-lived tangible assets $ 367   $ 367   $ 460
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.23.2
BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Basic and Diluted Net (Loss) Income Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Numerator:            
Net (loss) income $ (18,959) $ (8,563) $ 4,300 $ (7,449) $ (27,522) $ (3,149)
Net (loss) income attributable to common stockholders, basic (18,959)   4,300   (27,522) (3,149)
Net (loss) income attributable to common stockholders, diluted $ (18,959)   $ 4,300   $ (27,522) $ (3,149)
Denominator:            
Weighted-average number of stocks used in computing net (loss) income per stock attributable to common stockholders - Basic weighted average number of shares outstanding (in shares) 137,643,910   132,152,652   134,296,569 128,220,893
Weighted-average number of stocks used in computing net (loss) income per stock attributable to common stockholders - Diluted weighted average number of shares outstanding (in shares) 137,643,910   139,988,123   134,296,569 128,220,893
Net profit (loss) per stock attributable to common stockholders – basic (in dollars per share) $ (0.14)   $ 0.03   $ (0.20) $ (0.02)
Net profit (loss) per stock attributable to common stockholders – diluted (in dollars per share) $ (0.14)   $ 0.03   $ (0.20) $ (0.02)
Options And RSU's            
Denominator:            
Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders – Effect of dilutive securities - options And RSU (share equivalent) (in shares) 0   7,835,471   0 0
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.23.2
BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Securities Excluded from Computation of Earnings Per Share (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Unvested RSU outstanding        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Securities excluded from computation of earnings per share (in shares) 15,723,452 7,991,829 15,723,452 8,002,502
Options outstanding        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Securities excluded from computation of earnings per share (in shares) 9,812,198 3,533,772 9,812,198 12,363,179
Warrants outstanding        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Securities excluded from computation of earnings per share (in shares) 10,222,500 10,222,500 10,222,500 10,222,500
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS (Details) - subsidiary
Aug. 02, 2023
Aug. 04, 2022
Subsequent Event [Line Items]    
Number of wholly owned subsidiaries   2
Subsequent Event    
Subsequent Event [Line Items]    
Number of wholly owned subsidiaries 2  
XML 65 ctv-20230630_htm.xml IDEA: XBRL DOCUMENT 0001835378 2023-01-01 2023-06-30 0001835378 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001835378 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001835378 2023-08-04 0001835378 2023-06-30 0001835378 2022-12-31 0001835378 2023-04-01 2023-06-30 0001835378 2022-04-01 2022-06-30 0001835378 2022-01-01 2022-06-30 0001835378 us-gaap:CommonStockMember 2021-12-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001835378 us-gaap:RetainedEarningsMember 2021-12-31 0001835378 2021-12-31 0001835378 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001835378 2022-01-01 2022-03-31 0001835378 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001835378 us-gaap:CommonStockMember 2022-03-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001835378 us-gaap:RetainedEarningsMember 2022-03-31 0001835378 2022-03-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001835378 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001835378 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001835378 us-gaap:CommonStockMember 2022-06-30 0001835378 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001835378 us-gaap:RetainedEarningsMember 2022-06-30 0001835378 2022-06-30 0001835378 us-gaap:CommonStockMember 2022-12-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001835378 us-gaap:RetainedEarningsMember 2022-12-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001835378 2023-01-01 2023-03-31 0001835378 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001835378 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001835378 us-gaap:CommonStockMember 2023-03-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001835378 us-gaap:RetainedEarningsMember 2023-03-31 0001835378 2023-03-31 0001835378 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001835378 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001835378 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001835378 us-gaap:CommonStockMember 2023-06-30 0001835378 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001835378 us-gaap:RetainedEarningsMember 2023-06-30 0001835378 ctv:TVSquaredMember 2022-02-28 2022-02-28 0001835378 ctv:TVSquaredMember 2022-02-28 0001835378 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-06-30 0001835378 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-04-01 2023-06-30 0001835378 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-01-01 2023-06-30 0001835378 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-04-01 2022-06-30 0001835378 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2022-01-01 2022-06-30 0001835378 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-06-30 0001835378 us-gaap:TechnologyBasedIntangibleAssetsMember 2023-01-01 2023-06-30 0001835378 us-gaap:TradeNamesMember 2023-01-01 2023-06-30 0001835378 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835378 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835378 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835378 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835378 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835378 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-06-30 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-12-31 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-06-30 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001835378 us-gaap:FairValueInputsLevel3Member ctv:WarrantsLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001835378 us-gaap:FairValueInputsLevel1Member ctv:PublicWarrantsMember 2023-06-30 0001835378 us-gaap:FairValueInputsLevel1Member ctv:PrivateWarrantsMember 2023-06-30 0001835378 us-gaap:FairValueInputsLevel1Member ctv:PublicWarrantsMember 2022-12-31 0001835378 ctv:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001835378 ctv:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001835378 us-gaap:RealEstateMember 2023-06-30 0001835378 us-gaap:RealEstateMember 2022-12-31 0001835378 ctv:CarsMember 2023-06-30 0001835378 ctv:CarsMember 2022-12-31 0001835378 ctv:PublicWarrantsMember 2023-06-30 0001835378 ctv:PrivateWarrantsMember 2023-06-30 0001835378 us-gaap:WarrantMember 2023-06-30 0001835378 us-gaap:WarrantMember 2022-12-31 0001835378 2022-08-04 0001835378 us-gaap:RevolvingCreditFacilityMember 2022-08-03 0001835378 us-gaap:RevolvingCreditFacilityMember 2022-08-04 0001835378 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2022-08-04 0001835378 srt:ScenarioForecastMember us-gaap:RevolvingCreditFacilityMember 2023-08-04 2023-08-04 0001835378 us-gaap:RevolvingCreditFacilityMember 2022-08-04 2022-08-04 0001835378 srt:ScenarioForecastMember us-gaap:RevolvingCreditFacilityMember ctv:A2023ModificationAgreementMember 2023-08-04 2023-08-04 0001835378 us-gaap:LineOfCreditMember ctv:AmendedCreditAgreementMaturingDecember2020Member 2022-12-31 0001835378 us-gaap:LineOfCreditMember ctv:AmendedCreditAgreementMaturingDecember2020Member 2023-06-30 0001835378 us-gaap:RevolvingCreditFacilityMember 2023-06-30 0001835378 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0001835378 2023-01-01 2023-01-31 0001835378 us-gaap:LineOfCreditMember 2023-03-01 2023-03-31 0001835378 2023-05-01 2023-05-31 0001835378 us-gaap:LineOfCreditMember 2023-06-01 2023-06-30 0001835378 srt:MinimumMember us-gaap:LineOfCreditMember ctv:AmendedCreditAgreementMaturingOctober2018Member us-gaap:PrimeRateMember 2021-01-01 2021-12-31 0001835378 srt:MaximumMember us-gaap:LineOfCreditMember ctv:AmendedCreditAgreementMaturingOctober2018Member us-gaap:PrimeRateMember 2021-01-01 2021-12-31 0001835378 ctv:NewRevolvingCreditFacilityMember us-gaap:PrimeRateMember 2022-01-01 2022-12-31 0001835378 srt:MaximumMember ctv:NewRevolvingCreditFacilityMember us-gaap:PrimeRateMember 2022-01-01 2022-12-31 0001835378 srt:SubsidiariesMember 2023-06-30 0001835378 ctv:IsraeliSubsidiaryMember 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CostOfSalesMember ctv:LegacyPlanAnd2021PlanMember 2023-04-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CostOfSalesMember ctv:LegacyPlanAnd2021PlanMember 2022-04-01 2022-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CostOfSalesMember ctv:LegacyPlanAnd2021PlanMember 2023-01-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:CostOfSalesMember ctv:LegacyPlanAnd2021PlanMember 2022-01-01 2022-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ResearchAndDevelopmentExpenseMember ctv:LegacyPlanAnd2021PlanMember 2023-04-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ResearchAndDevelopmentExpenseMember ctv:LegacyPlanAnd2021PlanMember 2022-04-01 2022-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ResearchAndDevelopmentExpenseMember ctv:LegacyPlanAnd2021PlanMember 2023-01-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:ResearchAndDevelopmentExpenseMember ctv:LegacyPlanAnd2021PlanMember 2022-01-01 2022-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:SellingAndMarketingExpenseMember ctv:LegacyPlanAnd2021PlanMember 2023-04-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:SellingAndMarketingExpenseMember ctv:LegacyPlanAnd2021PlanMember 2022-04-01 2022-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:SellingAndMarketingExpenseMember ctv:LegacyPlanAnd2021PlanMember 2023-01-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:SellingAndMarketingExpenseMember ctv:LegacyPlanAnd2021PlanMember 2022-01-01 2022-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:GeneralAndAdministrativeExpenseMember ctv:LegacyPlanAnd2021PlanMember 2023-04-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:GeneralAndAdministrativeExpenseMember ctv:LegacyPlanAnd2021PlanMember 2022-04-01 2022-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:GeneralAndAdministrativeExpenseMember ctv:LegacyPlanAnd2021PlanMember 2023-01-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember us-gaap:GeneralAndAdministrativeExpenseMember ctv:LegacyPlanAnd2021PlanMember 2022-01-01 2022-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember ctv:LegacyPlanAnd2021PlanMember 2023-04-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember ctv:LegacyPlanAnd2021PlanMember 2022-04-01 2022-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember ctv:LegacyPlanAnd2021PlanMember 2023-01-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember ctv:LegacyPlanAnd2021PlanMember 2022-01-01 2022-06-30 0001835378 srt:MinimumMember 2023-01-01 2023-06-30 0001835378 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-01-01 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2023-01-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2022-01-01 2022-12-31 0001835378 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2023-01-01 2023-06-30 0001835378 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2023-06-30 0001835378 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001835378 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001835378 us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0001835378 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001835378 us-gaap:WarrantMember 2023-04-01 2023-06-30 0001835378 us-gaap:WarrantMember 2022-04-01 2022-06-30 0001835378 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001835378 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001835378 ctv:PaycheckProtectionProgramMember 2023-04-01 2023-06-30 0001835378 ctv:PaycheckProtectionProgramMember 2022-04-01 2022-06-30 0001835378 ctv:PaycheckProtectionProgramMember 2023-01-01 2023-06-30 0001835378 ctv:PaycheckProtectionProgramMember 2022-01-01 2022-06-30 0001835378 country:US 2023-04-01 2023-06-30 0001835378 country:US 2022-04-01 2022-06-30 0001835378 country:US 2023-01-01 2023-06-30 0001835378 country:US 2022-01-01 2022-06-30 0001835378 country:CA 2023-04-01 2023-06-30 0001835378 country:CA 2022-04-01 2022-06-30 0001835378 country:CA 2023-01-01 2023-06-30 0001835378 country:CA 2022-01-01 2022-06-30 0001835378 srt:AsiaPacificMember 2023-04-01 2023-06-30 0001835378 srt:AsiaPacificMember 2022-04-01 2022-06-30 0001835378 srt:AsiaPacificMember 2023-01-01 2023-06-30 0001835378 srt:AsiaPacificMember 2022-01-01 2022-06-30 0001835378 us-gaap:EMEAMember 2023-04-01 2023-06-30 0001835378 us-gaap:EMEAMember 2022-04-01 2022-06-30 0001835378 us-gaap:EMEAMember 2023-01-01 2023-06-30 0001835378 us-gaap:EMEAMember 2022-01-01 2022-06-30 0001835378 srt:LatinAmericaMember 2023-04-01 2023-06-30 0001835378 srt:LatinAmericaMember 2022-04-01 2022-06-30 0001835378 srt:LatinAmericaMember 2023-01-01 2023-06-30 0001835378 srt:LatinAmericaMember 2022-01-01 2022-06-30 0001835378 country:IL 2023-06-30 0001835378 country:IL 2022-12-31 0001835378 country:US 2023-06-30 0001835378 country:US 2022-12-31 0001835378 ctv:RestOfTheWorldMember 2023-06-30 0001835378 ctv:RestOfTheWorldMember 2022-12-31 0001835378 ctv:OptionsAndRSUsMember 2023-04-01 2023-06-30 0001835378 ctv:OptionsAndRSUsMember 2022-04-01 2022-06-30 0001835378 ctv:OptionsAndRSUsMember 2023-01-01 2023-06-30 0001835378 ctv:OptionsAndRSUsMember 2022-01-01 2022-06-30 0001835378 us-gaap:RestrictedStockUnitsRSUMember 2023-04-01 2023-06-30 0001835378 us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0001835378 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001835378 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001835378 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001835378 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001835378 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001835378 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001835378 us-gaap:WarrantMember 2023-04-01 2023-06-30 0001835378 us-gaap:WarrantMember 2022-04-01 2022-06-30 0001835378 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001835378 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001835378 us-gaap:SubsequentEventMember 2023-08-02 shares iso4217:USD iso4217:USD shares ctv:reportingUnit pure ctv:subsidiary ctv:segment 0001835378 2023 Q2 false --12-31 P3Y 10-Q true 2023-06-30 false 001-40048 Innovid Corp. DE 87-3769599 30 Irving Place, 12th Floor New York NY 10003 212 966-7555 Common stock, par value $0.0001 per share CTV NYSE Warrants to purchase one share of Common stock, each at an exercise price of $11.50 per share CTVWS NYSE Yes Yes Accelerated Filer true true false false 139303254 43384000 37541000 0 10000000 330000 65000 43238000 43653000 4123000 2640000 90745000 93834000 260000 277000 396000 430000 18959000 14322000 102473000 116976000 27659000 29918000 2008000 2910000 834000 938000 152589000 165771000 243334000 259605000 4421000 3361000 10969000 10165000 1611000 2186000 5194000 5474000 22195000 21186000 20000000 20000000 1081000 1636000 9461000 6554000 1022000 4301000 31564000 32491000 53759000 53677000 0.0001 0.0001 500000000 500000000 138737104 138737104 133882414 133882414 13000 13000 367970000 356801000 -178408000 -150886000 189575000 205928000 243334000 259605000 34546000 33088000 65031000 58950000 8591000 7351000 16856000 13277000 6876000 9710000 13993000 16964000 11460000 14320000 23097000 24671000 8924000 9955000 18574000 21410000 2064000 926000 4094000 1599000 14503000 0 14503000 0 -17872000 -9174000 -26086000 -18971000 -248000 -13306000 -2723000 -15617000 -17624000 4132000 -23363000 -3354000 1335000 -168000 4159000 -205000 -18959000 4300000 -27522000 -3149000 -18959000 -18959000 4300000 4300000 -27522000 -27522000 -3149000 -3149000 -0.14 0.03 -0.20 -0.02 -0.14 0.03 -0.20 -0.02 137643910 132152652 134296569 128220893 137643910 139988123 134296569 128220893 119017380 12000 293719000 -132476000 161255000 11549465 1000 47151000 47152000 1496000 1496000 1521927 462000 462000 -7449000 -7449000 132088772 13000 342828000 -139925000 202916000 4628000 4628000 322943 174000 174000 4300000 4300000 132411715 13000 347630000 -135625000 212018000 133882414 13000 356801000 -150886000 205928000 4897000 4897000 2734320 250000 250000 -8563000 -8563000 136616734 13000 361948000 -159449000 202512000 5658000 5658000 2120370 364000 364000 -18959000 -18959000 138737104 13000 367970000 -178408000 189575000 -27522000 -3149000 4094000 1599000 14503000 0 9865000 5634000 -3279000 -15946000 -415000 4624000 1390000 747000 902000 872000 1060000 -321000 804000 1044000 -1130000 -1208000 2626000 945000 948000 -15901000 0 99568000 5591000 3516000 189000 221000 -10000000 0 27000 32000 4247000 -103273000 10000000 9000000 10000000 0 0 3185000 614000 636000 614000 6451000 5809000 -112723000 37971000 157158000 43780000 44435000 879000 363000 782000 137000 0 47152000 43384000 44024000 396000 411000 43780000 44435000 DESCRIPTION OF BUSINESS<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovid Corp. together with its consolidated subsidiaries, the “Company” or “Innovid”, is a leading independent software platform that provides an ad serving and creative personalization platform for the creation, delivery, and measurement of TV ads across connected TV (“CTV”), mobile TV and desktop TV environments to advertisers, publishers and media agencies.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovid Corp. was originally incorporated as ION Acquisition Corp. 2 Ltd. (“ION”), a special purpose acquisition company, on November 23, 2020 and Innovid Corp. was the surviving entity following the completion of its merger with ION on November 30, 2021 (the “ION Transaction”).</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2022, the Company completed the acquisition of TV Squared Limited (“TVS”, together with ION’s Transaction, the “Transactions”) by way of stock purchase agreement (“Stock Purchase Agreement”). The Company acquired all of the equity of TVSquared for an aggregate amount of $100,000 in cash, 11,549,465 shares of the Company common stock at fair value of $3.80 per share and the issuance of 949,893 fully vested stock options of the Company at a weighted average fair value of $3.49, subject to certain adjustments as defined in the Stock Purchase Agreement. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovid Corp.’s common stock and warrants are trading on the NYSE under the symbols “CTV” and “CTV.WS,” respectively, since December 1, 2021.</span></div> 100000000 11549465 3.80 949893 3.49 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements have been prepared in accordance with US GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative US GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Updates (“ASU”) of the Financial Accounting Standards Board (“FASB”) and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by US GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation. The Company’s interim period results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated balance sheet as of December 31, 2022, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by US GAAP for complete financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and footnotes included in the Company’s 2022 Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2022, have been applied consistently in these unaudited interim condensed consolidated financial statements, unless otherwise stated.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments, and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Software development costs</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software development costs, which are included in property and equipment, net, consists of capitalized costs related to the purchase and development of internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing or obtaining the software. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the estimated useful life of the software, which is three years. The amortization is presented within depreciation and amortization in the condensed consolidated statements of operations. During the three and six months ended June 30, 2023 (unaudited), the Company capitalized $2,825 and $6,281, respectively, and during the three and six months ended June 30, 2022 (unaudited), the Company capitalized $2,335 and $4,006, respectively, related to internal-use software cost.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of long-lived assets</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss. During the three and six months ended June 30, 2023 (unaudited), the Company tested its long-lived assets for recoverability and concluded that no impairment should be recognized.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and acquired intangible assets</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and acquired intangible assets have been recorded in the Company's financial statements resulting from     various business combinations. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is subject to an annual impairment test. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. The Company currently has one reporting unit. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 350, Intangibles—Goodwill and other (“ASC 350”) requires goodwill to be tested for impairment at least annually and, in certain circumstances, between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. The Company elects to perform an annual impairment test of goodwill as of October 1 of each year, or more frequently if impairment indicators are present. During the three months ended June 30, 2023, the Company recorded Goodwill impairment in the amount of $14,503. Refer to Note 3 for further details. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships, acquired technology and trade name are being amortized over the estimated useful life of approximately 11 years, 6 years, and 4 years, respectively, using the straight-line amortization method. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortization of customer relationships, acquired technology and trade names, is presented within depreciation and amortization in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair value of financial instruments</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs which are supported by little or no market activity.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments consist of cash and cash equivalents, restricted deposits, trade receivables, net, trade payables, employees, payroll accruals, accrued expenses and other current liabilities and current portion of long-term debts. Their historical carrying amounts represent the approximate fair value due to the short-term maturities of these instruments. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s investments in money market funds are classified as cash equivalents and measured at fair value. The Company measures its warrant liability at fair value.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill impairment recorded in the second quarter of 2023 was estimated using the Company's stock price, a Level 1 input, adjusted for an estimated control premium.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company’s financial instruments that are measured at fair value on a recurring basis:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,323 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,948 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the Level 3 warrant liability is summarized below: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,462 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,462 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,330)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to level 1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(706)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,330 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, the Company’s warrant liability includes the Warrants (refer to Note 5), that were originally issued in connection with ION’s initial public offering, the “ION IPO,” which were transferred to the Company as part of the ION’s Transaction. The Company’s Warrants are recorded on the balance sheet at fair value with changes in fair value recognized through earnings. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement the valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s statement of operations. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the fair value of the Public Warrants and Transferred Private Warrants (refer to Note 5) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, at the balance sheet date is determined by the closing price of the Company’s warrants, and are within Level 1 of the fair value hierarchy. The closing price of the Public Warrants and Transferred Private Warrants was $0.10 as of June 30, 2023 the price for Public Warrants was $0.40 as of December 31, 2022. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Transferred Private Warrants are no longer classified as Level 3 as of June 30, 2023. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from the remeasurement of the Public and Private Warrants’ liability is recognized in finance income, net in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instruments. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect these estimates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risks</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company’s cash and cash equivalents are invested in deposits with major banks in the US and Israel. The Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed federally insured limits. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s trade receivables, net is mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the Company’s customers accounted for more than 10% of the Company’s total revenues during the three and six months ended June 30, 2023.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*)</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*) less than 10%</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company’s revenues are derived from providing Ad serving solutions to advertisers, media agencies and publishers. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display and other channels.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provides measurement services to advertisers and agencies, streaming platforms and publishers. The measurement service provides analytics and the ability to track performance of advertising campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provides creative services for the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to creative projects are recognized at a point in time when the Company delivers an ad unit. Creative services projects are usually delivered within a week.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s accounts receivable consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be canceled without cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ad serving services were 77.3% and 78.4% of the Company’s revenues for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), respectively and were 77.2% and 83.4% of the Company’s revenues for the six months ended June 30, 2023 (unaudited) and 2022 (unaudited). Measurement services were 22.7% and 21.6% for the three months ended June 30, 2023 (unaudited) and June 30, 2022 (unaudited), respectively and were 22.8% and 16.6% of the Company’s revenues for the six months ended June 30, 2023 (unaudited) and 2022 (unaudited).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs to obtain a contract</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract costs include commission programs to compensate sales employees for generating sales orders with new customers or for new services with existing customers. Generally, the commissions are commensurate. The Company elected to apply the practical expedient and recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less. If commissions are not commensurate, the Company capitalizes these commissions. Capitalized commission costs were immaterial for the three and six months ended June 30, 2023 (unaudited) and June 30, 2022 (unaudited).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade receivable, net</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records trade receivable for amounts invoiced and yet unbilled invoices. The Company makes estimates of expected credit losses for the allowance for doubtful accounts based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The estimated credit loss allowance is recorded as general and administrative expenses on the Company's condensed consolidated statements of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes and tax contingencies</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2017, Congress passed the “US Tax Act.” The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations and the preparation and analysis of information not previously relevant or regularly produced. The US Tax Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div>In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. ASU 2016-13 requires enhanced qualitative and quantitative disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The adoption has impacted how the Company assesses its estimates for credit losses but did not have a material impact on these unaudited interim condensed consolidated financial statements. <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements have been prepared in accordance with US GAAP. Any reference in these notes to applicable guidance is meant to refer to the authoritative US GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Updates (“ASU”) of the Financial Accounting Standards Board (“FASB”) and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by US GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements reflect all adjustments, which are, in the opinion of management, necessary for a fair presentation. The Company’s interim period results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated balance sheet as of December 31, 2022, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by US GAAP for complete financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and footnotes included in the Company’s 2022 Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2022, have been applied consistently in these unaudited interim condensed consolidated financial statements, unless otherwise stated.</span></div> Use of EstimatesThe preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments, and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Software development costs</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software development costs, which are included in property and equipment, net, consists of capitalized costs related to the purchase and development of internal-use software. The Company uses such software to provide services to its customers. The costs to purchase and develop internal-use software are capitalized from the time that the preliminary project stage is completed, and it is considered probable that the software will be used to perform the function intended. These costs include personnel and personnel-related employee benefits for employees directly associated with the software development and external costs of the materials or services consumed in developing or obtaining the software. </span></div>Any costs incurred for upgrades and functionality enhancements of the software are also capitalized. Once this software is ready for use in providing the Company's services, these costs are amortized on a straight-line basis over the estimated useful life of the software, which is three years. The amortization is presented within depreciation and amortization in the condensed consolidated statements of operations. P3Y 2825000 6281000 2335000 4006000 Impairment of long-lived assetsLong-lived assets, including property and equipment and finite-lived intangible assets, are reviewed for impairment whenever facts or circumstances either internally or externally may indicate that the carrying value of an asset may not be recoverable. If there are indications of an impairment, the Company tests for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of the asset to the carrying amount of the asset or asset group. If the asset or asset group is determined to be impaired, any excess of the carrying value of the asset or asset group over its estimated fair value is recognized as an impairment loss. 0 0 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and acquired intangible assets</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and acquired intangible assets have been recorded in the Company's financial statements resulting from     various business combinations. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed. Goodwill is subject to an annual impairment test. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reporting units are evaluated when changes in the Company’s operating structure occur, and if necessary, goodwill is reassigned using a relative fair value allocation approach. The Company currently has one reporting unit. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 350, Intangibles—Goodwill and other (“ASC 350”) requires goodwill to be tested for impairment at least annually and, in certain circumstances, between annual tests. The accounting guidance gives the option to perform a qualitative assessment to determine whether further impairment testing is necessary. The qualitative assessment considers events and circumstances that might indicate that a reporting unit's fair value is less than its carrying amount. If it is determined, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a quantitative test is performed. The Company elects to perform an annual impairment test of goodwill as of October 1 of each year, or more frequently if impairment indicators are present. During the three months ended June 30, 2023, the Company recorded Goodwill impairment in the amount of $14,503. Refer to Note 3 for further details. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships, acquired technology and trade name are being amortized over the estimated useful life of approximately 11 years, 6 years, and 4 years, respectively, using the straight-line amortization method. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortization of customer relationships, acquired technology and trade names, is presented within depreciation and amortization in the condensed consolidated statements of operations.</span></div> 1 14503000 P11Y P6Y P4Y <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair value of financial instruments</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a fair value framework to measure and disclose its financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy requires an entity to maximize the use of observable inputs, where available, and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - Unobservable inputs which are supported by little or no market activity.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments consist of cash and cash equivalents, restricted deposits, trade receivables, net, trade payables, employees, payroll accruals, accrued expenses and other current liabilities and current portion of long-term debts. Their historical carrying amounts represent the approximate fair value due to the short-term maturities of these instruments. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s investments in money market funds are classified as cash equivalents and measured at fair value. The Company measures its warrant liability at fair value.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill impairment recorded in the second quarter of 2023 was estimated using the Company's stock price, a Level 1 input, adjusted for an estimated control premium.</span></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company’s financial instruments that are measured at fair value on a recurring basis:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,323 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,948 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants liability</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 36323000 0 0 1022000 0 0 18948000 0 0 0 20000000 0 1265000 0 3036000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of the Level 3 warrant liability is summarized below: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of the period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,462 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,462 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,330)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to level 1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(706)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,330 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 3036000 15462000 15462000 -2330000 -12426000 -13132000 706000 0 0 0 3036000 2330000 0.10 0.10 0.40 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risks</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company’s cash and cash equivalents are invested in deposits with major banks in the US and Israel. The Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed federally insured limits. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s trade receivables, net is mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.</span></div>The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements. <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the Company’s customers accounted for more than 10% of the Company’s total revenues during the three and six months ended June 30, 2023.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*)</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*) less than 10%</span></div> 0.16 0.16 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company’s revenues are derived from providing Ad serving solutions to advertisers, media agencies and publishers. The services focus on standard, interactive and data driven digital video advertising. Ad serving services relate to utilizing Innovid’s platform to serve advertising impressions to various digital publishers across CTV, mobile TV, desktop TV, display and other channels.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provides measurement services to advertisers and agencies, streaming platforms and publishers. The measurement service provides analytics and the ability to track performance of advertising campaigns. The measurement service provides insights into the effectiveness of TV and digital advertising.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provides creative services for the design and development of interactive data-driven and dynamic ad formats by adding data, interactivity and dynamic features to standard ad units.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when its customer obtains control of promised services in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company recognizes revenue in accordance with ASC Topic 606, Revenue from contracts with customers (“ASC 606”) and determines revenue recognition through the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct and are separately identifiable, the Company allocates the contract consideration to all distinct performance obligations based on their relative standalone selling price (“SSP”). SSP is typically estimated based on observable transactions when these services are sold on a standalone basis. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to ad serving services are recognized when impressions are delivered. The Company recognizes revenue from the display of impression-based ads in the contracted period in which the impressions are delivered. Impressions are considered delivered when an ad is displayed to users.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to the measurement services platform are recognized over time, since the customer simultaneously receives and consumes the benefits provided by the Company’s performance. Revenues for these measurement services are recognized over the service period. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues related to creative projects are recognized at a point in time when the Company delivers an ad unit. Creative services projects are usually delivered within a week.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s accounts receivable consist primarily of receivables related to providing ad serving, measurement and creative services, for which the Company’s contracted performance obligations have been satisfied, the amount has been billed and the Company has an unconditional right to payment. The Company typically bills customers monthly based on actual delivery. The payment terms vary, mainly with terms of 60 days or less. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The typical contract term is 12 months or less for ASC 606 purposes. Most of the Company’s contracts can be canceled without cause. The Company has the unconditional right to payment for the services provided as of the date of the termination of the contracts. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the practical expedient in ASC 606 and does not adjust the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenues represent mostly unrecognized fees billed or collected for measurement platform services. Deferred revenues are recognized as (or when) we perform under the contract.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs to obtain a contract</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract costs include commission programs to compensate sales employees for generating sales orders with new customers or for new services with existing customers. Generally, the commissions are commensurate. The Company elected to apply the practical expedient and recognize incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less. If commissions are not commensurate, the Company capitalizes these commissions. Capitalized commission costs were immaterial for the three and six months ended June 30, 2023 (unaudited) and June 30, 2022 (unaudited).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade receivable, net</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records trade receivable for amounts invoiced and yet unbilled invoices. The Company makes estimates of expected credit losses for the allowance for doubtful accounts based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. The estimated credit loss allowance is recorded as general and administrative expenses on the Company's condensed consolidated statements of operations.</span></div> P60D 0.773 0.784 0.772 0.834 0.227 0.216 0.228 0.166 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes and tax contingencies</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are computed using a balance sheet approach reflecting both current and deferred taxes. Current and deferred taxes reflect the tax impact of all of the events included in the financial statements. The basic principles employed in the balance sheet approach are to reflect a current tax liability or asset that is recognized for the estimated taxes payable or refundable on tax returns for the current and prior years, a deferred tax liability or asset that is recognized for the estimated future tax effects attributable to temporary differences and carryforwards, the measurement of current and deferred tax liabilities and assets is based on provisions of the enacted tax law of which the effects of future changes in tax laws or rates are not anticipated, and the measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be realized. There are certain situations in which deferred taxes are not provided. Some basis differences are not temporary differences because their reversals are not expected to result in taxable or deductible amounts. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly evaluates deferred tax assets for future realization and establishes a valuation allowance to the extent that a portion is not more likely than not to be realized. The Company considers whether it is more likely than not that the deferred tax assets will be realized, including existing cumulative losses in recent years, expectations of future taxable income, carryforward periods and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely on estimates.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 740, Income Taxes (“ASC 740”) contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2017, Congress passed the “US Tax Act.” The US Tax Act requires complex computations to be performed that were not previously required by US tax law, significant judgments to be made in interpretation of the provisions of the US Tax Act, significant estimates in calculations and the preparation and analysis of information not previously relevant or regularly produced. The US Tax Act provides that a person who is a US shareholder of any CFC is required to include its GILTI in gross income for the tax year in a manner generally similar to that for Subpart F inclusions. The term “global intangible low taxed income” is defined as the excess (if any) of the US shareholder’s net CFC tested income for that tax year, over the US shareholder’s net deemed tangible income return for that tax year. The Company’s policy is to treat GILTI as a period expense in the provision for income taxes.</span></div> Recently Adopted Accounting PronouncementsIn June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. ASU 2016-13 requires enhanced qualitative and quantitative disclosures to help investors and other financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The adoption has impacted how the Company assesses its estimates for credit losses but did not have a material impact on these unaudited interim condensed consolidated financial statements. GOODWILL<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,976 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,503)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically analyzes whether any indicators of goodwill impairment have occurred. In the second quarter of 2023, the Company experienced a decline in its stock price resulting in its market capitalization being less than the carrying value of its one reporting unit. Thus, the Company performed quantitative assessments of the Company’s reporting unit. The fair value was determined based on the market approach. The market approach utilizes the Company's market capitalization plus an appropriate control premium. Market capitalization is determined by multiplying the number of common stock outstanding by the market price of its common stock. The control premium is determined by utilizing publicly available data from studies for similar transactions of public companies. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this assessment, the Company recorded a goodwill impairment of $14,503 as of June 30, 2023.</span></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,976 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,503)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 116976000 14503000 102473000 14503000 LEASES<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovid's lease portfolio primarily consists of real estate properties. Short-term leases with a term of 12 months or less are not recorded on the balance sheet. Innovid does not separate lease components from non-lease components.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a lessee in all its lease agreements. The Company records lease liabilities based on the present value of lease payments over the lease term. Innovid generally uses an incremental borrowing rate to discount its lease liabilities, as the rate implicit in the lease is typically not readily determinable. Certain lease agreements include renewal options that are under the Company's control. Innovid includes optional renewal periods in the lease term only when it is reasonably certain that Innovid will exercise its option.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease payments are primarily related to payments to lessors for taxes, maintenance, insurance and other operating costs. The Company's lease agreements do not contain any significant residual value guarantees or restrictive covenants.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the following operating ROU assets and lease liabilities:</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.811%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROU assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROU assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,692 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,008</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,692</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,822</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the lease costs recognized in the interim condensed consolidated statement of operations:</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023 (unaudited), the weighted-average remaining lease term and weighted-average discount rate for operating leases are 1.8 years and 2.5%, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplementary cash flow information regarding the Company's operating leases:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the future payments of Innovid for its operating lease liabilities:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Remaining</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,732</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,692</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the following operating ROU assets and lease liabilities:</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.811%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROU assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROU assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,692 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cars</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,008</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,692</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,822</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2008000 2692000 2886000 3801000 0 0 24000 21000 2008000 2692000 2910000 3822000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the lease costs recognized in the interim condensed consolidated statement of operations:</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplementary cash flow information regarding the Company's operating leases:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 458000 472000 921000 947000 320000 126000 583000 208000 25000 6000 46000 10000 803000 604000 1550000 1165000 P1Y9M18D 0.025 1035000 1133000 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the future payments of Innovid for its operating lease liabilities:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Remaining</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,124 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,732</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,692</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1124000 972000 636000 2732000 40000 2692000 WARRANTSAs of June 30, 2023, the Company had 3,162,500 Public Warrants and 7,060,000 Private Warrants outstanding. As of June 30, 2023, the majority of the Private Warrants (the “Transferred Private Warrants”) had been transferred from their initial holder to other transferees. The Transferred Private Warrants terms are now identical to the Public Warrants resulting in use of the same price for valuation purposes.The Company’s Warrants’ fair value as of June 30, 2023 (unaudited), and December 31, 2022, was $1,022 and $4,301, respectively. Gains and losses related to the Company’s Warrants are recognized in “Finance income, net.” See Note 9 for further details. 3162500 7060000 1022000 4301000 LONG-TERM DEBT<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2022, two wholly owned subsidiaries of the Company, Innovid LLC and TV Squared Inc, entered an amended and restated loan and security agreement with Silicon Valley Bank (the “2022 A&amp;R Agreement”), to increase the revolving line of credit from $15,000 to $50,000 (the “New Revolving Credit Facility”). The 2022 A&amp;R Agreement and the New Revolving Credit Facility were amended by a First Loan Modification Agreement dated August 2, 2023 (the “2023 Modification Agreement”). The interest for the New Revolving Credit Facility is payable monthly in arrears. The New Revolving Credit Facility bears interest at an annual rate which is the greater of (a) WSJ Prime Rate plus 0.25% or (b) 4.25%, on the aggregate outstanding balance. Additional fees include fees in an amount of 0.20% per annum of the average unused portion of the New Revolving Credit Facility to be paid quarterly in arrears. The Company will also pay non-refundable commitment fees of $40 and $75 at inception and first anniversary date, respectively, together with a modification fee of $20 payable on the date of the 2023 Modification Agreement. The maturity date of the 2022 A&amp;R Agreement, as amended by the 2023 Modification Agreement, is June 30, 2025. The New Revolving Credit Facility is subject to certain customary conditions precedent to the credit extension as stated in the 2022 A&amp;R Agreement.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The New Revolving Credit Facility requires the Company to comply with all covenants, primarily maintaining an adjusted quick ratio of at least 1.30 to 1.00. As defined in the 2022 A&amp;R Agreement, “adjusted quick ratio” is the ratio of (a) quick assets to (b) current liabilities minus the current portion of deferred revenue. “Quick assets” are determined as the Company’s unrestricted cash plus accounts receivable, net, and is determined according to US GAAP. The Company is also required to maintain the minimum quarterly adjusted EBITDA as defined in the 2022 A&amp;R Agreement, as amended by the 2023 Modification Agreement, if the Company does not maintain the quarterly adjusted quick ratio of at least 1.50 to 1.00. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023 (unaudited), and December 31, 2022, the Company utilized $20,000 of the $50,000 credit line. In January 2023, the Company repaid $5,000 under the credit line and $5,000 was subsequently drawn in March 2023. In May 2023, the Company repaid $5,000 under the credit line and $5,000 was subsequently drawn in June 2023.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023 (unaudited), the Company is in compliance with all the covenants.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the 2022 A&amp;R Agreement, the credit installments bore US dollar denominated interest at an annual rate equal to 0.75%-1% plus the prime rate on the outstanding principal of each credit installment and prior to the 2023 Modification Agreement the New Revolving Credit Facility bore interest at an annual rate which was the greater of (a) WSJ Prime Rate plus 0.75% or (b) 4.25%.</span></div>FINANCE INCOME, NET<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the gains and losses from the remeasurement of the warrants liability related to the Public Warrants and Private Placement Warrants, as defined in Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in “Finance income, net” in the condensed consolidated statements of operations. The unrealized gain from changes in the fair value of the Company Warrants for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $565 and $13,159, respectively. The unrealized gain from changes in the fair value of the Company Warrants for the six months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $3,279 and $15,946, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also recognized interest expenses in “Finance income, net” in the condensed consolidated statements of operations. Interest expenses for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), were $420 and $76, respectively. Interest expenses for the six months ended June 30, 2023 and 2022, were $782 and $137, respectively.</span></div> 2 15000000 50000000 0.0025 0.0425 0.0020 40000 75000 20000 1.30 1.50 20000000 20000000 50000000 50000000 5000000 5000000 5000 5000 0.0075 0.01 0.0075 0.0425 COMMITMENTS AND CONTINGENT LIABILITIES<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pledges and bank guarantees</span></div><div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">In conjunction with the 2022 A&amp;R Agreement (see Note 6, Long-term Debt), Innovid LLC pledged 65,000 common stocks of its Israeli Subsidiary, NIS 0.01 par value each.</span></div><div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">The Israeli Subsidiary pledged bank deposits in an aggregate amount of $601 in connection with an office rent agreement and credit cards.</span></div><div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">Innovid Inc. obtained bank guarantees in an aggregate amount of $231 in connection with its office lease agreements.</span></div>Legal contingenciesOn March 4, 2022, a lawsuit was filed in the United States District Court for the Western District of Texas by the Nielsen, Company (US) LLC against TVS alleging infringement of US Patent No.10,063,378. On June 1, 2022, TVS moved to transfer the case to the Southern District of New York. On February 24, 2023, the case was transferred to the Southern District of New York. On March 23, 2023, the parties jointly filed their proposed case management plan and scheduling order, which the Court entered and thereafter opened discovery. That order sets the close of fact discovery for October 23, 2023, and the close of expert discovery for January 23, 2024, but does not set a date for trial. On the same day, TV Squared filed a motion for judgment on the pleadings under Federal Rule 12(c) arguing invalidity of all asserted patent claims. Briefing concluded on April 24, 2023, and the motion remains pending. The plaintiff has not specified the amount sought in the litigation. Given the uncertainty of litigation and the preliminary stage of the lawsuit, the Company is unable at this time to give an estimate of the amount or range of potential loss, if any, which might result to the Company if the outcome in such litigation was unfavorable. As of June 30, 2023, the Company did not record a loss contingency. 65000 0.01 601000 231000 STOCK-BASED COMPENSATION<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is related to awards issued pursuant to the Legacy Innovid Stock Option Plan (“Legacy Plan”) and 2021 Innovid Corp. Incentive Plan (“2021 Plan”) and is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,690 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,269 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,410 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,334</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,958</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,730</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the awards granted to service providers and non-employee consultants, the Company’s expense is immaterial in the periods presented.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June 30, 2023 (unaudited), the Company capitalized stock-based compensation expense of $325 and $690 of internal-use software costs, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June 30, 2022, the Company capitalized stock-based compensation expense of $490, respectively, in internal-use software cost.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options may be granted to officers, directors, employees and non-employee consultants of the Company. Each option granted under the Plan expires no later than 10 years from the date of grant. The options vest usually over four years from commencement of employment or service start date. Any options forfeited or not exercised before expiration become available for future grants.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the employees’ stock option activity for the six months ended June 30, 2023 (unaudited), is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">options </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">price </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">remaining contractual term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,658,085</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,923</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832,232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207,449)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,376,572)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of period</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,742,656</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.08</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable options at end of period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,563,845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,356</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the consultants’ stock option activity for the six months ended June 30, 2023 (unaudited), is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">options </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">price </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">remaining contractual term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69,542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of period</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69,542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.72</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable options at end of period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023 (unaudited), the Company had approximately $3,945 of total unrecognized compensation cost related to non-vested stock options. That cost is expected to be recognized over a weighted-average period of 1.92 years. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted Stock Units (“RSUs”) may be granted to officers, directors, employees and non-employee consultants of the Company, and generally vest over a <span style="-sec-ix-hidden:f-529">three</span>- or four-year period.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the employees’ RSU activity under the 2021 Plan for the six months ended June 30, 2023 (unaudited), is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of share units</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">grant date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,989,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,096,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,424,868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113,878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of period</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,547,317</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the consultants’ RSU activity under the 2021 Plan for the six months ended June 30, 2023 (unaudited), is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of share units</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">grant date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130,268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of period</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">176,135</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Innovid’s common stock on the date of grant.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023 (unaudited), $33,727 of unrecognized compensation cost related to RSUs is expected to be recognized as expense over the weighted average period of 2.3 years.</span></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense is related to awards issued pursuant to the Legacy Innovid Stock Option Plan (“Legacy Plan”) and 2021 Innovid Corp. Incentive Plan (“2021 Plan”) and is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;padding-right:2.85pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,229 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,690 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,269 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,410 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,334</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,958</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,730</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 435000 383000 876000 488000 1229000 920000 2403000 1399000 1690000 1529000 3269000 2109000 1980000 1306000 3410000 1734000 5334000 4138000 9958000 5730000 325000 690000 490000 490000 P10Y P4Y <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the employees’ stock option activity for the six months ended June 30, 2023 (unaudited), is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">options </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">price </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">remaining contractual term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,658,085</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.85</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,923</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832,232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207,449)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,376,572)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of period</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,742,656</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.08</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable options at end of period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,563,845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,356</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the consultants’ stock option activity for the six months ended June 30, 2023 (unaudited), is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.515%"><tr><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.557%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">options </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">price </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">remaining contractual term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate intrinsic value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69,542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of period</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69,542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.72</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable options at end of period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.53</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 10658085 1.15 P6Y10M6D 5923000 832232 1.55 207449 1.89 163640 1.65 1376572 0.45 9742656 1.26 P7Y29D 14232000 6563845 0.99 P6Y4M13D 11356000 69542 0.47 P4Y2M15D 86000 0 0 0 0 69542 0.47 P3Y8M19D 156000 66196 0.46 P3Y6M10D 149000 3945000 P1Y11M1D P4Y <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the employees’ RSU activity under the 2021 Plan for the six months ended June 30, 2023 (unaudited), is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of share units</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">grant date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,989,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,096,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,424,868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.27 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113,878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of period</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,547,317</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the consultants’ RSU activity under the 2021 Plan for the six months ended June 30, 2023 (unaudited), is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of share units</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">grant date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">fair value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at beginning of period</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130,268</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.60</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at end of period</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">176,135</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 7989825 5.60 12096238 1.28 3424868 5.27 1113878 4.88 15547317 2.36 130268 6.60 107343 1.18 53250 6.60 8226 6.60 176135 3.30 33727000 P2Y3M18D 565000 13159000 3279000 15946000 420000 76000 782000 137000 INCOME TAX<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a provision for incomes taxes of $1,335 and a net tax benefit of $168 for the three months ended June 30, 2023 (unaudited) and 2022 (unaudited), respectively, and a net expense of $4,159 and a net tax benefit of $205 for the six months ended June 30, 2023 and 2022, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s effective tax rates were (7.6)% and (4.1)% for the three months ended June 30, 2023 and 2022, respectively, and (17.8)% and 6.1% for the six months ended June 30, 2023 and 2022, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2023 (unaudited), the net effect of discrete items increased the effective tax rate by 0.2%. Excluding these items, the Company’s effective tax rate would have been (7.4)%. For the six months ended June 30, 2023, the net effect of discrete items increased the effective tax rate by 1.1%. Excluding these items, the Company’s effective tax rate would have been (18.9)%.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2022 (unaudited), the net effect of discrete items increased the effective tax rate by 3.3%. Excluding these items, the Company’s effective tax rate would have been (7.4)%. For the six months ended June 30, 2022, the net effect of discrete items decreased the effective tax rate by 4.6%. Excluding these items, the Company’s effective tax rate would have been 10.7%.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in year-to-date tax expense primarily results from a shift in the Company’s foreign earnings, resulting in higher profitability and current tax expense, with no offsetting deferred tax benefit as a result of an overall valuation allowance.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain temporary differences associated with the capitalization of research and development under IRC Section 174 and deductibility of stock compensation that would normally not impact the effective tax rate or overall tax expense, could cause the US to generate current state tax expense with no corresponding deferred tax benefit. Unless the US tax rules around research and development (Section 174) are modified, there will continue to be an adverse impact on our effective rates for income taxes paid.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lastly, the current tax expense is increased as compared to prior years, in both the foreign jurisdictions and the US, because of decreased net operating losses available due to prior year utilization.</span></div> 1335000 168000 4159000 -205000 -0.076 -0.041 -0.178 0.061 0.002 -0.074 0.011 -0.189 0.033 0.074 -0.046 0.107 SEGMENT REPORTING<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as one operating segment, which primarily focuses on the software platform for advertising, measurement, and creative. Our CEO is the chief operating decision-maker, and manages and allocates resources to the operations of the Company on an entity-wide basis.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by geographical location are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,952 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,914 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LATAM</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34,546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,088</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,031</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58,950</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s property and equipment, net and ROU assets by geographical location is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,967</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by geographical location are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,214 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,952 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">734 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,914 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LATAM</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34,546</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,088</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,031</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58,950</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s property and equipment, net and ROU assets by geographical location is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,388 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,212 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,967</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,232</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 31567000 29569000 59214000 52952000 465000 302000 853000 490000 734000 1025000 1549000 1956000 1595000 1914000 3038000 3043000 185000 278000 377000 509000 34546000 33088000 65031000 58950000 2388000 2707000 18212000 14065000 367000 460000 20967000 17232000 BASIC AND DILUTED NET (LOSS) INCOME PER SHARE<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net (loss) income per share attributable to common stockholders was calculated as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18,959)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,300 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,522)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (loss) income attributable to common stockholders basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(18,959)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4,300</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(27,522)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,149)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">`</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average number of shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137,643,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132,152,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134,296,569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128,220,893 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities options and RSU (share equivalent)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,835,471 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average number of shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,643,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,988,123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,296,569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,220,893 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net profit (loss) per stock attributable to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSU outstanding </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,723,452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,991,829 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,723,452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002,502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,812,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,533,772 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,812,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,363,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net (loss) income per share attributable to common stockholders was calculated as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18,959)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,300 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,522)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (loss) income attributable to common stockholders basic and diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(18,959)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4,300</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(27,522)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,149)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">`</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average number of shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137,643,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132,152,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134,296,569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128,220,893 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities options and RSU (share equivalent)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,835,471 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average number of shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,643,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,988,123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,296,569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,220,893 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net profit (loss) per stock attributable to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -18959000 4300000 -27522000 -3149000 -18959000 -18959000 4300000 4300000 -27522000 -27522000 -3149000 -3149000 137643910 132152652 134296569 128220893 0 7835471 0 0 137643910 139988123 134296569 128220893 -0.14 0.03 -0.20 -0.02 -0.14 0.03 -0.20 -0.02 <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSU outstanding </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,723,452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,991,829 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,723,452 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,002,502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,812,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,533,772 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,812,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,363,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,222,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 15723452 7991829 15723452 8002502 9812198 3533772 9812198 12363179 10222500 10222500 10222500 10222500 SUBSEQUENT EVENTSOn August 2, 2023, two wholly owned subsidiaries of the Company, Innovid LLC and TV Squared Inc, entered the 2023 Modification Agreement with Silicon Valley Bank, a division of First-Citizen Bank &amp; Trust Company. Refer to Note 6 for further details. 2 Exclusive of depreciation, amortization and goodwill impairment presented separately. EXCEL 66 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO=V]R:W-H965T@\W@GD ( ($& 9 " @5_H !X;"]W;W)K&UL4$L! A0#% @ [X0(5W^\;;W> @ ?PL !D M ("!)NL 'AL+W=OP &0 @($[[@ >&PO M=V]R:W-H965T&UL4$L! A0#% @ [X0(5TB+U[B*! F1D !D ("! M=?L 'AL+W=O&PO=V]R:W-H965T8(PP8 $XK 9 M " @7T% 0!X;"]W;W)K&UL4$L! A0#% M @ [X0(5^:*9O)-! U1, !D ("!=PP! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ [X0(5X(6%=

&PO=V]R:W-H965T 9 " @;,@ 0!X;"]W;W)K&UL4$L! A0#% @ [X0(5[=%*OF_ P &A, !D M ("!3B8! 'AL+W=O&PO=V]R M:W-H965T*,79?SP$ #,? : M " :DU 0!X;"]?7!E&UL4$L%!@ \ #P 6Q *@Y 0 $! end XML 67 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 68 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 69 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 187 246 1 true 60 0 false 7 false false R1.htm 0000001 - Document - Cover Sheet http://www.innovid.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 0000005 - Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY Sheet http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY Statements 5 false false R6.htm 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 0000007 - Disclosure - DESCRIPTION OF BUSINESS Sheet http://www.innovid.com/role/DESCRIPTIONOFBUSINESS DESCRIPTION OF BUSINESS Notes 7 false false R8.htm 0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 0000009 - Disclosure - GOODWILL Sheet http://www.innovid.com/role/GOODWILL GOODWILL Notes 9 false false R10.htm 0000010 - Disclosure - LEASES Sheet http://www.innovid.com/role/LEASES LEASES Notes 10 false false R11.htm 0000011 - Disclosure - WARRANTS Sheet http://www.innovid.com/role/WARRANTS WARRANTS Notes 11 false false R12.htm 0000012 - Disclosure - LONG-TERM DEBT Sheet http://www.innovid.com/role/LONGTERMDEBT LONG-TERM DEBT Notes 12 false false R13.htm 0000013 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES Sheet http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIES COMMITMENTS AND CONTINGENT LIABILITIES Notes 13 false false R14.htm 0000014 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.innovid.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 14 false false R15.htm 0000015 - Disclosure - FINANCE INCOME, NET Sheet http://www.innovid.com/role/FINANCEINCOMENET FINANCE INCOME, NET Notes 15 false false R16.htm 0000016 - Disclosure - INCOME TAX Sheet http://www.innovid.com/role/INCOMETAX INCOME TAX Notes 16 false false R17.htm 0000017 - Disclosure - SEGMENT REPORTING Sheet http://www.innovid.com/role/SEGMENTREPORTING SEGMENT REPORTING Notes 17 false false R18.htm 0000018 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE Sheet http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARE BASIC AND DILUTED NET (LOSS) INCOME PER SHARE Notes 18 false false R19.htm 0000019 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.innovid.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 19 false false R20.htm 9954701 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 20 false false R21.htm 9954702 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 21 false false R22.htm 9954703 - Disclosure - GOODWILL (Tables) Sheet http://www.innovid.com/role/GOODWILLTables GOODWILL (Tables) Tables http://www.innovid.com/role/GOODWILL 22 false false R23.htm 9954704 - Disclosure - LEASES (Tables) Sheet http://www.innovid.com/role/LEASESTables LEASES (Tables) Tables http://www.innovid.com/role/LEASES 23 false false R24.htm 9954705 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.innovid.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.innovid.com/role/STOCKBASEDCOMPENSATION 24 false false R25.htm 9954706 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://www.innovid.com/role/SEGMENTREPORTINGTables SEGMENT REPORTING (Tables) Tables http://www.innovid.com/role/SEGMENTREPORTING 25 false false R26.htm 9954707 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE (Tables) Sheet http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARETables BASIC AND DILUTED NET (LOSS) INCOME PER SHARE (Tables) Tables http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARE 26 false false R27.htm 9954708 - Disclosure - DESCRIPTION OF BUSINESS (Details) Sheet http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails DESCRIPTION OF BUSINESS (Details) Details http://www.innovid.com/role/DESCRIPTIONOFBUSINESS 27 false false R28.htm 9954709 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Sheet http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Details 28 false false R29.htm 9954710 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Sheet http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Details 29 false false R30.htm 9954711 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) Sheet http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) Details 30 false false R31.htm 9954712 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk (Details) Sheet http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk (Details) Details 31 false false R32.htm 9954713 - Disclosure - GOODWILL - Schedule of Goodwill (Details) Sheet http://www.innovid.com/role/GOODWILLScheduleofGoodwillDetails GOODWILL - Schedule of Goodwill (Details) Details 32 false false R33.htm 9954714 - Disclosure - GOODWILL - Narrative (Details) Sheet http://www.innovid.com/role/GOODWILLNarrativeDetails GOODWILL - Narrative (Details) Details 33 false false R34.htm 9954715 - Disclosure - LEASES - Schedule of Operating ROU Assets and Lease Liabilities (Details) Sheet http://www.innovid.com/role/LEASESScheduleofOperatingROUAssetsandLeaseLiabilitiesDetails LEASES - Schedule of Operating ROU Assets and Lease Liabilities (Details) Details 34 false false R35.htm 9954716 - Disclosure - LEASES - Lease Costs Recognized in the Condensed Consolidated Statement of Earnings (Details) Sheet http://www.innovid.com/role/LEASESLeaseCostsRecognizedintheCondensedConsolidatedStatementofEarningsDetails LEASES - Lease Costs Recognized in the Condensed Consolidated Statement of Earnings (Details) Details 35 false false R36.htm 9954717 - Disclosure - LEASES - Narrative (Details) Sheet http://www.innovid.com/role/LEASESNarrativeDetails LEASES - Narrative (Details) Details 36 false false R37.htm 9954718 - Disclosure - LEASES - Supplementary Cash Flow Information (Details) Sheet http://www.innovid.com/role/LEASESSupplementaryCashFlowInformationDetails LEASES - Supplementary Cash Flow Information (Details) Details 37 false false R38.htm 9954719 - Disclosure - LEASES - Schedule of Operating Lease Liabilities Maturity (Details) Sheet http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails LEASES - Schedule of Operating Lease Liabilities Maturity (Details) Details 38 false false R39.htm 9954720 - Disclosure - WARRANTS (Details) Sheet http://www.innovid.com/role/WARRANTSDetails WARRANTS (Details) Details http://www.innovid.com/role/WARRANTS 39 false false R40.htm 9954721 - Disclosure - LONG-TERM DEBT (Details) Sheet http://www.innovid.com/role/LONGTERMDEBTDetails LONG-TERM DEBT (Details) Details http://www.innovid.com/role/LONGTERMDEBT 40 false false R41.htm 9954722 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details) Sheet http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails COMMITMENTS AND CONTINGENT LIABILITIES (Details) Details http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIES 41 false false R42.htm 9954723 - Disclosure - STOCK-BASED COMPENSATION - Stock Option Activity Under Plan (Details) Sheet http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails STOCK-BASED COMPENSATION - Stock Option Activity Under Plan (Details) Details 42 false false R43.htm 9954724 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) Sheet http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails STOCK-BASED COMPENSATION - Narrative (Details) Details 43 false false R44.htm 9954725 - Disclosure - STOCK-BASED COMPENSATION - Stock Option Activity (Details) Sheet http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails STOCK-BASED COMPENSATION - Stock Option Activity (Details) Details 44 false false R45.htm 9954726 - Disclosure - STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details) Sheet http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details) Details 45 false false R46.htm 9954727 - Disclosure - FINANCE INCOME, NET (Details) Sheet http://www.innovid.com/role/FINANCEINCOMENETDetails FINANCE INCOME, NET (Details) Details http://www.innovid.com/role/FINANCEINCOMENET 46 false false R47.htm 9954728 - Disclosure - INCOME TAX (Details) Sheet http://www.innovid.com/role/INCOMETAXDetails INCOME TAX (Details) Details http://www.innovid.com/role/INCOMETAX 47 false false R48.htm 9954729 - Disclosure - SEGMENT REPORTING - Narrative (Details) Sheet http://www.innovid.com/role/SEGMENTREPORTINGNarrativeDetails SEGMENT REPORTING - Narrative (Details) Details 48 false false R49.htm 9954730 - Disclosure - SEGMENT REPORTING - Revenue and Property and Equipment, by Geographical Areas (Details) Sheet http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails SEGMENT REPORTING - Revenue and Property and Equipment, by Geographical Areas (Details) Details 49 false false R50.htm 9954731 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Basic and Diluted Net (Loss) Income Per Share (Details) Sheet http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Basic and Diluted Net (Loss) Income Per Share (Details) Details http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARETables 50 false false R51.htm 9954732 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Securities Excluded from Computation of Earnings Per Share (Details) Details http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARETables 51 false false R52.htm 9954733 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.innovid.com/role/SUBSEQUENTEVENTSDetails SUBSEQUENT EVENTS (Details) Details http://www.innovid.com/role/SUBSEQUENTEVENTS 52 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 - ctv-20230630.htm 4 ctv-20230630.htm ctv-20230630.xsd ctv-20230630_cal.xml ctv-20230630_def.xml ctv-20230630_lab.xml ctv-20230630_pre.xml exhibit101amendedandrestat.htm exhibit103-svbmodification.htm exhibit311q22023.htm exhibit312q22023.htm exhibit321q22023.htm exhibit322q22023.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 72 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ctv-20230630.htm": { "axisCustom": 0, "axisStandard": 27, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 573, "http://xbrl.sec.gov/dei/2023": 34 }, "contextCount": 187, "dts": { "calculationLink": { "local": [ "ctv-20230630_cal.xml" ] }, "definitionLink": { "local": [ "ctv-20230630_def.xml" ] }, "inline": { "local": [ "ctv-20230630.htm" ] }, "labelLink": { "local": [ "ctv-20230630_lab.xml" ] }, "presentationLink": { "local": [ "ctv-20230630_pre.xml" ] }, "schema": { "local": [ "ctv-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 425, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 1, "http://xbrl.sec.gov/dei/2023": 5, "total": 6 }, "keyCustom": 28, "keyStandard": 218, "memberCustom": 15, "memberStandard": 37, "nsprefix": "ctv", "nsuri": "http://www.innovid.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://www.innovid.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - LEASES", "menuCat": "Notes", "order": "10", "role": "http://www.innovid.com/role/LEASES", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - WARRANTS", "menuCat": "Notes", "order": "11", "role": "http://www.innovid.com/role/WARRANTS", "shortName": "WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - LONG-TERM DEBT", "menuCat": "Notes", "order": "12", "role": "http://www.innovid.com/role/LONGTERMDEBT", "shortName": "LONG-TERM DEBT", "subGroupType": "", "uniqueAnchor": null }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES", "menuCat": "Notes", "order": "13", "role": "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIES", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - STOCK-BASED COMPENSATION", "menuCat": "Notes", "order": "14", "role": "http://www.innovid.com/role/STOCKBASEDCOMPENSATION", "shortName": "STOCK-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - FINANCE INCOME, NET", "menuCat": "Notes", "order": "15", "role": "http://www.innovid.com/role/FINANCEINCOMENET", "shortName": "FINANCE INCOME, NET", "subGroupType": "", "uniqueAnchor": null }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - INCOME TAX", "menuCat": "Notes", "order": "16", "role": "http://www.innovid.com/role/INCOMETAX", "shortName": "INCOME TAX", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - SEGMENT REPORTING", "menuCat": "Notes", "order": "17", "role": "http://www.innovid.com/role/SEGMENTREPORTING", "shortName": "SEGMENT REPORTING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE", "menuCat": "Notes", "order": "18", "role": "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARE", "shortName": "BASIC AND DILUTED NET (LOSS) INCOME PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "19", "role": "http://www.innovid.com/role/SUBSEQUENTEVENTS", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": "-3", "lang": "en-US", "name": "ctv:ShortTermBankDepositCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954701 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "20", "role": "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954702 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "21", "role": "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954703 - Disclosure - GOODWILL (Tables)", "menuCat": "Tables", "order": "22", "role": "http://www.innovid.com/role/GOODWILLTables", "shortName": "GOODWILL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "ctv:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954704 - Disclosure - LEASES (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.innovid.com/role/LEASESTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "ctv:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954705 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONTables", "shortName": "STOCK-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954706 - Disclosure - SEGMENT REPORTING (Tables)", "menuCat": "Tables", "order": "25", "role": "http://www.innovid.com/role/SEGMENTREPORTINGTables", "shortName": "SEGMENT REPORTING (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954707 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARETables", "shortName": "BASIC AND DILUTED NET (LOSS) INCOME PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-46", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954708 - Disclosure - DESCRIPTION OF BUSINESS (Details)", "menuCat": "Details", "order": "27", "role": "http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails", "shortName": "DESCRIPTION OF BUSINESS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-46", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954709 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)", "menuCat": "Details", "order": "28", "role": "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-56", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954710 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)", "menuCat": "Details", "order": "29", "role": "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-56", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-62", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954711 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)", "menuCat": "Details", "order": "30", "role": "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-64", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-72", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954712 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk (Details)", "menuCat": "Details", "order": "31", "role": "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Concentration Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-72", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-6", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954713 - Disclosure - GOODWILL - Schedule of Goodwill (Details)", "menuCat": "Details", "order": "32", "role": "http://www.innovid.com/role/GOODWILLScheduleofGoodwillDetails", "shortName": "GOODWILL - Schedule of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R33": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954714 - Disclosure - GOODWILL - Narrative (Details)", "menuCat": "Details", "order": "33", "role": "http://www.innovid.com/role/GOODWILLNarrativeDetails", "shortName": "GOODWILL - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954715 - Disclosure - LEASES - Schedule of Operating ROU Assets and Lease Liabilities (Details)", "menuCat": "Details", "order": "34", "role": "http://www.innovid.com/role/LEASESScheduleofOperatingROUAssetsandLeaseLiabilitiesDetails", "shortName": "LEASES - Schedule of Operating ROU Assets and Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ctv:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954716 - Disclosure - LEASES - Lease Costs Recognized in the Condensed Consolidated Statement of Earnings (Details)", "menuCat": "Details", "order": "35", "role": "http://www.innovid.com/role/LEASESLeaseCostsRecognizedintheCondensedConsolidatedStatementofEarningsDetails", "shortName": "LEASES - Lease Costs Recognized in the Condensed Consolidated Statement of Earnings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954717 - Disclosure - LEASES - Narrative (Details)", "menuCat": "Details", "order": "36", "role": "http://www.innovid.com/role/LEASESNarrativeDetails", "shortName": "LEASES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954718 - Disclosure - LEASES - Supplementary Cash Flow Information (Details)", "menuCat": "Details", "order": "37", "role": "http://www.innovid.com/role/LEASESSupplementaryCashFlowInformationDetails", "shortName": "LEASES - Supplementary Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954719 - Disclosure - LEASES - Schedule of Operating Lease Liabilities Maturity (Details)", "menuCat": "Details", "order": "38", "role": "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails", "shortName": "LEASES - Schedule of Operating Lease Liabilities Maturity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-78", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954720 - Disclosure - WARRANTS (Details)", "menuCat": "Details", "order": "39", "role": "http://www.innovid.com/role/WARRANTSDetails", "shortName": "WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-78", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-82", "decimals": "INF", "first": true, "lang": "en-US", "name": "ctv:NumberOfWhollyOwnedSubsidiaries", "reportCount": 1, "unitRef": "subsidiary", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954721 - Disclosure - LONG-TERM DEBT (Details)", "menuCat": "Details", "order": "40", "role": "http://www.innovid.com/role/LONGTERMDEBTDetails", "shortName": "LONG-TERM DEBT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-95", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RepaymentsOfLinesOfCredit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954722 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details)", "menuCat": "Details", "order": "41", "role": "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-5", "decimals": "-3", "lang": "en-US", "name": "ctv:BankGuaranteesInConnectionWithOfficeLeaseAgreement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-119", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954723 - Disclosure - STOCK-BASED COMPENSATION - Stock Option Activity Under Plan (Details)", "menuCat": "Details", "order": "42", "role": "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails", "shortName": "STOCK-BASED COMPENSATION - Stock Option Activity Under Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-119", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954724 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)", "menuCat": "Details", "order": "43", "role": "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-125", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954725 - Disclosure - STOCK-BASED COMPENSATION - Stock Option Activity (Details)", "menuCat": "Details", "order": "44", "role": "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails", "shortName": "STOCK-BASED COMPENSATION - Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-127", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-125", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954726 - Disclosure - STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details)", "menuCat": "Details", "order": "45", "role": "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "shortName": "STOCK-BASED COMPENSATION - Restricted Stock Unit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-125", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-141", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954727 - Disclosure - FINANCE INCOME, NET (Details)", "menuCat": "Details", "order": "46", "role": "http://www.innovid.com/role/FINANCEINCOMENETDetails", "shortName": "FINANCE INCOME, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-141", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954728 - Disclosure - INCOME TAX (Details)", "menuCat": "Details", "order": "47", "role": "http://www.innovid.com/role/INCOMETAXDetails", "shortName": "INCOME TAX (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-8", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxesAndTaxCredits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954729 - Disclosure - SEGMENT REPORTING - Narrative (Details)", "menuCat": "Details", "order": "48", "role": "http://www.innovid.com/role/SEGMENTREPORTINGNarrativeDetails", "shortName": "SEGMENT REPORTING - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954730 - Disclosure - SEGMENT REPORTING - Revenue and Property and Equipment, by Geographical Areas (Details)", "menuCat": "Details", "order": "49", "role": "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails", "shortName": "SEGMENT REPORTING - Revenue and Property and Equipment, by Geographical Areas (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-6", "decimals": "-3", "lang": "en-US", "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-10", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS\u2019 EQUITY", "menuCat": "Statements", "order": "5", "role": "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "shortName": "CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-14", "decimals": "INF", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-7", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954731 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Basic and Diluted Net (Loss) Income Per Share (Details)", "menuCat": "Details", "order": "50", "role": "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "shortName": "BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Basic and Diluted Net (Loss) Income Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-171", "decimals": "0", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-175", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954732 - Disclosure - BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Securities Excluded from Computation of Earnings Per Share (Details)", "menuCat": "Details", "order": "51", "role": "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails", "shortName": "BASIC AND DILUTED NET (LOSS) INCOME PER SHARE - Securities Excluded from Computation of Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-175", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-82", "decimals": "INF", "first": true, "lang": "en-US", "name": "ctv:NumberOfWhollyOwnedSubsidiaries", "reportCount": 1, "unitRef": "subsidiary", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954733 - Disclosure - SUBSEQUENT EVENTS (Details)", "menuCat": "Details", "order": "52", "role": "http://www.innovid.com/role/SUBSEQUENTEVENTSDetails", "shortName": "SUBSEQUENT EVENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-187", "decimals": "INF", "lang": "en-US", "name": "ctv:NumberOfWhollyOwnedSubsidiaries", "reportCount": 1, "unique": true, "unitRef": "subsidiary", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000007 - Disclosure - DESCRIPTION OF BUSINESS", "menuCat": "Notes", "order": "7", "role": "http://www.innovid.com/role/DESCRIPTIONOFBUSINESS", "shortName": "DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - GOODWILL", "menuCat": "Notes", "order": "9", "role": "http://www.innovid.com/role/GOODWILL", "shortName": "GOODWILL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ctv-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 60, "tag": { "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CANADA", "terseLabel": "Canada" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "country_IL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ISRAEL", "terseLabel": "Israel" } } }, "localname": "IL", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "US" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "ctv_A2023ModificationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2023 Modification Agreement", "label": "2023 Modification Agreement [Member]", "terseLabel": "2023 Modification Agreement" } } }, "localname": "A2023ModificationAgreementMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "ctv_AmendedCreditAgreementMaturingDecember2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended Credit Agreement Maturing December 2020", "label": "Amended Credit Agreement Maturing December 2020 [Member]", "terseLabel": "Amended Credit Agreement Maturing December 2020" } } }, "localname": "AmendedCreditAgreementMaturingDecember2020Member", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "ctv_AmendedCreditAgreementMaturingOctober2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amended Credit Agreement Maturing October 2018", "label": "Amended Credit Agreement Maturing October 2018 [Member]", "terseLabel": "Amended Credit Agreement Maturing October 2018" } } }, "localname": "AmendedCreditAgreementMaturingOctober2018Member", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "ctv_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets And Liabilities Lessee", "label": "Assets And Liabilities Lessee [Table Text Block]", "terseLabel": "Schedule of Operating ROU Assets and Lease Liabilities" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "ctv_BankDepositsPledged": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Bank Deposits, Pledged", "label": "Bank Deposits, Pledged", "terseLabel": "Bank deposits pledged" } } }, "localname": "BankDepositsPledged", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "ctv_BankGuaranteesInConnectionWithOfficeLeaseAgreement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Bank Guarantees In connection With Office Lease Agreement", "label": "Bank Guarantees In connection With Office Lease Agreement", "terseLabel": "Bank guarantees" } } }, "localname": "BankGuaranteesInConnectionWithOfficeLeaseAgreement", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "monetaryItemType" }, "ctv_BusinessAcquisitionEquityInterestIssuedOrIssuableFullyVestedStockOption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fully Vested Stock Option", "label": "Business Acquisition, Equity Interest Issued or Issuable, Fully Vested Stock Option", "terseLabel": "Issued, fully vested stock option (in shares)" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableFullyVestedStockOption", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "sharesItemType" }, "ctv_BusinessAcquisitionFullyVestedStockOptionWeightedAverageFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Fully Vested Stock Option, Weighted Average Fair Value", "label": "Business Acquisition, Fully Vested Stock Option, Weighted Average Fair Value", "terseLabel": "Weighted average fair value (in dollars per share)" } } }, "localname": "BusinessAcquisitionFullyVestedStockOptionWeightedAverageFairValue", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "perShareItemType" }, "ctv_CarsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cars", "label": "Cars [Member]", "terseLabel": "Cars" } } }, "localname": "CarsMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ctv_CommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and Contingencies", "label": "Commitments and Contingencies [Line Items]", "terseLabel": "Commitments and Contingencies [Line Items]" } } }, "localname": "CommitmentsAndContingenciesLineItems", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "stringItemType" }, "ctv_CommitmentsAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and Contingencies", "label": "Commitments and Contingencies [Table]", "terseLabel": "Commitments and Contingencies [Table]" } } }, "localname": "CommitmentsAndContingenciesTable", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "stringItemType" }, "ctv_CustomerAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer A", "label": "Customer A [Member]", "terseLabel": "Customer A" } } }, "localname": "CustomerAMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "ctv_DebtInstrumentPrimeRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Prime Rate Percentage", "label": "Debt Instrument, Prime Rate Percentage", "terseLabel": "Prime rate (in percent)" } } }, "localname": "DebtInstrumentPrimeRatePercentage", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "percentItemType" }, "ctv_EarningsPerShareBasicAndDilutedEPSAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings Per Share, Basic and Diluted EPS", "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]", "terseLabel": "Denominator:", "verboseLabel": "Net (loss) income per stock attributable to common stockholders" } } }, "localname": "EarningsPerShareBasicAndDilutedEPSAbstract", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "ctv_EffectiveIncomeTaxRateDiscreteItemsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Discrete Items Percent", "label": "Effective Income Tax Rate Discrete Items Percent", "terseLabel": "Effect of discrete items, increase (decrease) in effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateDiscreteItemsPercent", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/INCOMETAXDetails" ], "xbrltype": "percentItemType" }, "ctv_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisConversionOfWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Conversion of Warrants", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Conversion of Warrants", "negatedTerseLabel": "Transfer to level 1" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisConversionOfWarrants", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "ctv_FinanceIncomeExpensesNet": { "auth_ref": [], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance Income (Expenses), Net", "label": "Finance Income (Expenses), Net", "terseLabel": "Finance income, net" } } }, "localname": "FinanceIncomeExpensesNet", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "ctv_IncreaseDecreaseInOperatingLeaseRightOfUseAssets": { "auth_ref": [], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Operating Lease Right Of Use Assets", "label": "Increase (Decrease) In Operating Lease Right Of Use Assets", "terseLabel": "Decrease in operating lease right of use assets" } } }, "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssets", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_IsraeliSubsidiaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Israeli Subsidiary [Member]", "label": "Israeli Subsidiary [Member]", "terseLabel": "Israeli Subsidiary" } } }, "localname": "IsraeliSubsidiaryMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "domainItemType" }, "ctv_LegacyPlanAnd2021PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy Plan and 2021 Plan", "label": "Legacy Plan and 2021 Plan [Member]", "terseLabel": "Legacy Plan and 2021 Plan" } } }, "localname": "LegacyPlanAnd2021PlanMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "ctv_LesseeOperatingLeaseLiabilityUndiscountedLeasePayments": { "auth_ref": [], "calculation": { "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Liability, Undiscounted Lease Payments", "label": "Lessee, Operating Lease, Liability, Undiscounted Lease Payments", "totalLabel": "Total undiscounted lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedLeasePayments", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails" ], "xbrltype": "monetaryItemType" }, "ctv_LineOfCreditFacilityModificationFeeAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility, Modification Fee Amount", "label": "Line Of Credit Facility, Modification Fee Amount", "terseLabel": "Modification fee amount" } } }, "localname": "LineOfCreditFacilityModificationFeeAmount", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "monetaryItemType" }, "ctv_LineOfCreditQuickRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line Of Credit Quick Ratio", "label": "Line Of Credit Quick Ratio", "terseLabel": "Line of credit quick ratio" } } }, "localname": "LineOfCreditQuickRatio", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "decimalItemType" }, "ctv_LongTermOtherDeposit": { "auth_ref": [], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long Term Other Deposit", "label": "Long Term Other Deposit", "terseLabel": "Long-term deposit" } } }, "localname": "LongTermOtherDeposit", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "ctv_LongTermRestrictedDeposit": { "auth_ref": [], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long Term Restricted Deposit", "label": "Long Term Restricted Deposit", "terseLabel": "Long-term restricted deposits" } } }, "localname": "LongTermRestrictedDeposit", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "ctv_NewRevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Revolving Credit Facility", "label": "New Revolving Credit Facility [Member]", "terseLabel": "New Revolving Credit Facility" } } }, "localname": "NewRevolvingCreditFacilityMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "ctv_NoncashOrPartNoncashAcquisitionEquityInstrumentConsiderationEquityIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncash or Part Noncash Acquisition, Equity Instrument Consideration, Equity Issued", "label": "Noncash or Part Noncash Acquisition, Equity Instrument Consideration, Equity Issued", "terseLabel": "Business combination consideration paid in stock" } } }, "localname": "NoncashOrPartNoncashAcquisitionEquityInstrumentConsiderationEquityIssued", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_NumberOfSecuritiesPledged": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Securities Pledged", "label": "Number Of Securities Pledged", "terseLabel": "Shares of subsidiary pledged (in shares)" } } }, "localname": "NumberOfSecuritiesPledged", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "sharesItemType" }, "ctv_NumberOfWhollyOwnedSubsidiaries": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Wholly Owned Subsidiaries", "label": "Number Of Wholly Owned Subsidiaries", "terseLabel": "Number of wholly owned subsidiaries" } } }, "localname": "NumberOfWhollyOwnedSubsidiaries", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails", "http://www.innovid.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "integerItemType" }, "ctv_OperatingLeasesAssetsAndLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Leases Assets And Liabilities", "label": "Operating Leases Assets And Liabilities [Line Items]", "terseLabel": "Operating Leases Assets And Liabilities [Line Items]" } } }, "localname": "OperatingLeasesAssetsAndLiabilitiesLineItems", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ctv_OptionsAndRSUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options And RSU's", "label": "Options And RSU's [Member]", "terseLabel": "Options And RSU's" } } }, "localname": "OptionsAndRSUsMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails" ], "xbrltype": "domainItemType" }, "ctv_PaycheckProtectionProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paycheck Protection Program", "label": "Paycheck Protection Program [Member]", "terseLabel": "Paycheck Protection Program" } } }, "localname": "PaycheckProtectionProgramMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/FINANCEINCOMENETDetails" ], "xbrltype": "domainItemType" }, "ctv_PrivateWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Warrants", "label": "Private Warrants [Member]", "terseLabel": "Private Warrants" } } }, "localname": "PrivateWarrantsMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "ctv_ProceedsFromPaymentsForDepositsInvestingActivities": { "auth_ref": [], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From (Payments For) Deposits, Investing Activities", "label": "Proceeds From (Payments For) Deposits, Investing Activities", "terseLabel": "Increase in deposits" } } }, "localname": "ProceedsFromPaymentsForDepositsInvestingActivities", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "ctv_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Warrants [Member]", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "ctv_QuarterlyAdjustedQuickRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quarterly Adjusted Quick Ratio", "label": "Quarterly Adjusted Quick Ratio", "terseLabel": "Quarterly adjusted quick ratio" } } }, "localname": "QuarterlyAdjustedQuickRatio", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "decimalItemType" }, "ctv_RestOfTheWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rest of the World [Member]", "label": "Rest of the World [Member]", "terseLabel": "Rest of the World" } } }, "localname": "RestOfTheWorldMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "ctv_RevenueFromContractWithCustomerPaymentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue From Contract With Customer, Payment Term", "label": "Revenue From Contract With Customer, Payment Term", "terseLabel": "Payment term" } } }, "localname": "RevenueFromContractWithCustomerPaymentTerm", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "durationItemType" }, "ctv_RevenueRecognitionAdvertisementServingServicesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue Recognition, Advertisement Serving Services, Percentage", "label": "Revenue Recognition, Advertisement Serving Services, Percentage", "verboseLabel": "Ad serving services" } } }, "localname": "RevenueRecognitionAdvertisementServingServicesPercentage", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctv_RevenueRecognitionMeasurementServingPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue Recognition, Measurement Serving, Percentage", "label": "Revenue Recognition, Measurement Serving, Percentage", "terseLabel": "Measurement serving services" } } }, "localname": "RevenueRecognitionMeasurementServingPercentage", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "percentItemType" }, "ctv_ScheduleOfOperatingLeasesAssetsAndLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Operating Leases Assets And Liabilities", "label": "Schedule Of Operating Leases Assets And Liabilities [Table]", "terseLabel": "Schedule Of Operating Leases Assets And Liabilities [Table]" } } }, "localname": "ScheduleOfOperatingLeasesAssetsAndLiabilitiesTable", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ctv_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsExercisedAndRestrictedStockUnitsVestedInPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Shares", "label": "Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Shares", "terseLabel": "Stock options exercised and RSUs vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsExercisedAndRestrictedStockUnitsVestedInPeriodShares", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "ctv_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsExercisedAndRestrictedStockUnitsVestedInPeriodValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Value", "label": "Share Based Compensation Arrangement By Share Based Payment Award, Stock Options Exercised And Restricted Stock Units Vested In Period, Value", "terseLabel": "Stock options exercised and RSUs vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsExercisedAndRestrictedStockUnitsVestedInPeriodValue", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "ctv_ShortTermBankDepositCurrent": { "auth_ref": [], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Short Term Bank Deposit, Current", "label": "Short Term Bank Deposit, Current", "terseLabel": "Short-term bank deposits" } } }, "localname": "ShortTermBankDepositCurrent", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "ctv_SummaryOfSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of Significant Accounting Policies [Line Items]", "label": "Summary of Significant Accounting Policies [Line Items]", "terseLabel": "Summary of Significant Accounting Policies [Line Items]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesLineItems", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "ctv_SummaryOfSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of Significant Accounting Policies [Table]", "label": "Summary of Significant Accounting Policies [Table]", "terseLabel": "Summary of Significant Accounting Policies [Table]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesTable", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "ctv_TVSquaredMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TV Squared", "label": "TV Squared [Member]", "terseLabel": "TV Squared" } } }, "localname": "TVSquaredMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "ctv_WarrantLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant Liability, Noncurrent", "label": "Warrant Liability, Noncurrent", "terseLabel": "Warrants liability" } } }, "localname": "WarrantLiabilityNoncurrent", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "ctv_WarrantsLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants Liability", "label": "Warrants Liability [Member]", "terseLabel": "Warrants Liability" } } }, "localname": "WarrantsLiabilityMember", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "ctv_WithdrawalOfShortTermBankDeposits": { "auth_ref": [], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Withdrawal of Short-term Bank Deposits", "label": "Withdrawal of Short-term Bank Deposits", "negatedTerseLabel": "Withdrawal of short-term bank deposits" } } }, "localname": "WithdrawalOfShortTermBankDeposits", "nsuri": "http://www.innovid.com/20230630", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r626" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r622" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r624" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "srt_AsiaPacificMember": { "auth_ref": [ "r729", "r730", "r731", "r732" ], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "APAC" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r162", "r380", "r381", "r382", "r383", "r424", "r578", "r666", "r669", "r670" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r162", "r380", "r381", "r382", "r383", "r424", "r578", "r666", "r669", "r670" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "domainItemType" }, "srt_LatinAmericaMember": { "auth_ref": [ "r729", "r730", "r731", "r732" ], "lang": { "en-us": { "role": { "label": "Latin America [Member]", "terseLabel": "LATAM" } } }, "localname": "LatinAmericaMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r227", "r599", "r672", "r722", "r723" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r251", "r252", "r253", "r254", "r315", "r432", "r456", "r493", "r494", "r545", "r547", "r549", "r550", "r559", "r579", "r580", "r589", "r596", "r605", "r611", "r671", "r712", "r713", "r714", "r715", "r716", "r717" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r251", "r252", "r253", "r254", "r315", "r432", "r456", "r493", "r494", "r545", "r547", "r549", "r550", "r559", "r579", "r580", "r589", "r596", "r605", "r611", "r671", "r712", "r713", "r714", "r715", "r716", "r717" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r227", "r599", "r672", "r722", "r723" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r223", "r433", "r450", "r451", "r452", "r453", "r454", "r455", "r582", "r597", "r610", "r635", "r664", "r665", "r672", "r722" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r223", "r433", "r450", "r451", "r452", "r453", "r454", "r455", "r582", "r597", "r610", "r635", "r664", "r665", "r672", "r722" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r251", "r252", "r253", "r254", "r308", "r315", "r345", "r346", "r347", "r431", "r432", "r456", "r493", "r494", "r545", "r547", "r549", "r550", "r559", "r579", "r580", "r589", "r596", "r605", "r611", "r614", "r662", "r671", "r713", "r714", "r715", "r716", "r717" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r251", "r252", "r253", "r254", "r308", "r315", "r345", "r346", "r347", "r431", "r432", "r456", "r493", "r494", "r545", "r547", "r549", "r550", "r559", "r579", "r580", "r589", "r596", "r605", "r611", "r614", "r662", "r671", "r713", "r714", "r715", "r716", "r717" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r316", "r646" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r176", "r316", "r630", "r646" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r225", "r226", "r487", "r489", "r491", "r546", "r548", "r551", "r560", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r583", "r598", "r614", "r672", "r722" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r225", "r226", "r487", "r489", "r491", "r546", "r548", "r551", "r560", "r566", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r583", "r598", "r614", "r672", "r722" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r176", "r316", "r630", "r631", "r646" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r674", "r707", "r708", "r709" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [Member]", "terseLabel": "Subsidiaries" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r21", "r609" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Trade payables" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r228", "r229" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade receivables, net (allowance for credit losses of $330 and $65 at June 30, 2023, and December 31, 2022, respectively)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r25" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "verboseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Acquired finite-lived intangible assets, weighted average useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r80", "r609", "r726" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r355", "r356", "r357", "r473", "r643", "r644", "r645", "r703", "r727" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r58", "r59", "r319" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r349", "r358" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expenses" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r140", "r230", "r235" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Trade receivables, allowance for doubtful receivables" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Securities excluded from computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r113", "r135", "r160", "r206", "r214", "r219", "r232", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r380", "r382", "r402", "r440", "r515", "r609", "r621", "r667", "r668", "r710" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r130", "r141", "r160", "r232", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r380", "r382", "r402", "r609", "r667", "r668", "r710" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r160", "r232", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r380", "r382", "r402", "r667", "r668", "r710" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total non-current assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r378", "r603", "r604" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r60", "r61", "r378", "r603", "r604" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Shares issued as consideration (in shares)" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [ "r378" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "terseLabel": "Share price (in dollars per share)" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CapitalizedComputerSoftwareAdditions": { "auth_ref": [ "r49" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additions made to capitalized computer software costs during the period.", "label": "Capitalized Computer Software, Additions", "terseLabel": "Capitalization cost" } } }, "localname": "CapitalizedComputerSoftwareAdditions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r35", "r132", "r584" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Money market funds" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r35", "r95", "r157" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash at the end of the period", "periodStartLabel": "Cash, cash equivalents, and restricted cash at the beginning of the period", "totalLabel": "Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]", "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r5", "r95" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Increase (decrease) in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CertificatesOfDepositAtCarryingValue": { "auth_ref": [ "r636" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A savings certificate entitling the Entity (that is, bearer) to receive interest at an established maturity date, based upon a fixed interest rate. A certificate of deposit may be issued in any denomination. Certificates of deposit are generally issued by commercial banks and, therefore, insured by the FDIC (up to the prescribed limit). Certificates of deposit generally restrict holders from withdrawing funds on demand without the incurrence of penalties. Generally, only certificates of deposit with original maturities of three months or less qualify as cash equivalents. Original maturity means original maturity to the entity holding the investment. As a related example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Certificates of Deposit, at Carrying Value", "terseLabel": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r127", "r137", "r138", "r139", "r160", "r181", "r185", "r192", "r194", "r200", "r201", "r232", "r255", "r257", "r258", "r259", "r262", "r263", "r291", "r292", "r293", "r294", "r295", "r402", "r467", "r468", "r469", "r470", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r503", "r524", "r542", "r561", "r562", "r563", "r564", "r565", "r629", "r640", "r647" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/WARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price per share (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/WARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrants outstanding (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/WARRANTSDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]", "terseLabel": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/WARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r29", "r68", "r441", "r502" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "verboseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES (Note 7)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r104", "r249", "r250", "r568", "r663" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r612", "r613", "r614", "r616", "r617", "r618", "r619", "r643", "r644", "r703", "r724", "r727" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common stock", "verboseLabel": "Common stock, par value $0.0001 per share" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.innovid.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Ordinary shares, par value (in dollars per share)", "verboseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r79", "r503" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "verboseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r79", "r503", "r521", "r727", "r728" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "verboseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r79", "r442", "r609" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock: $0.0001 par value - Authorized: 500,000,000 at June\u00a030, 2023, and December\u00a031, 2022; Issued and outstanding: 138,737,104 and 133,882,414 at June\u00a030, 2023, and December\u00a031, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r39", "r41", "r66", "r67", "r227", "r567" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r39", "r41", "r66", "r67", "r227", "r462", "r567" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r39", "r41", "r66", "r67", "r227", "r567", "r633" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r69", "r122" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentrations of credit risks" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [ "r567" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r39", "r41", "r66", "r67", "r227" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r38", "r39", "r41", "r42", "r66", "r112", "r567" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r39", "r41", "r66", "r67", "r227", "r567" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r91", "r160", "r232", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r402", "r667" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r40", "r227" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r105", "r159", "r264", "r270", "r271", "r272", "r273", "r274", "r275", "r280", "r287", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "LONG-TERM DEBT", "verboseLabel": "FINANCE INCOME, NET" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/FINANCEINCOMENET", "http://www.innovid.com/role/LONGTERMDEBT" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r20", "r75", "r76", "r114", "r115", "r162", "r265", "r266", "r267", "r268", "r269", "r271", "r276", "r277", "r278", "r279", "r281", "r282", "r283", "r284", "r285", "r286", "r410", "r591", "r592", "r593", "r594", "r595", "r641" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/FINANCEINCOMENETDetails", "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument, variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r27", "r162", "r265", "r266", "r267", "r268", "r269", "r271", "r276", "r277", "r278", "r279", "r281", "r282", "r283", "r284", "r285", "r286", "r410", "r591", "r592", "r593", "r594", "r595", "r641" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/FINANCEINCOMENETDetails", "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Provision for income taxes" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/INCOMETAXDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r8", "r53" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r8", "r209" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r17", "r64", "r85", "r142", "r585" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Derivative liability fair value" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/WARRANTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r110", "r384", "r391" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "WARRANTS" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/WARRANTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r143", "r144", "r401", "r485", "r486", "r487", "r488", "r490", "r491", "r492", "r493", "r494", "r516", "r518", "r519", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r585", "r725" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Warrants liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r317", "r322", "r351", "r352", "r354", "r606" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "STOCK-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EMEAMember": { "auth_ref": [ "r729", "r730", "r731", "r732" ], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "EMEA" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r151", "r168", "r169", "r170", "r171", "r172", "r178", "r181", "r192", "r193", "r194", "r198", "r393", "r394", "r437", "r448", "r586" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "netLabel": "Basic (in dollars per share)", "verboseLabel": "Net profit (loss) per stock attributable to common stockholders \u2013 basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r151", "r168", "r169", "r170", "r171", "r172", "r181", "r192", "r193", "r194", "r198", "r393", "r394", "r437", "r448", "r586" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "netLabel": "Diluted (in dollars per share)", "verboseLabel": "Net profit (loss) per stock attributable to common stockholders \u2013 diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r177", "r195", "r196", "r197" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "BASIC AND DILUTED NET (LOSS) INCOME PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARE" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax expense (benefit)" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/INCOMETAXDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": { "auth_ref": [ "r701", "r702" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent", "terseLabel": "Effective tax rate increase (decrease)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/INCOMETAXDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r25" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Employees and payroll accruals" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": { "auth_ref": [ "r350" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost capitalized for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Amount Capitalized", "terseLabel": "Capitalized stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r353" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Cost not yet recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Period for cost yet to be recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Options outstanding" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r12", "r128", "r148", "r149", "r150", "r163", "r164", "r165", "r167", "r173", "r175", "r199", "r233", "r234", "r297", "r355", "r356", "r357", "r371", "r372", "r385", "r386", "r387", "r388", "r389", "r390", "r392", "r403", "r404", "r405", "r406", "r407", "r408", "r423", "r457", "r458", "r459", "r473", "r542" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.innovid.com/role/FINANCEINCOMENETDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesFvNiUnrealizedGain": { "auth_ref": [ "r231" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Unrealized Gain", "terseLabel": "Gain from changes in the fair value" } } }, "localname": "EquitySecuritiesFvNiUnrealizedGain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/FINANCEINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r2", "r8" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "terseLabel": "Change in fair value of warrants" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r278", "r309", "r310", "r311", "r312", "r313", "r314", "r397", "r428", "r429", "r430", "r592", "r593", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r65", "r111" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r396", "r397", "r398", "r399", "r400" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r278", "r309", "r314", "r397", "r428", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r278", "r309", "r314", "r397", "r429", "r592", "r593", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r278", "r309", "r310", "r311", "r312", "r313", "r314", "r397", "r430", "r592", "r593", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r13", "r65" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r13", "r65" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)", "terseLabel": "Change in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r13" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "End of the period", "periodStartLabel": "Beginning of the period" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r278", "r309", "r310", "r311", "r312", "r313", "r314", "r428", "r429", "r430", "r592", "r593", "r600", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r395", "r400" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r10", "r19" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair value of financial instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r243", "r244", "r245", "r246", "r434", "r435" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r49", "r51" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r92", "r526" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r133", "r237", "r436", "r590", "r609", "r652", "r659" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill, ending balance", "periodStartLabel": "Goodwill, beginning balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.innovid.com/role/GOODWILLScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r11", "r47" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill and acquired intangible assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r236", "r239", "r241", "r590" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "terseLabel": "GOODWILL" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/GOODWILL" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r8", "r238", "r240", "r242", "r590" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "negatedTerseLabel": "Goodwill impairment", "terseLabel": "Goodwill impairment", "verboseLabel": "Goodwill impairment" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.innovid.com/role/GOODWILLNarrativeDetails", "http://www.innovid.com/role/GOODWILLScheduleofGoodwillDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/GOODWILLScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r318", "r320", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]", "terseLabel": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [ "r318", "r320", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]", "terseLabel": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r8", "r52", "r102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment, Long-Lived Asset, Held-for-Use", "terseLabel": "Impairments of long-lived assets" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r0", "r103" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of long-lived assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r1", "r87", "r117", "r206", "r213", "r218", "r221", "r438", "r446", "r588" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r247", "r248", "r527" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r248", "r527" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r161", "r360", "r365", "r366", "r369", "r373", "r375", "r376", "r377", "r472" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAX" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/INCOMETAX" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r119", "r125", "r174", "r175", "r210", "r363", "r374", "r449" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Taxes on income", "verboseLabel": "Taxes on income" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.innovid.com/role/INCOMETAXDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r147", "r361", "r362", "r366", "r367", "r368", "r370", "r466" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income taxes and tax contingencies" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r36" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income taxes paid, net of tax refunds" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r7" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Increase / (decrease) in trade payables" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r7" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Decrease / (increase) in trade receivables, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r638" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Increase in accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r7" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase (Decrease) in Employee Related Liabilities", "terseLabel": "Increase in employees and payroll accruals" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r634", "r638" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Decrease in operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r7" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedTerseLabel": "Increase in prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r182", "r183", "r184", "r194", "r321" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders \u2013 Effect of dilutive securities - options And RSU (share equivalent) (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r48", "r50" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r93", "r284", "r290", "r594", "r595" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Debt related interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/FINANCEINCOMENETDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r153", "r155", "r156" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r415", "r608" ], "calculation": { "http://www.innovid.com/role/LEASESLeaseCostsRecognizedintheCondensedConsolidatedStatementofEarningsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESLeaseCostsRecognizedintheCondensedConsolidatedStatementofEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r705" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Summary of Lease Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r706" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "terseLabel": "Schedule of Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r422" ], "calculation": { "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails": { "order": 2.0, "parentTag": "ctv_LesseeOperatingLeaseLiabilityUndiscountedLeasePayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "terseLabel": "Total lease liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r422" ], "calculation": { "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails_1": { "order": 2.0, "parentTag": "ctv_LesseeOperatingLeaseLiabilityUndiscountedLeasePayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r422" ], "calculation": { "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails_1": { "order": 3.0, "parentTag": "ctv_LesseeOperatingLeaseLiabilityUndiscountedLeasePayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r706" ], "calculation": { "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails_1": { "order": 1.0, "parentTag": "ctv_LesseeOperatingLeaseLiabilityUndiscountedLeasePayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "2023 Remaining" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r422" ], "calculation": { "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails": { "order": 1.0, "parentTag": "ctv_LesseeOperatingLeaseLiabilityUndiscountedLeasePayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingLeaseLiabilitiesMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASES" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r24", "r160", "r232", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r381", "r382", "r383", "r402", "r501", "r587", "r621", "r667", "r710", "r711" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r84", "r116", "r444", "r609", "r642", "r650", "r704" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r26", "r131", "r160", "r232", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r381", "r382", "r383", "r402", "r609", "r667", "r710", "r711" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r20", "r72", "r73", "r74", "r77", "r160", "r232", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r381", "r382", "r383", "r402", "r667", "r710", "r711" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r20", "r115", "r720" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": { "auth_ref": [ "r22" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Commitment Fee Amount", "terseLabel": "Non-refundable commitment fees" } } }, "localname": "LineOfCreditFacilityCommitmentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate during the reporting period.", "label": "Line of Credit Facility, Interest Rate During Period", "terseLabel": "Annual interest rate (in percent)" } } }, "localname": "LineOfCreditFacilityInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [ "r641" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r22", "r641" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Average annual fee unused portion (in percent)" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r136" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r154" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r154" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by / (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r95", "r96", "r97" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by / (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r88", "r97", "r118", "r129", "r145", "r146", "r150", "r160", "r166", "r168", "r169", "r170", "r171", "r174", "r175", "r190", "r206", "r213", "r218", "r221", "r232", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r394", "r402", "r447", "r523", "r540", "r541", "r588", "r620", "r667" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss)", "terseLabel": "Net loss", "totalLabel": "Net (loss) income", "verboseLabel": "Net (loss) income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r152", "r168", "r169", "r170", "r171", "r178", "r179", "r191", "r194", "r206", "r213", "r218", "r221", "r588" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net (loss) income attributable to common stockholders, basic" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r152", "r180", "r186", "r187", "r188", "r189", "r191", "r194" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net (loss) income attributable to common stockholders, diluted" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-cash transactions" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r226" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets", "netLabel": "Long-lived tangible assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportingUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.", "label": "Number of Reporting Units", "terseLabel": "Number of reporting units" } } }, "localname": "NumberOfReportingUnits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r206", "r213", "r218", "r221", "r588" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r416", "r608" ], "calculation": { "http://www.innovid.com/role/LEASESLeaseCostsRecognizedintheCondensedConsolidatedStatementofEarningsDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESLeaseCostsRecognizedintheCondensedConsolidatedStatementofEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r413" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "verboseLabel": "Lease liabilities - current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r413" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "netLabel": "Lease liabilities - non-current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r414", "r419" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESSupplementaryCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r412" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "ROU assets", "verboseLabel": "Operating lease right of use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.innovid.com/role/LEASESScheduleofOperatingROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r421", "r608" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating lease, weighted average discount rate, percent" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r420", "r608" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating lease, weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r71", "r109", "r463", "r464" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "DESCRIPTION OF BUSINESS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/DESCRIPTIONOFBUSINESS" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r134" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r28" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other non-current liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": { "auth_ref": [ "r33" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for financing costs associated with business combinations.", "label": "Payments of Merger Related Costs, Financing Activities", "negatedTerseLabel": "Payment of SPAC merger transaction costs" } } }, "localname": "PaymentsOfMergerRelatedCostsFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r31", "r379" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to acquire" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r31" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Acquisition of business, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r94" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToDevelopSoftware": { "auth_ref": [ "r94" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.", "label": "Payments to Develop Software", "negatedTerseLabel": "Internal use software capitalization" } } }, "localname": "PaymentsToDevelopSoftware", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r637" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "verboseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r32", "r467" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from loans" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r32", "r641" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Proceeds from line of credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r6", "r16" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r9", "r439", "r445", "r609" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r101" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "verboseLabel": "Useful lives (in years)" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RealEstateMember": { "auth_ref": [ "r673" ], "lang": { "en-us": { "role": { "documentation": "Property consisting of land, land improvement and buildings.", "label": "Real Estate [Member]", "terseLabel": "Real Estate" } } }, "localname": "RealEstateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESScheduleofOperatingROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r34", "r641" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "terseLabel": "Repayment of line of credit" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r34", "r470" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedTerseLabel": "Repayment of loans" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r70", "r359", "r718" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "auth_ref": [ "r3", "r4", "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.", "label": "Research, Development, and Computer Software, Policy [Policy Text Block]", "terseLabel": "Software development costs" } } }, "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r636", "r639", "r719", "r721" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Long-term restricted deposits" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)", "verboseLabel": "Unvested RSU outstanding" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r81", "r106", "r443", "r460", "r461", "r471", "r504", "r609" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r128", "r163", "r164", "r165", "r167", "r173", "r175", "r233", "r234", "r355", "r356", "r357", "r371", "r372", "r385", "r387", "r388", "r390", "r392", "r457", "r459", "r473", "r727" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r207", "r208", "r212", "r216", "r217", "r223", "r225", "r227", "r306", "r307", "r433" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r126", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r581" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r227", "r632" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofConcentrationRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r60", "r61", "r378" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/DESCRIPTIONOFBUSINESSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r648" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of Stock-based Compensation Expenses" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r396", "r397" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r590", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/GOODWILLTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r46", "r90" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]", "terseLabel": "Schedule of Revenue and Property and Equipment, by Geographical Areas" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r46", "r86" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTINGRevenueandPropertyandEquipmentbyGeographicalAreasDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r318", "r320", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Share Based Payment Arrangement, Restricted Stock Unit, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r14", "r15", "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Share Based Payment Arrangement, Option, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]", "terseLabel": "Schedule of Short-term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/FINANCEINCOMENETDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r38", "r39", "r41", "r42", "r66", "r112" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "terseLabel": "Schedules of Concentration of Risk, by Risk Factor" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r202", "r203", "r204", "r205", "r206", "r211", "r215", "r219", "r220", "r221", "r222", "r223", "r224", "r227" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENT REPORTING" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SEGMENTREPORTING" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r7" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "verboseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding at the ending of the period (in shares)", "periodStartLabel": "Outstanding at the beginning of the period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of share units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding at the ending of the period (in dollars per share)", "periodStartLabel": "Outstanding at the beginning of the period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r318", "r320", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Exercisable options at the end of the period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable exercise price at the end of the period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "negatedTerseLabel": "Expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Outstanding intrinsic value at the end of the period", "periodStartLabel": "Outstanding intrinsic value at the beginning of the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r326", "r327" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding at the end of the period (in shares)", "periodStartLabel": "Outstanding at the beginning of the period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Amount of options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r326", "r327" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding at the end of the period (in dollars per share)", "periodStartLabel": "Outstanding at the beginning of the period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Expired (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedPaymentArrangementEmployeeMember": { "auth_ref": [ "r320", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Share-Based Payment Arrangement, Employee [Member]", "terseLabel": "Employees" } } }, "localname": "ShareBasedPaymentArrangementEmployeeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityUnderPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": { "auth_ref": [ "r318", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Share-Based Payment Arrangement, Nonemployee [Member]", "terseLabel": "Consultants" } } }, "localname": "ShareBasedPaymentArrangementNonemployeeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONRestrictedStockUnitActivityDetails", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r607" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "periodEndLabel": "Outstanding exercisable intrinsic value at the end of the period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding exercisable, weighted average remaining contractual term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding option, weighted average remaining contractual term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]", "terseLabel": "Short-term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/FINANCEINCOMENETDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r417", "r608" ], "calculation": { "http://www.innovid.com/role/LEASESLeaseCostsRecognizedintheCondensedConsolidatedStatementofEarningsDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-Term Lease, Cost", "terseLabel": "Short term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESLeaseCostsRecognizedintheCondensedConsolidatedStatementofEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r98", "r158" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software and Software Development Costs [Member]", "terseLabel": "Software development costs" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r127", "r137", "r138", "r139", "r160", "r181", "r185", "r192", "r194", "r200", "r201", "r232", "r255", "r257", "r258", "r259", "r262", "r263", "r291", "r292", "r293", "r294", "r295", "r402", "r467", "r468", "r469", "r470", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r503", "r524", "r542", "r561", "r562", "r563", "r564", "r565", "r629", "r640", "r647" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r12", "r30", "r128", "r148", "r149", "r150", "r163", "r164", "r165", "r167", "r173", "r175", "r199", "r233", "r234", "r297", "r355", "r356", "r357", "r371", "r372", "r385", "r386", "r387", "r388", "r389", "r390", "r392", "r403", "r404", "r405", "r406", "r407", "r408", "r423", "r457", "r458", "r459", "r473", "r542" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.innovid.com/role/FINANCEINCOMENETDetails", "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r163", "r164", "r165", "r199", "r433", "r465", "r484", "r495", "r496", "r497", "r498", "r499", "r500", "r503", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r516", "r517", "r518", "r519", "r520", "r522", "r525", "r526", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r542", "r615" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r163", "r164", "r165", "r199", "r433", "r465", "r484", "r495", "r496", "r497", "r498", "r499", "r500", "r503", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r516", "r517", "r518", "r519", "r520", "r522", "r525", "r526", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r542", "r615" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r78", "r79", "r106" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Common stocks and equity awards issued for acquisition of TVS (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r12", "r78", "r79", "r106", "r331" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Exercised (in shares)", "terseLabel": "Stock options exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.innovid.com/role/STOCKBASEDCOMPENSATIONStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r12", "r30", "r106" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Common stock and equity awards issued for acquisition of TVS" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r12", "r30", "r106" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Stock options exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r79", "r82", "r83", "r99", "r505", "r521", "r543", "r544", "r609", "r621", "r642", "r650", "r704", "r727" ], "calculation": { "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.innovid.com/role/CONDENSEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [ "r409", "r426" ], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r409", "r426" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r409", "r426" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r409", "r426" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r409", "r426" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUBSEQUENTEVENTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r425", "r427" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUBSEQUENTEVENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash flows activities:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology-Based Intangible Assets [Member]", "terseLabel": "Technology" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade name" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r43", "r44", "r45", "r120", "r121", "r123", "r124" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r418", "r608" ], "calculation": { "http://www.innovid.com/role/LEASESLeaseCostsRecognizedintheCondensedConsolidatedStatementofEarningsDetails": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable lease cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LEASESLeaseCostsRecognizedintheCondensedConsolidatedStatementofEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/LONGTERMDEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r612", "r613", "r616", "r617", "r618", "r619" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "netLabel": "Warrants to purchase one share of Common stock, each at an exercise price of $11.50 per share", "terseLabel": "Warrant", "verboseLabel": "Warrants outstanding" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHARESecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.innovid.com/role/Cover", "http://www.innovid.com/role/FINANCEINCOMENETDetails", "http://www.innovid.com/role/WARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r180", "r194" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "verboseLabel": "Weighted-average number of stocks used in computing net (loss) income per stock attributable to common stockholders - Diluted weighted average number of shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r178", "r194" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "netLabel": "Basic (in shares)", "verboseLabel": "Weighted-average number of stocks used in computing net (loss) income per stock attributable to common stockholders - Basic weighted average number of shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/BASICANDDILUTEDNETLOSSINCOMEPERSHAREBasicandDilutedNetLossIncomePerShareDetails", "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]", "terseLabel": "Weighted-average number of stock used in computing net (loss) income per stock attributable to common stockholders" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.innovid.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org//815/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.B)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org//280/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//350-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482610/350-50-25-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482633/350-40-30-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13A(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r622": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r623": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r624": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r625": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r626": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r627": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r628": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r663": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r71": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 73 0001835378-23-000116-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001835378-23-000116-xbrl.zip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�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

07WU H][ > +9 @!)=,Q?]\GEB]O:;@6'\OQ[#3#D<4%PM3[!778WN$Z M.R)V]7%;TRZL:V?@#6#VWN9)M!^^+,XB'O2*8K9PLX(7%JYU7';.'L3 8*=! MZCK]+GOA/F5MTG2N>(BC+%;*FEBN+JX[E"4MN(GO0]-O2 M;UTQ_@4$ ?P:]& M<%^ _R"(]U0//0HY="@6G(6;A5CD4((?&:_6>(Y7E7WC MU2[0Q^R;.K"ZJ>MHJ('/CQ#SH$.^'(5B2\KY*%0OZP:MDAKHGE[9('I=)H0J M?8F2&Y_?"+\-CY MVKYKMPX)3+)15-JY:EJE2IU"IU4I^L/NQ(S<_$ M,[U.?X&2X_#?%=0L+U+GO)C:+7_&)H5Z?S9_D47-A]YL8)/ 8#XX)N!=<[A/ MSET8@$$4>I1"F.W2$7-WT7H NUV#^1+,=__>%7YI-A]+0A,,JDO[8/7QM]": M@ $)UP$P-!Z- !CH P@O@1D^P<1@"Z01?V?WXA\LJ@C\ 826?ACV1^] :]7' M]9K85DVA!V8+U"]Q(:B_^7V$U/!F;OH^N2GR M'"9YK-5/^.S ?R;W?VEV/\^]E1&,N6-L\T88S."4OV .0Y:*_PX'A^M#0"99 MPM<^T9? "F?3+?YOB;W810.%M@0>-A8,!ZF,\;<5&)2%+.%+0J<*[\3']AW' M#[GATBBZ@?@IIBU&,G%DMWH-1C@>4L!C"[T1'.*,&R(*;P-3'Z#U%6/>.B/3 MCF)*D 5P@/!*;(.D@_.$P2D+O4)G;30CJW-QW,3BQX.-^F/!]8$%XXDH%S_4 M9%D, \%#V2#BZUB":@B19@_"P/=1F"P*8S\("%D@N_ &^"W.2:$_"N1 KTT8 M4^)FTY-ZWG'O" HI\"QV;\(56%6.$PG@5(8Z!?PI$&TC/(TP%/D05]M1Q!K_ MPC]XB= +<'D6YKDH I'$)BT%&>6==ZSH>@,GL P4 )<2IH'AGC\".PR*)IIM M4?#VX.H<@X!JNTS%1G9]J,0)<+M%FYQ9_KS M#<\B93\:*R*A6<>80Z=Q/[_YNT<[_18 ;8C>QM0_KBPZ[)JN2BJ$:)I'%-D0R96ASY;*<-D*71;)SLG]ZPY MB50<6@],^\XZN['I\&9<$W3CAN0'^ <5SUU\K!#@U#")@0?=.#;SMGL$OPQ&2+Q98_A*3(M=$+T M'D]#AQ(?,"0&9:/T=GRUCGEP=HA.Y#I%>T_#C#C3-W YC>ZT3-(S+=:_-EQ3 MF^]SRSC^@H18=T_XEM!ACYB[6LO$*=!5 W*!Q"!NX>/1L0-H>+/]5,.;F 9F M?AVZWSYJW-@SU)E5A(@#@Y?(EW%F259:3N4LUAYL2O7D]4T-;7U]4UZJE)C5^_7Y7ZE9Q!#*4N*1.IUA=;T.AC4JMI7I7.GZ'9+ M^\YD7N+<[5*V='=O[ D,'''UP3V8 LL9H=' K;5@F4%;NMVH5F5M4K.Z2--: MK4UET*M?/9B83-1>"CEP'I!+<0.8H@/,WBM-1\$\4'$4[RT:,J'\Q%]-C.2^+ M^9A19G-:HL JB:;OQ^(35%,VL8H!!D/1(.<+$P)T4+P AC@IHX('1[538=&4 M'N9;64D7D-D!,8C\S7! >/V*0:Q^.Z/$[*0F^9K(78P<,?"U+1/,*V;F8#1L MS1&\L!>6XYU4C(3>F.F'7X9M:^"9<$./>:*3QTU>_V9:%B8=F&.+(Z=N5#*& MB;4H^X C![_>B/W5<)YQ,B@L&K.I%2O7\%,Q9@R%P3ECBA&O3?M(-LP"Q=^" M.PB>OHYQ+[BB#KB7<4.5^8'.LC+T)D-J1H.)7%1T"5WP4+%P:LHM) 5H*X:T MZ#EL =(5G!XNV<;>Z!02AX?(_$CA:ANV57\VFJPZ(^)PX,9E.,'HQ25&Y,O' MT(!Y@M!2>X )RKE,R!S @2'.+,I+0@<3FOX <#JYT/18ZBO,/*.,A'H!!"_F M3R2D_^--6"M&F9)PO.Q50PPH4)(P!@.:NP1I4D3Z8*B&JT^OT5IS'$08^+I^ M8$$$U*>+$XA5%MRXT?*5ZTM%19%2>[0(,WJM6*]]9V_["B^;*\P 1NNW$!R] M.:[A47MJ!"'>]@8=<=J+<_;3YD0&A:]TO*BD(H),1>XZ](*8Q?PR/D ME?KRKGQQH@!MYC58 ;SWN_:*8-(#5=U(0=]][T1HY'K$X?6\Q\Q=6V)DNF MK0MF%&4QF*G7RHI1EJMUK:R7:[JDE8E>J]?57IV452KW%H.9Z>M1#UO8V<9B MJWQA%N]R$]);"16V^9DEAA@YJ"RYN#*\"#T9+3H3?9 :YG+JIJL'0S"7-OJ=U)PN78I:8TD9GYQ..P&7(=EJX0Z^C'HUI>$-G-9(FF)U/I8$LTE-GF8RAZX75J&3B7*?\91L3"5C@@#I$?@!BU\FQZ9-5N]9Q0GF M<*<13>!-G*MP.E'(-IGPM+A[>@T6 ; _<"OQ*)[JRA_1[3$HMGIB!9?P=*!3 M./$O)DA+/HAG<<6HSI02('G>YH@."Y36E8JB<4?TP_1PJF.5_7\$& M.($G]%8TS/=*PF28+HT"SG!/V+R>G:3#1KC5@E4YKGS@-#*?WR-@XKY&LV^& M.:P)!>Q5!)GN+%IN%&6L3\M%A2%EQFBXMHX MUMFPO JSZT*\HCK+6'"!G*B,E(S 0R/Z8#X7RY)/K"(&J]K6ZOW)&C)^LZ\% MB#= 3"6@'/8VI-O.AX M@3DE%99ISA0$XUV3\MQ)1<<$**%[%CDL"XXUN"$6@,B/)-)BC@HK78TWV.8'$X5+9<>W+?V=HE>3HRLRE3C.\D]RY1+IAXX[3B.NXD^S#"K)C@OZ MX%N9LW#FJ =][RG/_)@V)'A^+%[*C+U@SZ 8^E.97XO M6%_,-X%0)CQ=]Q/CI0\;^_&24(J'<(_&/ E(S2)7;UQ>3UQ.&'%^*T1BKZKH+U'PIY7Z7+(7DJO\2FZTK%<7.UCL M<\I>6.C)7]8HAM4&)V>J(9M*M9BP)WW/RA*N0T!JG3A!1E6 E+;GQ_O)-V]Y M/,$BEB@-\*C_">R!;ATY,'3DC^C")DE2>2-4NIGQ8,@O1*? MKNA$\S6OJ7U,E^,*"BX7HF-48#]OY4)$;(5& JSWP9N@FR<#4<*U.+=FF^[6TSM,>;M=MJQ MSC5D"CA.A2JGHG./H&U@=\L MI<=%\E=5[ 1H5I<58!S \[CN"R MG\/H)Q7C<&NA7%W"R'0OX%%?6]*3/D^Y*+(&*7;N.B:_I' 6DP?AN10B8;RL M532&RF)U-*T5XXG8Q@HM2CM_Y8OT#IYDO[R$+_D^TP?@+]CG!#9*ACVZF]PG M.\"L2G1YPTW]A,6S,N/\5<6Z:$Z!/H/]BM'I4730ROU18@ULR^OAJTC)X&\O MM\SC]M3=M)_DP0--)'(>7@KG&9Z#]UBC:B@P*^!ZR['5<(29<60->L$DY0FW M%!C.JI%$OSY0>V=_FP:57W,_,=\IA0KRW=%N1<"9NS1\3*R,>9HM_;93%*E4^FF A\Z8U9U_W<:)I1M2TFG&*.E$GSFON?^ M38IB. 5=E'#)XVYXF\P"@35-:J%W"AH-0'/%8\AQ7JU?@(>R=S.'!<(A*/XJ M U0D\.+1)[[ML'TYO@['_U%+.UFF>YQ.1&WX=R'IO MRZIG8T>U,C%+Y,\GQ-3-0Y3KQG3)P@+D[!^!'(O: /[YQ'X1'^9IY3)^&(7H MTW6<*+5],B_A7ZQ4B5C$+42LJ5(WF7U.WFINO/KY0#&7C428 ;C9 YPLC(B^ M9YS7<1$=Y9*D< F5^;V;LBPC)GZ U_%WP%/ >VD_W!$;NRZ*!( VWY[$[$/VC]_!Z@!%X>6#%]#AZ4>_ M3R^'#IZ9>2!T/_SKPO?34[C_1XQ^$V\67_?HJYGI)OP[<]A3#6WNUTI/G?O= MHF55K:<,Y_]TT;*+OS.4?K?9H;'2LDMF ][*=Z/I$,4632-=\+)E]F:S>D^S5ENV/7D3I5R5O4J/R,?K9E.M MNKR4MN6E;">H>S0I%ZMGK'2 [7)9NER6;O4NEZ7+93EVJW?IA(77RF6Q3L[4 MH6P9PQ99PYV3J".7A>327SK08_L!>D-IH^.H(Y6.5!:3RM)Q+J] *FH;2>6M MTSAV@1D7N);/I9J7B6(WHP_<7B>)Q>B-0$1 M21/2T+9&&O7H^:I29-5LF ZMEFHHC=%JN2YOZ"=GFB(#$#K4.F346B;1M\RQ MMI?#O46T>FN'T+[G9"[1_[LU-G$V[J&BN$%.YJIG:&\8RMC.BUSH\YZN5MUA39ZY5:H5]@-\#NV&'3@5]1MKMI@SQCN<8,] MT:M:=%.2/KI72:)9;[WM=B_;*Q"4$Y2/& P-,.'P:/9 4KXK#3(W M1N'# 8RV!F ZW-LZB-^4=QP^U.?U>WT#^#00@-U][( 8WK T8F>QPX\,F'* MO>.%%3V!=4*WGO=N!RX'ZMA;\? 'Y/+3%KO\\E#Q6L73;JMX MVLF5^<%>UDMXL;;K,ER9]-_"S=Y!0FK!T#"KVIJM*^CY;X\>0QEOQ=YY+.(>JY5K[%JJ5;[>.*[1DS1 MF&6*,1P _K4M[CB'.7XCV_DJ<")8CGUB_'\;&*2;LDTOX. ,BVP3- 7&V)1,5WB!8X0!+9L>T@@/TE7D1P$/A M %LPBA;77./?>/->D-+]3)6B".PQL!B76E_! Q\BYE-]>E&#^]MT 8L GU+\ MQ!X!L-)D_D\6UKR\SKB %0NJ574FQ;OTWX>H*#^X9Z>CB-D_3^TQ;/:#[3_; M+_')OT^?$HXH%A_T>PC467C,+^NI @OQL+\32%4*$@A25]?7-W]>?9*EBYOO MWWIS=]^6[5[?W%W>2G?\%^W-U^N/IW?P1^?KZ[/KR^NSK]( MMW?PP=?+Z[O;U4OAW_)6:,4/7@)O?(XH>FJXPTD_4MQS:&UG@T@&?5L:::^KAO*^;:97%OS2/.J3\LEK5R ML:,K-'](E\E5R%H=_![7M5T('#]U83_X>-Y-[%W$1.CI.DR89+[' MY>Q$>F81DT*0*%Y@^SXV;8@!HICT!. -&!?MSR"*I:N;Z_RM'LAZS_:E"<@S MSX']PMH@LO@6\2E-^1V>EZZ^W]$R]P%UL$@>0,K?/TC,CK!T)\9->#$])_ 6&UZ,_@% PU-% M[/2QT&;PC#'[ MAELN@CCBVUBMB=KTU<6VVKSM#92WV9YVYL=QQX\H>B$;&:01$$TE@YSMIC!'A=@%JOL778MS^ MP_8"+C! L,2P[C@*'XDYH3I7:'73D@:?GZ4"(>2FFZE-*W!C4-A1EH*Z'SZ" M\A> 1!5Z'7 QEP4Q0\].0(XE&[7%7+V+9_2[?83UYT*J,]C'(\W50-[Q:+L, M]0U;BB? N\< X4GH!1PX'D)J9,?<+(B8SY[0>!*CW;R .PQ1/N"M3/T]"E.A M-!+@T?J!VTZBE"!*"D4\NQ=A#7A/I(L'=@(8(%9^"GWX-(4;C!) &^PW2-_ MCT$;HAO"Y%]J%P\[_$?JWG,S(G#)R@*U,XS@,/!M$"9H%934*#($)H O7DS& MTD5AV@ [31\G=.^ ':GOEE\#]I\-IIQ#!RV?9@9%&K56O @#]%EP9/ONQ3\O M@.^#\(5_%2+0F#7G+;#E;76L#'1;,51W9 V=_MA4QGW+L*V^ZS;JJ+@#;TF] MFV@*%G3)#@%#B@ :\5[281TU< MK B(X0#L,I#2SB)X$/?RX@15 M.WC%A!;"1^SX@6B%_L&*V4AR-E6'DQ(LZY+9RSP*(,3$)/?3FOT:QLD\0V@N M/(@' :MAY"P XL_!0PSBT?X': (C._@99Y+CQRTM=!5'-O.GG"PH@-@O^#EW M.Y2O2?P6=#,NVUPVME,_R8RY:7[I)2F_:^'W 0"71*+]&*:X\5GGC>TX?!MH MKDT)M2F3,B;_(WPZ9BY(-_)G!=3#%23IHX=L^@\6\&]DP>,X?#C:/MHOR$GA M>0:"TI7228A >R0#Q(!K=)N@1\+Q4';YH6,GA9OIQZTLG7\[OY"ERZ^7Y]Q<_W)^=_YU&L'@ M?KQ[$IV(H66^B)@$V@H*8[Q_@!(8!R&A G^*Y3XRXB'T^VPWF2I5H"&J1UZ= MYC,;S=J/*ZQWGR^5GQ4'&1A=X7A\*@CJE/MHIACT+'^.4^U5(XG2!BK(K0,O27V< MNC,E@6_&J(5\?,'_?H;=A5&U>3.FA^]E\^:;8*[KK"!59*S <9&8X6(>0W3. MPQU*JO+;O!\G88(<#]E]"KMU4_3\TY/)0\2X?AM[OV"Q('D CAP@'Z^QU0^S M$[1A]'1SY<;"*R^[?\V5N\V^UF;-E99M3[M::S\;"]\1-ZMPL6UUG=Y3J-S6 MMIE]K<.,F77K;!]-F M#9$[B'80[2!ZN! ]FJ'&%\(S))TO$:*'V:YI;I90D&(&3B5!2%N<(#0;^?S& M(OS OF=%'M"I5K@:^R=GZK;JSS:L(MD%]'];BXN]PM#IO<#5_[,>TS_N?FQ- M"5S?+H$/.@+O"'Q- J\IO]M-SLO"J-/_>2_Y+([S*-+B"&NC*-YW'G+Z'(6/ M%R*\)]4)IHE MF]@NT39\%\O2(W,]6P(V'3A9XAV5,L4/\#5/2Z!%'$SB#)TTQD24.('G[,B5 M)0_M%ILG]N%OL;1-1Z]WAE$FR'%6^%[?2FMI:M3O6O##<(6_6]?^*7 M5T& I\F//8%',/D!G\(?LO*RDO7=EWG5Y:DO+MF=T-\/6#,5B+K,5PW"'_=%PZ#!5 MM_L.*'2::LS+AUNN\TV_1W4&EN4H;M]T74-SS*&BP.;4\=BV%(6-C;U) YLO M K'--ZDP)54G(DD!WV)F'@D'++D*)UG=2EGSP9L^%5H//?H"^CH6M+BB\0HE M;G*+BQXN*TXH\LH_&C.JCB 9G"E:N!(:Z/NO>^2E.[D.*ST_ -C*F:I2.$JH M@(AR)4,?P0UW]>AARG5^15C"$8@\:9YF'[&QSYPDSDI_8L\5E3U%H7.V#_9K MPA\-17XO%:;D>9O\_L.X0(GI%-V:8^!^'$S6)GV%\LK/;R^DNW "E]I7^K*4 MV26DIQ=YH+SF/D]$?">Z!N"/X6>B:OR*=D\]/WPF33L MA$WB#]([]3TP *Q#&+]D$*(=\ W8^19^E]YI,X].:6*@Y-V+%..BS(I6@E_J M[XM-\E3(HE=^;ZXEVGLLN>L1(T*X%\Q MUE7N)6U]!D0MYPN+@H;43[R)/Q> LNA!$3&TF)"C"?J*L])Q)*UB64X_:&LZ M]H024($D1XS8F0?'#YPDKSV/V<0&JF-8">D=CM[;>,O'H2_('HD+Q,T.T%N\]J MOMSB!44/KC+.QAS)>!5%SI\(%J%/O[/+>QEA@Z[]++[YGKD=N+'N:*?K[X!4=X M_'K!1JYFOLKPD;G%4X*C!'AP[-G ]\1AD:*UO)=\I.YFDWK+NN2&F;GG\ E+ MSJFT%&QGAS/W7*K''K(E.V"@//LOF=CE]C\".GT4[& $=OD8%0*AH.7=,&:] M8"6&T)/R$PC=+9ZS^=H]%VXN@3*'0Y^Y<@O0_ ?I/#,0H!+AJ&3N<*C%1.1*7"L7*!9MP&H^7:Y8* MR!\L)^0VN"NN7"QE8^@P+R2C"D %YW+?L'=3[/W0KSBFN4"',JEQL\S80M[ M!P3*T$=TJA&+2JAB8L>IZ$7.BO%XTR?Z'("]6D0%)PHLBZ;P-][!PE-]- &% MG ]N"OK^2Q%AL4[.^LJLEQ!,OAPXX-@@7:>1"?$/%UN,@+DQ M7V937*[P]BFD6J M(O[-S9>\T*^L4NSQ]>6J]V3B>T+23L@%@9>*]K#K,2X# MLJLCDS-D6!&9B%YKXF?"&!=\ JLAIS3W#.+Z.(@:5*IA?IR 5HPO MGL*,S$*GEEDYRJ%60764]!=S %;I;AA\UT9JYT9D60[\N/(KM(D5Z3,/,G7+BSM7UYQK1][WP(9UG43^\ MK5N^B5NQAR*GIRZE9Z"ROY16R@WTZ/M79JGUA)DL&BA_*$,K\"./:CM^=PW3+U"&T)0?2L(:G3O MU5F7:]V[]5:[UD_.AOJZ]\[5B>6EW4OO&I2B.AMUG?MN1N>EUPJX+8&7<7*F M:;W!+JB[\5Y-V*O:JZ87_I;?W7J46GED]W3; ]NL?A+JBU\5XI2;3V'M^4 M1BO]-JI!U:5!TMD>W8IK66.WKP[ZFM$W^_ \_+_J."-;-0Q]68_NUJ3:78 N M2$$T'K)#'5JH8ONH]6;F/QPBIGPAZA^.)@H8#3&/3H7WD?W(V_P \K$@1L.1 MM_YACQ,_?&$"_>ZIOU)"2AQ]385!(D 3P(8+UT=(/6#HPT($4"?L7Q3[N"^> MG>W;5-ID)GWDLRHW@(RK%I=T-:[ !4W8,FRFXU&./2&<_R63)._2*8Q\-0U/>2VJCBC^,L^2\K+1A3 MJ[Q8%JHBZD,/H+&%4:Y11:!1.4+9 !&0AQAF#R^:#<)28KM_IS9EP\]V<80' M4*."?>#\M_"1Q[9$&TTX#&A)TCS2R00TK@R^S+&% C=.J05S[1I%R8,X M']?*L">H:(I,$"G2]86[5R2V%:HJWE"115.ZAQ+TO5*/4U @N=;L\VPB%[N* MQE15^,0RQ3+.6J&*N_^W>,,VWU55J5$QUA6U';^S?\TKNQH,][.,BA],2NQ? M(DD#_B48M"@%V4=6-'TJ;C!-4D27-.;VS,Q\I G8?'P@$667XC-PKH><#'E> M9C;#"9<%>V'N=]DRG L 0#U 8H>8"N:Z"?9 '81S S3O'UMT;BU0FU,9YI0Y M67OHDBV:_W3.H1 E ++-V7GI\*M%3WWD3,7YMET!_X\UI<3.C_HQ'[AF8*8 MD3=. Y?_%=#2$0/V$Q32-4LX; M,=L)0!9&=O0BN1Y.\4*^+9*3["AZ@36?[0CUH=FT*(Q^SKGO?+]9;1UM.<;M MYFD.%(R.LXZ]M.V IVW0 O8S?ERD>91"JN)0I7%=XA?D48CRYOL4O06RQ<[A M":9X9'D<,Z>8VGFQ4_@D=?!G8,,'(+'BF+(N1$Y6$0*F6"O\,D_?PILI#1FP MGVS/)V@SC+Z36,RVEPMKN CJ.\V-;4)NG!2 Q^3S <"83M(B#9@#9H;&LE6S M.']/ND6:I\3+Z=L5#];?_8A1SD&>5HH)4+8?UVXZ8C%V^N9WD.&]BY!+/!+& M7+'9__2!B-VGOAUA?BSO-8V=;VL0A\]6(03EMUE,DP"RM'FE((;DBZENA5(P MW1*=)Q]+J,B(G&V$/K7H];V?C#Q9 !2ZR"KZ%#X>D:) Z;JDWGB\EW?M0ID? MJNYL6:@_>T]9_RNY[!Y3D8@L5$\O((T/3B28&T>@HEUWP:4(@[*!)F7^(YQF M<4E)RX=W@,H(5)[8>34NUR'YWT*5XR!!7@G8G//2\=RC8K-[<<^4ALGUX*S/ M,2BQ\ [GI:Q1YD0Q=0JN&Z*(B\,T(D6W@%E&6K01\;-:DI1S)199RB3SKV9S M"#F+S=D,'F,"8B_@51#($.\]ED\H$1OAQ3RTQPA1 #!LWK2/_:!6S-X9&(HL M"57GCGABN:P$OLW+2E"AX]-ZI.0Y/,5BD4(]X-4Q)%9YOWE7R RN*172&*D] M'^'" 2]<>P+CQEX4)U2*0DGV88Y5N2*4_0#^^,D"9)\S0H%_3D&&0H5 G,P* M3J@&G*,R!Q!)I8K4@25<+RL^0-UA,1>0278%I=;Z19Z8\Q"0I8>&0B)4@ZFS M9)PB!HRP:2(-+H9.W&G\SPKT,SF:I8?"33 4.>C9YE,!1!0"Q3#+"_31 "H# M5PCV?#]")$LB7P[X-R@,R53Q5 8".KNI_":]*S$PDISO<_!,,5EN(V/!R2.% M0EB2^*R:^)G/+XMY[1N^OY0$.Y5--*5%<'SB9A^GT_T4HC=!/K].TLBEKPYD M $]PCR4'H"['-%'D(1\;^^,625-CGVCD\F$1\#_/Y./2P51!O&9[^$ M+6/GK1Y&>;)4-NR3@A5<-P)ZR#+Q:1GB[["Z4"+EVK%+V;(T7,H+^%W"6LD4 M951UVF+7T^L6+ALDLL#%29GNSH,QK03-E P02TN]#B)1AXZ,Q3D9\"'U,.A-D>O'Y@FO( H MFRQHB*C[Q]67NRL\V#VUF\@D818?@E=3V(I8VB,VE\BBAC0HR ,DM".N"]D\ MB_4V'=%,X,_\-7'!7RD75R#.O1^.:,A, H8!:9^@5Q$1N6(/&3[1S-$Q\27! M&M#9"UM]Y]$!WY>NKW3\/-Z.TU 0!DDV6*=T0#O)3R@7518+%A*C9O)-YT*9 M^'QET?K)QQ-RP@@VB'TJ$G$+=LQO%2..68A2V,8YMM)+O)*#8(.Q**UQXS3S M9L$VSKD+%-,SHC (4:P3Y7/_UEPO5V4.N<68H0Y'8^::IJ&-;-L9#36G;X]< MU1UIKC7K%?M.NC%@_KD;3A"=BHU(TSNIMN$XA*S/^EC&NC&0I= _NPIXRWH0 M1'VNNGP^O_V8S3T_O_U!WYRJNBP5L\VN2K/-B.B B_ Q=M(7;N6\XQ7/NM9_ M_V$JNPU8R?23L-7ZA0M=-=]#4:=9^K 0@#7>#+0U%L0 "E^:L'0>F.]FXYE! MY*"QR:OU6>'"F./Y2,@?N$TS!#"S7K MYR-N%E/)N(T-!P1RYXDJ&'8O5##5Y%D5LAA#B N \H)4 I6ZZT(%N9\3%>!2QQC]/X.$I!^GDNJ3"4WX+J@,@FR?S# M67UQG@.2[WE.]*/66;Q*ILA\[;K+]CA3C2[;H\OVZ+(]IC%_!45X'A*3LF(: MNJU;BJ4IKFZHJFJ-AX9N6>IPV'>9;EO_"UNUC+XVL)2^K@U.=M+V4UT)C_3> MBJ6GF<;]1QBZZ";ZE OSJG(]5"I=F33#,(9C!70ZV^B;+FI'C VML:MH?5 3 M9Y7K/VYN/OUU]>7+8M6Y/K=YV:O6G$%X,\Z.7G/@R@'V1(E'[: *KL7!_^PJ2-K;Z8!#LV>JFK[-%QNMX#L&?VN/&:H0>?J M+4"N!:H%GY]'!C;5WN-# MD#Z>NF%R*GZ9%ZCIA9*B@3VH]F5KL/$D@Z;#@YK..-C)[)Y=H$5VE^0W\2+T M>G3#01I#\5T3ZE)7HZZK_$+0_=N8UG3TO2@Z.DACFD8W0X07!/>DJ$$VY*'GI;[ ($IY8@?QE MNCJWB+6YE!#NX&8I^R2)A6^2-W;E6;B4!\:_!/#^9$E1WLO=6KQS;3&=9\I+ M0W9:5G:#I<5%,)"W/;Q[2./I_14Y-M,IF'G-4)X&4VU8,+LV9FIZD=C%LQT7 M[93=J4:WV=&R7#TQ"&/Z0S%*101(BX*9>K!,_)0W>,1? T Q])FUX)Y$[-%+ M'WO2U]J?>M/[?,DZ$+]DF:*\?P3O%/;X2#-D\-K"-*'8'U55O)3/Q2\TJWXJ M_88?=&9?U0T40V1H+(F#>)NG M*8&LI(C9/4]410+L^X*;?VQ=[CM E5]D! M)9#N8_[9.2; B#1UPD:O7-4VC=!%158M)OU"]L MLUA'O]7Q#:-I?.,+QL#939:L_84!$XMK//[]2O6OJ2N*;JI#9Z ;FF6/K"%3 M36-DN"/-&(+Q/1,A^')Y?GMYNT: 8_F+IC>F]1U;9W!;6M\P5-<=:N98'6BJ MRBP3IW7LC?]6C-<"@>#CK109%J6^M:*3;W#_## M4TI!I(7B;*0 ?00_K'8(S6IH=XH<6M%,FJ:4Q)0E/-8D9A%/$)%)$8[(;Y2A0"*[9?VIB<90O1 MXR!N0.AZ219%XX]/->CG^&.[GE_4 *!X[TD7HA!A%D1Y=FX$.W_&@I.)R)7. MYAL4/26GRHM1URC.+5:)Q<^QYZQ8+\L?FMHTIP)J40S&6_6.1@[QO21>EE>XG-?P(O(<5K!KL0X@6K*??$SIZ ?R/FHUE!&<"8 MEI1#@@ M$L]-LR".= _&"GS,&"^T!(X(DH94?BRK@FU5F,[*S:C/*1GQ/'"_%(3!)>@= M K!&;@[V.%(^V\BY&%I37.#WFQ]9BB;>;X5M;!Q#7SW%:DKYVIO0N[Y^Z'UA MD-SH#15K7R+Z>L\PS*UO5NWUU>%K;%:S]'V!+*"!NMJ&5LR5F!MKL59)#N"1 M_K=QE0Y7"O\W=9P?*ASRU&N=!_ZU*5@<*7*\^Y'W]'L=U)AZ=%,@EZ([JT:J MVPW^0KG8!O0/#CQ?9I6M#DH=$FT7B8XAD/X=_6:7Y#?;*"+VE,&Q;2 M1M^J3BCI:*.CC;;2QI*EGISI\E!1 M6T0;QY#(?V%'\\WIP\RZ;X3]2VI:&LB'L?>+N:?_9%%8A_[:R1EE*VJ_;TH M6\R^[ZHX=HM/<[CI8DS2.TPZ"DP:;,29JGB#DP>K,1C/PNVZ^&U;L'V9J!I"[NH MA\D6R\FVZQKISW.L9Y>X"^:Z477Y1FC43KUQZM\[/M%3^U8*6N$_F9:KYE)_+Y\.C:CW?MQ]LX;'Z%+@T-^UB $+X( MXZ2^$!=.-]LGPG&'SFCLN+8U'!B&R89&?VPZ!FS*ZAMCM[_'A;M%H:XH@TT? ML8@[ZS24M6# OA&EN6ZB*G[)X(IB1LG4U.ZNSG=9G:_6LZSY7Z]=X&GV#'7[ MI;.O5XWZ*D7)P_XK0%;O6\>(L:R/CGO M$5?]WGJ_5H#)IF'R5:KI-FZZW&Y OU9;UN,$I=:!LL/*UH&R4&V74 Z-!^;]!^N VTUP#M!UUQ?X?V>X/V2_KAKX;V^LF9M7FI2X?V'=J_ M%=I;VT![ ]#>&+0([8^A&)\:_$M%@_]:ZZ0K:%Q5G2=PW@$T%V*Z>7*F:]6< MWZ[P]7#P9(G^NQJ>]$_.5&WCUCT=GK083Y8HC*OAR>#DS!QN/"FOPY,6X\D2 M#6LU/,%JD\T;278U](UN>69"RMKZU:I&TG[C^1+]*@/F0C3'KI!FB^R(;0?& M.RQ9HEVM@B6J%PB"4JZ4+.H)^<#6O&%J]G<>U#A?T2B[ZC MRHXJW\0$6$B5!JC^RK8:3W94V5%E1Y6KV5PEJFS4Z<)035"Q9=/<5M"L(]J. M:#NB7Z@-P'F.!/I9S\HO*1MQ* M[](\C5^F@G^^#'-/;8">?<^DB.$$]R+9G3)+L-M#Y4G7BQVXY$2*[(31"/C9 M/L,T1'YA*P=S<:;17^*=Y_R5W[.]T9<8+5.G4!K Y7QPT^B%V5&!Q - XMYP M]K8E?(C/+9]+:D A(Q8M;$^Y)%5JY@"?!,B^ \2^L0C+/'*R.]6*+6.E MNM]DG&@_8330WG^9WSIEQ;8+M0''#CQS&)ONDOT7ZL-Q*MT5MBKV?0X M07TU&&QO?O,:C^Y%"=G<=@-;F[Y^B(#9[BCV8QYVO.5Y[D<#GV/(\;E E6%B MP[VA'FL_HI(6@_K@^*E;=,=Z! 4AC?(&6/X:(]B[FHNNYF*=4J-O]@NB7=S8 MA+?0A%?T TRGZBCC4"FC4372NI2A*>3C\ZTES+ K2D@E9"X5^ MIB]QM $.<#/^[*%V]#\4-6FH1&FD1&T^!+9+GFU*^$97Y/VJ]/$I9=>PXMTS M\Y_85Q+.=02 O3XV;W'3E>0U17]S+?0_CI*(+:$_"H2[YYJ!\8:&"9AZF^IJ M#HOI+ZJ8@#.(+ *P$[AEFEFQF[";MBF FXXUJSMB6RC\U4:D.LG38NK^44*> MS;QG.,U='NA[/;FLD[J-H(N8]4&Z0@< .[H:^'=O)8#+)'KYRX%'SRD<64>$ M_9,SHYI170EO=P)X^R6+"\*^QYC8O25Q?5")W:\^"7U51;ZQ<#^$T>C[D7.^ MU;&DE+]K&KJM6XJE*:YNJ*IJC8>&;EGJ<-AWF6Y;_SM03G:2NJXN(P^*W9F] MQ1GCE0CG)WCHB8:+7@5Q$J6$].>!^Q_,A0/=GV.R-+%I3+[V0TS@J0EU#F5"8%_G7__?DZ3'V=ON.6U O59 MX,N//PTNT["&KCERW=$ _@G8IMM]RV+#D34P3=74YML"BMU'-"R]> M";"(P 6.@CP>EZ-CS%PP7&#J4Z* !S<+NB$J:D)R^\0< MAJ4[XCF59U++TC,L\2^-BM25Q1I8(7P^PS[_Q&W>C(L/UQT,;^@JI>W5#(:G M\S4[PY)$PU<[ W;_EW6EV@A]IHQ)^L/V LXG03YCW1B-"P?*% 0W#T>(1*>' MV IF\MD+[,#!>;9.^,AD*6!)3S 1Z98QZ3H$>K>(*L=I1"S"98GM^74D*6V# M)C?4V?I-=+8]G!K?S9_?YOSY?C=_?H&)T&,^B/-&.@F^.1:6IJWQVQ6>/UR\WU'Z=WE]^_2I\N/]XM M-F%K=;WE+YS9H V"3=$US1HYAF/IHQ$;N1;3M;'=9YIA+.$L.^*K-X%TGMZ# M,)*,3*.<;]BEH]AS/3MZJ>ACVASC#J-WUU1R#I8=6##^R\USP-S;;"6/Q=5R M=]##GL/(C5E09]8!()/GL*I$/M/R4HCK2W'I!9FI)E0N.<^*_O+E@HCN[D_I M]N_41KOI*G" *BD42 "2!XNFS%^FC'?R$!]\"GTGRAM&RX0SP-?@G' S<1FFK.^Q/\*+[@97]#RC;5C;(ACUIO;<*1F M^S1><9^@>9ISW +E:R(2RT'/WR5]MATR';+;XK9W_8T2DN"""U>2G@';*_/VVX\/WC. [X' M-P-[AL\BQ/EW( __NOU/]&T\,@G[34@3/XV;]KH8F@MX%V]?Y, I.]&[QMOL;_$5U;&_@RP61 ;]_L)V%)P#[OV0K=V MQT.P8VMW+$LA+PRU[^^QO00 N>08DT:VCT9H3SIW7;(IX-+&C.5UI=D?G'=2 M*Q6XN:;''ZQQ_!]!&C/WPI[ W\D+\/I'+\$[_,R6W9Y%MU?E!;^1-H:8^9B) MD*Q/3$HODR9A1.<1WR[&>^" (\8+Z<_' /6<+]CXL%P_6!C1S$V84&>.^WG05%]S\C70H+?!IY8XKAP.\TO9TX3 M2&.:;5B7543+@9EQ/Y.O4A4%F9<"8$*__1? M!+8#CW+")Q:@XU+&J "6(\*W6(61B)9;* A!98N1_1"Q!4@.$T^2 MQO+!6"#!RS3RW_B^[_BZ&D/"T+&)EEZOJZH]1:$HD,O&7K ,!^1,Z:H[:>:C M%0I-?GI49_AC=APS#-&$I"N 21$A7I:R<:1',#/YS[-O2Z('MLB#/F F,#!' M>]EN_KNT>K8+="^[#*-!="P[KO5&IP%J$F HXUFH]Q1I6K;C\"X22#S>$_(- M\D/S"(473ZT,SXK>5*'TXU;ZX_S\V[2,@^=)P@E4(]=XACD\U@88] C"MQ"7 M.7PO/U[=?3K'[:]X04VYSY3)*+DA7$(0)M/[J]G76V#X?V>O/1=O78SF!J)Y M39/2 LWWD8.MU@YP4>"L?+]I I2&X99FHGI9D\H-;%3#;-A?8$E4;Z.]]%%U MJ+67JU@EM(!&@+26M>C=9/.#AH#47G$OP[F.ARH@A4*"J-^3K@+I/VTPD4&) MJ2:81(RLBF8@7^('^LZR"HR;,1XY7OO,8%[-\0FE 24T%,H7>;<:VPK6$E?1 MMRAT&'/CSU'XN-%13&7N43 *CSY'$&4 ,Y (;F0_!RB4OMJ1\T"71K?XU=[: M#2[)I-SP!@L)8JJO?H-+K+T-;[!T%&V-&R0SA"[P< 5E,JV7H=6$BKY'&0>Y MLD\7G2G\#:"QHZ-_B[PPRNR[>8IA"7F] P^W^?=4T8A:,J@M[K8S 13*8(0 M]%%A#\[U70+V\*2JA@J?MV8_&C'7GP+-JSMW@39."AT_*EU'BY31P]7 MC=/CM].FVUR6E[C1-E%3K?/"^<+VF9#CE^ LO!5EUR1\&SC>!, /^,YL8+K5 M:^4QUAFTF&<%K.#3(R19ZLI^ME_+EVTM2ZK6BSIEM;5937W&Y_GD][ MAE/5YJ=O):/):G,6^J!IC+[PIV+N^05![)X!C2W..S<'LY'Q_@A 92M]4]== M0W?8L*^8FCVT&%-'FHJ)P=.A^XN;KU^O[BCI0SJ_IM20NZOK/^!OZK M+U=W5Y=+LM)K0_K+-S*]<:=O.GW-M$:J9AFZJHT&QF@X5OLCQQJ.%$7=64A_ M;M9)_=5_\YE[SW@ZX@B#T?=@28 ,9Z5"K^4JC2@?.<62K ^J3HE3I.9@RY4@ M^7#*/]M5@EAO1X4\\/9IT/01!E>H007_2 /.&4F%FJ^&2._B+(.S+TM?0EB* MAA0@/WP_G; PH;MLG'ZO*NH**1JW/*$!*)RCC-M8P08+MS]'P\:P51CP]"92 M2K$CW543^*%.;E4G 9]G.E299SV*G!Z4CA"5S^KR,QM8=>"CA>(6W_D M+[P*+G),^0L0Y8:0A&IC,R5LF;4_6Q_.G+%CFVJ?*8[AL,%0 MU>$?(\T>*V/#4C7L+G1O^^)7PG-RT-6Q2P%RD\7#\F(#6_+MYS@%Q1:]I&// M+U(Y?@08G)#(/(NE3QY/2)$NPC0JDI7_8C&04%!\#4K8'?L%:XDTCVN/^3$+ MY#R\\>['[7N>^G^/-9J)=/?G+48WV#TO=QYCZFP^$.7'K?0-W@]_7(<]59&5 MOB[K@V%/NA&!H3R? )=Y#)]$B:>HQ>;A!.M_$\8_:15 M/[-1Q .]1KGPG!8A3W*IS'OE14444B^O"'8K)1?](_0HX,6!SXO.)U&(U=PN M?RW@BRU ,O&SV@?G@;FICS"CAB.R<';S2!)>45%&0:N"X!N3]WO"4*>FCE!/ M+'K!I" [X8M(/!$*C^N'O.I\#$IK\3#=^XV3A"-XN#A.EF>?_XK] F8U^[L\ M@LY_!^ =I4F1VP/O!G1TL\F/ $C;)^#E=>^N_2*7JT4XQ##IDZ=[PJ_^D;KW M''?X[\ \M='&B$6L]#.#_P)3^)[Z@#O:.^>]!&2>VEFI/33;'-<8 M-JX]S(,7-V.\&1;$!.KOO$(?IPK'Y 7\"+S/S7I.50,=?6U6(S"TOCL>*X:F M.ZIA&6-KI+B&K@QMTS#,D>/.!CIN[VXN_NOTXSE7,;]^ V7S_.[JYGJ-T,;R M5T]O%>28K3B.HPS&(V,X<$8C%9"@/W8&PZ$S[!?99RL"]9:+ P#IY>/$#U\8 MNV71D^>P I)E6)_[ $KZU\WX>][M@!>LT 74@%O?T]$MY&D^'=DD3DLP("$5 M@+SRIKI#V,_HX8,/XQ0Y?QK%J5VDJ:-*Z;SD$0%:6[KA50O?4#:_$\F_XD'\ M+&\U@XP8N)*:__PBC":8EH2&"#+5J17HRS)VA_&$^E>90Y\<81D\W MC>W/C]%ZRG#=L;!O/C*VV^QK;G:U,<<-A^2L%!*@?G\?M-[0;*H\5#KD6OLY MI>CN(6*L?D[1-@:J[BE4YLYNVF1LTUMCY,%-A5IQI/3RTQ[/(*W*L.ENPEB' M2]O"I4W[XZ\"NGEK' A,F\TO[R#:0;2#Z.%"]*WG+>1IWV_H$2( H(<+7<7W M8>C&>(UNO2[;Y.!MFYZPZ;3+-@\[VGR$$4RR6^/,/A M0ZX26PF$-DS\ M1(>-7%L*Z#1$K@&9\LK&P<\.N5J-7#N)CPR&J$4::L>Y#ANYMA0?:8A<%G*N M@6ZT"+F.Q@EY%R:@0ZZ7FRMRM46-FS[!1B,I%CU3OO9JF=QM2U:I3^=NG*RR M%="TA;/4PZ099]E)[&Q(TTST&LZRHXZV=0X:$1 UR_^3!UV_>+KF4G7 M+_[(^L77-C-=VIQTIIFIIJG,M0S55ON.X0Y&=M\R+6UDF&/5E4=S$*-C7E+T'L:!T--0F/>7!7[=#]YP.QYJBSPX%,FVJ_B0MC7&$>U3G4A MQFZ>ZN#WN-Q^U'O$/LK8\#KK\3RA5JPQ]FR.$>O?C?RNF?#?42\I- ML9L,.&T-O?(#A/P TJ/](HU86?KS06T1\";7B^ B0_QG)O@7JP+9K 1!U#WI M$B=E\U?EK^"C*O Q:@@.- VOP?$0DD\#K),'^'1Q?WBM0@F$^J,*ZDH^%SBZ^EA3A%3AC^ V/G@IM$+LZ."%+!B69DU2R5\)I;&4?A( M9W/%Z @Z-1^'D8'\"<=YIW%J^_Z+A -$EIW6J#UME= KI_TX>UKZSY\XVB*X MY^=5:P_\#$8^:&;%F:V3LW&81OR4E;/3J7$"*PN^GP$%-C%F-)(''L8Q%NP7BQP/1<"(C7$2.LMO"CZAL1GVD^WYU.L= MAZ.,TR2-!";/CA5<<]I /9R)@ 0#.$=&YR4O=[B-ZE@!2]G3L0+GH@__2T;2 M.0,0&KZPO01MVP(,^>2DQFHPV G[T>[?ZO=,U5RKV[_6TU?LQ]ZPS;MI#EZC M)[VVWJK=9G>UV;[^YMW^M]5&?8/TO3=SV:W6@)3KT+MS+*ZVRW#<^AT*S: Q M"JW0!/=PL.TO^H.Y;;]-&T!JW[.V;S/3.MN^STF$RG1'&AUIO-DV^8A',1@R M07\/6+ 2;.>Q[3M_YP7<<'W_Q@33ON[HY_?W$;M'WX0'=^@%,9C#3[:?,NF= M5XJW;=@ZO?V%O?70N4F3.+%I@BG.!1WAU%[">!SV2>Z2 R_P;9A_$Z-_)*ZF MX$S5^%Y=?]Z:_TIX74KW=)T^CH"OK)2NHQ1^&>R^I,A]QQ3E[=$?>4MM,88T1$ADL(7'M%\LYTN'.N(UT*]?P;JK]U=(W=HGIJ M1]$[FR*S0.:W%OGGQ5WZ6XLR+47L[YER?5'HUG>@6FO+XU&6?G+6[Q52K#+7 MN>/M'6]?(6]Z26.6+3+UJ\ST^!,MCZ:IUI:!J=:65FW+>IQ,_JT+YG?2<8GG M#LQE:4?6AVR>W35X9;N+KB&^$JD2?T1A'#>VO,R3LZ&NR9JNM:AU6=<7;].. M)O-MA<%FMD+<"">;V@O8%ZQG'N! LX-9XZV=C[L@K,]9\M-: FX?'(OUYW[7 M.@DG;B*%EU_5902N(N$&.,YY(!M&M3EG9 ML$UC!G;HE6KE&L=@P%&:]=$9<.V3;T6Z^_KR#9L&]G6Y;U3+05:7;RW6F \3 M%ULIWVK0L9E\,Q4%Y5N_L^#:N\8Q6' 9FG86W,82#NM*KN(X92ZO+.5L@=A( M7"Z]R4'>4("9"A^]->C+YJ#JA.Q,M-8B6TM%&$?#M068=G*F](R-!5B+L7'? MUSC EM0KY3^RP-U*YN-T7ZEUVK3M46Q]GMP;MCPGTE1T;(DX,#2Y;U9'6>Q1 M;+T1NNU'X\.C;FUXN,T+YRLMPW8F6)J*@>:VUO&'%CH!5C[07A#,O*3,P3XD M99J*>7(VZ"G#K21E=C*DDR$-$CF7-(UJ2R*GJ6#RC5&;"=9)DX,?K5F/Z4+_ MH(XN60. >9;H+I!C6O+9E^7AS4^ MNSWB6]O$QI97'+X>Q>VQ?K15V.PI%]JA"5YB1$U-\"$&#*QJ1E?'?-H>Y=C6 M>=M";@O#=&]FP,\GI7D&?'W3RVD#WL*J2GW0AJK*3GYU\FN[YO]VJ&W:_%>; MVO\JIFZILK[?T:8VB+*:J3E[VF:VU$RZ:S3;-9KM-MO.S7:-9D]WW]:N:S3; M-9I].RAUW32[1K,=:72DT36:G;_SKM%LUVBV:S3[AN%BJ^U)U:J*%\Q-[D:?C1.SH:'$'I\@P3C+*8%@&*+>7;W MY/23Q]#<:;/VA0?84F>.N:JKN^Y>./9^,??TGRP*Z_1:$SG04%.UWP^XF\Z1 MH>(B"VL:'UO0O7!U5.T? ZKN^QI=XZ=#<-6^E>S;L._38GXQV!J_:+'GY,@P M;9>BK6'7I]41=7@,B+KO:W0-H;J&4!L+1*WUL4OK$&*7^]3MY14)9H]]XL?2 MR6.^,J.U-!*J*?L?"=TG_M!DC;WK!K5.,2FJ^7L0/=74DS.]5S0;[KI!=3+D MC2*NT[)CMQ%7#:U9]?MJ>OVU'5[VA<3>.-N3QK.UN[+JK773*L-)>I= MJXR=)Y4=>ZN,7=G7Z[=ZT@RRKSOFTP[FTV2-KM73:UCGK]+J23/1.C?U-N0V M=_*KDU_;M>U?J=53U;BG;LY=5\+MMW*:94M[TMHI1AM^63_OPCCY#I,_H?!2YWP/@!XK#A^KD0H Q WLE73/9B:8.$KX9Q1OCX< ML]@ _!$G4L1\ ) +#TOP^U.^9:G<*"ON27J-^;=?' M0WA +TAMSKY*U";PV\#V79,PIAU\H+OPGICHVB78>.E7@CB5XB?V* []-)G_ MDX5D_3H-#E:D:M6:@5?IOP]1T:G@GIV.(F;_/+7'L-D/MO]LO\0G_SY]2CBB M6'S0[R%05X>'^ 2Y<'\GX*F(;P+/U?7US9]7GV3IXN;[M][NVE6LN-WKF[O+ M6^GN!K9[_>GR^O;R$_[K]N;+U:?S._CC\]7U^?7%U?D7Z?8./OAZ>7UWNWK' MO+>\%5KQ@P=LQ'-60.-W5Z4>%#)P1X>A&Y\8*'R$S$_\Y=J)_7Z62=!_9S@% M\1M/TU3F6H9JJWW'< [^YWJX?4GT1ZAUF6FO+[]]L?U&E24W]_+SW:+R@=[T%!%K(R'(]!B$6 M(ZX'0C,)\9],B+B8< 4EK%S,LLI&B<>L\,#?UV MHG>H9-_!&S[Z\'VQ;W@3 ZUM@HPZ2MG:C0G?7..>;:::XVG62A60O>B@"H8/ MXSU402U7I6\^[/CPNZJ"N35\+][DG;?I(2T+]N/4['=M>Q)O/U1#( MT23;=#WGMM-SSGRMI)7+OU/0RZX"4%M3JD&[ 54LNGNP ^&/S[UFZR6SZ-K) MV4"VAI8\U YA=%F+(L,;T\7^1^<.),@VOQV=^3I)(JM3_4S$^P^4OY] _'X& M\3:=?WDS.SUE8[]7UXEDLQ@<[$^-T07,:]*P@Q8V3,U63 M%:LO:_KP@+N?'!F>+I0]@QW)GFE474L F1A^U=J$J,?0EN9/TAB.K"?-NST2 M OR"UA8"?C5"W/^HU%9 LZ>\ M::$V,=S':):AGIQI/?VHZJ'?OK],2X=H3!?%[6E*;BD_O$O*[9)RNZ3<@\HP M[9)RNZ3<+BFW2\KMDG(/9A#TJ_M;L"U^+E?O'_S9%QC,,?R MZ+3_+AGWN-G_QLFXQO#D;"AK6C4WH4O$;2V&[I< V# 1U["VP_W?3O-O:2+* M$<:ENLSA_9^)]-J1+!,SAP=]6=4/H;E,ES;IUBJI=4Y%*AEH8MK4N-IKT82#9AT2,LZTHT MZT4* \HH#O)\1#)^Z"H+PR7-%YG*,DRD>0X0& M#9[@:]*&X%E::WX+_!9#>[7))8UFDX!.M"?324P->*4N#VI*]CF>K#J8A+!P MX>01FW\9Q(SW04]*6"XU'4.B]]L^B,34J7AESAR2!F-(-LS$QI5H5H%IZ+9N M*9:FN+JAJJHU'AJZ9:G#8=]ENFW]KZ6>K%@NL%TR55<:7F'UI/H9#*X-^U=T M3;-&CN%8^FC$1J[%=&UL]YEF&)PXX3=PZWA?KN*.''.L6_I -]S^R%)'MJ*X MMJN/C1%\=7+&YV!<2E?7%S=?+V7I^O*NYHIF6]G7[&SIF_:$1=Z5QC;E%!T3 M!=_;7L '(_AA',.'XRA\I&\B4 'M.(U($\P*8H#L**8M^9X]\GRL@2DQ$7SB M&^@W0.]_90_BTM\B[PGES#??=OARV=8$$Q,LD4Y9>6=6C%5\%P-.9+ 4L$4,Q\"%1N.0BJW:IA D52YO/ MG(+_(8T=+S0$;FWGXZ<820N "#)[1 N."LX#6@-QMO"T[E*>!Y;?>%8 13,P MFI1 $:[ A]JTZ'YF$6LJOP=+Y#<9,+?,22.0!RS^_'3M_V+^RZN@0L-:N"TB@O7F M@*9>7]J@"NU' $\!4I-7?VKT]>[/@AFOS5 M,7M];=8/,QCHBF%KEJ9:(\-U]-&8#4;J0#.'BC4>#+39L7S<&R/=G?^_%;?^ M$VH0M3:+PR8OQN*AR<#4SEA+[%R/%L9'L7F+[YM6!!0JO(QME?LIO('** M%G"6^==WF;TOO\?O\,X+SM2]X/XF-X/S&SW5BBL%=7+0JTG,_8TNJNF>AV^R M9[1X>VK=GIOQEGI4E-][F5@<*9M16+^FW MHV46G]>5>S+/1T"11E>"DL %[3%B"9/@B4=TGL%?E+U LXTK+$@:O31%CEGV MPY'#29[F(,8GL:,KW- W%J$%4HL8ZLF9TJNZ37[K29>_'#^EM%HX12S.)I>= MW0NXK/0G3AV M@Q:S?&YK:*%3[6W[T&(CQMX(+5!A'O:J^B#@Q:'S.VWW_&Y6==D:8IN48-D^ MQ*X_\!;QN;\--J>M@ UPC&UCPZQJ-$/U6T"+ 2JQ5<5[ZVCQ!CIA(ZP8DMNL M&J783R:'%F#&C# ZB0EKITG(4T_Q3C(OQ"0"F$:P =1D4S\1N3^V%#]XXR0+ M;,[>+^C*\+9 @E6Q\UTLBU\C\F#%(1 0..8);2&*_PZ4XX&.X9M\?<@L0%0,071]GW*/^!^0AO[YF*4=B]O M[0H.X+H449(EAT4)9ET E4W""/L1NQZ@.<#/8=@D. X=C\++!#\*/]L3\GS_ MD\,"8 30@BMR'@CX+@,C)9Q0ZA7O67SU_4*Z99S^U($AGG)3^$1<&K9%)?_W M5-YH\F G@J #="YARG(0 K8 E@ GG,/M@+=F%S9U_PXMY-AIS.BG/VXQC8PG M0\//,IRA*/H4[F:(XX01FF$A+WVKPYV>]"/P61SGZ^.>4A_A2!G[\P'UK@2? M]Q(VB'T,X1X\YA+GBW 7<*#,*RXR9FV\2#@K$A^'"=Y'&I7 PCTPA:-7^'DG MMN?N)>Y^L>,$G12$B%4RQ[3B0CNR*0]]8D<\91"8$,"!DFIEY!]P/H[1&9_Y M1QIYL>O13<1YJON/6QF S1$'I6\N;E$JBS0+0 B1TV@_V9Y/+;)=?D_%6Z4T M\3*R:656KZHH;4[K5=5>PW#3+;M'\OK.@+7A)2V*.@VLV:B3TA^;X]&PKSG, M,6QE:*FZ.K#Z?5,SAH;MVK-1I]O+/S!F*7V__';S_>[J^H\U@D_+WSF]1QWC M5(IKJGU;-=RA,APR75$L1;&=/GRD[&6PBA,5B9_Y"ES,[W:AP5I3),LK6&_& M-QGA"AR)JVGZH"(^AY$;LR)#LZ@<&P)HPX#5E$+D'$'L$%2/!P]X?J$#C4,G M15XAZF+B<)P\(\^?^':"FR!^39P]\6)8299*Z='<08L\"!E\3[H!?G]Q>8.< MCYCB@\?&I4T@,##8=_IH_V01_S%H H%:!HB8O)P^>R[#XB%OME2A&:DZ#Z 2^.QF_!WD(N!W_!DTQ,M?"8L" MV[\ W 3I%6'<[4L8W'^!H[OGP'"3^./+'RR\C^S) Y:GG2-OOD/^6Z7PH5JA M'GMD*M;8-@VF&*JKVOK8<%RCKYF.ZSC5N/*>T)* (!I^]R782'33I+\"LAW\ M_ ?#Z.FFT//4V%>FK#02XJ_>A2KHBSU9)KS,\ M8T^AKLO ,-0*^#?\M-VP%\+^-HVB/\0 ;-=K#P* MD&E-F.;ZW5)76.- 8/KN1Q[17 4;.XAV$.T@>K 0/89FOC]N9Y&HR>G:UBZM M_HRKMTNK.V);VIXU;_E:K5EH5*"2N:2)V)90:0"6K[(Q(^U0 MJ=6HM*01P990"8-B8MOOPC&42$]X\KMEA6JLQ[35"'0TQC89V*'JUC6&':0>$:?W7B(0T MQ+0!89K1)N_V,;@DOYS?G7_M?)(+:.--0CL6]MH:=IZBPT:E-PGM6-;)F3;8 M6&)WJ-1J5'J+2$D?6RSI@P-,V>]0J81*KQ$IJ:*2>G)F*FUR4+^UVY!JW5\7 M&^9TI,!IT%(D.A7M:%0K[61V6-"*NKRH-Q3]!72X;S=,L;$/U1RN5HW8MB3H M^JM:/0EZFZ!I"S.KA\D61_R\OAW;5[#0S9#-FCFANZ2\]8SH;6#7CMT\'6_I M>,MV>,O._?Y]10?>HLO*L&K<=;REXRT=;VD53+8XQ^XM>(MQ$O'6SK>TBJ8;#1<\NUY"Y:3#F7+K-8;=+RELYGFCI_M'LWI;V;TGY$4]IK9SJL,*.A_G?+NM/O2S_ZND'!DPC'"XB!3>SO MU)OPX08X5 4_^G[S ZW\;>BP^_B_U [5GZ_*^/I]>Z_AJ]UE?H'+P7 M?1>WV0Y])1 L"\N]F51;#3Z?F,-P[HNDJW)-P&Q[6',@?3R[UN9=.^JC:$S; M2HA.K7X,&;-7<60SOVN?>S0-V?I+"GROPT!,=^1#OAJ[Q_K 1F6])JJW]WEV M'54<+E4L*4;>F"H&2!4#I4W9I\=0:5SM#-]52I6P?DF&V<983W4@LJ9V#>,. M&X^69!-MC$<6X)$A*ZWJ87D,UL%W%B?9!-J_PLAWI;78Z;'4'BP)3E?)H(+I M&)+0#W&L1(V8FF8KN^@:SI57="QSBVD'DYG6FY M,/>R+K%G7M@8?T995::AV[JE6)KBZH:JJM9X:.B6I0Z'?9?IMO6_*M8$K99% MM-V+5E?*SU.UGO1_IS)4JX4/TQA_:4SD[./Y M[=6%='[]2?IT]>4'Y@E>7]Y)[[[N)\\3,=U[Q _:R!FSD)@3W+Q MZ'B48>?R U+&W3L_C./WDA8?1TT^@R\KK-OMIFS3?)=;3V,]?Q[B%B3 (V ME#S$$@MK]6@$F7Z-@E.K8*^-IV,Y8/!S =5K8&*[OTV^-* MO^T@VD&T@^@K0O08DE;(#V4G\*ZUD&G51(9NC?:L<0RIK->SSL)-DM[:%H^K M]Y@VCL>U,JXVI^9]HTZ0,>P?_E6)L+'DBG#C"^!)X_!:G[)U+;/:U[8BEO_;9$?UGCCZES[=@.6W0@=6][ H&,H^\Y07LM\?@4VHNUHM^MR#WV>0Z M MR>C:&LGH'?=J'?=:KS'+OG.O-_)UO (?,QI6_[9&'3+GNG$Z=:AC*,?'4-;R M$KT"0^DW8RC;W_:Z#&4PSP'6=GYR#.D#GU@0/GK!^GDQU02IV:+%;>1?;3F' MJ]OBFVUQ2PYG+DV5&FJBO[W 94'RX=2JEIKM5-+\17\P]]2&7=GW3 )^B5VO MPS'W.TMIS%S)"] 9/4D3./"\ZC\^]6"Y"_N0DMM:UN.G_HK_OT.">%M3\%I/ M_O72E=?V/@LF(-4P 2SJC:4P3>+$#O#$Q].87Q3P+B! JX4>BQVK=0'0[T3LSGO]W^D-[Q)C0X'>X) M+CA(YA?F'5Q#U[58^V Q<[\*G(CAF#W;%_Y66N:\9.;?A5D3).9^LU_PX?,H MLH-[^MU,.N+8^\7*$';GD5T H[?P MR(I[J)B6C;6*?N>3/2)<6\LGNS5<&R"N6;(U',JJUB8/1H=KKX!K:WEEMX9K MP\XO>T2XMI9?=FNX9G6>V3:F#F$!ZR0*QUZ>#G2T>4#=&EV&S:(,FT-J>;5I MV6*;>S:L4>V<#8%8:'9J<[/;:V=)U A!0SDY4WJJT8XF#5WKDB,D@W6H8#A# M!6LBOXK(KU15OSVJ6.VHKZ.^-Q="ZI:%D(9TJ%7=F)T0:A.J=&2PR'VQ!3+0 M21RUI(W MW\1:@/[F_AM9'?UU]+&>SIJ^ M>V 2GM4.7B0FSB\E\"$?$(WM)R9A I:H9_MY4)D2#&1I O_%@58N-DF&_\)7 M]B/@0C*5+"G9B<1LYP&#U5[HXNA361H#B.DU3@'GO.1(#+S&$'?#.=?C,*)5 M^:MB"8QHP"[:(7/L-&;80 /.B-N"YQZEYS#U7>G!?F+P'U<"^-MPU-.\\HE1 M,50W);O)LOLWR[G;;*NG9&>D IR>+5:2]OG);E1X-RH\ATHW*KP;RKR'P.]& MA7=8V3[@=Z/"NS','40[B'80[4:%KYGU\"-X8C'ZD;#G3=FY=3S=;M8JF1N8 M"PN9-O3#GI.WL6EYDX'E3:8\T'39V+R77OL"/QT*3J-@OWTH:"K8^\:R5'FH M;5S+V6%@VS%P<4>$W6"@VC'!8T+!Q8T2=H."VLG94%84339K(LY[WQ"GU?KL MC6CCV#6U69F"%I?D[X:"]),S2QZJFJQ:PQ:5Z7T'047=^7=#0H..Q0\)A1L M863*M#H4/"84;&%DJJ^T% 57* ;"OQ'$7I#:O)!V>XERN!*"R#,-W=8MQ=(4 M5S=45;7&0T.W+'4X[+M,MZW_516XZXYHQMTQV-!T.X?L,V3-O5^X;+1B/=L9D^-F:K MI6Y_?+R]_.\?E]=WTN6?\-_;ZN4VJ,#912'5_YU!/HXM2^%P=A-(Y^D]X)^D MR1)FBLK2?#X"-P$LP8Y>JKQD*L9X=?TYNT4G>?J0-8C]ZR'T_9>;YX"YM]E2 M'IL>80#G=Y!//(>1&[.@CD5H)V?)\6)25??:B.#F] ;Z3Q;0$]*_ MVH^3WZ6[""$O]M63 )HLPN*RZS!A4I_JR<9I!-N( +J)[?EQK\IFI+G(*3#$ MP$JN21A[^/B'B/DV\O2B@.NWZ9Q>@Q%@Q7 M2*7>(6>B%3]X">S564$&7"7L4=)ZTE<[L/D8$QI+,O@]ECYYL9/&1#=(F.>! M[;_$7LR)*+ #!^M +\+ )<3D8^!8G/H)/7(S81'11+PZOW[36MBY@)I?'5L4 MPKK3L+%+L E38!0Y?)PI^$0%?,(_"/-. LGQ@;+NHA MZ7J/( -$[B4MSH*8_XMR2:G M7A[#!HAGTTC7N_3 P&P-/AD,F' D^$TS(_9 M,S VK(D%1@OG^&_@P/ V8.'?V22,$OHY;B)[]=QW\+61*=I>P,?7X^_. V"1 M?K8:'.LSR!E)54[_*Z_4?8'=B!*G3\QA-'-%5TD2:M([7 114U-^IP_F+TA/ MJ;^_[X$ D5#=)# ")\3OJ29]A_3 26^.+\[)HN T\ M$A584W4UK$2+XYM9X+!85$ZSNM?BX9;T\> M>VZIH%@H%C+UU4/NQY752>0!53A^F(+J&XZ39VQ9 2?(#?A]#:)\$?()]&2 M1V:4,.P8C"%@ !'+V:,#PH&S(A?8!(#LA3.-1V;'*9]DQ''D^@P_X(K"7GTDXP0=8\.1% M82#8Q#D)JZSD5%@EMN.$G J 0O_+!OX725\9:/BR%,+;)5/Y+=/S<5%-47#A M;&?8G6'T(OVXG=IK/&$H2.' 0'>^]T_\3'!*#CC.T[QHZE<9*&: QCEH 5-9 MFJ01J- ,>, H]?R$H'J!IW?"QQ$)JES.9JHV\BD;P OG.K7O@Q#0S,EN+I*E M!_P:Y0'\-HT1$L^X10[$\ED1OO=1^ Q\+OK)$M[#XGC M)S8-4H[8CR 9O0E ,7,7Q676?AX\,!!HT>G'- 9I_W="G].]^?A/ ML!GO_7 $)#QS[?Q3_Z6\)2&7?\";_V"@6J !_.._\-V_P&Z5I7-8$&\4".D" MX N( /^ZBB.;^3(8M\&]#?*+R=)_VG 3?#_G<#MPR9[=DSZED>AF@F.:0;N1 M_N:2#U%+4.X$$/@7Z1Q "A:1J6!A_Q;GR/4,J T;0045^Z6\$#*!C ?DP)-A M?!5H("/Q'[?$)B9VE&3Z;YDGD;E*>NY]>)J$IQD5)+@ZDN8SH]_"ZPJ9GH$6 MGF* 5=AZ)N,#&07&&32?P\AWRU &PR5@L/!_I'XJ2Y>WWZXYJ*X_7OR84@KI MW?#SG\BMB3G0!H#: N=%PDXRN)Q#8@I]%Z2U &S^^O9-EKZE([ <@.__$87I M!"[EYC& 2WSD?W/GQ17) WI0?(Q$'L8]OJ%/R&-3?)0S+ ?4/]0RB,Z009YQXZBD5TZSY9+4 MZ?$/0 BFU/((98FI_D:0$J(/+P^Q-)2\1^R-%'-##QD9$52F-K@%R28SW2_P M$KZ!6_UK@G?DO4[Q@U85)5XY8T%LE=8=^HNK\)ZKVVRP@KX*%#+5Z]AQ( "!\5ZYI\3<,?IO= ?&7 MB)^#7F4_9FVK,A8'*B7\!N]@._2WJ5EAKF-6S(T)O96]<1?!C[F'NJU.J95L MC8LPFO1(2(>1!YLE/P"@'7P<(^"0"C+P.**WSN9PQ[^?0TL@=PS2 % !XI$N%W='Z%S"E+EB2QS M4&V2EY(7)>OZYK.LZ9L'T@]DV7VF"^ IRB\4W$J5WN%OBU-(I;O-_3_[>,^ EOB8&BAG0/J]P#PHM>@R26L >>!!?C4^ - M\-:.'V205K)I6++1-_,9SN-9J.8M!+%-X=@&2_/)]E,2=O^B]X9*T8"0"Q+N MCLH=O#%2G37%-S3KT5U)S'Q+N 4QYPTK<2<%*'7<#I_V_O79O;-K:T MT;^"RIO,D:<@FN!-HCV3*FTGSNO929RQG.3,^3(% DT2,0@PN$CF_O5G7;J! M!@E*)"6*!-E3-=D6232Z5Z]>UV>MWE'E_L[&XH\JSGWTN?O/9&T),,B*1J2L MI3;/M'#^!GU5%%DD87^_M7ZZN?D-3$N2:ZD,&,W<+T+/ ?R5^Y,RD^*FX-=Q M<5[+^E-P=N!.< 21A.(&3\*;!(?5T"B-(VI(RJ&D?$X2LLAQ6.X=.(3T _D" M#L)/Q8(&F+F^(#&=;OAJ#V4T=4VET1(*ON-L5&?8,?YPG$I0W1 '(<$Q1/*;2(AA(T\TT;S[ M3(DI/$VIH.!LD02C4TW=A\&9=#%:SXQZ7QQ\FQ)E*N2+\H-_21&W^LRR"CTW M-?C+PD:12*8=MVC!?(B5K,MU24R6AY&>'&Z2!%+,N: )8V$TCJ;!HE_B0%>T"(^QQBCB8WO M1744!O^26:V:7)8/WFV&H4L?,U%E;!W[C<>3Q)VAXO**T#!\GL8D[2EI8X'1 M'44B5.J$QZ)H;#JE+$*"BCT,5; '!_(X3,\A'- LSE8[@&1!-<,OE6(6IVT M PLFT! ,S)0D[_JF8K.XQ$\TNH"9*I#$OX0X0 (44_H*#?I% &)_& MK/)P+8=N>>AC)W.]Y/BI6,L=^&$SH:U*#SO"I^)KD)*B+%(UAQNANSED_@N#$01LBH,'].GX-/# M2-K8E91K.@W&&1MYN'Z7 */O9*@7&;^Z9?I^(8L>_<%?X]3-4P&4([ !QSZT MY-%A6>XFTN=49,3C1*7$06B#^4Y.&ECWLG-?D11:G_-$%4 8/)W)2+Q?(C$4 M6J%(=I+'5G[/P()"Y:$?27 .,/?*_"A,D:6HKBG+.=B(JB;] 5-W,0AH@VD( M3 (^7O%^N0OL=E(5K)N4RH^S%:!.%8.B Y@EL9][HCH]I:4(SX%^("V(3O'2 MJN"4H?'@UR=]<=(!WOC!65OT0L-+\BMG O;&HU6S$PJ&*WPA[0$9S/1@G2YP M?"KA$K!8%O$<+TQSSY/*EU%J:GOI:#]F'A]Y@+C^\.$PG"=6&KS7*M!,'S,X66IXDL%HP+$I@4'EF M)%^5)S:>S>&]Y"_$B.4)=&YL5712U5'7/$]">.TOQ"QE$CT0UHS]'IE8G>6 /$H1T@XU#+ MR%K6X)2R<.G60RH.1*6/\K15@!((;91J]H7"9R(^*LXG4ZP35&CB<1QGP*UD MY6N7Q!%P\^:WFW>V]>,O/]YPJ.+GF\\WOSP5?%GDW^LAF IQJ>"63=S?/T5% M]DE/A:N:(E<*93;N.3DF),PV$L(O*JLD%ZAM),')SDR,]C#(=.(&W4*K8"1 M]'T1"R MQ@_G4ZI(786S:L*.C4J:-T'J2VOPX15LYH%8^'\&#/ B8(#>LX ! MNFT#!GA"O4\<"9EI?6*MZ-%4T'Z2QEU#9;)2,B3[EO5O8;A2B)-];2JM*,-3 ME?"5J^=H-&]?Y?3+Y O)V'$,,IJL7AFHLEF8NI16X0B!F[DJH[ *G,A.QK+5X+/[@#XS:&"=>DDLKLA\SY4.IC;9'5 MD4>>'H2?_K^_V:P4*0Q8$/#S'[@)=3% &[SC/,(+E^$?X!>BKV"K7[(/(,9@ MM 44%EJ%VQ/M@";C$"=3B1+R-;_P<]:ZBJ]6 _L4MF6_IR9:Z;ESI=>)2V6L M4RB_Q812&DM411$X8E;:BL*8]9?YB%87>/\5Q]AQDW+*;@VW=RA3T M)X7G.F@45 8&WQ4PPWU_?@1\WP4BP7/L'#4J,[8HU#A)4(V$PE6H98I4N[+8#!: M'2D<+$\4P5XMQ;"$.:>F(+(JXO(>)><(L29-%?\N+,0+YBR5J-^%+H90VOQ^ MRX*%!<>*ED9H+= ""YC=]4(-I-0XI\IX!F!N0Z^C<1K>Q6FFA\:;N.7+:Z#] M"]),MX8)N9MR0"?))>Y#0X$5IL(R^DM+V3$(D(=1G4>F,8-$Z.R5MO]8("*9 M? ;ZO8*9150K7P[ S5!B[XNLJJ>L891*)!HHQ3&;_1JN03Y/X7778V-1]=.A MKV2"7":%,*J-'47T2MV$DK9%Y4C],/0#K$8! T4V.9-+*7($."YE?IO(^>#V M@_V/J96J$=C$$[!N+25P7!Z)ZHE8XDG[J4QI5X[#-MSY7,Q9QYNJ4D"1 K-Y M=ZCL.9; ]:T(>>%_40IKCCT8(LRA:8+%EK@Q\K8*.E+UPCTB6.Y17<<(L5]MFQA #QWB:4\MZJ=C2KK*W]9UI$612ZJE>8N&" M::C82U]LBHP!LZ-RO[9KT[([IV5-) MR'ZF?D>,SONJ]3T2-7V3NO9*^YULB\<[6Y&';BPH#V_BBP0[X83N/!5OU#_> M^D$Z#]W%FR"BI=%#;ZO#(7!OG= M5:O?':S]NMURUC_ZT+#M5F?0W6G8A[_KM9]_LM>M_G"W45]^KHTB[+#5[N\Z MGY>>ZU7KNCMLR%P'K7:G*72];O5Z_8;,%7B@U]MHU$SVC(]OUMG?FQ0K2G M,MUPF7A9/&\ZY="PVX"SUB[X\5O+3I1JG>HIPJK;2C=" I= M$.8JSF$(/WVU7PX[.>)]QS!R2A(^A^ Z.0(9[C+<9;CK*(EGN,MPUP&XZQ$# M;+5%N^<)L7IMK[[Z4(R/Z^[EE8*LQZXFKEEC[3731[?2;Y^TQ..^0;O;L_N] MP9:73-=SZU[O.5]ZY4[WG&_*@,>W2_#?@VS1(=;ZW29*:%O^,$*I44*I:[>O MKXU0.NY=,D+)"*4S$DJ#OMWN.D8H'?5=BD0-C:(N-MF+MFW0UA[FN[/]S6+*K?Y;U*H*57[B2!FKM)G?Y! M=NCP LBPQR8TN[*[?7.&CWR3.AUSA@U[K#,@C& ZWM3?-(3[VV)PYQ.?$'L[ '@YZYA ?]RZ= MK28^ARS]0VT[SR-JY3AV;["M.V!BBR^.?3_3V*)ACXT.<<_N;AWU,8?XA7>I M9PZQ88^'\D=V>VBR?$>^2UV3JC?L\< A[MF#*P.:._)=ZITK:.X<4O4;W#MP M'I&K:WO8,>'%(]^DK:%_IQ)>-.RQ6;)^V-^V2L._2V>;Y#'MLQ!Z.W3.PN6/?I:VC M&AU\Y)MD=+#AC@="N;L'N\&=:[-V36L4<\: [M]/3"']WAW MJ-P1KW5?&T/KQQS>(]WA[IG:#6?0S;^?1"YD2>L(/+BF;"M2)Q;-OZB MT]O"JC0!PY?>GBW4PJF$"0UG;,897;O;WL+D-V?WI7=H&Y/?'-ZS8HV.?=7I MFK-[O!NT12#4'-VSX@RG;P^<*W-VCW>'.B]N%1W^\+YT;MT/[@X4B_DY3M-7 MTF.W1F(<)\+*W*_EC?.'V RKV PBS"YQL5&<^"*YS.+Y&^3 - X#W\*9'_<9 M7(\$&'2VSR9N1H0&13M/:U?[VT>I][:CAX^0&G9Z&C5[MM/M'%)J[U9G9V34 M,3.58SC*R,C38>>+3M?N#K8(%1DAU81=[6Z/U3%"PK#36G:RNWWC;)W8IAH1 M<69HE,\8Q;+B2 :WS@R)XMC=KNG\?N2;=)BNWHGO/+ MBQG.V*RSH],_S'4 9I/VUMG1'.%SXHZ+3KMO=._1;H_I_'#JG1]^%9EU$6K@ ME!VC-[R(-UW89S_.1Z'@",X38EM'1ZIO#T*:8SDP#U0!]H>[QOR>1)KFA7B? M_Y <(4?TMU#HA^6&P\>'GXD5C8PV,OHAP%*WW6XLO,2HB)-3$4[7<.,1;X]1 M449%O3A>[,KN=[9O5V%TQ*GJB(M>8[C!R&@CH\]!1G=MIVIC## MX24TI1)>9RZL555;PG_4G&9N,@DB198A,=^>YDPCO@DRH)#W\"HZN(I/XDY$ M>5FE^OC4]5WY*T^S8+QX^60.S?WS5%C A??9E*ZA3H$QL,-U/+;>??[#NG=3 M*X-??!$+RT\"8!W\YD,4Q7>!3WFOJ[>IE?#ZU3A!1,^DPHMAQ+]S-\GXN4Z[ MTVU9-ZD%([OPKKF(4&Y$68#4L[+82J?!.+/&23RS<*IN@A_"1&SK7A2_Q,]& M(A+C0/X4WQ:Y69ZXH747A_FLF(I<1C";)R)-@SA*<2!?A+@4X5OC&":6)Y;X M&J34V1MI$ %E/=B4>":2M&4U5F61*,\@Q^#B/C0,@N(KG#+:KN,&Y8-M4W'/^:P4AY M(O *-OAH#$2,)BWK71*G2-)0L?CR3T&8YG0C.[P5V<+# G0O#."[E-AO:58Q M<)&+%[X5%- B^;L1%@_XNSP(/O<<- MD[^"K?W\QZWE>EEP%V0+$F,P^S#'AV%0_&G,W?Q1)*C7N,!6\&D0TX]H2CZ+ M&^+E8*:QC>O]G0=I@ ,T5$1,00(29:(8&3:"Q8USOKS0PU-C>5,WF@@BCXN, M/D$1G&9((DVB6G1<-#[9@M./1H._PW7!DN424NM"? 5V24%-X,>^@-5Z ;&+ M;;FS&"RH?]%?)'\FJQ<_@B:+[R-04V%\_VHK@I#Y4]B(;.P!84)WGHHWZA]O M_2"=A^[B31#18NBAM]7A^O,56X^8C[]^>Q_XV13-L%:;3#&%X9!OEE^WZ*LE MRY6_ WD_'*S_NMURUG[WT+ @._KKGWQHU(>_Z[4'9JYFKF<_U_Y&HSZ"ZGHT M"-!=_>T.;8C4$-HC'@A7D3RWXKC>R%O]7&_-6F"$U/0(>BH)AV4<99W+7^/U MOUVAU0KA'J?:"0SR9*&UQ8L;P347Y-G$.0SA MIRMQR,/M6B.(]QU:_C*TMP'ISH] AKN:Q5V-H]&WUA]N$N M#H9"Z[BHED+G MT%%A.62S;>%--N0'!]+=';L3W(8?CA\V=\S,:.1TD9*KR/)E=WM&REMI+0NI3M-X@MOZ1!\%*^\F[;HA5Z@R6\JO:?Z=)&0&_=1?K-Z^HJ88DZ27>B1A6Z]?U_C!)X2!%.U6@WU4! M]+MJ]7;"B]H$];MN#7;"B]K6/ F G$ (!B5'.$\79WJM#2@AF712&+(YC4N0 MK^]F+L'94LM-TQC!7?"C^P QI'D"CV=BDM!G=0!1A*P&*:'GYBZ(%3>$N<3C M<2HRGHLO2D3H7"1I'$4B+.;"[TU$FH?X)Q%3PR3"%$$>$X6T=E-X V R M[04(9P!L!L!F($8G#3%J%H$,=QGN.A+TFN$L VHSH#:3B'M*UF5@7_=WO$B@ MN9FX>A>;WOM0=-[D[QY"632*BPZ?OS,H"R/<]RWZI%CZZ[WLG#'X:#5=_J[H!V[G=9@ MQV9@#[?MZCG7^V@QUKDRY=@PJS[3$,SBWQA'.X-RV&<=@QPRZI]'H MGF81R'!7L[BK<30RV+$=L6,&CV7P6":'],1^2L-AH_KG/$.4T!+MC)/3>V<&Y M;@@O'%XZ/QLVZGDN?&P$RJK;:B^AK(#ARB9\5ZWV[DWX>KL\O">,U>!9,58% M8BO=/\BJ@8WU;MT0AD?*P1R_"%KXN?34,R S,U/4OV/W!J:%BTDL:3S1;13.[_#))9/Z-V)ZWV*Z9W>;U?_.B.E] M\T3/B&DCIHV8/B:28*>M0;LAJ!PCH??/#DWAA<-+Y\9VKZI#M*QO7#5<;ES5 MUB!5O=5[3;?H7.4X2^VBGJUUU2J,:@5IY><")Q'&]R(IL4HMZT-D(6HA\"<>4=E]]5 MD]N2O]KE(^XHQ1M9US_R(&?N)T.^(6-VKI8RX=I_ITD9+YZ(RQ%0_\NE.X;) MOG'#>W>1?O.ZNDI8HD[2G:CQ.)+2- L[!UR,F:N9:Y/F:G!<^\OXZ*>YJ'(T,BLN@N R*R^2=]M*LHVNWAU=-2@<_1_+) M=.?: _:K49=N'CYM94 %1KCO6[CW[,&5TZ1C:9 %^^:)GFFB:,2T$=/'1)(+ MQ^Y?F5L6C826[#!H""L<7CB?!?3+:0V6H%^#$OG5Z:W>6;AQ,ZU.M^7LHYG6 M&M27?BGAUJBO>J"7/OAU,?AZU-<6EPONCS-HQ,T;7_TD(I&X(3<-\V=!%*19 M0F@TT__*X*;,7,U<3VZN!C>UOUR9Z7]ED%,&.6604P;;LF_B&>24X:Z3XJ[& MT<@@IPZ+G&KHM8?K(RX&6F72.IN2Y-H>=LS56":UHSM !B-EDN]&2A\328;V ML-]OTJDT4GK?+-%M5+LT(Z6-E#YY*7WAV.VNN<#02&C%#J8]ULECI![ O:R' M2JULZ^KU@,_;)"N)QR)-86A8,-WWQVVRNA5,4R@F^M<#,J-5]<#$*S@MAO69^G04K@JKD+O.N&,+UX M/$Y%1M/#9\KYB:_"RXGTHSC*TV("!?9LBQL%32.FY@,TS%S-7)LT5P,HVE\* MR31B,G B R[[/I*.W7,:!3LQ2>Y]\X1IJ&?$M!'3 M1T42O*6OVY3V/$9"[YT=G&Y#>.'PTOF<8$B=UO4R#*FKM6QR6KV=6S8YU]KE M=\_-T-TF\0.1D0;$7WR(MJQ MG>YUDTZE$=)[9XF.$=/G =UZ.!Q3H+<4>H?16QK8B+!;P"X%=*N]6PLH==W> MZFU[&S600M22*#%&B%Z:Q6E6@7+IO9AJEXFAW0!#A1&P6 Y_I_$XNW<3@;BO MOX27I75P*=/5Z9PP$F:N9JY-FJO!].POBV.Z.AE$CT'T&$2/P5SLEW@&T6.X MZZ2XJW$T,H@>@^C9#=%C #TF$;$I27IV>V@ /28180 ])EM\'-0U0KHF6]P? M-JHYFA'2^V8)DRLV0MH(Z6,B2E,:2G M/R@OA=NEGY($]/16 3T;]&*J@?-H+9ED-R1L.+4&Q0-3+J^Q&\-RL*M2$&5N M- D0;>.FJ:A#\\ 7UKT(0_Q?&*/_1+C0^F9%3/-^033O72VER[;_3I PF3\3E"-C@RZ4[ MALF^<<-[=Y%^\[JZ2EBB3M*=J%$]M;4]LYO3<^JG./;O@7FM8#9W@V0&.VTZ M39TLRL?,U2YCT['Z[4:EMDT3;-T_T.DWBA\/GT S4P8CI/9/D MW_[/=/J$W\C9,4S#NG/#G+!R^$DBY@BD@['S*,@L\16. MLF\%66IY;I(L\ O^O3:#+79)>R%A!LLYC8C'8MXS."-?!!!G/D]BUYNVK!ND M?2+2/,QXIA5RV/I&P\\\E"UXS6,=Q25;N#.06!EC$37.,^W"S@OH8N9JYMJD MN1I@UOY2<:9=F(%E&5B6@649X,Q^B6=@68:[3HJ[&D&$[EI'"'0)_628(2@G%%\)[9!V>R/Z#3BYAV;W@<1 MQ@.1]/%,V%8D3,>FTP5:F+F:N39IK@88M+]DD.G89*!!!AIDH$$&O+%OXAEH MD.&ND^*NQM'(0(,,-&AM0.VA$(A)8Y@TQB,DN>CTKE=TUG&&JTW^8N_,X#2$ M%0Z?N3 99B.:]WX:NW:W/6C(D332>>_\T&LWA!>,>#;B^>3%,TCG=O^Z27@/ M(Z+W+J*'37&F#B^B&XO]J491#OOIEI?W$>P'6:+ _8!)U^J^>D)'IHMV MJ[/3\]3L)TBIQ<\\$7X\PU5DX4*_)+!8BVH]5&U&%.<)/)\D\%RZTCM(/J&^ MMP*\+7$,WP"IB#2R@=!=C!?VA4&V(.R41XV-5AI"3?E*0&P(Q 009[CHI[FH_( MTGOE%GS_'Z/D]?$@0Z?!C&9:B/2]WT:G;X]<*X:-B"BXVV%]-G]"L/3;B(WF39()XLA,7,U#.K)H)X,+F7?Q#.H)\-=)\5=C:.103T9U-/:D."Z\,=VL=.S M3K$T/(MB=[O])R513BY/9 M]SV0L5F+Y)*\W$.0R3Q. T3JO$D$(H'NA,26\)'0GY))X';YB#N">>39^D<> MA(SM)]N[(6*L,US*ZFK_G2;E!DW$Y2@1[I=+=PR3?>.&]^XB_>9U=96P1)VD M.U&C"J"K+91J$" /T6C+*#+0%\)##K,R]ZN5N!F\[EXDPKJX:@U>?6>YD6]= M]%H._%/AR#;JQT4/,B(O$>F1C][+ZM5"H_I_]Z^&*;&_6J)KW,1 MI=3H2G:X4HL^!,H'NVOU6KVB_97LJ%5WL]X&#;6HGU:OU=FQF]8V@"/GJG4M M$4>#EE/BC39XU=[01H>":2E60G(OA(O2X-('6A'1%+_-DP"6 1/ 1>=A!J2A MS7:M=!J,,[55RSL =(77118,&X$T26WY.'<,LZ8P%9' X/$X@)/*; M)"+*]"G8UGV03:THMN+Q.!49C>&+L8!?^O3#D8@$C&.Y*4R+WX,)!*!J#&+* M#<.R+9D%?\7W&!-^\BV'A]BV#[ $,\9-;3S0 2[2'\QF\>)FRPL/P#&3[#3 M&U B36,O<''#B'ZX2YX[IV9H_V): (V 6K!%WI2([PM@Z'@^PPV@#F_6AT_O MK%OD=/BU<]63O_)S^$1N&HR19K'W!53W#+>+1\ZF;F;=QWGHP[XE,R#Z OZ1 MR4YS-)?5,XH=^M2&5?;?<_-4T$._WZ*LF,!^TP.*6])LF6T5RWAQ@H M<&Y1J-0:'&)D)9>V*4;Y W1 \00R!)@=UL>\K"3,7WD2I'Y .Y'2'O%&VD!L M9AQ@T;(O9"2 X'-D'V2(,$Y3W.D[-P@)\^GS/I5OM7)LDOBOY[D8=5T@&4<* M_/_\)NCWNFYWV!YVVGZWYSC.<'S=ZPZ'SO7UP!===_B_3G?XS2;O?_:==AY+ MN?%.!W_G@:^$^3L6-]8GD0*#@U!J(O/^*:RI"X=RS)U&?3JKDH. XX#-\A0> M @'B>K!X!LBS+I/+)S8'HN0)'N)"GV93D"^3JFTX+"2>5;?DZ.3#\ M!'0GV/E^RK] GO_P\=="_V8)+-GU6%&X:/V )(+_!;L_B>]1(TL)CZN!LP'3 ML\:NAS(]$&DS;9J;%.FW:KB! 8%[R'2SF7H"M@J, H$=4ET6\ED"0D1(ZL) MW_:ZK>O"),4?H>RXCY,O*#GDYMHHWM,@)6F"NR?%&VA? 4.38E&?A0%;.D!@ MFUXPN&X-U M:UJ/31\WA>?DL#XDS0)D%7D"6SK?.U75IC=O6MU>#5KN8.NDB MUO5@&6D,(\="E0,#)T*QX#Q1>I)5.PA$^ .L#/H!MYEE"0G?T$!QA!I-/H[Z M>WF(((*?$J_%,["SY:?YG*=G>2"()04?X.1&*C^0'R,1!F WL);_*IF%V*PX MSY*HLG K>;[9]2K6UP[!!9X>"[86$^MF;M@/2*MO8>H!TYM;*$GQB;3)(Q'J$;N MB+(T"-K2)!)@W SX$KZ.Q(2/=5+^!RI!R??C4 M]RVVONVWM0_T%Q/YB\%X_ZWW4H6K]W-4M'Z.A61_<"0.ERK: MT9T$[X,$=NMGI-PO%.?PV&8(0_+-_J9L0Y492C6D1SH;C\@!0RC)NA M$36V+MQ7UI^W_V7]!FZ=L#[A3^=AGEKM5J?_'5TY,7IE]? /VY*VKCN!YR=L M@V3 CQR: @U/44G+NI$!/GCU6 @*C82Y+]0?S--Q'I'E#^]I?XJPPO>E@A)Y@=?&XH8"S'K6-@SNM=IM\8'1KH\=(KP1* MW?!2DJC#6KP2CRK_3#KG\%8\G37N.4A>.#B5>*5VA(HHS M0-?!%W"(9K0JMT+5PLG-H^4 !$D1\,KQH*<6LBSXAR#@Z#)BFX1XD%9&AM\F M)$I@7;_?6C_=W/Q6R8[1U2UA&JO]I?"JVBZ:%0P4S$"(E,>^H.^/__CP^8<; MG/Y&^[/]F1]7N,V/81/0R:G,KV9>Z]FJK[%5$\_I@^$@TLXHX/!(4HE#S;%L M9+ADW;*)XW^ 8S ;B41^Y126H\8Z'$X%UOBVH]M04D55#2LI^7$6+; >K?]R M0>.#MF ZZZ,F@A3BM[J=QI$438.0:8?SK/P,;WI"$Q9.G9 7/;GWE./^A=)* MG,;^@'^^V)M)O_*+F\@D'Y2A)C-(Z39Y?+M(Y/,Q^K:]%.:%#YPREEK-]8,\ ME;8QB&3$T!2"4.J FJOC"X44J6"ICY/V*72,P!LR- MF&'J=8XYP_0.E>/[,+[?(IET/*&)3;A3SWYN"*!IXAFF:^MB1&.0S<(==_(9 MFI'_PNB-'KLLSS<!D!^N_?LY6*<.5GYI.*.=>/?S43BC/4K;?1*IU5M&X)UYM_6M=@O:U=4&Q MMR!Z59NL-==KG%L#Y6'O^H3;)QO^/77^O7#Z]K!]1,WS=U,PLGCCI!1,$-V) M]!$%LU%M50UQ&E(DU;,[O:LMY6L]*^Q5BBZ]L[A]NDE[8C*/JR7SK7N^@? M%"[I0E7%O*)4XL;@^ ,5GM+DK9KHU0;JHUH+W046\>,<0\%GW%'A.4ESW)*E M;U^WMVUI]HS4.;!):1.Q[[J;&^1'_)D;-GBX6CROQ^+./#-JB'> MH-SMQZ7DK%:C6'$R"/U68@.#:!SF@HHHP2L!KKK/IFAZ+%=4*N1TB@!:9:2D MC'<*0R%+??FM.!-">8J$C96YNV 4A2PXNQ.1'V/QL%8%6;X QH07IW$4"2R MX?LJ,%?'FXD M;"X!Y BOHTIY-B0WH8C*_@ P=2Z,LE)8+ **);Q7#EO"Z38:O(F,^F[)%7[] M<$X&(9*PV9ZLL!PIH"'M,6P"5N)AR3C!$;RI&TV8A5:*0O6*VP7L B*X\0=1 M'%T2L8-,S!"Q3K15N7) P8I(J*"]' M+@.)M-X+5%-(<\.IC>$!6;()7'KO)@E! ]?#ODQ]UO==YP3KLX[G4+Y?QNI) M5,\#F*B-2V )\_AMNS4L 7QN!L[K*&?H#TB_XA!CX?1%YZK5?V67@&(\V<4I MA6.43+B4[-M.O]5A>&"WU5V=S'IIP+66*V.6:E%6D&-K@7'=6>=")2J87CWN MC13+&W" JO[H:)LO9?<#&W_A]%O#5YON?;?E;+3U%]>MJU>\]Q>]5ON5);N* ML-HD5?],NU\KMPNAW<2M1BM)HTY=Z?,RX)%;"TB.D*#9LN+IVRLX?@7"F:K4 M])Y/A;U(3R:N+[3BB53U=\'N53$:/YI%*=^(AAU55LAAD*]@>EE 38SB\1@H MD9%I$%4Z:,TE4+LP'N6KLHJ96%B!R&PI]O:1%8^(T_:28,Z87VN);,LDXW5S M,0?;*ESLJ$\(6SKDI35K6S%U!J@K=Z&20**5+*,K"86#P M5T>":E90VM!>G M7!#$U$CC<7:/7H"^/BYE*^V4"JWT+BKPFL]_W&Z/@#Z\I_>A2,@VV]/;05=7 M.OG!#A;BFTZ2IC+KDM858; B^&N?H/XG[:XF%5:* 1Z9-.@8GIN2R7X"MFZ$ MJK4*VQ0GCX"WK?9[@T>.ZCD*P\+RU<@WX M/4FE2ZSI0I\ 36E;EI[B!+G62Q4F4O6((GK9/VO%,EDAVD**..D&XLC<66]9 MJI'94]9"X-\\&%DEM!\P)2Q4+8ZYWA\-A1;6QB&E5__;P$/]OLBCGM^A;FM\ M_M"AKLLU5PZU]>V@U=_]J+:L)?TL4U?E)):.LE+X6/ODQ_>14KA+W6_X-%=/ MX[(Q8NOGI&IH5$P4K641ZT,:O%N*Q9>OZ>D?=4T/_"(!>J&A\7$$!T3K=?;/ M"/?L/7>JH7#.)ZU-S9&>OBWERL_$1N_BV2S(CGE9C_6Y(KL2SU;924ZUFRH[ M+M):BVX;*7=. AL5M29U%X.3EJ?45R!EC8D&;DH'J^C"P*JUKT76L%0RGLO( M,)Q8F(NX1_?KLU;8C!,$'BM,U]K)%<_C3[D;VBR0T6!9FFH55:E*?E%WJC&V M7Z)6E2!RX&DJ0FU=E>YH,7\4B$F0LM/WK:/)5O(R'4WI2NFRU/X*?S:+$VPN M EM=?-Z0UL1;GH_?@)(3Z3%0)Y:?N'6PM,30<]61E5$*XW M/5H&V:@CI\NGC([0DGFB"#9";I&6M'Z E\T;S8N.L?>=4** G%2V%#PW\5-J M!Q>/L"6!&GY2,*/JSE(T>-&B%NUJ>_-E!J 4F/9F34(V,NSS456W%]V=7)#C M]VD>L,,Q#L*R=/KW*$#BWV;4]_B'@-%&H!#!;RHD[)^@ \#9*+_&X(#XRAD6 MZFH3B# 5(&55Y?S%[[>ON$W4!+8+- @Z9=C/:<)=R,?8Q(_;B9Q7&;@%JPP^E@OQ';^D2N),D\5"VRO*GP\Y#"/IC45VJ,FQ3@%JF66S)(!%;Q M.&.]BH?$#U)L29&0VPFZG@:QN .+;/U)KB9V#BQ_3/O^T]EQ1;$A==_=&&8V.\9?U$(1'\-(]D?R6> M?_FC8B)@,H48*,0]2#-L1"7;;T@14.UP$2#)*$+O8B--[-N#S;2PT3NUIHTL MC%_,M$932JZ"F4;QI>+U/":<+.JU MCE$83,MJR\+#F$=C]RY.<)IZJUZKU"&5_C6!3S3F)A$H^V)J,XJ=X"^W;(_C;I*_HQIF=?319:>^E(TS[>M<)/?1*9]!]]LD.6X/]=*_9 V&' MK9H(\4B'FO55$*:ES]-:^FR,SS]N)KH@1S7.80@_72EA M.-UU'T5SHL:1K/,<@N44"6-XZ8F\M&MK@9WH<71U==ATX (C7*]DVU/3V^K\ M>@-=V\/^SI=4F]96Q[*1Y\F^/;O;;IOF;(:#&\O!%YTKN]_I& %LV+>1[-NU MG=ZQF0_GTEJP8KM;'(1_2O= ;5>6^T(TL"_51;^_:W.,QRBP V,>@@+?;1(> MV&>GP]-B**?[I%Y$9\14V_#.2;'(16^])6>XX&RX8+WB.6$F.('YKR>X,8Z=G^X;0=5 M$Z)Y)N+_M-H2ZLSN=G!Z=K^]H]=\1)UX3WR7Z#;KSG)[CX-OTQ:[T4"B;W T M#&GWQ\_F7I+-:'F[IEOIF5U#TK>[77,1R9%O4L]VNCO>U&I;U]U=X15&>=P,Q)S\:N0R7MNEGOAOMHMAMQ/DB=1JWSBU?V.UM M&X,P_N!+2^GNME+:^(-/(OB@_W!1CJ'K?AC9>((;8D@%S(; +GBIGG4ASLW_ M,_D-LTUFFYYKFZZ-%WCL6W3PDW0.?N!'O++KS-R_CBDF//(=NCZZ'3IM)Z5S M]7! Q-!UQT#FE7'^G@4TBG[ QUVEMT6VVPITV7PO5WEZRY:/(0F[UT^_RF)GXS MNWW7[\;FW;ZW6_RQG/+Z5??L?J]S2,Y[<@/>/;2R>J:X@#D]IWYZ+AQ[,&@_ MI2?YBW'O8TQZ#KQX"BS7LP?75\59@":P_67SQR7,TKGQBW.Q:? M8^F*D2-R/;;QKB5O,'7?++=A;VHG^OH-=+HMYWC%_UYW:(?#?8@=VNV.EN?O M=WP6Q^&BW]K"_C;<:+AQG\2^:C4IEF).@SD->Y7-5ZV=[Q$\0VXD'^1UYL** ME#$,_UGRQ? /[BM#IT"Z[KZRZUH=>'*5! MFJ76+$ZS<&'%8RL1,^&F.?Y/E!7],+(8_GGGACE?N0._B_/$NG>3Q(VRU%YZ M2GX]CA.8!*PU'Z6!'[C)@A"*5V_Q??!Z^*#J5S2!E!;]GYNF M<=!NXH"(,L M@/'Q8J)X+A(@430!BJ1YB#^ACX$:090)^#!3)=DMJWF+OQB]LA[L1R89"CF MRPXT!LJFPKK][>:=-1/)1"165@[4:B IO%?6@YUCBK,%M)@G\5BD*?S.#:VQ M0&9)TQAOM((G[H-L2L1QM>'@H<]_W#:1+OXK:VT3 ITF2?5'\"W("URT)6;S M,%X E9JX?/'*6JJ\"=+E4P!"(HVC2(3PA9_3"4CA"Q?.C>?E"7QH^7F"4@1_ M/0X2&.7OW$U @"#E.NU.]UFDQ_?_,4I>?[]V((X[*34_K)HR&*(*QHN7!SX0 MF?\4%K",M1PI0UF[_-DOM HX<)944<1]4E#3@023)O "$7D+W" P=V![,KIF M#OY?:CU!,MP#C6:-\A3FDZ;E&&G+@@F-1!C SO-&PL;!_*(XNOSIYN8WV$-4 MO@&\K)B$"T.Y81KC0L9YB*\.HCM0$''"1P%&#V+B&?DOO G 38(4N46JV,J$ M6A8LW@]X5>'"EI,8!Q-Z(0BAN\"'ET;:&I')M&5JRCU+1.2GUOU41.K-\%O\ MID;)X;U\ZG2C!3!RX5^V-5K V??"G%X39&(FV?Q>@%D(U,D*HB$U@$/!ZLL" M^%-?7ODZ^ <09H9':[UH.&*N_?PH4TQ=6'P8S(*,&0O9UH7=7) ]#+P ;@SM M5SJ-\]"7)&3*PY8"UP.K X>$)5U_!;E$?Z]/@C6)3.UF^VV)NJL.JV^L\ON#?<'+1-.X.W M!XH-P!26:#%$2@!Q%^JH)&(<"@^,]JD;3>"E063C!GMN.H7OP'1@ZYOVV&;[ M/$Z^X+GQW#GL6 @FO_#3M[ON3G>PK$HZ';-?U?U:5CY^#&_3-X^DFMP.,HM M7K-. G\IQW^N[.7:W\.I!QO:RW)L3!'/X%32,V:#7_I QM*D)0,^42H5';Z) MU%Q*10M0BO?3P)M:=$4=[F 0Y0*5/(AQUP(M6[C/DR2^!\\@A3V&@19F6U]X M6V-X+ LH5 (:.Q%HF<-CMG1J>-=QH[-ID/BT=0OU:8UWM\;UI1$2,> _2BN/\P!F08_?Z2/F80R9OR,D&Y^'M?>!G M4QF^U9^2V]4N'W%'8"J#7;SVD0>="4]@2.] F]KM+F$RM/].DS(6,!&7HT2X M7R[=,4SVC1O>NXOTF]?55<(2=9+N1(VJ:U476C#NP#X.#3*5![#B9BX!8VG3N+DRSXE_P@ MX;@/;3 X\ DZ\"HJ/'.#*%QP # #WS[ ?*G*,'DBR5R*7^+?X"6@.U&\3/CZ MN\CQX4HF$P^IET;*5UQ5MUH41]>L-+T'X.3*2R$I)1M?B_"D:7N8_/,@Y->T$"MXAD\SN1Q36^Q4CPD5G8OPG$VO9S!5DU3F>EI6>_C,(SO5<)E=:(VBA82 M\\5$YODH#-(I3L%-*_1](%?X1(L>1PK\__PFZ/>Z;G?8'G;:?K?G.,YP?-WK M#H?.]?7 %UUW^+].W_GF( ?<>0SEP\=Y/+[\AQL29]U.!?#C#4);F/L;>;)O M*"+Y7WDD6/YWVS8ECHES_(!31\1!J.79=X9#/@WF*<>L\@@//99P$!_'R024 MY+]4WB?1E 5&OH#=Z5F;30/,.F5)[J&QXQ:)YZ:'K'?&C>)0&G)6\\+\XCVH7?@&$\A8;Z M$4@Q ^YIY 'ZB!H@2+V<<#ML9B]E3?(H0MF- SZ@[Y5.7OE>^ \9,S0*H]0'A9P"> DLJGOPHXD/IT%.LR_ MW\I$[F<\0?3#(MFO4 *K[U!V?PK&(BK-F?M%X)GD3;71)\EG<[DZ6/=?N3^1 M@08\S2Y8PU[&T*89,HB67):F]A8+EJ%V06M#BYWL79!B@N:VQ4B,UG!3QG04 MZ\%MF0:(OR"F1M<\052(8 A?9-V!81T#)5B.Z(M7H(8" B)]+S<% Q&].Q'6.(EG!F+CWA'##8]RH<$KJ#B_+//P=@LDM M3QD'$O-8Z@:"FQ5"-T_+X-228BHBI=LQ:1/#"9^D3_A)>/&$?98N<:Z?VV#B^\'KN6" MBUT8FJ7ORQ:.#)1CK-++2;$3V-%-?)LY"G/O=ZS8@9%:A M^_1>$J>I]>[S'T"!>(0J%?\)ZO)+%L_YWT$*;UNPN<*^SM1%F'$S[8;/)1,Q M4%8"6 L@+T6FBLVHL@G;ZY)';'1&! M?E/-_TTT4$"_" 8A9M54;Q<\[L MT(]U$8&;JS\TAKE07!Q/LQ0I.%(.,ON!4V;P"M]W>Z>(5SC*\Y.P$?$O42A= M1O$#BUJ@#F'N&+P?85HQY7!8',HJI5F )E9QTC"2$$GGG9UBGF@!^TQZ@"F) **5F-! &8Y3'&4)YZ'TO&!Y91$]FXN7UG?8[G<#8' M[8%M*4.*# L5ZI,13;7VU+J0!CD^#(])8_N5%"7 =S-,*F@YB<(J@QDGE.^M M&L1I)N;I&^O">64%F"H'1E 4HAGP!-QB"F^MB\[23RNJ [321(:-I&VL1H(G MNZ_*2=)W.IQPG@ EX4<]6 W,SI.9R]7?:,5(F[T7B7/1?U7N2Y6[W#4C8?U3 M"O]*QX'P&ZF;WF/-A!Y+ILVVCH J0)=@KCY%Q23/%S\OCU8YK(R9 M8=K&G5/0"(ZD3/<'L/R($O(^_2)E/TF$"\5# 3YA5XZ?VOZTRHE+AS;&WY5O M6,<-1>"24]A*=TDE&,813BH,90H:'E9'[/;V-W6\6A;\@>R0+>;H&L+LE1_H M:Y'1$8H#(H#&L[(0B>-AA7PB6L2AS_5'VERH_JB1S/9)N4E:S:!;XWMP@E.> M1%\*>,V;8"\KA#U*X-@])EA5L+'P(="(*D:[Y,UQ_16I@/D2+DZ#+YC?\>L' M)O)AZ2NM=*GXE10HF)M&=I%S8EKD:-V?S,YF]9Z YC8N[7-\AW%D0J6#K>^Q M;"^4>AJ@5'(C 4YDN%!:E_T5)'0^D])@!'[$&.T!:68S**/&:]=+[JQB!24, MI7;RM7,NW7*5Y3Z532P\%"#F7V3Q+!$ Y;HUCP/"#=#N%=*L.)22^5/)]NA0 MM*QW*[Y/Y15YRDE,[>!(S6+="_&ED03^7,.$,MR82H9F5:=:#6B(I['V@\H. ME1&F4I3:%=ZE$[),;9L8O11KR_.J2L%:O5FFYPH;R-8R8O!]RE^/@C"4:#Z= M+:94 ,K)>%7::U&7% GFQ=E7Q7NI77',5#-["62"GRM=*XO')/\L9'J0![70 MPDPQ)+6P%421BUGHUC@'B\S-L1W(YZ5MQ\$>WO.GH*[NH13 ME(])%U@>3X*XZ?:RHCC'X[CJKY+7E!D)#/C!M, 6Q1=7.$/YQ3;JA8+E4)G/ M&8=7.-+2M!J)[!Y%Q(K.(/MX3$JCG#D6,A'21BI;M!]+"P$77HQ3?#K'8\Q+ M<[.5$0A3#(R+AO5"N$EQX)O(,#\((!BJRJ34Y,I!DUV0\DC3W=2M10IGJKD- M,?XA\4BZ!BDLMC*:L?JN9<,@M2Y(PXCH%6;;I!;1X0*2/[8YG4>3U7KO@JN( M$$Y&:Q6YNB!"<%ACH75U,L>UQN5BQXD[$UA\3Z 9YA$9K4^]$"->:'J7])#8 M?OR%UE"J96GT0S<(X:C,-"2!5!Q-1G-*_!Q!3\CR]XM^#_@&*A=Q U^F*TAT MP,35*Q?6A8OAN2#C(5^5:5E58H(LCZK.]>] UKD3]#.P/?$74>JBXE7EN!SK MH+9PX:(2B5*B38Z!2,( 7R7+6);=(]1EK"@U:D\#$,Z)-UV4<"59I'*,T717\Z. M9IMP?Y-LF@@!DO-.A"EG*>A9VCD$_HP$9\,UIBD'VKFI!E;Q'.B@_(Q+M1SK MTOJX0C$]FFS]G<=D1"=DQ%SDD2M+!UX16W&,RRM/BL9=LFY#)GN8C[;73++ MZ>"TZ@"M/C#&1N',='I1+ 4XW*-F?52I4ORE4Y@/#M&"2G0:2X\NT./WVO.& M/AF%__*YA!2.%L 46182SCB*E4Q1>;Q&6BMUWG"M'M4[[U')%CFT^ ^4B2!! MA.S3F&)]1$;1-DHKPH<@D'VAN\[4'%)]#K:A_+#HRV;CAPE80NB9)^!!HBV+ M_]+[WVDH!&QI!M)[N5FB^ASW3WHD80QBB[POK%[DA!!(0 V6Z;E)0LA/#5(J MS3?2/G,PA+]23%G7$7Y>Y#O2*;R.WS'#9"[/I\#!:C1MO$=4L PW%E,0/NJ^ MN2CT=HYMOB@4&X)X#3!$014D2\S#^I#U$H6TEI1<81(5M6-HY,@6H9HQ4'W2 MI,P?2)GW3EINL'^6>)7Z(24X$QF.4&C,#9J9:^*JLIY3'X?[ ")D9( M$!HU(!\M90V1"K,M9>(H$[T<2Z7D0:[-@GS62,6UOORH+D:V*B4"903AS_\L M^@Q+H#UV!4P"6#N%.8,TS7F[/.RJR9X%A2H_?/Q5DX$@$!2FSL-R(<'M?/ - M,ED)O[<^_/;1EAE+U:H)WZ<ZR%[@"* M\@*"B,&PJH2Q\O<(LU1T>.M<3U5Z7YV+U"H2]!<1;%:.?!>'=Y3:XM8FA3\( M#V>8S( =TC,JJG($?T/:.A%XLX"-B339_U:36:10J#M*2DKW7:DB]8H]CR*E MVFNPBK^H5]RQYNYH N\?2FM6.=4AA8,Y?M9$IO]Y>1&VM!%9,^&1EEAM]%GG M15*?6C@(^61-?QVVN^X"<2]-<)A-SR8:\OZ,&:^K[3)EOV7W4B; M.J I.K7JR/J*> MTFN')HP2!BQ*2HPKV9=JUJY"=%)Y+>N'LF4_1_H).J"2N-2T._BJ\ 0B0CM_ MU3^BX#<7:+Y:W4QD89CCRH&NVV.)^9+UFL1]8(UHLY;=A4:ZF=U$8?>3\N%E MT]WJ"6^BK*NLB)L*UPDO#5RT'+,H@Q!KZOKQY%*F"@\OL^#J?U4Y6G'C 0B- MD<2/ ,,7TRQ"L$5F4CN$\QQ,?"RV9_>!T&EU Y8PP:J+HP.Y< M>>E"T<>%+R=A_RX8EYT)[3**IN6?T=N91$5DS"TAX]KV2H@Z&9D8N'>]:366 M+%,$(?O#"$!)*DMKYO8@"JG;;V/'+<7![/9TWE:./J=/]&(5>*HH5BFRW07Y M90FV*,**&C,7?:A4,RPVIS%H)CL,5FP;NTC-RW-!M@1OCE;]/J\("A69Q,7;*?7KN^*BF*1^P6"MD :ZDY8[SA*VJZD&D:EFM'R9/9(MN&:2-#RM!^=JC#6QY.; M@Y?BH!23BF:=M;7>L*H:4X6^_*DF 2!%8FFM?NOT['Z[H9&9V[)6Z %3@L(' M*KE'S?W=*$VXIZ7F\$5.91C7A+ MMM>;X7$HNHF[\DY!+RN=U^R21)GPIA%,9L*6/.?B(W?&/B#7A95M7PO;2<]( MT;5283!F^5 FQF&_'(?.'_9L'*A_X6MZZ@\X9G,.W^!%4JS#\28*7,(E+J?: MWW8&LAO[%C9Q*SY/EQ:#$(K=MP; SQVZ-*GS[[N#$TR='XW' M_8XO)"+)D\;C[)YK_,H6#*0!FB@+;M>NQM8P9T47K"!:$WJ4""K]ODM/(QK? M$K-\*Z1RE-IX0_KYF M$O5O5Z7*Q:**." 5N)5%#+#, *M.DH6J7D.9-B%)B5'($.QD7[J5&7]8E(3" M R-V_-5PQ>M59EE!9I552J9Q'GE2M&9D$*HUI2X%-T4T13>N4(L5@AM)"I$W\ \ MTQ>@1 U6RI-K0S:9]+TKAL-+F1I-+#[YH%URPC::^U5>N";;0C7QJ%171?7S MLWF>:7&V)="0#*LIJ#U=1A=3,Q0&W[*<5\ F'+9EO5O[78'8)SD/!$6WV2,5 MA6TD)"/+H(NN)JO98[T7Z^($E:RZA<)3,&N,^\"8(%I\%E_6$B)C'2^L(+:E M'Q]H_4!(7J;:9; @F[DDF@9P[_'CLH1:JYM4R44M$,U/D I,"B0!E6A&7!=4 M6 HUJZC,O)PI7;&-CU5CUA+;5 9Y*,<&3Q:Z'G=&0TP4E4' WIB3(%"GG)Z> M%>7HMU0Z9?&/BK*";Y67'7:8,$MG3(VJBGGE];NL2BJ[*W]8O_:%;B7S38M8AJ;R(6DMXXSU^UAQ M-TN%6C:EQZ!N"77$9,8]22G5L^]K5O;U*:H< BXZKH_MKK)/F0HI8MHJ4KY) MD+AN;J0 HE4"4:[C+@N(N2(P(B5$;24Z5:%[O7GO\Q[C18RT*ZL.S NX1W> M0IM\>2@JJV#G!E5<&H.')"KH$W6T:"+RL=HC2?TDX%12?J;,L"EP+HO80LS@ M,N:@]B(5>\O$)! %W$I.A+U#FB/> 822JMGMPC'-==6CY!BMZC/)1#T)!M\6 M23 TZ!AZ:&7W\27V82O- VX\1VI57!L$DQXV#),VH MRQM9Y7'!584AI!Z /[Z(B(% %:7 G_.E+X4)@3RI\D24X6)69@*15EK1.D6Z M*MTH5623[BJOTBD[/U (DVJJ9K!3F30-*FM1DB(%CG )=(.#(3RERO^J6:_2 MH\J!AIT0TJ5%*T(VA(/=\>@N9-6LE^HK-.*JZE5S2->G996^A(H$ MM/9^^SOK0A-@I#E?%>2I"%GP,F%*B(:@FC&0&AEWXEZ2O@J^FY:W[VGQFTK+ M@(H5P?PD4DZJ($23*9*16^L&V$9P'U>5*QN3A+,'H MTHBT:S&D:EA"R@8<'TI@K*QR,E9MVG+6U7%+S"LFT.6=:,5]&#+\5?0T7[Y# M1 ?9KBQ*:D7R/Y3- A,C8[:U3,JB6ZXR-BB6!99"C"?#Q9^F4S#\IG'HD 3"AF[ MY')[@-M\1(4R[_DU:2E?J1Q3,LXDC$>$,"[2AV!7T2'RY1P4 M/]4V14!NO AH@:^T[=.67X!<$#>.-%#0.GV!;E:LT"[C-P\,Y M!;*HF72AE MDO,K@]:7 U$W_844@]BS.I.[0 ""254EX86[1DDMS+D0PL0;(_F>^I]15?' M?%_1)[9>]8LYDCB**U[FWMT7P'BXJN:?%O'6G6+6M M7S*M]25G-Y:CWO7/48,GK!>UIN =W@ML8B]DR0$%E^=\ 3.5B19GEFYKUNYE MQ+J0I+BMQYL&XDX%AW&T1.O&$:MZ5H*V:M=FJQ]/*'[P^)JM69Z6K<\8R>V5 M(7N9+\*@&@9X*>Z/D(*BME[VBRO(MN3!8T?"15DTNWJ+=A&:PBL_P+$/&+-; M/]>B:H-S&D$BT;W'S:[U)_.7@F:%O_UC)2I:JLM3.J6_%\U$TWR.*);B/ML" MJU3T7=2OWBM93 _VXC?O?OQ(S[][_Y&T9)EB*5.\FL3;3!18%YKR!JY%Y9U: M3M>]=/H7@N]F7O)R5>6& MRZ/094$;2U::U$@B:A"I-7 6*,UD8)(#0)3]4OTY G6K;B//I%:>_T&B#-79 MLSYBU*T, Q1%;<>]SK4Y:-C^HML[:*^RX4UQSV6D>I"CNJ&Z\V+QI:W[T#$9 M5X[)6#\F^MEX9?F< Z-C'I,VHIC1&-@87J9:71%[XYP5.+%HDH!Z%2-/:[M%&FS[0W[U]7J_>AM78?!-X[WQM_*3+)X?:(OJI1H',S_L[L8- M&^C&.2WK9S&!8TSFDD!KH9'VTI]"0V 1NA8S;V["W:31*0EIF?-RF03G(TBQ MS*QYH1O,TJ)_7'&-,A=(8]V^37E\<$IRU3A$E1U.)@F,GU'/0"5(^7[/5!D0 M=$]6GE31NT4]'4PLE3<,E+*UN$?"!CD-W@+\L;"+>^=UN*^M]?L@*2]AU+)S M=D% M2RA/RL[J?V*:,HG*K_$:6/'5I0M,,9OX:P#[(R*[0"U<_'[[ROKYYW? 5 B2 MR:S/?]PBBDE,"&P2C=$** "4O]]:O[D$6?LU;CEMNSWHVMVK:X3.][IZ56Z- C2J*;I MXN.#,M5QK')$Q"*"6R?YZ?$,"Q@&* M'].^J[KIG@9/FY_W(C)BP_!^0=Y5EYY0DBCUUN^4?X+4IH0K#7GA@ MG2:3G%D/_"N200HZCO@1:N,]9Q9D*0&.61*@L3O1O"YXW],,7'F56YU('&^2PU,)>H,3A9A!Q"EC'5DVK+P,.;1V+V+ M94>JLK^K55]A[P>^C)QCI3W*OCA-M?J+YVGZ^,1P^56GB7;638OR-]9[QL0V M43F"-RKF&:=K4B\)1JP*Y?J0M:0)K>)'[[&TSVE?_K<41$HG2E<5+30)CJ% M#^N KE,R)GG?JEU25+JH1?T!G E\48*4E6ACZNQ;8K+4[2WU4U4S10UIW7!? M# Y9H,!2\__G4;!]OX%LWVF!E026<9"RJKUU0T8__PC6+,AA+0Z(0OAW5H[2 M%SGR0U*_[ V7>]Q+6P>9B>IZ_V_*O]<-Y-\NW0?FDKOU.\:9;T6$E6+GO)'7 M3@,WLM>R?L'2WEMW+. @:AB+9FY@!M;T'-9/AMWN6]EKX%;VP>>A(J0/)8RC MD9OX^N8).U<+VH6I>)>P/KQ\\$W*6,*W1[Z=@Y;UX]=I, H>P/*^6 )A,P(> M3U9A>)IH/2Z0+K81(R^7>(FG.T_%&_6/M_**^3=!1)2AAY8V"Q=R)Q*ZATY. MD6;+7Y=K;+5YG5D"_^^K-\NO6_35Z\Q?_>ZZ-6RO_[;=[/3D0W/M M=EK=Z]ZS#SML#?I7SSZJX[2NKJX;,MF]C3K8C']>$]LRZ\+IP./VG]]TORG/ M/]TL^:9M.72ZU'A[_JG37_EM9_X5?[TJ/Y=YU=>FX\I/8J5O*%$+_X*IN36>KZ"A<;;0\_/FB9B#.Y_ELW3-Z]?W]_?MV": MK4E\]_HF\::(ZW\M_(F;O(;C[KYVKKO][M7U:YBNTW&ZX)IUG':W=]5W7@O7 MZ76[@X[XVKET_A=;$GI_=UK3#,[KS201HFCT^!OB!^*Q]8M()@@:8)A.B3Z6 MZ6N'FE')5GT@;CY\_-66SV#%/*(NM+\ZG.S^$$58T8"])-QEM[C!(NKQ8 6= MSNO+?YZ"0-YPM<""E_!-[_J,UKR9_#V5U;8'KSO#UYWG67)%&3VO;WDP==Q] M;G5LE.Z1*UW^9Z>#<^]V7@>L[S"< J_ZBO KZFC >O>=^I,!4F78198S*6VY ME;)LE@A!;,D61Z09B]I&\S5K9=L)M&:LJ=V%$_RZT]E54I^,KMJ9 D97-5)7 M#3K7G6MT$#N]_O7@M5Q1MW-)!;?77[^PEOK'@IL;%_K(>@=JZI25TF9^6K/6 M=,HZ:1O!U8PU.9W7Z%SM[#VI!(0HO14 0Q1*!#5^8*1($Y["0DR$MD]%BI_^/@KMYV+L6X>6YZ'TD7[ MK+IN_)L[F[^%/[&IY#NM#^Z]?+4[@<=T57B 4](R:K@Q:SIE-7QZ#F.[0SFW MA?OJ-;7"Q'_M%K=\X3JGERF,.=@I_?<]ECT=4O288-4) MB)[.!J*G;$9L1(\1/0=?5/?9JU2,Z#F Z.D\W>IQKJW?6[>M=RUL)T0/.MU^ MVPB>PY_1?S]5R6.,GA.0/$\W>HSD,9+G)5?EM(W-TWS)X[0=>2>/&_EXF;J; MR0I:=5-/Y%N?Z'/XX]S;"P_N%&7[C,7[C>5+5\_T><)/&]2%+JWC^.$[Z\+1%!I++* M-_D$T\#RQHD3QC]A)_#3R^6=;.9U2Z.M&8MJ7[]VVJ;<$?;60*":JQH+O=:] M3.]&L]@O(@"LV=X'"6@44F6_:%]NI\INP&J7]X[&&%" (2_?!1FL(DKI)VM0 M3#MKP Y?26+<@8.+AY-T!_[=.@*)=X!U]<_ZQWJQ[^^&G7V\^__[I MQUNKNJ1F7-3QFY8Y0XLV$7_G04)V=''?^Z,7VO.#>#,4 ?SQ-D,_#Q>6Y^8I MW6587 F/KQD)*X6%\[V)0887D$_=<,R7QPN^JE'^@&SI/(*':#PWSZ9Q JOS M&WD!:\$@+WL%Q-!I#0:#76Z Z U:P^'PV9O_]UMMI__LH_9ZK<'U9C=+/-8L MV/6^3)(8&/%2LL:8_J^^H:$^QF#S,9XMEK OZ>9T\+Z 7W_]^,>''ZQW'S_] MMGKF'I#G&IF7E+S3YVM0GIGTAQQC'R;Y"VSYBI2B+?_!S<0;%;:X5F&+#4,6 MC6/[>AK\8_'F<$M6 Q^!$4K$>)V^MOZ_N^"+"P-FF7:+QLI)/YX3N>48:WO8 M(F5/91]/? ]/99O6H&N-?C7ZU>C74SSPJ%\_N]'"M6X0>B;N+O_IIO,@.D$9 M?19Z]DSV\E2V:PVF_.SU[=I@_)H#5K5;_6JWNMF1_^=?3S$$/A''JN5>5^H>3 M"B*NY=G4G5Q5[H;MZGGE7U_?O?ORMVKUU^M!%[4\*Y@1UT=-1K!/;/1(_2GR MIP3=>^P'?<"H[V!_[+%9M?I5DC6]^3.CDZF/&B>-T[A9?)5=CD_KC?.SQEGU MXQEN5#^>C$;5<_O\O&I=8#)NG([./E[@]Y/+SZ?C.OEH-:K6N YM\1B:66-< M/?N$3\CG>L,^&Y](ID_\DEM3,L,(AN;RRR=^59GZ_ORR5GM\?/SP>/K!8Y-: MX^2D7OOUMFO*II6HK4/='RNMGT;,B=N?UL3E$>8D;F[Y#RNMJ>MZ#]3^8'FS MFACLR=GI2=Q6<*);>%.7^]BU%KQMGU7]YSGA]W#$[J.NSYSQSQD;[X",8_>?6L4V> CYYQ(SBWF.PIW4YLR;$^93PI,KH&0P961\58%UL!K[ MZM\=//H @L0M4OQ7)Z"X7 ,2XG27 XEIA?%=53CHWR&A:HYXW'-&BHX;2#@L MDQ+F__?A6]@I.GP@L0+G+S%ZFXR+CAY(J$MW&+R@'L)U1.VK2M.#X+V"Q&]W M@TYF)"5[#-O&S&)V2SF^GLA_=51=AOE5)*F^U-;;KG$).+$-]ZO\O&[6$7'4 M9 OAFD'DIEM5Y4:RZ,=8=]LT:O1:>L_46_#!-+J=EC;46]=:5^LU=?.;K@_- MO.I6,U)BT0 3- DB<&(>:(D4Q1Q12';-[ 2.NYC!L.;$I^"P'M#;I6K$L;3 M76!$/ZWT\G/9836'\/^MWAN:1MOHZP-MV(&K+X$T@Z,2SH_YX%RR1T8;+3LH M(Y!)53>_:;T;W>STS*'1_/[W-E&7#)6@GNTR3P5_)#LH$8PM MW6P..GWAGHSV]1U,(MW,B]AF6B4XGT682;GE>#Q@1'Q9\A$XQ)Q*A()Y=WNK M#7XSVF;GIM=I=YI:;Z@UF\9=;]CIW?3!8)L=/2\L.9DI<3I?QREB+#!*L$9+ MWBAF7B+H;@RC==_I=G."LVBN5/_%NOICTA(IMZMK9FZ[CQJK%%L_65=L2%@B MM=YK@P',W+R*7317JK:^KMJ8M$3*[1J]FZ$^N&WIU\.\EILD42JYD;)?(*\* M>B08E$C53>/VMC.4 9S6$W&C6(3@6[>C77>ZG6'^-3,/)R4PI^O )+@B8(N6 M?%&"<8D DYG3M2:#_-L^1.0R+\X;UVPF5L+R,17'"$95R0DE694(B':G)PI. MG1Z,7^_I>1U5BDRI_$_KRH]8H)#'>P1<2J3W<-1#[=><"E^V5VKZ;%W3(2T" MXA(IV-1OA+\=Z'UC('QM7M^R3J94=RJ+C5B@!8\2:1U\J<@%6ZU.]VZHMV!. M=PW3# VPKP_,;]I SXE$+E9*=%*YJV0K%^&(L7 \Z"?!^^=XI@![)/F7"#GS M[EJ42L%P]>]Z_I0@1:9$))7.+EF@D$>IM)ZG1-/W'&I1PO=:]UDPW8+8Q<6G MCY]/4LE<_OH/^BGNIDPWK_(!,,0C9\^81BR5B*8RQR*(AIV4"<^XX%8(L34B M)2:II#%F4$:-AY6X0OI>(5%J.Y4+AN1EU/7F=+J8=]K&0HE%*C7,RLM+B6' M,),]B:0RKO3MZD+&%4N)O#$2^'#99W2FM[27%KE5K6Y$!"2%*:2EQ86H) MSHWGV8_4<8J9@)J/$MOLHMDJ^M4 M:2FI6N+"4D(CD$*@I12(NO)I,@M!4%*2Q&D.L*]8F!);SXY./8-8B6:JS+A M\\VA@[<-YO/PP3>8/3.IA"Y5;ERZ[&072/2!1"O+YBWV T;]YSVMT"KV2JA3=4C%ZIQ>CN,NWW O ,SO]0,C#QV\ M87]8[..#*L6F\CJ5"J5&JI@;]P; S?R7, MJ6I>YD8@<:H?.D1ACRCN$LD^Q0-(RQFP;L9FUYOD^9@I4]A+7MR/O&IBH MV"B!2>_32^UO+GTLLJ;D 7D@;D"P:_?#YZ(^PT?]CX#.1=UX]'Q#O G#\ZEX M4*'&""ZZU6Y?W:FP/TUOH]N ?=2]O%<9"R"_+$1XCT;/*"D%DF*4TE;R[&,7 M>Z\LT&"+.@$$!SWB=SW..RY8 .D39DXQ*^@&]MVKTG)29:-B6^RK!0- >1(+V4B@$4B$IUILE96!JBOU\LE*M/UE.8!-[S+Q9TYO-@W#8RYO4 MAS.L%PBAM+-4M:NHG2V%0[%T2(B'$O*MW#XOM]&MGV$ONI%Q,[42YG2U:_T@ M_%\=C2^UU7<:A-]7WGL@WGH0O4M&8F7Y#[_#@FP18O,VF'0?/XMKO.VQ%IE[ MG/K@W1\@!P6[CI).>7 >CR MQ99_51EC1SS(7;S+X:JR"RN7.H[8.GQ5\5D@ M'@DOWNMS"2$"]>RA?&J['81;1.-K(^R(-YS !3*BXH48 4A#_4"TN6%>,+^J MA VI3V85%#[Z/?QEYKE$W)7OP!7!?/E^B'6MM,C([[@P2OG8]CZC,S+ OECE MQ)Y5/"&92LA!J1YS^!J7O(-;OMM(,!'=J >HP3?P9$U&;.IK$T;DY?!FI3MI M$8O,1H2)%ZC)0$]A3FX)%;!]D M9O-C&(L9S&8@DC$VZ<2E8Q&A^9HE7[\"",1/C !?0@0OGC7&PFSV/O;P%U'P MLWT,UMI M]NUAPE]L8M$9=M3C@7@48[<)SG[X3'=>WP_L(]$:\9)+;V0!BL6XNS39DF MN0?.AU30/$H=SKWA""O^R6")BL8=AV_[E]%F$ MOL%(SN[=G'KHFP14 _..;_?LF]L>#L'2B2X@V$Y,M4Q,%.!QI@JZ)=\4E15[FGMOS527=$4SB/J,/V"=QSK)]1!F- MCV%"K^[$YAN70E4^4(S'*^<%R7F5(X?+:O[*Z5LR7NT[Q)Z(ETQO"?52;7>/ MY0[I,IJ8*:92LL4QS)\V=85:PIM9^M-Z'/>#D4.MG'G'QK;'L#IM*KPV \:V+4=;:8[3?'N>:V$^-5@? M,S_ZLJ&T$=^*%@]^H#8)E1]=E/6.;!>UMPZ.M>8M[P=<8_F CIF(EL.2@##I MB6QY_;QL$FUIT!XQ2Y:#N/X$:P6L5K:H!J8/"/"P@-1Q^W*XDE^V*WE%B5Z[ MJB6+XIL/;XOC;Q 9BHH4"1^S$^\OR5Z-=F1WI/#@E]QY$Z2K^ M"CYD^XWAUQ/H6!>>./I?;BY5%=JV4!PF4\CKMP$OR&>M'WWF^>%-7O@T87BF M"!]59,?@K^*4QO"GA.7-?U8;'V?LN'W;GF'YGMRU5S]_R>Z_#6R. =3(?R^" M 1'9*K*#;21'&C"L;YB7QR6TQ>$-O6]JT5BSP"W"X97ONT0UI+8\->!*F<0: M']_ECI84,3E59:A<+ XTVIAHER)<(KJ)*F8[E=ZVLSF.@AMY!+D]1PBW=@=[ MJZ]2T_VI=W[E]GP.2^ ,?WWW/U!+ P04 " #OA A7,##&+I05 !&Q M% &-T=BTR,#(S,#8S,%]C86PN>&UL[5U;4UM)DGZ?7\%Z7S?;=;]T3/<$ M-GC'$6[C,.[IV2=%7;*,MH7$'AU\F5^_64*X 7,14AT0O1MV !('G:\JO\I; M9>7YZ]^^'$]V/F$W'\^F/SWC/[!G.SA-LSR>?OSIV:\?7H%[]K>?__*7O_X; MP#]?O'^SLS=+I\=AAZS#N?Q_W13G^$.[_-NM_'G\+.NTGHRZP[!OAY M\6+E3\^. M^O[DQ^?//W_^_,.7V$U^F'4?GPO&Y//SJY\M+__RW?6?Y>)J[KU_OOCMMTOG MX^LNI(_ES__YRYO#=(3' <;3>1^FJ=Y@/OYQOGCSS2R%?C'K=^+:N?&*^@K. M+X/Z%G !DO_P99Z?_?R7G9VSZ>AF$WR/9:=^__7]ZTNW'$^GLT_C_$.:'3^O MOW_^\N#MWO[;P_T]^N'PX,WKO=T/^WLO=M_LOGVY?_CW_?T/AS2,Q%23J=+*;G#;U>?G1% MUQ8Z?NEQFO%LJLYO/IFE2Q=-JJ!FW?E?3D+$R>+=T>D?G.9U.W*?Z7IUU'*WM4&-=84(%0LH#B+$ ,3D.PV1KGK3+%#C*, M)8#+H[E A=TN[GQ\>+SX1Q MC\?G?U^ZV?'&DNUGK2;W3'P$N8U\W\ZF:8DB91FI37G.+&@C[G6E9)1LD4$+3[C^9=AR=AG/>_G.!TCKO3?$!^1G=YC$:XPG1V($71H!0&\"P6&G+PRGLK MDF2-Q[@"K.U38>MPXBK'6\NC&>U?AOD1P:G?]O_GE+S+"4&9[_8O0]=])4_V M'V%RBJ-@8U+6 ,X&SR MD!./TCCC!3;WT&_!LPH=U).A0W,)-./$FW&(X\FX'^.<5-)A/TN_'\TF-+WS MJIKZKZ.88RZ)''*?*RIT$:*U&DJ0S'.=-3>M0YZ[,#4<\TC:I)4SY(&63(ZM M-!&#"U. M4P6$%%QJFR20-R9 .H8,DNNE%)/$6FT@8(K>.%3BJM^S,37NTG>/ZQH-RH@-!3"$41PEP9U+ M)4/19)"5)(?<*_+43+*.>_+"1D!#?H69@'6E?8M-FZ=N1Z"O1>2;I'4)XO)@ O)UJ2;)N\RB ME+%U-NA:(%MJWEI)?LT9']*&48092 ,CQ&(]*)^1<#@/D3-3?,A!-'=OVOOL MU5F831>?>Y8>R2*7R#GYCC[440E-JTHG\%;:K#UGQ> 3MM%#-NDQ#:4^W6^ MV=K3W2YAD?.XCCU,WH5Q?CU]&4[&?9B,/*/55)!"8ZW)*1":UFHL$K1,1EMD MT<7FVW#70]DF;=:8 BTFOQD3WF,?QE/,^Z&;4I0PWTWI]+A.->8]+.,T[D:JXX]J>FMM]B/.#<\BNS 9U-J MWWO[=M,:B7NMR6TFVM?3/DP_CN,$EX/"?O]+FIS6$N%OR)@V*A96($F]J,[U M-#QKB8-<.!V9X+SU#M,JN%:AA'Z*E&@NE&9T.2#-%.HFQQL,(D':B:$=,_ZH%KLP M2!.<+(6B,X[<@F(IDQ?CR(N)5B:;O!;!M6;$=4!688)]DDS8>-J'2-I_JQ?D M7/- <7E!3DYL"0*B0$M?LJ6!"5)5K?V%NS9JUJ\Y>A>^UG*7;_5/+C&/4D'A MJ28>D%99U*HF"J),03AGAZHVNHQDFZ+=#3EP4['1!E/?C-[[QR>3V5?$][A( M$%TS4FZ+XLPY"L8I6B-7G(&SF8.T+BH,D6G6N@3U3E#;%#4W)D=;@;0L4>Q. MKX5CO+4B&@;&"TZ#5>2Q,9T!'IN!! QZY$AI2!&6T [E40L(2?5.JMR.Z)M"K0;,Z.A* 8N=9!)96]% M!F,<0:=H+;4HUJ3'RNN@C5ETC: O'ZT-D>9I3,0-$N@M&TV_A:X+T_XZAK(0N$Y) ).\[N#S!($%"=8: M:4V.SIDK6N/:S::;[["E_M&&4FXXJ^T,X'(+; ]C?W%X@BD1:\%9Q@#*E@B> MXCX0612T1ARI?Y0H_7>8/:O,.&OSZ].U!MZW;);Q>$'^OK+_ML/ MAP>O#M[MO]_]\)I^>QG.^FTK;OCTH?I7K#*81HTLWF+_>DIH\,UL/M_]%,:3 MFE3Y,+M0*;>LK7D1YN,T\EDC\8J"I!3)#;#"@3>$#?5 M/9=N-THY40C(/#D[1M(ZLA&7 &R3VSDD5Z[JH/6ET' ; M]/S^KV@JS@[RG)*+O/259]/Y"RRS#L^N^Q"^X'S_2]\%DLIX&KJOKVDR%RJ9 M_I+FF6[S\?6TQP[G_:B>@%91%!"FGK9DF@94D@:#.11ZSP=L'$% MD>=$<;;)!G0TJ;9-D?6H5 ')14QHO8ZE]0Q= V.;EM^V\/'&V'%-Z36)"U[1 M$*=I.?9EOXJZ1S[RRE.(4@04*VJ_ 17 TVO 6L))GA"7<942M)L^_YZ1'_R? M8D@SP;1/O%[@JDI:%DP))-T55+04X111RZ<,)^O"@AXNVWJ3IEFGE/P33D_Q M7/!=2/UOX_[HY>F\ISMTWVI%ZKXP_<\D_5'(9)2])Q%(2R(0M7 XXS;\L M0>3 3>.1KP%SFW3PIOSYOMI\6*DU6SA[>-)A&I_-^S3O'L^Z?OROQ00T8KBS&^>4>F6^!LE49NS9=68FAW, \79H*P_!*ZW[$. M=:GD1R(8&Y)D8)FE<=JL:_6*@YBRD"5)EV)I3(N;T=PS=_>T6-%(" V/-9+4J5SR&90/%?LKH>H.>U"4*$X(*!6'26W' 7FA?)W KHGLF\ MIT6-=J)H5SF.4QKCI*JO?#R>CN=]'?&G<^=PE',V65HD/2:0[)LB4)8)HBS+ ML4CO0FY>4'X[I'L6%3\MAK041\.^-O/^H"R]HU$.,0G#-)08:^999@A2"O#, M*,=U,<37QHRX!.">-<-/2_[K3W7SLR2OCT_"N*L*:C$J)EAM,Z$@L%K2I[& M3V?'7()(40G!56M%<"V2>U8*/RWY-YC\9D2XG/4-4>A8 @.A9:)1Z0(1/9(# M@SQZ);G4KTX M!1IQF-V,[Z!L5?#?FDF;3?PP2OK6;<"]\>2TQSRJP:9W1M4] #)/.I)EDDJ" M]BPE5H)B5RMS'G#3> FRK>FB]</[R.%1:U9>[A[^_=6;@]\&*5GYX\,?HF+EAJ$T*EBI[<6OM!C_HU'" ML@7YY39YX\XUJO2(XQ1%X86"]Z[>%&@!^F3_ZBN:76 M#HS%NA6'-"LF15!%A!@D)I5;9^2:]\KK8BN M0WCV_?5T^4R5/2S8=7C]LU5&TCD> P4+3GH'RBF263#DMQ3RAM G MG4UK_W$]I/=4T8,'7$.0[IIH;&B9M@S9KV"]X:C/B'N*%K,RH'E0H+@3$"3G MI#6*-,$2TN:==%<&MTUZ_=%(UD)PS7CU*HR[A>.QF__[=+YH=W]0EL=(YJ,L M5=:I'CQ(NE;^1@6110[%(LU'';QN?5#C5D#;='+G@?C33D"#U!#1SQ.\KHH% M.0M"8H8B3'T.C61 WHX&QH/E/BLN16MO8!5;&D(BF8BLFU[E9U)ZAMZF'VZ!1:1U##\N=*IY'S,. / M_^WB\QD*#SKK JX>IEDWU#B7E KG G7;&U+.BB(1PGWU>2W7'L2Z[WU7(8[_LD,J@,Y&U+O^]?S'% U93 M/ 0;UI? T%7!(26OD)/O)"LAN:G%(<@V)"=[1"#)R@D8;T NP3HE8O)!/@ER,#JZ>3::)ZQ MVEDUAI*206]:IUWO1O4$]@^;\ZFMJ :AT*+V\^!D40J__P6[-*:I&#F=4XIN M,6!B=J%1.Z,CB,@<([O!$>22LJ1&.,,K[UQN%-6+;J1/$#T:6)7-J=']VD^.X==N-9_CZ3 MLNS%L?\E'87I1WQ/]GF_%$S]2#"G)2.7FM6Z2^6-);-,0;)5B11I5 Z;GU1[ MV!$^8#F@==JG[!,X[RB64$6 XYI#]DKG$I15S1\IMVXYX!.N2!Z6X]=D$X80 M_]"AY.OI)YJ_R_B"+]X*9L&RVK9*.(3(E097 AI$953S9C>KH]LF/_?ITW-3 M\3]&IL.C]Y)Y!0DI&%0V<(B:*<#DDXZ);'H:H%_I6IF.Q_6BGSX]-Q7_8VC/ MG).)AO#9&+'6JM(T,$YPM0G2D.MI'RH1=Z?VO-]VZ,5HZ3R5\VIV_DSF^75S MH9PA5C )G@=9=U8BV3PF((0HO"E64T"UPH;H_>^\34[,0-RYN"4ZL&C:94:6 MV#[,=A.IF@YO?.COR&O%<]VE]=E7;:(<1.<]<)J5DEV1TK3NPKTZNFT[@S\D MOP:6W7#<>G$Z'T]K2\G:B_6@+ S>V6_RR)84A'$)BE,T$=DP<%D*0,FR*4IZ MQ-8^Q'WP;54KO\?B5ROYM7DHR[@_REWX'"8'Y?!HUO4U^?,B3'\_U[$CQ:WC MRAA@N?HEB?P2AUF KNTJDI4",UO!UMUYHZ>0>6MIV]K._ #J9MET\'!6^L^A MPQ$G+*EH1K)-&91+#CS*!)D7QG4).C?/TMX(YBF4X@^G2#:1S)"M,M[L[Q[N M'RZ*U1:;G^\QS3Y.Q_]"BJSZ(WIOFNOARDP_S&>3<:Z[I(<]?:WCFI7]T$UI MNN9[V(?Q9'X9\4KM-!H#:-!R8\@I:=26XQNXD74Q>V\\)%6WAH+2$%1V((5# MDU -4)_S[>9M'TVX& YY8QP1+8A0:K5,K+UDBJ\=9(SC7B3G6Z?VOT>Q31'; M>I*^_8&#]Y[IAI6H2Z/Y!PYGC!+9,8B\IFH8^5#>DUY4-?F<8HY6MW9_OT>Q M39G<-A+?<*:;2?P?H1O7 T,71J49T[7=% UM\20*7;<]:9 Y"AD"8[YY>[+O M0&Q3:K2-O#>;Y^$]C,-TA/ET@K-R_<%Z\K1^"?UI-^Z_;NI+K'&K9E[#IL/< MT#^H0T+?IWF\7QQD@_SXC?G'NHHV"2,=Q(PU",MB!Y"IJC6,\Z] M#X$'6>Z8_O7OOO$3+%>]Z_Z71)?N'M=7(V]+]LIQH.^UCM8I<%X;*"0 CU$H MW;PTLP^ 225061B(VD:0 M7&>61#TZV]KC617;-OA!V\BT=<6WC79UQ!_0LM+-'M&V7AWJXUE7D8(N)0K( MJCA00FH@UYN#5UI0'*:3E?9I6M?SF[S'XS"FR>T.RBN"$2;_A:$;<7[][^\U_^%U!+ P04 " #OA A7Q"7)R8Q+ !".P, % &-T M=BTR,#(S,#8S,%]D968N>&UL[;UK2U[9<[ZP<&G8G%"DAZ2<>'[];I#4C:(DDB_>EQ3MJI0BRS+Q=#\-H+O1 M:/RO__W7Y>"GKS">]$?#?_S,_D9__@F&<93ZPT__^/GCQ5MB?_[?__HO__*_ M_A]"_L^K#^]^>C.*5Y@Q^"NFG/_O3SS]-/\-/OX_&?_2_^I_>#_PT MC\:7A/SK[)^]'GWY-NY_^CS]B5,NKG_M^F_'?\^"<:NY)E)[3B0-@=AD+8G. M0^8B:.G\__?I[T9D!C)R$C/#W_49?RUF3[3R% SC26O#[ M?XK9;S/GW"^SO[WYU4E_U2_BQ[)?_L]O[\[C9[CTI#^<3/TPW@Z PZ?IS3^\ MBT;],O]+_-5)_^^3V;]_-XI^.B/H61%^>O0WRI_(]:^1\B/".!'L;W]-TL__ M^B\__337G!_'\6@ 'R#_M/CVXX>3ATC[P^DOJ7_YR^)W?O&# 2*>?<+TVQ?X MQ\^3_N67 5S_[/,8\J/HKT4NH%2!\_^63_NE,:;/"&0O1UW50Q>E74I92J@6=C3[_=W=&17K[PWY9 M,=[A'Q?_N RQ\?CPUQ2&"=+//_73/W[N)X#LHC=)*2<3BRY)JQ*S A=EYJ/M MS3^B(+G&,AC%>Y\X*&O9Z&:8@0\PF/VTEZ#?N]Y>3H9E"_$+$>!D"I>37O Q M:F,4P;5+X$[! PE29A(A9J=TTIR)AP1.K@UB O%OGT9??\%Q?BGZ*]_,%#FG M\)G1Y_IM)M4%_FXO!L>8UIEH[X#(I!7Q* %13#"TIQ1YI%6D**/=1WUK%T?C M:_R+J;'EW,GCT64+[$U'%90W9P;A__S3:)Q@_(^?:0T2_^/*CZB',$.;#HF/A,@I*,& /@@Y#2BA7+RA9\+@U\0-0V4>E#EED-EM_# MN#]*Q\/T!KW<7HY9<1X,B9QY!*100+":6%P*LW+@A=)5.+XW[ $QO+TZ'_++ MJRS%8X^^11%R87,YJ"13=D1HRA"3\QA?2(PO0&23&'.4^3K+\M+(!\1R(Z4^ M)%HT(?IX..U/O[WM#^#TJJBCYWE6@:I(P%J)6X?AQ!HEB9-2:3#4,Y8:$;P\ MX@$0VTB)#PF5S0G] )_ZDRG:V?347T(OR)"%DY2HF".1VD1BM>3$)!J9,8Q: MS2J0>G_4@R&V@3(?DJN:DWLRC*,Q+APS(<^GN%6\'ET-I^-OKT<)>KA#2.6E M(X#\SIF$#: :!8"/CG\P;!?0[T/>3?->3]*:0R3 MR>)_15S6\S8SGJTE+D=*I*..!&'0-GD4($*R:*P5.%\Q],'PW52M#[FV;7#- M>]$%;Q0XDDQ&4#I&%-.@ 09J,^0L1;*M<,T/F.O-U/J0:U>-Z]?X[=GX8O3G ML"9/ MG(W?CT=?^\,(O:1MP-B/$:M<*L RL2[/8L%,#=?2*5./ZZ71#XWP)LI=P7JC M;-D]8.]'DZD?_/_]+S,7TM!HLO2).%J.=2UGQ.-7E)HQ;424IDIDMFKL0V-\ M>\6NX+M1]JPL-D=C\#,@,25A@J)B"A8;I<9*.<'@_>?1\#JKXX(H*?5 LDFX<3CT$9Q ?U"ZV2+"N93-HJKE M$0^ S49*7,%HH]S8.<2K,9H7X^&B/QU 3UO#P.+H2DF)#I_4Q&ET^'1T+(I@ M#(K5B-'E$0^ T49*7,%HHX38Q=B7&JSS;Y=A-.CE3 5 5$0SAOX[*(UK?E:X MY5O-P6R%K]?IJ/$91YX=>Q>S01;^:]'3, M*@L9<8^G:'8IXO8NO">4>RJ3RB&H&B'NZM$/@.UJREW!>H7\UH5, M5CD,';_&$/S3:/RMIQB32G)+;,@,A?2EB $2!M\F"\6X,+Q9\<^*00^&X^U5 MN:(HI$+VZOS2#P:OKB8HWF32HS98J0'W$>9%.0OQQ/,2JTD)64'P(&JDHN\- M>C#4;J_*%=162%$=7\+X$VX>OXY'?TX_OQY=?O'#;ST7-0-N/.%1>/0+*1H? MBD?M:CF<9D*6X<*B7< M/7"Q\;B1($8:9&IZU6R1KT"[P, M1#+/B0NA1 ,F@6?>:*AQUG!WS(-A=VM%KN"U0JT7(KDLQ2FC^,?Y9S^&R=G5 MM-RC*I%]+PC$9P1Z"A'#>1EBP#TE:))E<(DGYEFL<;[P%(:#X;V:HE?8086R ML-E:L>"8U/1J*LHE9S@Z"; MS>5'ASXXJK=5ZPJR&V7'CA!2FL$:^$\]EH/4+I04C<35)6(@X)(W!'T(X%9* M9V6SJMU[PQT J=NK;P61C1)>BZ3;[4)R?7]'>ADA.$3!!;J&*0/Q.B02$PH< MM,C.N&8G_X^,? #T5E'JBKLR5>XVWI'TPH]'OC)Y"S/0H2CO_J3 M7BRUPH$! 18,>A-1DF"%)39Q:2)UC.>G'+3L)V%&UF*DN77 8#JY_LFMF3P+ MIJ*M/-$RXEG;V8+F41OJKG@C]AK873QO9@OG6HAZ2STL*AG"0S0U]X7'&G#< M\E^9KE$KNN[&"G)D8$PI/@T.K3UJ6SS.4@.E3:F:PS^S?:V>R0_(W M47$;I-_FAGZ;^4J]%)S,,6-$$=%'P=C"HTM*44BGLM7:ZAR>"MFVXGP91'>. M8"UFEHENI-:*K2VN ?WNQ^4BZ (,BX%FE1FA1J(-)Q0RT"!(N1S&$DC-GFRU ML@W']P"\>'ZW5^>C<_A__;*D#'16_]BVU=#9Z9OCT_/C-^<71Q?'OQV?7IR? MO7W];T>GOQZ?GYR>7YR]_O=_.WOWYOC#^?%_?#RY^,_[X-;K2K3I$!4:> M:JG7$0,:E8N1A2BE8-H)R R$Q2],)A5Z&X]6R1>_C5$<#8S1B!ZFQ$!1:I.) M]4%CM&*-9D:@R3UUUM7(";]!T73A.1G&,?@)O('Y_T_FJ^+GT0"-?W+\WU?E MHOIH,'@[&O_IQZDGM )I R4ZYW+_@2GBE$E$!9= N&AHJ!UY; BQ^\6KH6TL M+UYM4M+"UO7D\94.N(EZP4@T*J/T-)&@M"-@Z%#)&"Q9G!I9N[7(&5:E+E0!A)11!/E=5OMWXNHSALBVBH M]8K=G^XA.IE,KB"]N1JC8<[/3>;V>A01X[R\9=(+QF>=0B#.V4 P=HOHM0E% M(C=&1RYDE$^EN;;7(R.4IJA M\H/WOI].AJ_]E_[4#V;V7]HWIU*D!<.)G_=:FTL!YS#^VH\P%_ #Q-&G.9$S M67LB\J S*"(%QK 2O"*>QT",PNU8H[/(XE.EZMM88-LR';;E[I5%5.SWM=8B M/_O+LR^SJ7G\%XQC'V7L04@>$D>O(4D,94PH_8ER)CPK*X*V.>JGB@FJ[\@K M41ZV5;;,6L5N8NOL *L!"W0AC!*"<"BQL\#O4#&4,!.3 1"0G^Q"5'NS_F%E ME3FKV+HL3K_V9K;_:GD1/BH)X$^SK,RK;[>_\MY_*S\Z*BI:*6(50)7<):E#-R %TM>Y8,T M[4X%.$PC?CDV4;&OVXZ$7G@R/*BL="( Z+]([B2RA.X,1&\H"S[X[/9S'ARP M'_MB+*)BQ[MK_9["M'18O81WHPE.29T@2N>)\L4+\MD0%Y@AR6:E; :1:>TJ MB7L #M.^FNNZ9A.\M5+@-C'NC-6$"<[027&E+#N[4A\2@HB26UD["[3^8425 ME#I&CH)I0*4K;G#W\2A4F?H9J&H /!@)BB M3,D3RTU&ZDQ$(V..F]H%+_<1M%T,V](Q8@,U[ET![-RPRB8V&I:,S*S2BS+C M;!*11%UJA"%'XK.TI7\Z#]$ERVG]\Z,G '5="%N#Z,=LIK'"6SA"7,*T*!-: M!U1+E; K >VX&+8Y<:.VM-Z926A-V:PSI_9)X0S(@,;O'#&"6QNX17^F]B[8 MH2FL6QG;D25LHNQ."F01B]*!"T(90-DS.7I#Z)&*K+ER8!#A4U?37VB!; 5R MGJV1W42S+10:/7((LP"G3-89 Q4B5:G[=DD3.Y,W,942!'D_<7)V>G9VU) -6VIQ42$_U%MU&WNF=M,V$RGS_N1^A%#2!PPR9,&8SY3'GG M@&;$J51-$5\P&F"OBTM142XD(;M+&LS((=K M4RT2TD(%]GG\#.EJ &=YA2B35]_N_&E^SN$Q^ P,0UHJ2_ULQ.\"0]#&:)\Y M4!"I>C7JAAB[.CEL;7]KE91].65<(=HL5^ZBM" I0R\N6)2%"6*-0X$TLQ(X MIUG7/D9X!,K.3A9;I?]Y7VIC&KKQK1=1*2P2;.L ;.D$\EEPNSF-K$+E&N;1 MG(>=&$RY-&SC_^]MO1A_\\>WM^\NOIR=N3UT>G%T>O7Y]]/+TX.?WU M_=F[D]GI2'-[#F=K0\EMARH^7%%#0F7#C*4TMHJ+:PQ2CK!'/>11YJ3 M-=S3+'M;CMF@>/[J\M*/OYWE\_ZG83_WHQ].CV(<70W+JU?O1X-^[,/DUJN& M+#PP:X@O!U_2L4@L]X9P$Y2SF4H6Z1HS=\-A&Q]LC$?H_DV_O1^4<8:II!V^ M%!_ZXP3RU>!=/T,/ 3+MD\1YE68S3!,GR^WNI$4"93FCM<]RUH#5W9K6MC4\ M..VHS$D;+5[FY_[]_YE?)+B:POA\E*=_XKI\72(PZ>'6K*+W17RJB"PM^"S@ M'AX94](FKBRK7G>S!J[#-9SJK+3@#)]N2&8,H)40J%SD-!-\(P"T1JB%X%RIVIW"5H+V.':3GU>6N@5 MI0HQ0:S=+7,UDL.U MAPJ:;Z-IRSS$3&^+GF&VA)T,IW[XJ1\&,%_,EDX[[KA4%DRBY5'Q8,IQAY"X MMAGM2[=1;;U&QZIZG6 3O(=K6YVQV$(3E47;VD6[V;/QAX+S^L+LK C@YB\G MB[^=L)[BSE 'EI@<;7G< /UZ[@01F6H%$1N@AVMS[?-6L9-*4GO_>GGUU>3Z>@2QHN*N0L87_94$"(S;0A+DJ%>>":> MEBNA.L;@I/):K).96'_$PS.3%C5>N?G) N6=YE)'"1?)*9IQ@3?K0#7\M&A$ M-7F/!HX_Q26T%YB6F7(@O#P3*UDY%:8L$(8>GDN)!LW7R3QO._Y!VTR[;%3N M&O(0\V_@)U?CNXCO(%4TVN2T(MD!;K@,]UK'O2>9ZR"T5]RX=0K"-AOU>[&6 M:IJOV%-C?8W,2P T@(I, XDQ)MPD5;ENHBQ)'$QDG'&AS1H&LL&0;5?9=&D3 M;6EZ7VIM'DUVO_IV@1\Q._W5S'(9,*!$$4H+)10I*)M(0O\+0M#*N]H-']: MU74-3JO6L.X1Q):LM)!(?A1B 7A]TVT-B"T5XJP!;S>E.-6I7==T&O*R(Q.* MI>&*C9X8QP/.(H$KN(FEO$ *FVCV--1N.KXSTWFF.& M@-.]"]4JE3@:C#Y]F_4H?J"*.4BJ':>9*^*D+HU=\8M5 MU)9B[!,4@:_Q<*VCT-P3E6C!(X#8WFVW_KPQ@'^?SM70D;9_NNRB"3 MPHW6T%F#70Q%;2P/0 O(&%J U*IV2Y_UD!UTY%6?FQ;J#F^@W3F?FSS$NY@[ MZX!M*^3:!.B. JX6&'_,J%JCJXU(:R/0Z(=Y \:2J!,G4FE.K- 8,]"0@)H< M4_67N/; MIZ+LO;-M#9AJ4V3.AE^N9I.9AI@BSV9>1$ELX&X$-&9UY"),ZPT M\ 0C,Y/1N]K=4I^ LP.'J#TB'S.9ABRT$%P]W2J:42Z-\YEP[H'(G"7Q.3O" M=$P)YTE0M':5ZEZUU^_2#ZK'1 ME]JO;RJX#ZGOON[\1<6MU6]]&ZYWUW1=9 M@]& ZY=CN01ZA@3'@&2:0HQ"167]RS6%1GWWZUO")LJNW,7B_57 A>^Z/GZQ ME^48:8PY$F"ES93PD3A+$1F3VFN-WA5;YQ&X59^]+YVT-U+YJ**^*N[],SSC M_EY[ MD5QW]1KE&]]TG@KTP_2N[T-_@#A*]F[F&:?RH'6\&I=G8%_Y27_2=@>32O"Z MZGO2AC:7NJ48EDO2-7(3)/J5,> WGFF,2E0TCOLUNZ540EHI*%TQXMG2B!^' MHS"!\=?B7L^BIU(J/XSXK_S]%H=]">EM!L1'87)[ )33V7-?'F/T60,3Z2WACA/<3D4B0

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

_#_L'A![)#!Q\.MHD>'SRBA8%\GJY6&5IU MNM-%N67MEGXQF?96)J#FG""DH)C:RC_+!"%37%$D)D4[KXC-!R$]3U%74:5! M)W-$ T+SVFP/ X08:F)MX-X&&8KX7Q%5-L3#NM'E)J+?VH1\PWF<=6A$+E;I MR=Y_;&$];OZVA=EX@I)&]N*Z,OL1'UT(GA!%'4%G&#G.C/:AB/2!\2(CO3M* MVW@-/4-.L^K_QS"K# M88@&K60:EZU!;'S3M@AQUXC&[YBFIS]'3K\UHA8DG MNP#LJH&!.A['![_4(YU/!Q^//M4#G6WBL_N/:!*9/4M7(T-RC)^K*_D)O\[F MJ]+8ZWM=P[!W7Y.&W M;P_?_W9R\);BAO='Q\<73L''@T_'?]O[=+"%H5GKL2V,S^;T-S)(!V$^)5C4 MIH6K@/?F1B479*SFQ0OC0*5BH!8Q@S'D"3.!7.36Y8]/T;*K0;K_W!OD2V>% M-RA!<.]!2>W Z6BA)*$P6I>\;NW0/$E,O\:G"0[N&Y\V@A^HR3G^[-]5H(?K!F8YV2IZM:D*V,RD8O>+DRKL=YZKZ<*V+Y?@T+'$Q MJDE4]6X-^*I5EK,>? D.LM-9N,B*:CZ6ZRX%_?9#Z0@Z.PAY !#Y1#H@ KY< MSL*N)PVK7)/3KV?TDJO1V/?7@=(ARD1[MV6UG0O+&1S7$FR1C@4*+E3SS.JM M".VWJ4E'@.M>90/ Y>'IUS">KYJUS=^.%U]GBSK:N,X9>S_^AOFBR.X^CYD' M,L-*@8\62:K6@)=1UW(XSE0,BCT<):]>.[U1SE M5K',!7,6+%8IV8SA,)M+Y>P4Y_?M,::2LO2* MV%GYIK&Z 9P#5PY=T4%+;+U9;D9AOWV+.XLC.E/2 "!XG81SGP_G@PHL1Z(^ MU(NKZG/2I@_)^")#,$4WGU[V%"UKP(#H$<2DDRS,2:S]P+U;KIV*8TKG=VRUX9XCK5U*N^A#H) M% -U=P5U^?B7NX!ZC)_NKY_(>Q?1.0667'ARXZ. 4 )9KT*HR5(PLE^OYOKI M.'W!?#:I@$# /W5BE_48LA;IPA'I9X>O#FO']^1H&?S6V?O M+OL860 1@ZH)?!9<, (,5]JC1(RL>;[ZYF0.]@:OA8'N2ET#]5FO.KAN[97> M>T#+KK(=>I:;=0FU+(="<3+DVIE8>:=KDW4'PCFI.--1^-;%:"_:6_;&.;EZ M[2VKBXGG@ J88KIV,A4044IPGKN4I&5H6P^+>H:KL]LA_;F7K_1H(,((EM@I@10NK;'$]$"UR49;H7'YGW'VG2; MK6,B'XM;+IJ@WHM27,XIJU@[JXN:K1QBO7)TCI M-Q!K )^6HAX$8A[V5;Y:%.>_AN79G/Z]QZ(41H8L:!5$2P& H-W6*T\L1BF9 MHO6A0NM\BRW([#=^:HJT;E4T4._E\6YCVY_K/_>X[KJC=>CM[-B#*A,B,]H( MVC,$9:.&P*0%H;/C)A2G<_.VL[WV2+OQ]@\(+[-SQ&.'$YAFGZ?C_R&B<#Z>75!Z*T&@H$Y>!N!&>5"JSD#TC$-*Y#I8[2,K71TH M-6?F5?=5VP333P>#?<)C "[!C2 >Y_QX24P=?:V?+BZ;E-_??I(C+R@X"1)Y MKD=V'J*PH590,A.=3)IW=SFV+=7]NJ:#0/Z+*/P50/QFW.V*]]^F8Q+U'V&> MGV#?,Z^ET :0$>>JD. #9PZ2*TI[B2*%YD75;5GHUUL>,/B[A,)0/>][W:2V M][D??U 7':\Z]+.?[&VD=5!!UW(R,G&DZF0A:L]KCQ'%'$5[:%H7*G?6]^IZ M%5SFQBYJU7]0&WA.LVMMK:/ M&SS\I1IU=6A'GVS3A-HER1TC7$@!JK96BL(%R$F8* ,G9+?VGKIJUW4KB+SW MAIJ%DV@1O1U/SLB9N+]2;+#*\@!*9 TJ9P&AEM);403/EDG5O&OSEJ0.M-77 M)AAZ)O+O3&F#"GKVILMQKBR1,3^N:6*K"["#[VER1LO\HBRFUM1?'F\\W0HM M6,^10CN2@.44]J$!7S^30=DD3VT(J+?N/^CA'=BZH'NI>_/3C>_W3X ML1[+'[U[\QOM? ?'QV]Q&<:3;7;O9Q_78K]>G]Y6HP7FG\-T_#\K2O=GT\5L M,LX7"V&:/][BXE;I[S%]!^\-MQ QJ3KA55IF"2E*04#E(//,E'?.*]_Z-+P) MX>WLZYNSQ7B*B\5>^N^S\6*\.CA[#ST"JV;LG?S[\7^?D2CS MKW@:<3XR-D9$@9"\E: 4\R23Z($)1Q%9BMEC6"/K\=YCAP>"'10V:R.]85H4 M2NF,/%+_/98C$JS*/V'H&AHZ5'S$'(@L)QBTZYDG7,K7L<_(BF MP5FK+;4_ZU 5 X#6(X(ZH,^6YX=3>@DNEHO#Q>(,\]&\_EM7Y8>S:J4O;Z0O M?SKR"GW"8" I^D!"3&2SC2#/P"F!7,807\!IVH+R?BUB9S#M0:W#!/.*G8_S M<<)1,HC24VS-=?4KK*FC[.M(GF!9EM9;JYJW[GZ.H'ZS6EX2>ELJH6>O_H=K MZ/X2>G@ )3,E1_Z=KR12_7 M'>MY'KOODU61RIVLYRE1@XJ9@T<9(1N=Z&@ MX'LWGHZ7N,K"O]\$NC70R 'B=8/HRG4UFG\]7 M9<(/1'?!%#->L"(T>&5JICQ]<)H%\%H8:PK7O'E1Q%J$]7L/^Y*0:Z^G(8!O M'C)6 5W1+XQ)TH@ .K-*OT1P-76G%*>2+M&1I%KC[!X-_=ZOOBBD=I'^ -!S M??'QYOSZT[^-<4Y$?3E_7T.CE6^A"ZJL99V5&@VYNQ1NN<041+EJ8H/*Z-99 M3NM1U@_27C1::*^A(>'NLC']*K/K(7^7*Y0\@ULE(68#21H"3ACQ=%C,R M6U(VK2MB-B*P9Z^M X0\!<+FZAH2%E<#$!8KB?%+<\Z#3(J["#XF6ZLM"WC+ M#3CB3Q6N4FC>?/P9<@:"L_8@> IN.VID ."Z+CR[R(NI5;6SZ:H.K:Y)SH2R M/A00(B"H4A2$4CQPDW*F-1DU:SU(Z5F"^DE1>LGMM)T^!@"N>SQ])2664DF O*9.Q9_?<&V1W=\L MO9[5O]XV^_XZ$1.+#,B=)>M8IY!ZGL")8$'8J&M'>\73.L#8\+7]9*:^A!O2 MM0X&X)0\>8?_VP++V>3]N."(T,%-R!1\FKPJ-#6T8LBG5]G(C-H)SEH79ZY! MUM SO+:$Q+JI-UOJ9VO(?<-YG+6ZX0M?Q\LPJ;VV+QH7X?PZUR/GBS+7$7=* MIQ"JP.KLID@&WV%MN,VY5BX+[7CK4KEUZ!IZQD,;V#77T !,W>'IUS">U[5S M5.YUP?P;3O*[V9S6U,@BRER(*2VUH"7$?6W]BV ,IB C$UZWS@)?B["AGYVW MP5U['0T >%2,C.!3=G6\BZ[YYIJBVDQL*>%=\W:1CU,R M]'.D-M!JH(4!8.EJQN'-0GE?J^F91<>"DE"4K^E$>E62E\"&Q(J.*6-J?33Y M."5##P;:8*F!%@: IWG$Z'-C.C#$1;2^^D(AML30 7O7'! MD.N)K8."7>A="Y?FM>/RQ30Z /2N$D..RN7ISM'\4^7KX#O.TWAQ441__Z:K.\/?Q\LM5.N5EEYP3G)^.=)2R<&.!9\5)CJ) 8&C!FY2B5SH8 MN<[AW?IO7 MB[K5"K$/I#P-3E_/*5OK*9,R7M&0J.ZN!9]//EW//:A/H5/7Z M&4>1&U680!!UJI/BM4Z?\0B:Z?4$[W$N M;Z687/)XBS?-DLO>:"@>R:W@Y%%X$0*4V@'=!"VL7Z>MRV9O7>]PF/VYP-9, M#:^Z5<95]\19N4Y,NO!\PYU)X9?"RG4X6#J;STE:=5#$HNL&&XW(>[FV'%W( ML_MF'BIB$,PQX*N>NQHE.-0>N"LB*>\DUZV[$K1OYO$@P^X1>1_=D_=OTUE< MT.JOEYZKA+QJ(*:)_BK<- S-J(1-O("7J(&VGEH,SB58ID6QCF67FE?R->9A ML&U$-D'>DZF4?2AZ #']K>3H6YO9NSG^]QE.T_DJ&:SXY)GW!7(0%A1&#J#;;BM5#@F@:Y4Q:70H2B*6C*I#[E*" M4"N$A>-9*Q%#,JUSQOY\I8<;(62GTL--U#4D+#Y6Z"9I[9K@0)N:DE18@)"\ M!Q=UT$;88'GS-DU_CM+#C4"P2>GA!AH9*+C$)2M2&*69#9 8-Z B8Q",2>!% M4@99M*%Y"[IGR!G(GML+N+;1R$#!)2]9\>13Y.(2D%DG5IP2$)00X(H*-D1O MBWN)HFDYB&8DO8)K&XT,"5R[>\$WMV)"L2B8^&P5%VY-J@RI"++[3C883@;9W"7#*WQ6/"UN= :Q/7\X5@6U \*,?J0D-# M@%[-CJHY,DM<')6W^'6V&"_WEOMA/C^G17TQY27XFGW, S#$5%-7"D17IYTF M[A63O!C3/&=W#;KZC8,Z!EQKO0P :[?VC^?$QE*(0EL#S.::BQ3LZ0Y$< M,S?"%&Q]DK,>90.)NX>R#7>@S@& ]"VNFE:,O]V6\X@L>F"%*\!DJ<;2^5^3?;D)\CK/OMQ$T0/P/=;)UG(\&4PN 1?58U-60M"T MN>:,TEMEBHN=-??]7Y-]N1%NMLB^W$2)0\+E,XE=0D?#%$D+6:XGTTG48#=! M4"S$:'4,NK.,]M>96BY*ZDUOV!GB7H3W/^U'23W5%Q0T+A[I*]+X[+=<^EMJ8D5EN)2%KW MM;L\=Q*L-2%:&T,LK7O%=,[40*SM[@#L+@AJ@(:>6RU<]1ZYYN-JZA29BXP1 M046B7@67(01B!G/4GD>?.+MW#_IH3?L3CQ\(M(8!@%E;;0S)WOX@#9M\%JF% M!ZEJ%AA6S]S1=A5-0$\^.KK2X?8_N"E.0_<#6JER2 !=*PN295E",!E*J7G6 M,3AP:!7(Q(TTQCHE.ILV]N>IN=@$(3O57&RBKB%A\;$\666]STY!,K50Q=,6 M0GN'@*A+.\3HP6H)DA@0A=($BDJ$#4-""6H^NN#J4KI@:R)_2&V^X64@,0#6E5 MW=JU:X?*!\PO[G*_N"NKZX#X(B\SZ2*4T1P0/1D\KDE9.M$'IW64Q4A4G77( M:?C63Y>AOFRUT7TA"0^KL@[G*8Y/0[?XL6_ M(VT92T5FX-*D6I1'#D3V 7PV#"47',-+M%QISMB?YE9G0(NL.V3U?![>1B#[ ML^DW(H>^?]/=>\2M"$BZ ,M=)BG484)..Q(*\HA>8KS?/NO1(_7N*/S3''LV M7"@#PL3F*\-?K(PI?@Y+S"<#=^I89%@2NU<)0,DRWQ616N37N*8 M]663 5#&11:N_K^86&QHN_OUP=PI.O[J.:8#TY M=%\34 K/SEH.(?'5 -9:*!@]"$FOC9P9D5MGO7=7$_! J!>GC-H+Y6J-)9-" M@+*6-BP6"Z18%WYF]+/6U?N/4S+8_/Q-4/"@*'5WH0_@S.^(6D=$!N(2)3=<*(@$ ['#AIC8\):3FV/EW_$4T# ]5."/@AO'90 MQP#@=1PFN+@<./(!EY>WO=9Y3N068*EH6H"L@&>Q#I\N6F&4T:C6:9V/$C(T M(.VBZUEKP0\ /8\LM1/ZT]4JXR)S7;LDQU1GEQ?FP4<*\4M)(67MC>?-.\H\ M34Z_AZ$OL\]M)?HAHJ@RTA[[P")TAB4C&2$#?&JM;]$9XA M9VCV:$N5_]#[WD[^0X#2Y0# !RQ=VU>1F",Q(0\UH3@Y<'4P:@K:9^L/2!H8I+95_7U(-=1#C[!:S)>C7\-_S>97_%Q4823C3#$D&6L=+3:RX1"\ M$4!.) 6[4=M@USKPH,??0A!]=8.>Q]_<[TU%PUVL@6![AL6'<(I'Y0X/E^L& MA9$ZV$S*C*KVE,D02*V QJFL8O'Y_KC7K=#Q) ']6)06&IVU%F_/EZI7E.]= M6CV='5.T-L#%S$"A(=*+2K#*P C:FHCWTG<>O0F]]]C^]-U(2;,V$AN"^W'? M0KZ_SJY3(9:0I8;L%45V/-4F4PD!+:M7-;&T'^SS-#7]7M6]1#2TG>"'"*&; M2:]\Q#':$FE9%1-KCH[>_'[Y_?W./^,MLEO\83R;;7Z/^^)DM[D?5._:F^9"HGGX> MD[&ZZ-'Z2(O":#7M>-E#(;^' )(X1*X#<.^0)\%S(:-?8]0=2N[;IUTU,( ][HJ% M$28GG>(*"BIR[UBL!^B<@61H.&9!/+7>SZ[>/0RX;*W$)T"QD40'D^=]1?WA MZ=SQ6)D9#!1D@>8G2!>#*V78#E"2MYEH>LPYJYLZ5U*^KT\Z HK M.TA[."F9U\!G(F7O;*)PH98!2E[+ W%GCFA%U)K$;L"2[^GFF)5AL0-@K(F0+2!%H AY%MAZ+_6ET4[[#\#<6TWPAAHT/W^8._X=NKN$=F]4-,H/QW]=B'*0":P%@W=2E_?WE#M]+H6QJP= MOXT,WNI=-\FJ+B>N-/DY7M<4,%]GF_C :B)/T)QY85GKN9MW*=CE6N%*K$*[&] MUF_?2G0L\)YO,C_.9_DL+8_FQSC_-DZ7^22&%6V2@T3A(]3F+W52I0&?4&BI MI#=\K;WO!Y>8C[V['\B\A)YG#84^#-!4F5QR<-4#, LAYR$!_5V'[J[3AP#94< #..S[A&%RL" -X-7X[B"+8#R M+*&.AK(: M$.1@55.#.SWO(*>>M;O&1OK^^MI6FI2MT1:L MMH(V4^+0*<>(0U<\85AKNXZ7NLD[^T'("SH;G2IA -O+7=X^C3]_61Z5WQ87 M!Q2CD(VQT3GPIC8D]KE Y$F",$1+]#JQW/J"Z5F"^O-MN\/ K"N%# Y=U^7W M(T5F-M6S+5IZD014/'AE$ R&2/)A&;%UR?,3I/1GP'I"U'9*&/2YX(JO_=GB MHOO#Y^GX?S"/I\LO]+UIQND",WVRF$W&N5Z>'5<_KQZ.SLI!F$])+CN?%#8C MH-W983@T48D40R(?&XVA&"_[>O%6S9M @CMJ;EN7X+8Y37Q\A56ICP+] M%S/+8)6MU\$IU%YQ"$RHB(XQ84/K8$&6G[>A&TLX 'LA,=?9O/E M"R?5P2X9E3*.""(VA'+T3K/K:;X:&SVH>&>-A.G-OC8+8, MDXX=X08Y.D\\J)UC^B+Y.?=@PDIT.F0'+-2DBBPI>O(40A5N,G"F#>^T;?_4P@J0>C5S^L6R ?I6Q*KE$B]TQ1EI<\H&Z$\JRVR2^VKB-J ME](#8[$PZ1GFU#K?;5,:!^7V=@:^794SZ%.?X[.OM)W50XLP/]\/BR_O)K,_ M#J=E-C]=O6#G]*\UG]\PWVL;CKK9,;D422957>/:#R5BAD@1$[BL'479,D31 M^I*YRQWS8SA?S7T:2:=-Q%K4F NY>M%%B%%;2$%IEBA>Y-CMLUPL$)^X@KE:+1=.(BWYH_*.MNPP^4\,\U&2 MSGGGB7?C=1TH)&A!A@),6BE4,$[%UNU.MZ=V4/9L$]0\/!9X$84-P*]?B].W MM;WB]^7)'SCYAK_.ILLOBY$)=?I (,?1^E1G"V=P010H+J(TM)/(T/[X:3M: M!^7G=P[+797UBD!9%]S)'[.1+#%P[RUHEU?S86WM=:-!V)R\<]8+V3K6W)#$ M01V@OP0$MU%-SVEVS[+VVS1?QM&8[SJYY,;F%+V S'D$I4*=390X67V!.:!0 M+*8?>'[;OWU0!_';X.J%!-_LQ+XCHW:;RX/OB7YU[[1^-?+<)U5'7V=M.

U$@ M^-IES",3%.Z)8'W[NY/U:%L+>.:U V];9?S)3E5&]X8^=WJN,N*]GJS?EB+;QB60'X%K>8<0&D>P'%:,7@T7Z6>7Q9.F) 25P%TS@54]AIBD\/6BKV$8[ XCP'^5D5>NIDLLYF0P:2ZVZTP9"+7- ],RZR(U(S4=> M/$5,S[TY&VE['1!M+/JA8NBJ[WY6VN=(GI?7=51W0G V&["L: RR&!%:I]4^ M0\X <;2YPM>!T1;2[_G0Y^-9G(S3U4S=R]K0($*1F#+$XF)M "BK7&H;-]3* MUS(;%7[@*CWU[ %"81NES1I*L&\$K/9RO,< *\5I;LFX.F'(KNIZ8LX%,9!X M<$9YFH" SO+< #[R27UE\1[+%Z0.(!C(#_-)DL!MA?DL44* MP#,:&UO[_7<(Z'E,26.0["[C 0#D4:&\OR[/#!P=6F: VUJ6FS"!TR%!,1)U MMHQY_R(^Q_M^Z_+[<%^W4\)0(75TMEPLPS13*#D*&4M21@$%BN2B*8M :P^! M\RRRIQ7CVH^[_0%- W1AMM3_.M#:5AD# -?-,<6[,)ZOQMT?E9MOWA2!)U^T MCX9VYE+;J<0LP<<<0.C"9/*8)5NO2-D ;U@9LG2AGJ,?]1Q]^.3GX].O; M@SY5#'B?.'B!@9=BB_V>5H+C25C@L0XP(Z?OD>&<,/+@W;"+V 6Q7=UFXF#*N7!VV$($YED )'<$7&RC>*(&Q M$JQQK9,,'U+1=W5VD_7@T'(S,@]#]@%,/7M2*7!PDC&@:*-$$H@0 M[0?$/4)'SQ[RCKI]%BI;"'H 8/F$WV:3;^3"WV7FZK"2V928R9"$6K6(*."\ MM)#(P3;-SA[EJ AP6<;?3]HK-E*^ - TFUS?,F!RR(*1A(I5M?. 4AV M6!8''DE$26H7VF?"/Z"BYSBI-69V%'//5PH?\(_G09^4"(B%0]+.@V*"V*BM M96D=H,Q1*A?6:=+YH_?T?(;<"A3-1=ISW^]/8?KYHK$U*UIRG33(1-Z;4LE M-"%#\$PH%8LVZPU<^D&?[^L7]EP)T]25W5Z20U#_)6HMYX6,&H)6BI9##@J< M(.C:X)7,@:%S:[D>ZP"@[[;=6RKKOKJWD%S/"O]U/!V?GIU>$BXS;6*U%QE3 M2=58WX)W#,&3#RYL,L:4MG;J&S60GY]*SY\OT6X0=28T8!# M3X13T 51>*1%H)U+(FL>6JSU.R_MKWE[$\5O+;^>%7_=2O4XX33,Q[.5V?., M_=_VOJRYK1Q9\WW^2]Z+?7F9"-F6:Q3CDMR2W#7SQ,!J4-71'2K:\P/$ZCO_[A+N&R)+NK^,IC]2&.9ABLL0V6>&6R!3(&5,F!%S I9:W"PE MPPW21:9BC:!P)0'];185E#JN+>%&8/)Q/$G!36^2846T,MYRH&5PA4@<-T%K M-"061:!1"DK7JC59$R,/5^\1('54^@Q(=I!O Z=2Y5KI[BG"W&I,)&E./,_E M=2P* )RPI6"!!ND9I;3ZG=M3*GI^GMS)UUH:D64J^& #.&XD M%(R#D9(!MX*Y2*/AU9M1KZ*E_VO:773\(F2V%'C/9YI'176_CR,ZW;#0P]=) MFF_6-]6^(@M5RD*MM*X4PUATF123^F@-5\RC:3W*:Y\]TWQMG9: L:TFQQV) MM6^(?)^7R2P<[AT?\V>MHZ\?4IASA R3)6^)&6VX). R49C140N^O&1V!L6& MAD7%6D7VFZ[;[REH?0AU*?:F(7469N,Y:]3W 8QN-CNN)MP%T/.=8/]T^']!1QV0H :H#AO8* MDTL;'/Z@,AO!5;3UNRJ]1%#/K90ZV83J::#OFJ+K8@!G^8]OXZNK7V?_&J5X M<>VGPSA$BTO3 3$Q">,H1,U*$.88>*TQ3S2"B6!L$I2M$?F^LDQ[M=!;*G/< MC60;\SFE+QU+/J"#M %-QP6DW3$"RACFI!>>^=HS5N^OWUZ]T6YPV5G&/3N1 MAZGB[>:Z' OBOJ:!P*W:$TSCJ/>8,]JDP$IA@)"DF=$H&>W7<".O+M3>??3N MCJ2N=!MS)3=B.AGA]Z?I?)S,A_F! /(W'$=TDR$*ZA+@3IT!&6$8YFD!@5C! M9,X8!=9NW+0)?>U=1=5W155UU"C^OHRNR]QB]P/_//OU?OS]^W!6S.UCNF]H MG&7C/+'@V<_W2&SOO8:A>D#UI9-@CE# MJQ,B PVT/'4Q 0,%2R!)3&\"4B9\]3;UZY'67N;7'01WU4S?7>J?8>G^_>$= M4Q;YL%()2*)T)Y T@"&:8K"A<\",VD2:UPCEUEYP+1#IPP%1=])N"$+_N!Z& M/\\++P-,:KFA'GVML1$Y$!:L3PDX%5P2EG6R:PTR>/;;UP*'.5QP;"G'GI'P MCVLWP6^Z^G44_]_U=);B/38$B5)S99!NB6QPRL$E24!+2K**7-&\SANU%Y98 M"Q/VL#!12Z(-A#7GZ<>RZ_Q9+H*9WIYX,&^$2(R LSH@(T+B=NDS).)-,%D' M+VM?")>"?*:;2=V?NSWW\_N?S] M^/3RXNCTP_NST\N3T]_P3Y].CMZ=?#JY/#G>8<;&!E]>H_G9MKQ4ZHEVEXR7 M^0GOQZ,R&"6-PO.S$ZPLS_Q, L8SYE@8-X$3F8&AT3OG,'Y:[[7T)NU]-B%P MEU#\A846M^#'A?I!> M5=8]/Q!#ZJ?CJV$LD\&.D9$R=F3Y;$[ZB/X5N+ :!*-E^+;.B(BH7$(GG&V- M9X2KUN\'1_6U.ZXLZ@;ALJS3DDI&+H,'PA)RX:+#M$))B#E92Q,GSM=XGKR: M@O[>%=;1["M0V4+,?3\^O5<&<_,PTCH1I55@LK4ND;4* M2EY[>/IDY;; L8TNQ]4$VR,L8AH./J6O[FHNB45W0:L<,9$&H)1GS"-I D^\ M!2K*.^TLC4XOY5O3%/[CZ_CG?^)7+R"!'^[0\,R"_505=;:U["K2GM&PH'II M$ (#,IUH!I)]F?L1$SA:YHZ7DX8L653^I>8VKT/A_FK]N(2=U36N(+N>[PU. MIA.7KH:W;NRF"1OS.@@;-"BK$?Z&,W 6K2$18BEUGE#_Z$#OV1QEQ=?WI^_M M]32N*[2>]?Z"_[L[1B*2)Q.%ALA(F2I62OVCBI"")#0I88A8YU7G.FOU4T78 MV4[0B8@;J5N_2*%,MT4V/E^E^#7%@0Y44%*$4TJJA>(>T(L*C*!D%%E1[_TZ M]0DK%V@R ]U2A\^4J^\FT ;.\XN4QJ.+V3C\^=E-SB;S[C]Q/@GC MN=&?']*/\70XNS435]X+L52>HI4&@LZYTD#0@L=,SI)0YJVL$Z0\\]5-;D>[ M>YQ=A=@ !GZ[=F6"3TK3DQ%*9Y1"TI[05"'*FCTGO#B\NS]_WYW=''\ MX?W9[Y^/3R^.+D_.3N>^]>S'7*>+0>&_OHQ0KY^OW&C[:\/MUZIQBUB)TUJ# MEFYOBLXRPOI'&DWG+)VGJ[*9O1]/9]/Y3N81K73ZP$\6[!F(7X5N*UU>X]C$B;?PKI8LT^8DF.5_R M75GR/E%'5_.OQ$]G^3R%\=?1\+^1J/D+DSFEBP0H>1JIP 2(9CT?CE;&C5 & MA"LK=3 Z50_=.F&DYX93^\/RXU"P?U@TD*2 M< KC'1#&$TRU'"9=/C)TS2R(ZG-C7B"G7YPV )9Q-YIK%X0W(S5(QF@[.PA. ME]=23(*/B@ AR 5S)FM9^UG1BP3U"\1J:E\/3EOHH % %1,[RQ?NZO;Z40=/ M>-0:LBB6IADKHTP9BH8S0:Q5/M7N1?*$B":!LXV"GYRI["+M!N!RCII KYA M8O@A_4Q7XQ]%0L=_%7=^TYF'&:J9"!1"5AX$B6A;BZ;=GFD2G-*Q]A2L-E$S\N;\^2],SI+K3M"5@M9WO::7 &)+<3:]RO^]-6%7X5^ M=*"H+%H^WH1^1#N"&04(05 B4I/2D9FAS4BG1:8^BG6: ;ZP1!OJWT9KX_HB M;, ]_+:X6RO;]/6B=%U'ZSAJ%+A%LH45$BRC&8+TW,CH*'G0)A!,=/48-D4IL8J;:N M>EZ_-G4-P6H;(#S.Z[O12@-XJ^/A/]U6NE@;$F5:8S8K,F[_6>&GY($3;7@T M5%)?^VZO,@O]GAJTM_?VB9 &#&3)68K/,[X\V&T>M1UJ\C[A4\X\XU>5 %=*=NLC@GK%TM]^2+NRN->YF'-NK@ ME-$BB(R;O^ * 82?K!4.G(C6$Y52I-7;Z#12![?"ON^"I>F[7T]CJ7^Y25SL M4R$X;K,3H$5I$%LJZ[&ZMY!< MSPK_?3@:?K_^OB0\Q%2.U"E$9BFZ5R_ R^C!V40"(=:87&/L_(-%>U;Z-BH; MUY!?WXIW?]TCW&:I)'GB"VMCC0DS@4(S3E8*A1PRKGQFEE/:U;70DXX;P/GM*>'=P\>;@F\>A2T&3P+%T!%E"644$W@=M(PF4E6] MM' E,3TG7KWC9-6]P$Y*:P!]YVDZFPQ#.1@NK'P9#6?3\XLOM_WEI)&$6\A> MR?+VA96^RQ0L(ENTJX=Q M)?.@6J6REWZC-0W;/N&T![G;O!]^['<.:N MRM\N)THYHH(/E&$TID7IE*_ .*8 64B6)E\Z"S99@O"$E<8CCLJ([*3N8#=X M-& E=Y:JAP)5V-SP1GSDCECSN.KR?0&D;9GJN MVCR 4*ESB+QE6UGXCH_CR?*ORK^C@Z2,]J3<208ZSM1[JB\*O?Q M"#3%$'G$:$MKSYY]*U6I%ET&^@\"40>- G-E;BPE$+2*CA$N/*D=)_V[*G53 MS'97E;J)^AN(@9X^J8PI4V9\ ,/QAPB>(P-$@%+94Q--\JR-%\T'4+6Z$1A> M?<6\B69:@]9-(YNHB)'6@4S%,J,O57F1X"?+!2683.?:[6H/X!7S1HI=XQ7S M)E)N "@;O)?-AE+.2D+0O'A@3U&OE;>T&BH?\BGDC(&S_BGD3 MK32.-\S0TD/FK"6$!L* 6,I I&3 "97 21^-#49RU]T=^1H$]GO9L4_4[::; MIH"W]1&%%UPQAAN$BV4LB L1K.("(XIHA(K*^U3[Q?R>*C8.H+1XEW!NS[H_ M9+0O3DFF9]>SZHV-\%C+'.J!XVV9R&)@W4#8('6T#"(K1676$#!:>Z"1#H= MH.@Y99Z -N7AV?P5.Z;CX,O8+>$9!I+=M<6JQL:!%CRU:S&[0N4-["VHAIR& ML^M)NI7#P)G,N P!+#(+0N11R)@T>A6>PVNW-=[@7LMU<+J3!HSFF?8 M.-"2J7:-9E>H-&0TI;3A9#J]3O'#]>2V=G+._?1>W0.RG"9AB.(8^,"]1]E# M2-* X,BH]3Y#YB[%Y$3"/+*V36Q,Y8'6,W4(^6X5W1"BJR=<&7EE)')@)GH0 M3'(P+CH(PG%E22!2[OT=?2=YN?H[V4.O,-DQ+S\>Q29L9>DKR@'[S>%$$L0+ M82#'6'P&Y1A$J@C4<\D9?F*LM3.L)TP<:$;>QN'N;I!X(W9QSSG\D89?OY6J MX9]IXKZFF]WU\V084O%E>>G+N)949$L0WQ2]1[8,=18TT*"5CQG#25%]&/3> MN3S0[+T-R^H85&_@V&M-"0TL#4Y'S,TBM[$T?I9@B=:0F!1$&6^(JST::D^L MO9GKETX0WH]!;@2WP[FP65EO\>PQ_,L"TM1':Q3$A)H4S&GP/)4N@)XQ'8,@ M'58&=L[>@8:3C=ID3[ [A-WQ-=$\<]3_HGQ0%DPZ56Z62TM.XC#L43Q TBYQ MJ6U0:N\W1I5Y/-" ]$!MLTL O@4#?>9:X64')EF*N72C3$:4; 3EXV2),SQU M3#LI>'/[YH8\OIFKJX,PT"X!^#8,=,']>M+13,IDC0$?BBIE,."XR1AD2!VR MS,SQO==[5^7PS5RR'8AQ=@6^0S#-2KFX%\&$Q"*4KJ @$LE@"*$@!5/*2LL9 MJ]TRL*6CGT.XX6O"&'N VQNY^[AW ?1R<&]-Y"6X5P2E@J(AX"0O#P]M\(HE MPZHW_-X3:P<:L[9QR]$%?-[ _G84X[Q[D+NZZ[1QUS[#$R%D\A(T3Q&$*6V\ M$L&\6>L0@\LV-%>F^")#!QI8MF%!]:#2BMWXUX7A-]ZHSU-Y\(Q__WX\FHOF MVEU=ILEW-K!!644C!27F+Y^=!51:ALP(U^AS6':R"VO:+YN'?558$>2U>O#N M"7%OP"A7[_&K1$0'A#M.B)(8/RL!0L2(^2S+P(EAN/M[*DTGC[WVR^9AWQ6V M:Y1=(ZX5HZR3TIZ@)(:CZ3#\TUU=IX&3*LQK]Z0,# 6!0;=+40/FL.B<)/&Y MN4QM)3.'?>'7L8'UCI[#J7[96APLHW8TIJPI"J'*41@@;+#07CG=146"I, M)S73G7!SH&<>AQ3Z[8*?JM:TCV;<>U,^VVC235UPTLI2 M.6$#B%* :)*1X'T@1F.D)%SM3KUOI4FW3U*FC"Z$99Y!*,W *9]!2ZJY]81K M5[VLXM]-NC?$;'=-NC=1?P-I^=..P3038SG70*(J4XE"*#T"'.2<:;,?5 #K= 9'A-8N!5F_.<,! M-.G>2+%K-.G>1,H- .6I!:UL!TV]DDPY]/'S+B8Q$VZ-P+"]DVZ-]%*XWA[V@B:,FNR)@F+8"?R/,W2SE?S?I M[A)UN^FF*>!M7;EAI34Q,@IB/ME;"0]&D@B22B>=3VLN_O==G3VFD5M(4C'T1>4'IJZ MW.:X:+6V-%O=C&5LQ>&!5L1LB=]:YM,]F/X>IK;LED.C= $- 92@N.-J)L&H MB![1TZ@53<:;[J*ACID[4 /; \+W;XQ;P.WP;^=?%<_#[@&#;*)4RMG2' !U M:)P$6XKSI)=)DYBC%H=CC ]Y.]!*L[=DBSN ;6M3_)DF?MS\IOC/N09O):.] MX3D3C=%,F5%&908OT5,%P66(2607JW>P[=KUMG$S7/;K MN"><)#/W.BE(BI3Q<#0"!@H6(C71VRA]4LSR#<&PP48P/&2(1.JL2<; H9G&H9TDC.W5Q+TE@]P%;BU5H'8K MG$>/2N:1_0?T*!_=<#(O-KRO:!,SC8Q'H%F6841!@.4^ K.>&Y4XU6GO;9OV M*X(#33X/YJ2U,SC^/8YB7Q7?( K+E74*B.&H?VH4YNI) ^?<9ZLHB^YP,M+U M^7[S![C=&4Z#3F C%/_M#G]?%Q_-3@CM.=HJER!"&<0I908FNSC M&S)_H#OXW\H3=(GGO]4!].NB"R)$'ZD"62; "9R^K7I>9Y1E'I")RY^5-W!29G 3DZK:+G,K+#R0HV MX?S-'YR_ 1?0&9+?M/UOD$T%;8AG)BSZ$ I9>GU&_.19PO IT!0/J%BD\IG M(9_1OP';[PC%#;^)_WAR>G3Z_OCD]/W9[\>GQY?;/WE?]4TU7K2O166E!^MS M3)R,<.UT-(K'?Q6 W6O1H$S _\D$6FL+P@2/*LJU9$ MQDO/OG=20@M!!FID\3AO[FZ+CQZ/BK>=/S%EF4K-,K) E =!T&6Z\L34YFRB MDQJ9K6T_+Q+4S@OOW?3^9(QY+24T@*A'/"Q?]QE,N9F2!CS' %S0J,!Y9R&% ME%7@BL98NYGSLX3TC*!ZBA[7EGH#T/G#E;!PMGRFF=$7!QXE!*M*C5302+R2 MP*)))'FI+*_M?!X0T"]4*BAT7$NZ#4"C.-J[7&!N+BEEA](@$(@IC:ZT *]+ M[SATM=%3KYRN7;;YE(IV'JE6W9%V%'=S@#EUW]/2A&0*+IHL0?$BEFPP0.YLB#S^X76E3X\_-D/$NA* (_ M?9VX[TNGR65.T5(-2G"&)H6I@Z?$0F;1RLBT5N11EZ,GF?<:R[0$BVWU..Y& MJ TXE@>>]JYXSM!4^HAQ8%EC\)9*C:M'$>D@11+.12[K7Y,\1TG/-Y>=Y4B[ MB[T!\"RBNHL4KB?#V3!-/_X\'7X939*[&OYWBK\5,PM9!^TP]E>,H ]&XT+W MR\MT=2.XBE0;7_O$_76J^JZ1VUWWS^9+U131 +1.1OA=:3I;'G4540UL9#(Q M3H%F9D%8K\'[S,!)4;RY,71_]G^ M7N')5]2X4'B9KDHW"8NCXDOWUUT_T;O#8I5E2!@6Y_G0#!LX6)\48."2=,@6 M8^;Z9K22G-T=Q?*KE_!]ET8I#V<#[K62'GF+RA_',[0LZ9@0PH1'"EOC;F@ MX(7E0)3)/B1+0KC41A>#>=:N^>9F:2,&:. LS*I(V<.SF4'Z**-YU8I M0FL/3-J,PGX+X/;KPZIHJ=&<[N+XM]^/3R_/CS^?G5^>G/YV6BX!BP1V&)?R MVE=6&8NR$=V59^G'^,)[FI?;S$7I"16Q #22H6!% U@*0;K-FN9 M1.*:^MK3#5;1LJNC6G0\.,O+[7KT=;G0=" P#9$L)J 8'"*39=>VPD%R5,4@ MRX,I6YG)E<3T?-Y8 P>/?4\=P1^(FSE//]/H.KE1_#P9(\.S7_BQG+G^*"S[ M7[^E<@/TX]LPN*NC27+3>NYHZZ6[<%MUY-"U>\N8'UIM&5A"$PCA-#@3)2#\ MK%9&4BJJWUUUY-[N[I^6HI]^1/,^1@%.1N[J_?5TAOO^I.3)G\:CKY]P0XE' MTVF:39]% EHIM.T> >/:ZN@;4PN3O,_"3?TG)C,&%0MD(R3&C]C&C81+'K)2. MKG=F]AJF5A'0#Z8J*G9<6\I]GGV-KT>SR:_!EXM!%DHG@6DT%YZ#("*B#$B" M+!+1DA(C]$OW/M,4_N/K^.=_+K]Q 8WE'^Z0<;=>CS"HH[3Q3A)L0.?OCP;* M9)Z#CF"EQOU9XD[M:$[ >7D,;Z.0_J4X9S.=OS_JY_ZE.YUO*,&>MX2CZ=!] M=F&8AV%9HWQRE;P9.%^;D;JXV!W MJ;9P9/W[\=&2! 611\.-9,3;M<8FON(E MGJ[G!"XQ] MF(@YBMH72-O2VLJSO;V=;^U5N>V N+!92I3*H?0?P]FW&U:/_PI7U[&<6".; M^/]2-3>(W'-'18"$VS':J:+@F.: 8@TIH HJMYV[S$-_3K)7I"V MDQIV&-1ROXMTW9OY=T<7)^^/3C]\./GTY?+XP^GQY:>SBXO%DXK/Q^<7_^OH M_/B=FV+L,XH?AE?792@&DC.>3AK/6W>6J9-X:0H%AE I"8U;AG=681!KJ$TG9T>K%SRMHJ=G/ZI4^<:], MV=9<*/3W"71R! 1G% PSM)0%*D^8HYI7[UM>B_B>.XW4P-E+/;+VI]@&-O(% MY?B/%_>+&&9PK@5P7L8?D9P!::; DZ6.2T9M]5W\ 0&MW./O%03C6AII $[; M"^Z.[5'\?.5&]SHY9&6)]9J!CK(<2)2PV"8/TK(D@L9XQ]<^[N^"CW[!O0.L M-FV1VK6.>SYP7/9S11[.+[Y,EX=F2KE -6X^@9-8+#Z!00%C%)^TME)XK^4K M@>>J[^Z[F4'?VAY7%/TAN,C7)Y^Y4JBAM ;K@RGEBA%\X3BHA!DCB M-'>&V>?>OF?=-X!V3$,7*6A)1F]#]=(.D%(:P'OO0"1OP66=@&0>DDV9>5/[ M@FSMGA / M".@73Q44^A)$-I)N$[.I'@KDIQM>%0]^.49S^SX>7#;P M+BN5M437SF.9J\O!J-+ZBSEO(E7(8^V3J@U)['<3[1A@E36TO7<:S]S5G@&X M/+4=B$2-=:4-05)E=H52X -70*0,.0HEF:S=[G-C(OMM&-$G"+?14H\PG/

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�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end